1	Effect	NN	O	effect	_	0	SENT_1	[p1l153t81r400b151],
2	of	IN	O	of	dep	1	SENT_1	[p1l439t81r524b151],
3	the	DT	O	the	det	5	SENT_1	[p1l561t82r701b151],
4	Stromelysin-1	NN	O	stromelysin-1	nn	5	SENT_1	[p1l743t81r1376b168],
5	Promoter	NN	O	promoter	pobj	2	SENT_1	[p1l1439t86r1867b151],
6	on	IN	O	on	dep	1	SENT_1	[p1l1905t104r2007b151],

1	Efficacy	NN	O	efficacy	_	0	SENT_2	[p1l273t169r619b256],
2	of	IN	O	of	_	0	SENT_2	[p1l656t169r740b239],
3	Pravastatin	NNP	O	Pravastatin	prep_of	1	SENT_2	[p1l781t169r1316b239],
4	in	IN	O	in	_	0	SENT_2	[p1l1355t169r1430b238],
5	Coronary	NNP	O	Coronary	prep_in	1	SENT_2	[p1l1473t173r1893b256],

1	Atherosclerosis	NN	O	atherosclerosis	_	0	SENT_3	[p1l358t256r1067b326],
2	and	CC	O	and	_	0	SENT_3	[p1l1108t257r1271b326],
3	Restenosis	NN	O	restenosis	conj_and	1	SENT_3	[p1l1317t256r1801b326],

1	Moniek	NNP	PERSON	Moniek	nn	5	SENT_4	[p1l307t396r475b440],
2	P.	NNP	PERSON	P.	nn	5	SENT_4	[p1l496t400r530b440],
3	M.	NNP	PERSON	M.	nn	5	SENT_4	[p1l553t398r610b440],
4	de	NNP	PERSON	de	nn	5	SENT_4	[p1l634t396r688b440],
5	Moot	NNP	PERSON	Moot	_	0	SENT_4	[p1l707t398r837b448],
6	,	,	O	,	_	0	SENT_4	[p1l707t398r837b448],
7	PhD	NNP	O	PhD	dep	5	SENT_4	[p1l862t408r935b448],
8	,	,	O	,	_	0	SENT_4	[p1l862t408r935b448],
9	J.	NNP	PERSON	J.	nn	11	SENT_4	[p1l953t399r984b443],
10	Wouter	NNP	PERSON	Wouter	nn	11	SENT_4	[p1l1007t398r1176b441],
11	Jukemo	NNP	PERSON	Jukemo	appos	7	SENT_4	[p1l1190t396r1370b448],
12	,	,	O	,	_	0	SENT_4	[p1l1190t396r1370b448],
13	MD	NNP	O	MD	appos	7	SENT_4	[p1l1392t409r1462b448],
14	,	,	O	,	_	0	SENT_4	[p1l1392t409r1462b448],
15	PhD	NNP	O	PhD	appos	7	SENT_4	[p1l1486t408r1560b448],
16	,	,	O	,	_	0	SENT_4	[p1l1486t408r1560b448],
17	Shu	NNP	PERSON	Shu	nn	18	SENT_4	[p1l1583t396r1661b440],
18	Ye	NNP	PERSON	Ye	appos	7	SENT_4	[p1l1683t399r1752b448],
19	,	,	O	,	_	0	SENT_4	[p1l1683t399r1752b448],
20	PhD	NNP	O	PhD	appos	7	SENT_4	[p1l1776t408r1849b448],
21	,	,	O	,	_	0	SENT_4	[p1l1776t408r1849b448],

1	Aei	NNP	O	Aei	nn	5	SENT_5	[p1l111t452r252b496],
2	|	NNP	O	|	nn	5	SENT_5	[p1l111t452r252b496],
3	ko	NNP	O	ko	nn	5	SENT_5	[p1l111t452r252b496],
4	H.	NNP	PERSON	H.	nn	5	SENT_5	[p1l277t455r321b496],
5	Zwindermon	NNP	PERSON	Zwindermon	_	0	SENT_5	[p1l347t452r641b504],
6	,	,	O	,	_	0	SENT_5	[p1l347t452r641b504],
7	PhD	NNP	O	PhD	appos	5	SENT_5	[p1l665t464r738b504],
8	,	,	O	,	_	0	SENT_5	[p1l665t464r738b504],
9	Poymon	NNP	PERSON	Poymon	nn	11	SENT_5	[p1l768t455r940b509],
10	Honifi	NNP	PERSON	Honifi	nn	11	SENT_5	[p1l965t451r1093b496],
11	Moghoddom	NNP	PERSON	Moghoddom	appos	5	SENT_5	[p1l1115t452r1420b509],
12	,	,	O	,	_	0	SENT_5	[p1l1115t452r1420b509],
13	PhD	NNP	O	PhD	appos	5	SENT_5	[p1l1444t464r1517b504],
14	,	,	O	,	_	0	SENT_5	[p1l1444t464r1517b504],
15	Marion	NNP	PERSON	Marion	nn	16	SENT_5	[p1l1540t454r1700b496],
16	Beekmon	NNP	PERSON	Beekmon	appos	5	SENT_5	[p1l1725t452r1939b504],
17	,	,	O	,	_	0	SENT_5	[p1l1725t452r1939b504],
18	Msc	NNP	O	Msc	appos	5	SENT_5	[p1l1961t465r2045b504],
19	,	,	O	,	_	0	SENT_5	[p1l1961t465r2045b504],
20	John	NNP	PERSON	John	nn	23	SENT_5	[p1l116t508r213b556],
21	J.	NNP	PERSON	J.	nn	23	SENT_5	[p1l230t512r260b556],
22	P.	NNP	PERSON	P.	nn	23	SENT_5	[p1l284t512r317b553],
23	Kostelein	NNP	PERSON	Kostelein	appos	5	SENT_5	[p1l342t508r542b561],
24	,	,	O	,	_	0	SENT_5	[p1l342t508r542b561],
25	MD	NNP	O	MD	appos	5	SENT_5	[p1l564t522r632b561],
26	,	,	O	,	_	0	SENT_5	[p1l564t522r632b561],
27	PhD	NNP	O	PhD	appos	5	SENT_5	[p1l656t520r730b561],
28	,	,	O	,	_	0	SENT_5	[p1l656t520r730b561],
29	Ad	NNP	O	Ad	nn	32	SENT_5	[p1l751t508r814b553],
30	J.	NNP	PERSON	J.	nn	32	SENT_5	[p1l831t512r862b556],
31	van	NNP	PERSON	van	nn	32	SENT_5	[p1l884t526r962b553],
32	Boven	NNP	PERSON	Boven	appos	5	SENT_5	[p1l986t512r1132b561],
33	,	,	O	,	_	0	SENT_5	[p1l986t512r1132b561],
34	MD	NNP	O	MD	appos	5	SENT_5	[p1l1154t522r1224b561],
35	,	,	O	,	_	0	SENT_5	[p1l1154t522r1224b561],
36	PhD	NNP	O	PhD	appos	5	SENT_5	[p1l1248t520r1321b561],
37	,	,	O	,	_	0	SENT_5	[p1l1248t520r1321b561],
38	Albert	NNP	PERSON	Albert	nn	41	SENT_5	[p1l1343t508r1478b553],
39	V.	NNP	PERSON	V.	nn	41	SENT_5	[p1l1495t512r1539b554],
40	G.	NNP	PERSON	G.	nn	41	SENT_5	[p1l1562t511r1615b553],
41	Bruschke	NNP	PERSON	Bruschke	appos	5	SENT_5	[p1l1640t508r1847b561],
42	,	,	O	,	_	0	SENT_5	[p1l1640t508r1847b561],
43	MD	NNP	O	MD	nn	45	SENT_5	[p1l1869t522r1939b561],
44	,	,	O	,	_	0	SENT_5	[p1l1869t522r1939b561],
45	PhD	NNP	O	PhD	appos	5	SENT_5	[p1l1963t520r2036b561],
46	,	,	O	,	_	0	SENT_5	[p1l1963t520r2036b561],

1	Steve	NNP	PERSON	Steve	nn	3	SENT_6	[p1l254t568r370b610],
2	E.	NNP	PERSON	E.	nn	3	SENT_6	[p1l393t568r428b609],
3	Humphries	NNP	PERSON	Humphries	_	0	SENT_6	[p1l454t565r702b622],
4	,	,	O	,	_	0	SENT_6	[p1l454t565r702b622],
5	PhD	NNP	O	PhD	dep	3	SENT_6	[p1l727t577r800b617],
6	,	,	O	,	_	0	SENT_6	[p1l727t577r800b617],
7	Cornelis	NNP	PERSON	Cornelis	nn	8	SENT_6	[p1l823t565r1005b609],
8	Kluft	NNP	PERSON	Kluft	dep	3	SENT_6	[p1l1027t564r1132b617],
9	,	,	O	,	_	0	SENT_6	[p1l1027t564r1132b617],
10	PhD	NNP	O	PhD	dep	3	SENT_6	[p1l1157t577r1230b617],
11	,	,	O	,	_	0	SENT_6	[p1l1157t577r1230b617],
12	and	CC	O	and	_	0	SENT_6	[p1l1253t565r1336b609],
13	Adriano	NNP	PERSON	Adriano	nn	15	SENT_6	[p1l1357t565r1539b609],
14	M.	NNP	PERSON	M.	nn	15	SENT_6	[p1l1559t567r1616b610],
15	Henney	NNP	PERSON	Henney	conj_and	5	SENT_6	[p1l1642t568r1822b622],
16	,	,	O	,	_	0	SENT_6	[p1l1642t568r1822b622],
17	PhD	NN	O	phd	dep	3	SENT_6	[p1l1847t577r1907b608],

1	It	PRP	O	it	nsubj	3	SENT_7	[p1l107t701r127b732],
2	has	VBZ	O	have	aux	3	SENT_7	[p1l144t697r202b732],
3	proved	VBN	O	prove	_	0	SENT_7	[p1l221t697r338b742],
4	difficult	JJ	O	difficult	acomp	3	SENT_7	[p1l356t697r481b732],
5	to	TO	O	to	aux	6	SENT_7	[p1l497t705r529b732],
6	identify	VB	O	identify	dep	4	SENT_7	[p1l548t697r674b742],
7	high-risk	JJ	O	high-risk	amod	8	SENT_7	[p1l692t697r840b742],
8	patients	NNS	O	patient	dobj	6	SENT_7	[p1l858t700r989b742],
9	for	IN	O	for	_	0	SENT_7	[p1l1007t697r1055b732],
10	atherosclerosis	NN	O	atherosclerosis	prep_for	6	SENT_7	[p1l105t743r355b778],
11	and	CC	O	and	_	0	SENT_7	[p1l377t743r441b778],
12	to	TO	O	to	aux	13	SENT_7	[p1l463t751r494b778],
13	determine	VB	O	determine	dep	4	SENT_7	[p1l515t743r685b778],
14	how	WRB	O	how	advmod	17	SENT_7	[p1l707t743r780b778],
15	they	PRP	O	they	nsubj	17	SENT_7	[p1l799t743r872b788],
16	might	MD	O	might	aux	17	SENT_7	[p1l893t743r989b788],
17	respond	VB	O	respond	ccomp	13	SENT_7	[p1l1009t757r1054b778, p1l106t789r207b834],
18	to	TO	O	to	_	0	SENT_7	[p1l232t797r264b824],
19	medication	NN	O	medication	prep_to	17	SENT_7	[p1l289t789r484b824],
20	.	.	O	.	_	0	SENT_7	[p1l289t789r484b824],

1	Recently	RB	DATE	recently	advmod	14	SENT_8	[p1l511t789r660b834],
2	,	,	O	,	_	0	SENT_8	[p1l511t789r660b834],
3	a	DT	O	a	det	6	SENT_8	[p1l685t803r705b824],
4	common	JJ	O	common	amod	6	SENT_8	[p1l730t803r873b824],
5	promoter	NN	O	promoter	nn	6	SENT_8	[p1l900t797r1055b834],
6	variant	NN	O	variant	nsubjpass	14	SENT_8	[p1l104t838r227b870],
7	of	IN	O	of	_	0	SENT_8	[p1l241t835r275b870],
8	the	DT	O	the	det	11	SENT_8	[p1l291t835r342b870],
9	human	JJ	O	human	amod	11	SENT_8	[p1l359t835r474b870],
10	stromelysin-l	NN	O	stromelysin-l	nn	11	SENT_8	[p1l492t835r712b880],
11	gene	NN	O	gene	prep_of	6	SENT_8	[p1l735t849r818b879],
12	has	VBZ	O	have	aux	14	SENT_8	[p1l835t835r893b870],
13	been	VBN	O	be	auxpass	14	SENT_8	[p1l911t835r991b870],
14	reported	VBN	O	report	_	0	SENT_8	[p1l1009t849r1054b870, p1l107t881r227b925],
15	,	,	O	,	_	0	SENT_8	[p1l1009t849r1054b870, p1l107t881r227b925],
16	which	WDT	O	which	nsubjpass	19	SENT_8	[p1l244t881r343b916],
17	has	VBZ	O	have	aux	19	SENT_8	[p1l363t881r420b916],
18	been	VBN	O	be	auxpass	19	SENT_8	[p1l439t881r519b916],
19	shown	VBN	O	show	ccomp	14	SENT_8	[p1l538t881r647b916],
20	to	TO	O	to	aux	21	SENT_8	[p1l666t888r698b916],
21	affect	VB	O	affect	xcomp	19	SENT_8	[p1l715t880r809b916],
22	the	DT	O	the	det	23	SENT_8	[p1l825t881r876b916],
23	transcription	NN	O	transcription	dobj	21	SENT_8	[p1l894t884r1054b925, p1l105t930r178b962],
24	.	.	O	.	_	0	SENT_8	[p1l894t884r1054b925, p1l105t930r178b962],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l197t930r256b961],
2	investigated	VBD	O	investigate	_	0	SENT_9	[p1l275t927r477b971],
3	whether	IN	O	whether	complm	6	SENT_9	[p1l495t927r635b961],
4	this	DT	O	this	det	5	SENT_9	[p1l653t927r710b961],
5	polymorphism	NN	O	polymorphism	nsubj	6	SENT_9	[p1l730t927r970b971],
6	had	VBD	O	have	ccomp	2	SENT_9	[p1l991t927r1053b961],
7	any	DT	O	any	det	8	SENT_9	[p1l105t986r170b1017],
8	impact	NN	O	impact	dobj	6	SENT_9	[p1l187t975r300b1017],
9	on	IN	O	on	_	0	SENT_9	[p1l316t986r357b1007],
10	the	DT	O	the	det	11	SENT_9	[p1l375t973r426b1007],
11	risk	NN	O	risk	prep_on	8	SENT_9	[p1l445t973r505b1007],
12	of	IN	O	of	_	0	SENT_9	[p1l521t972r555b1007],
13	events	NNS	O	event	prep_of	11	SENT_9	[p1l571t980r688b1013],
14	,	,	O	,	_	0	SENT_9	[p1l571t980r688b1013],
15	especially	RB	O	especially	advmod	16	SENT_9	[p1l706t973r873b1017],
16	restenosis	NN	O	restenosis	appos	13	SENT_9	[p1l890t975r1054b1007],
17	and	CC	O	and	_	0	SENT_9	[p1l105t1018r169b1053],
18	progression	NN	O	progression	appos	13	SENT_9	[p1l181t1021r379b1063],
19	of	IN	O	of	_	0	SENT_9	[p1l390t1018r423b1053],
20	coronary	JJ	O	coronary	amod	22	SENT_9	[p1l432t1032r586b1063],
21	artery	NN	O	artery	nn	22	SENT_9	[p1l594t1026r697b1063],
22	disease	NN	O	disease	prep_of	16	SENT_9	[p1l706t1018r832b1053],
23	and	CC	O	and	_	0	SENT_9	[p1l842t1018r906b1053],
24	whether	IN	O	whether	complm	28	SENT_9	[p1l916t1018r1055b1053],
25	the	DT	O	the	det	26	SENT_9	[p1l105t1064r156b1099],
26	effect	NN	O	effect	nsubjpass	28	SENT_9	[p1l168t1064r259b1099],
27	was	VBD	O	be	auxpass	28	SENT_9	[p1l268t1078r338b1099],
28	modulated	VBN	O	modulate	conj_and	6	SENT_9	[p1l351t1064r529b1099],
29	by	IN	O	by	_	0	SENT_9	[p1l543t1064r585b1109],
30	treatment	NN	O	treatment	agent	28	SENT_9	[p1l595t1072r758b1099],
31	with	IN	O	with	_	0	SENT_9	[p1l767t1064r839b1099],
32	pravastatin	NN	O	pravastatin	prep_with	28	SENT_9	[p1l853t1067r1053b1109],
33	.	.	O	.	_	0	SENT_9	[p1l853t1067r1053b1109],

1	The	DT	O	the	det	3	SENT_10	[p1l105t1110r163b1145],
2	stromelysin-l	JJ	O	stromelysin-l	amod	3	SENT_10	[p1l185t1110r406b1155],
3	genotype	NN	O	genotype	nsubjpass	5	SENT_10	[p1l434t1118r592b1155],
4	was	VBD	O	be	auxpass	5	SENT_10	[p1l613t1124r682b1145],
5	determined	VBN	O	determine	_	0	SENT_10	[p1l704t1110r895b1145],
6	for	IN	O	for	_	0	SENT_10	[p1l917t1110r966b1145],
7	496	CD	NUMBER	496	num	8	SENT_10	[p1l986t1113r1054b1145],
8	men	NNS	O	man	prep_for	5	SENT_10	[p1l107t1170r176b1191],
9	with	IN	O	with	_	0	SENT_10	[p1l188t1156r261b1191],
10	coronary	JJ	O	coronary	amod	12	SENT_10	[p1l274t1170r428b1200],
11	artery	NN	O	artery	nn	12	SENT_10	[p1l439t1164r542b1200],
12	disease	NN	O	disease	prep_with	5	SENT_10	[p1l553t1156r679b1191],
13	and	CC	O	and	_	0	SENT_10	[p1l691t1156r755b1191],
14	cholesterol	NN	O	cholesterol	nn	15	SENT_10	[p1l768t1156r948b1191],
15	levels	NNS	O	level	conj_and	12	SENT_10	[p1l963t1156r1054b1191],
16	between	IN	O	between	_	0	SENT_10	[p1l107t1202r248b1237],
17	4.0	CD	NUMBER	4.0	num	20	SENT_10	[p1l266t1205r322b1237],
18	and	CC	NUMBER	and	_	0	SENT_10	[p1l339t1202r403b1237],
19	8.0	CD	NUMBER	8.0	num	20	SENT_10	[p1l422t1205r477b1237],
20	mmol	NN	O	mmol	prep_between	12	SENT_10	[p1l496t1202r608b1242],
21	/	:	O	/	punct	22	SENT_10	[p1l496t1202r608b1242],
22	L	NN	O	l	dep	20	SENT_10	[p1l612t1206r636b1242],
23	,	,	O	,	_	0	SENT_10	[p1l612t1206r636b1242],
24	participating	VBG	O	participate	xcomp	5	SENT_10	[p1l655t1205r867b1246],
25	in	IN	O	in	_	0	SENT_10	[p1l886t1205r915b1236],
26	the	DT	O	the	det	33	SENT_10	[p1l933t1202r984b1237],
27	Regression	NN	O	regression	nn	33	SENT_10	[p1l1002t1206r1054b1237, p1l105t1251r245b1292],
28	Growth	NN	O	growth	nn	33	SENT_10	[p1l276t1248r403b1283],
29	Evaluation	NN	O	evaluation	nn	33	SENT_10	[p1l435t1248r610b1282],
30	Satin	NNP	O	Satin	nn	33	SENT_10	[p1l641t1251r724b1283],
31	Study	NNP	O	Study	nn	33	SENT_10	[p1l756t1248r852b1292],
32	(	NNP	O	(	nn	33	SENT_10	[p1l883t1249r1052b1289],
33	REGRESS	NNP	O	REGRESS	prep_in	24	SENT_10	[p1l883t1249r1052b1289],
34	)	CD	NUMBER	)	num	35	SENT_10	[p1l883t1249r1052b1289],
35	study	NN	O	study	tmod	24	SENT_10	[p1l106t1294r206b1338],
36	,	,	O	,	_	0	SENT_10	[p1l106t1294r206b1338],
37	a	DT	O	a	det	39	SENT_10	[p1l226t1307r246b1328],
38	clinical	JJ	O	clinical	amod	39	SENT_10	[p1l267t1294r381b1328],
39	trial	NN	O	trial	appos	35	SENT_10	[p1l401t1294r466b1328],
40	assessing	VBG	O	assess	xcomp	24	SENT_10	[p1l487t1296r645b1338],
41	the	DT	O	the	det	42	SENT_10	[p1l666t1294r717b1328],
42	effect	NN	O	effect	dobj	40	SENT_10	[p1l736t1293r828b1328],
43	of	IN	O	of	_	0	SENT_10	[p1l846t1293r879b1328],
44	the	DT	O	the	det	47	SENT_10	[p1l898t1294r949b1328],
45	lipidlowering	NN	O	lipidlowering	nn	47	SENT_10	[p1l969t1294r1053b1338, p1l107t1340r253b1384],
46	drug	NN	O	drug	nn	47	SENT_10	[p1l266t1340r344b1384],
47	pravastatin	NN	O	pravastatin	prep_of	42	SENT_10	[p1l358t1342r547b1384],
48	on	IN	O	on	_	0	SENT_10	[p1l560t1353r601b1374],
49	the	DT	O	the	det	50	SENT_10	[p1l614t1340r665b1374],
50	progression	NN	O	progression	prep_on	40	SENT_10	[p1l678t1342r875b1384],
51	of	IN	O	of	_	0	SENT_10	[p1l888t1339r921b1374],
52	atherosclerosis	NN	O	atherosclerosis	prep_of	50	SENT_10	[p1l932t1340r1054b1374, p1l106t1385r255b1420],
53	.	.	O	.	_	0	SENT_10	[p1l932t1340r1054b1374, p1l106t1385r255b1420],

1	Patients	NNS	O	patient	nsubj	11	SENT_11	[p1l276t1388r406b1420],
2	in	IN	O	in	_	0	SENT_11	[p1l425t1388r453b1419],
3	the	DT	O	the	det	5	SENT_11	[p1l473t1385r524b1420],
4	placebo	NN	O	placebo	nn	5	SENT_11	[p1l543t1385r676b1430],
5	group	NN	O	group	prep_in	1	SENT_11	[p1l693t1399r795b1430],
6	with	IN	O	with	_	0	SENT_11	[p1l811t1385r884b1420],
7	5A6A	NN	O	5a6a	nn	10	SENT_11	[p1l904t1388r1002b1420],
8	or	CC	O	or	_	0	SENT_11	[p1l1019t1399r1055b1420],
9	6A6A	NN	O	6a6a	nn	10	SENT_11	[p1l105t1434r204b1466],
10	genotypes	NNS	O	genotype	prep_with	5	SENT_11	[p1l217t1439r391b1476],
11	had	VBD	O	have	_	0	SENT_11	[p1l406t1431r469b1466],
12	more	RBR	O	more	advmod	14	SENT_11	[p1l485t1445r571b1466],
13	clinical	JJ	O	clinical	amod	14	SENT_11	[p1l584t1431r698b1466],
14	events	NNS	O	event	dobj	11	SENT_11	[p1l713t1439r819b1466],
15	than	IN	O	than	_	0	SENT_11	[p1l833t1431r907b1466],
16	patients	NNS	O	patient	prep_than	14	SENT_11	[p1l923t1434r1054b1476],
17	with	IN	O	with	_	0	SENT_11	[p1l104t1477r176b1512],
18	the	DT	O	the	det	30	SENT_11	[p1l195t1477r246b1512],
19	5A5A	NN	O	5a5a	nn	30	SENT_11	[p1l264t1480r363b1512],
20	genotype	NN	O	genotype	nn	30	SENT_11	[p1l379t1485r537b1522],
21	(	CD	PERCENT	(	amod	30	SENT_11	[p1l557t1478r641b1518],
22	26	CD	PERCENT	26	num	23	SENT_11	[p1l557t1478r641b1518],
23	%	NN	PERCENT	%	dep	21	SENT_11	[p1l557t1478r641b1518],
24	and	CC	O	and	_	0	SENT_11	[p1l658t1477r722b1512],
25	l2	CD	PERCENT	l2	num	26	SENT_11	[p1l745t1480r827b1517],
26	%	NN	PERCENT	%	conj_and	23	SENT_11	[p1l745t1480r827b1517],
27	,	,	O	,	_	0	SENT_11	[p1l745t1480r827b1517],
28	respectively	RB	O	respectively	dep	21	SENT_11	[p1l846t1477r1054b1522],
29	,	,	O	,	_	0	SENT_11	[p1l846t1477r1054b1522],
30	p	NN	O	p	prep_with	16	SENT_11	[p1l107t1536r127b1567],
31	=	JJ	O	=	amod	30	SENT_11	[p1l145t1538r170b1551],
32	0.03	CD	NUMBER	0.03	num	33	SENT_11	[p1l189t1524r288b1564],
33	)	NN	O	)	dep	31	SENT_11	[p1l189t1524r288b1564],
34	.	.	O	.	_	0	SENT_11	[p1l189t1524r288b1564],

1	In	IN	O	in	_	0	SENT_12	[p1l306t1527r334b1557],
2	the	DT	O	the	det	4	SENT_12	[p1l350t1523r401b1558],
3	pravastatin	NN	O	pravastatin	nn	4	SENT_12	[p1l417t1526r607b1567],
4	group	NN	O	group	prep_in	19	SENT_12	[p1l623t1536r735b1567],
5	,	,	O	,	_	0	SENT_12	[p1l623t1536r735b1567],
6	the	DT	O	the	det	7	SENT_12	[p1l750t1523r801b1558],
7	risk	NN	O	risk	nsubj	19	SENT_12	[p1l817t1523r878b1558],
8	of	IN	O	of	_	0	SENT_12	[p1l892t1523r925b1558],
9	clinical	JJ	O	clinical	amod	10	SENT_12	[p1l939t1523r1053b1558],
10	events	NNS	O	event	prep_of	7	SENT_12	[p1l105t1576r211b1603],
11	in	IN	O	in	_	0	SENT_12	[p1l229t1571r258b1603],
12	patients	NNS	O	patient	prep_in	10	SENT_12	[p1l277t1571r408b1613],
13	with	IN	O	with	_	0	SENT_12	[p1l424t1569r496b1603],
14	5A6A	NN	O	5a6a	nn	17	SENT_12	[p1l514t1571r613b1604],
15	or	CC	O	or	_	0	SENT_12	[p1l629t1582r665b1603],
16	6A6A	NN	O	6a6a	conj_or	14	SENT_12	[p1l681t1571r780b1604],
17	genotypes	NNS	O	genotype	prep_with	12	SENT_12	[p1l795t1576r969b1613],
18	was	VBD	O	be	cop	19	SENT_12	[p1l985t1582r1054b1603],
19	lower	JJR	O	lower	_	0	SENT_12	[p1l1107t697r1212b738],
20	,	,	O	,	_	0	SENT_12	[p1l1107t697r1212b738],
21	compared	VBN	O	compare	_	0	SENT_12	[p1l1236t697r1405b742],
22	with	IN	O	with	prepc_compared_with	19	SENT_12	[p1l1429t697r1502b732],
23	placebo	NN	O	placebo	pobj	19	SENT_12	[p1l1528t697r1671b742],
24	,	,	O	,	_	0	SENT_12	[p1l1528t697r1671b742],
25	whereas	IN	O	whereas	mark	28	SENT_12	[p1l1695t698r1839b732],
26	it	PRP	O	it	nsubj	28	SENT_12	[p1l1865t700r1885b732],
27	was	VBD	O	be	cop	28	SENT_12	[p1l1906t711r1976b732],
28	unchanged	JJ	O	unchanged	dep	23	SENT_12	[p1l2001t711r2054b732, p1l1105t743r1249b788],
29	in	IN	O	in	_	0	SENT_12	[p1l1270t746r1298b777],
30	those	DT	O	those	prep_in	28	SENT_12	[p1l1317t743r1407b778],
31	with	IN	O	with	_	0	SENT_12	[p1l1424t743r1496b778],
32	a	DT	O	a	det	37	SENT_12	[p1l1515t757r1535b778],
33	5A5A	NN	O	5a5a	nn	37	SENT_12	[p1l1556t746r1654b778],
34	genotype	NN	O	genotype	nn	37	SENT_12	[p1l1671t751r1829b788],
35	(	NN	O	(	nn	37	SENT_12	[p1l1850t744r1880b788],
36	p	NN	O	p	nn	37	SENT_12	[p1l1850t744r1880b788],
37	value	NN	O	value	prep_with	30	SENT_12	[p1l1897t743r1989b778],
38	for	IN	O	for	_	0	SENT_12	[p1l2007t743r2055b778],
39	interaction	NN	O	interaction	prep_for	37	SENT_12	[p1l1106t792r1294b824],
40	:	:	O	:	_	0	SENT_12	[p1l1106t792r1294b824],
41	0.038	CD	NUMBER	0.038	num	42	SENT_12	[p1l1308t790r1431b830],
42	)	NN	O	)	dep	37	SENT_12	[p1l1308t790r1431b830],
43	.	.	O	.	_	0	SENT_12	[p1l1308t790r1431b830],

1	Also	RB	O	also	advmod	13	SENT_13	[p1l1445t789r1529b830],
2	,	,	O	,	_	0	SENT_13	[p1l1445t789r1529b830],
3	the	DT	O	the	det	4	SENT_13	[p1l1543t789r1594b824],
4	incidence	NN	O	incidence	nsubj	13	SENT_13	[p1l1608t789r1764b824],
5	of	IN	O	of	_	0	SENT_13	[p1l1777t789r1811b824],
6	repeat	NN	O	repeat	nn	7	SENT_13	[p1l1824t797r1933b834],
7	angioplasty	NN	O	angioplasty	prep_of	4	SENT_13	[p1l1945t792r2054b834, p1l1107t835r1207b880],
8	in	IN	O	in	_	0	SENT_13	[p1l1219t838r1247b869],
9	the	DT	O	the	det	11	SENT_13	[p1l1260t835r1311b870],
10	placebo	NN	O	placebo	nn	11	SENT_13	[p1l1324t835r1456b880],
11	group	NN	O	group	prep_in	7	SENT_13	[p1l1468t849r1569b880],
12	was	VBD	O	be	cop	13	SENT_13	[p1l1579t849r1649b870],
13	greater	JJR	O	greater	dep	27	SENT_13	[p1l1661t843r1785b879],
14	in	IN	O	in	_	0	SENT_13	[p1l1797t838r1825b869],
15	patients	NNS	O	patient	prep_in	13	SENT_13	[p1l1839t838r1970b879],
16	with	IN	O	with	_	0	SENT_13	[p1l1981t835r2053b870],
17	the	DT	O	the	det	21	SENT_13	[p1l1105t881r1156b916],
18	6A6A	NN	O	6a6a	nn	21	SENT_13	[p1l1173t884r1272b916],
19	or	CC	O	or	_	0	SENT_13	[p1l1288t894r1324b916],
20	5A6A	NN	O	5a6a	nn	21	SENT_13	[p1l1341t884r1439b916],
21	genotypes	NNS	O	genotype	prep_with	15	SENT_13	[p1l1455t888r1640b925],
22	,	,	O	,	_	0	SENT_13	[p1l1455t888r1640b925],
23	compared	VBN	O	compare	_	0	SENT_13	[p1l1657t881r1827b925],
24	with	IN	O	with	prepc_compared_with	13	SENT_13	[p1l1844t881r1916b915],
25	5A	NN	O	5a	nn	26	SENT_13	[p1l1935t884r1983b916],
26	homozygotes	NNS	O	homozygote	pobj	13	SENT_13	[p1l2001t881r2054b916, p1l1107t934r1288b971],
27	(	VBP	O	(	_	0	SENT_13	[p1l1308t928r1393b968],
28	38	CD	PERCENT	38	num	29	SENT_13	[p1l1308t928r1393b968],
29	%	NN	PERCENT	%	dobj	27	SENT_13	[p1l1308t928r1393b968],
30	and	CC	O	and	_	0	SENT_13	[p1l1410t927r1474b961],
31	40	CD	PERCENT	40	num	32	SENT_13	[p1l1493t930r1579b967],
32	%	NN	PERCENT	%	dobj	27	SENT_13	[p1l1493t930r1579b967],
33	,	,	O	,	_	0	SENT_13	[p1l1493t930r1579b967],
34	respectively	RB	O	respectively	advmod	32	SENT_13	[p1l1599t927r1807b971],
35	,	,	O	,	_	0	SENT_13	[p1l1599t927r1807b971],
36	vs	CC	O	vs	_	0	SENT_13	[p1l1825t940r1860b961],
37	ll	CD	PERCENT	ll	num	38	SENT_13	[p1l1884t930r1965b967],
38	%	NN	PERCENT	%	dobj	27	SENT_13	[p1l1884t930r1965b967],
39	,	,	O	,	_	0	SENT_13	[p1l1884t930r1965b967],
40	p	NN	O	p	appos	38	SENT_13	[p1l1984t940r2005b971],
41	=	JJ	O	=	amod	40	SENT_13	[p1l2026t942r2051b955],
42	0.09	CD	NUMBER	0.09	num	43	SENT_13	[p1l1105t973r1205b1014],
43	)	NN	O	)	nsubj	27	SENT_13	[p1l1105t973r1205b1014],
44	.	.	O	.	_	0	SENT_13	[p1l1105t973r1205b1014],

1	Again	RB	O	again	advmod	5	SENT_14	[p1l1223t975r1337b1017],
2	,	,	O	,	_	0	SENT_14	[p1l1223t975r1337b1017],
3	treatment	NN	O	treatment	nsubj	5	SENT_14	[p1l1355t980r1517b1007],
4	substantially	RB	O	substantially	advmod	5	SENT_14	[p1l1533t973r1747b1017],
5	reduced	VBD	O	reduce	dep	30	SENT_14	[p1l1764t973r1897b1007],
6	the	DT	O	the	det	7	SENT_14	[p1l1916t973r1967b1007],
7	incidence	NN	O	incidence	nsubj	13	SENT_14	[p1l1985t975r2054b1007, p1l1105t1018r1204b1053],
8	in	IN	O	in	_	0	SENT_14	[p1l1222t1021r1250b1053],
9	heterozygotes	NNS	O	heterozygote	prep_in	7	SENT_14	[p1l1269t1018r1505b1063],
10	and	CC	O	and	_	0	SENT_14	[p1l1521t1018r1585b1053],
11	6A	NN	O	6a	nn	12	SENT_14	[p1l1603t1021r1652b1053],
12	homozygotes	NNS	O	homozygote	prep_in	7	SENT_14	[p1l1669t1018r1893b1063],
13	(	VBP	O	(	ccomp	5	SENT_14	[p1l1912t1019r1973b1060],
14	o	NN	PERCENT	o	nn	15	SENT_14	[p1l1912t1019r1973b1060],
15	%	NN	PERCENT	%	dobj	13	SENT_14	[p1l1912t1019r1973b1060],
16	and	CC	O	and	_	0	SENT_14	[p1l1989t1018r2053b1053],
17	15	CD	PERCENT	15	num	18	SENT_14	[p1l1110t1067r1191b1105],
18	%	NN	PERCENT	%	conj_and	15	SENT_14	[p1l1110t1067r1191b1105],
19	,	,	O	,	_	0	SENT_14	[p1l1110t1067r1191b1105],
20	respectively	RB	O	respectively	advmod	18	SENT_14	[p1l1214t1064r1432b1109],
21	)	CD	NUMBER	)	advmod	13	SENT_14	[p1l1214t1064r1432b1109],
22	,	,	O	,	_	0	SENT_14	[p1l1214t1064r1432b1109],
23	whereas	IN	O	whereas	mark	26	SENT_14	[p1l1452t1064r1597b1099],
24	it	PRP	O	it	nsubj	26	SENT_14	[p1l1619t1067r1639b1098],
25	was	VBD	O	be	cop	26	SENT_14	[p1l1657t1078r1726b1099],
26	unchanged	JJ	O	unchanged	advcl	13	SENT_14	[p1l1748t1064r1934b1109],
27	in	IN	O	in	_	0	SENT_14	[p1l1956t1067r1984b1098],
28	5A	NN	O	5a	nn	29	SENT_14	[p1l2007t1067r2055b1099],
29	homozygotes	NNS	O	homozygote	prep_in	26	SENT_14	[p1l1107t1110r1331b1155],
30	(	VBP	O	(	_	0	SENT_14	[p1l1349t1111r1443b1151],
31	28	CD	PERCENT	28	num	32	SENT_14	[p1l1349t1111r1443b1151],
32	%	NN	PERCENT	%	nsubj	30	SENT_14	[p1l1349t1111r1443b1151],
33	,	,	O	,	_	0	SENT_14	[p1l1349t1111r1443b1151],
34	p	NN	O	p	appos	32	SENT_14	[p1l1460t1124r1480b1155],
35	for	IN	O	for	_	0	SENT_14	[p1l1495t1110r1543b1145],
36	interaction	NN	O	interaction	prep_for	34	SENT_14	[p1l1558t1113r1746b1145],
37	:	:	O	:	_	0	SENT_14	[p1l1558t1113r1746b1145],
38	0.002	CD	NUMBER	0.002	num	39	SENT_14	[p1l1762t1111r1885b1151],
39	)	NN	O	)	dep	34	SENT_14	[p1l1762t1111r1885b1151],
40	.	.	O	.	_	0	SENT_14	[p1l1762t1111r1885b1151],

1	These	DT	O	these	det	2	SENT_15	[p1l1901t1110r1996b1145],
2	effects	NNS	O	effect	nsubj	4	SENT_15	[p1l2011t1110r2054b1145, p1l1105t1156r1179b1191],
3	were	VBD	O	be	cop	4	SENT_15	[p1l1194t1170r1280b1191],
4	independent	JJ	O	independent	_	0	SENT_15	[p1l1296t1156r1507b1201],
5	of	IN	O	of	_	0	SENT_15	[p1l1521t1156r1554b1191],
6	the	DT	O	the	det	7	SENT_15	[p1l1569t1156r1620b1191],
7	effects	NNS	O	effect	prep_of	4	SENT_15	[p1l1635t1156r1742b1191],
8	of	IN	O	of	_	0	SENT_15	[p1l1757t1156r1791b1191],
9	pravastatin	NN	O	pravastatin	prep_of	7	SENT_15	[p1l1807t1159r1996b1201],
10	on	IN	O	on	_	0	SENT_15	[p1l2013t1170r2053b1191],
11	the	DT	O	the	det	13	SENT_15	[p1l1105t1202r1156b1237],
12	lipid	NN	O	lipid	nn	13	SENT_15	[p1l1170t1202r1241b1246],
13	levels	NNS	O	level	prep_on	4	SENT_15	[p1l1256t1202r1358b1237],
14	.	.	O	.	_	0	SENT_15	[p1l1256t1202r1358b1237],

1	Thus	RB	O	thus	advmod	5	SENT_16	[p1l1371t1202r1459b1242],
2	,	,	O	,	_	0	SENT_16	[p1l1371t1202r1459b1242],
3	this	DT	O	this	det	4	SENT_16	[p1l1472t1202r1529b1237],
4	study	NN	O	study	nsubj	5	SENT_16	[p1l1542t1202r1633b1246],
5	suggests	VBZ	O	suggest	_	0	SENT_16	[p1l1645t1210r1788b1246],
6	that	IN	O	that	complm	11	SENT_16	[p1l1801t1202r1867b1237],
7	the	DT	O	the	det	10	SENT_16	[p1l1878t1202r1930b1237],
8	stomelysin-l	NN	O	stomelysin-l	nn	10	SENT_16	[p1l1942t1210r2054b1237, p1l1107t1248r1211b1292],
9	promoter	NN	O	promoter	nn	10	SENT_16	[p1l1230t1255r1385b1292],
10	polymorphism	NN	O	polymorphism	nsubj	11	SENT_16	[p1l1396t1248r1637b1292],
11	confers	VBZ	O	confer	ccomp	5	SENT_16	[p1l1648t1247r1769b1282],
12	a	DT	O	a	det	14	SENT_16	[p1l1780t1261r1800b1282],
13	genotypespecific	JJ	O	genotypespecific	amod	14	SENT_16	[p1l1812t1255r2054b1292, p1l1105t1293r1168b1328],
14	response	NN	O	response	dobj	11	SENT_16	[p1l1198t1307r1348b1338],
15	to	TO	O	to	_	0	SENT_16	[p1l1376t1301r1408b1328],
16	medication	NN	O	medication	prep_to	11	SENT_16	[p1l1437t1294r1621b1328],
17	in	IN	O	in	_	0	SENT_16	[p1l1651t1296r1679b1328],
18	determining	VBG	O	determine	prepc_in	16	SENT_16	[p1l1708t1294r1910b1338],
19	clinical	JJ	O	clinical	dobj	18	SENT_16	[p1l1940t1294r2054b1328],
20	event-free	RB	O	event-free	advmod	21	SENT_16	[p1l1105t1339r1275b1374],
21	survival	NN	O	survival	rcmod	19	SENT_16	[p1l1290t1340r1420b1374],
22	and	CC	O	and	_	0	SENT_16	[p1l1436t1340r1500b1374],
23	the	DT	O	the	det	24	SENT_16	[p1l1516t1340r1567b1374],
24	risk	NN	O	risk	conj_and	19	SENT_16	[p1l1583t1340r1643b1374],
25	for	IN	O	for	_	0	SENT_16	[p1l1656t1339r1705b1374],
26	symptom-driven	JJ	O	symptom-driven	amod	27	SENT_16	[p1l1719t1340r1992b1384],
27	repeat	NN	O	repeat	prep_for	24	SENT_16	[p1l2009t1353r2054b1374, p1l1107t1393r1181b1430],
28	angioplasly	RB	O	angioplasly	advmod	18	SENT_16	[p1l1198t1385r1406b1430],
29	.	.	O	.	_	0	SENT_16	[p1l1198t1385r1406b1430],

1	This	DT	O	this	det	2	SENT_17	[p1l1425t1385r1490b1420],
2	variant	NN	O	variant	nsubj	5	SENT_17	[p1l1508t1388r1630b1420],
3	may	MD	O	may	aux	5	SENT_17	[p1l1648t1399r1722b1430],
4	therefore	RB	O	therefore	advmod	5	SENT_17	[p1l1739t1385r1892b1420],
5	act	VB	O	act	conj_but	5	SENT_17	[p1l1910t1393r1961b1420],
6	as	IN	O	as	_	0	SENT_17	[p1l1977t1399r2014b1420],
7	a	DT	O	a	det	8	SENT_17	[p1l2033t1399r2053b1420],
8	predictor	NN	O	predictor	prep_as	5	SENT_17	[p1l1107t1431r1268b1476],
9	,	,	O	,	_	0	SENT_17	[p1l1107t1431r1268b1476],
10	not	RB	O	not	neg	11	SENT_17	[p1l1287t1439r1340b1466],
11	only	RB	O	only	dep	8	SENT_17	[p1l1355t1431r1429b1476],
12	of	IN	O	of	dep	11	SENT_17	[p1l1445t1431r1478b1466],
13	disease	NN	O	disease	nn	14	SENT_17	[p1l1494t1431r1620b1466],
14	progression	NN	O	progression	conj	8	SENT_17	[p1l1639t1434r1848b1476],
15	,	,	O	,	_	0	SENT_17	[p1l1639t1434r1848b1476],
16	but	CC	O	but	_	0	SENT_17	[p1l1867t1431r1920b1466],
17	also	RB	O	also	advmod	5	SENT_17	[p1l1936t1431r2005b1466],
18	of	IN	O	of	_	0	SENT_17	[p1l2022t1431r2055b1466],
19	response	NN	O	response	prep_of	5	SENT_17	[p1l1107t1491r1256b1522],
20	to	TO	O	to	_	0	SENT_17	[p1l1270t1485r1301b1512],
21	therapy	NN	O	therapy	prep_to	5	SENT_17	[p1l1315t1477r1447b1522],
22	and	CC	O	and	_	0	SENT_17	[p1l1459t1477r1523b1512],
23	risk	NN	O	risk	conj_and	21	SENT_17	[p1l1539t1477r1599b1512],
24	of	IN	O	of	_	0	SENT_17	[p1l1612t1477r1645b1512],
25	restenosis	NN	O	restenosis	prep_of	21	SENT_17	[p1l1659t1480r1833b1512],
26	.	.	O	.	_	0	SENT_17	[p1l1659t1480r1833b1512],

1	©	NN	O	©	_	0	SENT_18	[p1l1878t1480r1999b1512],
2	1999	CD	DATE	1999	num	1	SENT_18	[p1l1878t1480r1999b1512],
3	by	IN	O	by	_	0	SENT_18	[p1l2014t1477r2056b1522],
4	Excerpta	NNP	ORGANIZATION	Excerpta	nn	5	SENT_18	[p1l1107t1527r1251b1567],
5	Medica	NNP	ORGANIZATION	Medica	prep_by	1	SENT_18	[p1l1266t1523r1400b1563],
6	,	,	ORGANIZATION	,	_	0	SENT_18	[p1l1266t1523r1400b1563],
7	Inc.	NNP	ORGANIZATION	Inc.	appos	5	SENT_18	[p1l1416t1527r1472b1558],
8	.	.	O	.	_	0	SENT_18	[p1l1416t1527r1472b1558],

1	(	NNP	O	(	nn	5	SENT_19	[p1l1477t1570r1541b1610],
2	Am	NNP	O	Am	nn	5	SENT_19	[p1l1477t1570r1541b1610],
3	J	NNP	O	J	nn	5	SENT_19	[p1l1555t1572r1570b1604],
4	Cardiol	NNP	O	Cardiol	nn	5	SENT_19	[p1l1585t1569r1707b1604],
5	l999	NN	O	l999	_	0	SENT_19	[p1l1728t1570r2052b1610],
6	;	:	O	;	_	0	SENT_19	[p1l1728t1570r2052b1610],
7	83:852	CD	NUMBER	83:852	number	8	SENT_19	[p1l1728t1570r2052b1610],
8	-856	CD	NUMBER	-856	num	9	SENT_19	[p1l1728t1570r2052b1610],
9	)	NN	O	)	dep	5	SENT_19	[p1l1728t1570r2052b1610],

1	therosclerosis	NN	O	therosclerosis	nsubj	6	SENT_20	[p1l210t1704r747b1773],
2	is	VBZ	O	be	cop	6	SENT_20	[p1l789t1704r850b1773],
3	a	DT	O	a	det	6	SENT_20	[p1l895t1725r935b1773],
4	complex	JJ	O	complex	amod	6	SENT_20	[p1l975t1704r1310b1793],
5	multifactorial	JJ	O	multifactorial	amod	6	SENT_20	[p1l1351t1704r1884b1773],
6	disorder	NN	O	disorder	_	0	SENT_20	[p1l1925t1704r2149b1773, p1l212t1807r336b1875],
7	in	IN	O	in	_	0	SENT_20	[p1l365t1807r438b1875],
8	which	WDT	O	which	rel	10	SENT_20	[p1l469t1807r707b1876],
9	there	EX	O	there	expl	10	SENT_20	[p1l738t1807r932b1875],
10	is	VBZ	O	be	rcmod	6	SENT_20	[p1l963t1807r1024b1875],
11	a	DT	O	a	det	15	SENT_20	[p1l1059t1828r1100b1875],
12	highly	RB	O	highly	advmod	15	SENT_20	[p1l1129t1807r1377b1896],
13	variable	JJ	O	variable	amod	15	SENT_20	[p1l1409t1807r1723b1876],
14	individual	JJ	O	individual	amod	15	SENT_20	[p1l1754t1807r2151b1876],
15	response	NN	O	response	nsubj	10	SENT_20	[p1l15t1931r357b1998],
16	to	TO	O	to	_	0	SENT_20	[p1l412t1919r484b1978],
17	medication	NN	O	medication	prep_to	15	SENT_20	[p1l540t1909r995b1990],
18	,	,	O	,	_	0	SENT_20	[p1l540t1909r995b1990],
19	such	JJ	O	such	_	0	SENT_20	[p1l1057t1909r1231b1978],
20	as	IN	O	as	_	0	SENT_20	[p1l1287t1931r1362b1978],
21	the	DT	O	the	det	23	SENT_20	[p1l1419t1909r1536b1978],
22	lipid	NN	O	lipid	nn	23	SENT_20	[p1l1591t1909r2150b1998],
23	—	NN	O	—	prep_such_as	15	SENT_20	[p1l1591t1909r2150b1998],
24	lowering	VBG	O	lower	partmod	23	SENT_20	[p1l1591t1909r2150b1998],
25	drug	NN	O	drug	nn	26	SENT_20	[p1l17t2011r192b2100],
26	pravastatin	NN	O	pravastatin	dobj	24	SENT_20	[p1l234t2010r792b2100],
27	.1	CD	NUMBER	.1	num	28	SENT_20	[p1l234t2010r792b2100],
28	—	NN	O	—	nsubj	34	SENT_20	[p1l234t2010r792b2100],
29	5	CD	NUMBER	5	number	30	SENT_20	[p1l234t2010r792b2100],
30	Treatment	NN	O	treatment	amod	28	SENT_20	[p1l837t2013r1241b2080],
31	might	MD	O	might	aux	34	SENT_20	[p1l1281t2011r1510b2100],
32	be	VB	O	be	cop	34	SENT_20	[p1l1549t2011r1640b2080],
33	more	RBR	O	more	advmod	34	SENT_20	[p1l1683t2033r1882b2080],
34	effective	JJ	O	effective	rcmod	26	SENT_20	[p1l1925t2011r2148b2080, p1l16t2113r160b2183],
35	if	IN	O	if	mark	39	SENT_20	[p1l192t2113r256b2182],
36	it	PRP	O	it	nsubjpass	39	SENT_20	[p1l280t2113r334b2182],
37	could	MD	O	could	aux	39	SENT_20	[p1l365t2113r580b2182],
38	be	VB	O	be	auxpass	39	SENT_20	[p1l609t2114r700b2182],
39	directed	VBN	O	direct	ccomp	34	SENT_20	[p1l733t2113r1047b2182],
40	at	IN	O	at	_	0	SENT_20	[p1l1079t2124r1147b2182],
41	those	DT	O	those	prep_at	39	SENT_20	[p1l1177t2114r1381b2182],
42	who	WP	O	who	nsubj	44	SENT_20	[p1l1413t2113r1578b2183],
43	would	MD	O	would	aux	44	SENT_20	[p1l1611t2113r1855b2183],
44	beneﬁt	VB	O	beneﬁt	rcmod	41	SENT_20	[p1l1884t2113r2152b2182],
45	most	JJS	O	most	dobj	44	SENT_20	[p1l16t2228r224b2287],
46	.	.	O	.	_	0	SENT_20	[p1l16t2228r224b2287],

1	Connective	JJ	MISC	connective	amod	3	SENT_21	[p1l266t2218r709b2287],
2	tissue	NN	O	tissue	nn	3	SENT_21	[p1l745t2218r966b2287],
3	remodeling	NN	O	remodeling	_	0	SENT_21	[p1l1001t2218r1446b2307],
4	and	CC	O	and	_	0	SENT_21	[p1l1484t2218r1623b2287],
5	wound	NN	O	wound	nn	6	SENT_21	[p1l1657t2218r1923b2287],
6	healing	NN	O	healing	conj_and	3	SENT_21	[p1l1956t2218r2148b2287, p1l16t2321r138b2410],
7	are	VBP	O	be	cop	9	SENT_21	[p1l168t2343r283b2390],
8	essential	JJ	O	essential	amod	9	SENT_21	[p1l311t2321r646b2390],
9	processes	NNS	O	process	rcmod	3	SENT_21	[p1l672t2343r1046b2410],
10	in	IN	O	in	mark	16	SENT_21	[p1l1075t2321r1149b2389],
11	atherosclerosis	NN	O	atherosclerosis	nsubjpass	16	SENT_21	[p1l1178t2321r1756b2390],
12	and	CC	O	and	_	0	SENT_21	[p1l1787t2321r1926b2390],
13	these	DT	O	these	det	14	SENT_21	[p1l1951t2321r2151b2390],
14	processes	NNS	O	process	nsubjpass	16	SENT_21	[p1l15t2444r388b2512],
15	are	VBP	O	be	auxpass	16	SENT_21	[p1l428t2444r543b2491],
16	regulated	VBN	O	regulate	dep	31	SENT_21	[p1l578t2422r943b2512],
17	in	IN	O	in	_	0	SENT_21	[p1l978t2422r1052b2490],
18	part	NN	O	part	prep_in	16	SENT_21	[p1l1086t2433r1239b2512],
19	by	IN	O	by	_	0	SENT_21	[p1l1272t2423r1368b2512],
20	matrix	NN	O	matrix	nn	23	SENT_21	[p1l1405t2422r1658b2491],
21	metallopro	NN	O	metallopro	nn	23	SENT_21	[p1l1695t2422r2148b2512],
22	—	NN	O	—	nn	23	SENT_21	[p1l1695t2422r2148b2512],
23	teinases	NNS	O	teinase	agent	16	SENT_21	[p1l16t2527r346b2608],
24	,	,	O	,	_	0	SENT_21	[p1l16t2527r346b2608],
25	especially	RB	O	especially	dep	26	SENT_21	[p1l384t2527r774b2616],
26	stromelysin	NN	O	stromelysin	dep	31	SENT_21	[p1l811t2527r1433b2616],
27	.6	CD	NUMBER	.6	num	26	SENT_21	[p1l811t2527r1433b2616],
28	—	CD	NUMBER	—	number	29	SENT_21	[p1l811t2527r1433b2616],
29	11	CD	NUMBER	11	num	31	SENT_21	[p1l811t2527r1433b2616],
30	The	DT	O	the	det	31	SENT_21	[p1l1472t2527r1622b2596],
31	transcription	NN	O	transcription	dep	3	SENT_21	[p1l1656t2527r2151b2616],
32	of	IN	O	of	_	0	SENT_21	[p1l17t2630r102b2699],
33	the	DT	O	the	det	36	SENT_21	[p1l124t2630r241b2699],
34	human	JJ	O	human	amod	36	SENT_21	[p1l271t2630r537b2699],
35	stromelysin-l	NN	O	stromelysin-l	nn	36	SENT_21	[p1l570t2630r1096b2719],
36	gene	NN	O	gene	prep_of	31	SENT_21	[p1l1136t2652r1317b2719],
37	seems	VBZ	O	seem	rcmod	36	SENT_21	[p1l1350t2652r1583b2699],
38	to	TO	O	to	aux	40	SENT_21	[p1l1614t2640r1687b2699],
39	be	VB	O	be	auxpass	40	SENT_21	[p1l1716t2630r1807b2699],
40	affected	VBN	O	affect	xcomp	37	SENT_21	[p1l1839t2630r2152b2699],
41	directly	RB	O	directly	advmod	40	SENT_21	[p1l17t2731r313b2821],
42	by	IN	O	by	_	0	SENT_21	[p1l347t2732r443b2821],
43	a	DT	O	a	det	44	SENT_21	[p1l481t2753r521b2800],
44	variant	NN	O	variant	agent	40	SENT_21	[p1l554t2731r826b2800],
45	in	IN	O	in	_	0	SENT_21	[p1l859t2731r932b2800],
46	the	DT	O	the	det	47	SENT_21	[p1l967t2732r1084b2800],
47	promoter	NN	O	promoter	prep_in	44	SENT_21	[p1l1118t2742r1479b2821],
48	of	IN	O	of	_	0	SENT_21	[p1l1512t2731r1597b2800],
49	the	DT	O	the	det	50	SENT_21	[p1l1625t2732r1742b2800],
50	stromelyFrom	NN	O	stromelyfrom	prep_of	47	SENT_21	[p1l1780t2732r2149b2821, p1l20t3001r159b3059],

1	the	DT	O	the	dep	110	SENT_22	[p1l196t2996r282b3059],
2	Goubius	NNP	MISC	Goubius	dep	110	SENT_22	[p1l316t2996r574b3059],
3	Loborotory	NNP	MISC	Loborotory	dep	110	SENT_22	[p1l612t2996r931b3079],
4	TNO-PG	NN	MISC	tno-pg	dep	110	SENT_22	[p1l960t3001r1248b3071],
5	;	:	O	;	_	0	SENT_22	[p1l960t3001r1248b3071],
6	the	DT	O	the	dep	110	SENT_22	[p1l1287t2996r1374b3059],
7	Deportments	NNP	O	Deportments	dep	110	SENT_22	[p1l1412t3002r1784b3079],
8	of	IN	O	of	dep	110	SENT_22	[p1l1819t2996r1876b3059],
9	Cordiology	NNP	O	Cordiology	dep	110	SENT_22	[p1l1907t2996r2154b3059, p1l17t3106r147b3162],
10	,	,	O	,	_	0	SENT_22	[p1l1907t2996r2154b3059, p1l17t3106r147b3162],
11	Biostotistics	NNP	O	Biostotistics	dep	110	SENT_22	[p1l202t3084r556b3154],
12	,	,	O	,	_	0	SENT_22	[p1l202t3084r556b3154],
13	ond	JJ	O	ond	dep	110	SENT_22	[p1l607t3079r720b3142],
14	Antropogenetics	NNS	O	antropogenetic	dep	110	SENT_22	[p1l765t3084r1279b3162],
15	,	,	O	,	_	0	SENT_22	[p1l765t3084r1279b3162],
16	Leiden	NNP	ORGANIZATION	Leiden	dep	110	SENT_22	[p1l1332t3079r1518b3142],
17	University	NNP	ORGANIZATION	University	dep	110	SENT_22	[p1l1569t3084r1855b3162],
18	/	:	O	/	dep	110	SENT_22	[p1l1896t3079r2148b3143],
19	\	CD	NUMBER	\	dep	110	SENT_22	[p1l1896t3079r2148b3143],
20	/	:	O	/	dep	110	SENT_22	[p1l1896t3079r2148b3143],
21	\	CD	NUMBER	\	dep	110	SENT_22	[p1l1896t3079r2148b3143],
22	edicol	NN	O	edicol	dep	110	SENT_22	[p1l1896t3079r2148b3143],
23	Center	NNP	O	Center	dep	110	SENT_22	[p1l17t3167r235b3237],
24	,	,	O	,	_	0	SENT_22	[p1l17t3167r235b3237],
25	Leiden	NNP	LOCATION	Leiden	dep	110	SENT_22	[p1l278t3162r485b3237],
26	,	,	O	,	_	0	SENT_22	[p1l278t3162r485b3237],
27	The	DT	O	the	dep	110	SENT_22	[p1l523t3162r630b3225],
28	Netherlands	NNP	LOCATION	Netherlands	dep	110	SENT_22	[p1l667t3162r1054b3237],
29	;	:	O	;	_	0	SENT_22	[p1l667t3162r1054b3237],
30	the	DT	O	the	dep	110	SENT_22	[p1l1093t3162r1180b3225],
31	Department	NNP	ORGANIZATION	Department	dep	110	SENT_22	[p1l1217t3167r1565b3245],
32	of	IN	ORGANIZATION	of	dep	110	SENT_22	[p1l1596t3162r1653b3225],
33	Cordiovosculor	NNP	ORGANIZATION	Cordiovosculor	dep	110	SENT_22	[p1l1685t3162r2153b3226],
34	/	:	O	/	dep	110	SENT_22	[p1l15t3245r306b3309],
35	\	CD	NUMBER	\	dep	110	SENT_22	[p1l15t3245r306b3309],
36	/	:	O	/	dep	110	SENT_22	[p1l15t3245r306b3309],
37	\	CD	NUMBER	\	dep	110	SENT_22	[p1l15t3245r306b3309],
38	edicine	NN	O	edicine	dep	110	SENT_22	[p1l15t3245r306b3309],
39	ond	NN	O	ond	dep	110	SENT_22	[p1l332t3245r445b3308],
40	Wellcome	NNP	ORGANIZATION	Wellcome	dep	110	SENT_22	[p1l474t3245r791b3309],
41	Trust	NNP	ORGANIZATION	Trust	dep	110	SENT_22	[p1l815t3251r949b3308],
42	Centre	NNP	ORGANIZATION	Centre	dep	110	SENT_22	[p1l973t3250r1174b3308],
43	for	IN	ORGANIZATION	for	dep	110	SENT_22	[p1l1200t3245r1278b3308],
44	Human	JJ	ORGANIZATION	human	dep	110	SENT_22	[p1l1306t3250r1517b3308],
45	Genetics	NNP	ORGANIZATION	Genetics	dep	110	SENT_22	[p1l1546t3250r1831b3320],
46	,	,	O	,	_	0	SENT_22	[p1l1546t3250r1831b3320],
47	University	NNP	ORGANIZATION	University	dep	110	SENT_22	[p1l1867t3250r2153b3328],
48	of	IN	ORGANIZATION	of	dep	110	SENT_22	[p1l17t3328r74b3391],
49	Oxford	NNP	ORGANIZATION	Oxford	dep	110	SENT_22	[p1l104t3328r336b3403],
50	,	,	O	,	_	0	SENT_22	[p1l104t3328r336b3403],
51	Oxford	NNP	LOCATION	Oxford	dep	110	SENT_22	[p1l375t3328r607b3403],
52	,	,	O	,	_	0	SENT_22	[p1l375t3328r607b3403],
53	United	NNP	LOCATION	United	dep	110	SENT_22	[p1l649t3328r838b3391],
54	Kingdom	NNP	LOCATION	Kingdom	dep	110	SENT_22	[p1l878t3328r1164b3410],
55	;	:	O	;	_	0	SENT_22	[p1l878t3328r1164b3410],
56	Center	NNP	ORGANIZATION	Center	dep	110	SENT_22	[p1l1203t3333r1405b3391],
57	for	IN	ORGANIZATION	for	dep	110	SENT_22	[p1l1436t3328r1514b3391],
58	Thrombosis	NNP	ORGANIZATION	Thrombosis	dep	110	SENT_22	[p1l1543t3328r1901b3403],
59	,	,	O	,	_	0	SENT_22	[p1l1543t3328r1901b3403],
60	Atherosclerosis	NNP	O	Atherosclerosis	dep	110	SENT_22	[p1l1938t3328r2153b3391, p1l16t3411r265b3474],
61	ond	NN	O	ond	dep	110	SENT_22	[p1l295t3411r409b3474],
62	lnflommotion	NN	O	lnflommotion	dep	110	SENT_22	[p1l446t3411r844b3486],
63	,	,	O	,	_	0	SENT_22	[p1l446t3411r844b3486],
64	Amsterdom	NNP	ORGANIZATION	Amsterdom	dep	110	SENT_22	[p1l878t3411r1216b3474],
65	Medical	NNP	ORGANIZATION	Medical	dep	110	SENT_22	[p1l1248t3411r1500b3475],
66	Centre	NNP	ORGANIZATION	Centre	dep	110	SENT_22	[p1l1534t3416r1751b3486],
67	,	,	O	,	_	0	SENT_22	[p1l1534t3416r1751b3486],
68	Amsterdam	NNP	LOCATION	Amsterdam	dep	110	SENT_22	[p1l1786t3411r2144b3486],
69	,	,	O	,	_	0	SENT_22	[p1l1786t3411r2144b3486],
70	The	DT	O	the	dep	110	SENT_22	[p1l15t3495r121b3558],
71	Netherlonds	NNS	O	netherlond	dep	110	SENT_22	[p1l158t3495r545b3570],
72	;	:	O	;	_	0	SENT_22	[p1l158t3495r545b3570],
73	the	DT	O	the	dep	110	SENT_22	[p1l584t3495r671b3558],
74	Department	NNP	ORGANIZATION	Department	dep	110	SENT_22	[p1l708t3501r1055b3578],
75	of	IN	ORGANIZATION	of	dep	110	SENT_22	[p1l1086t3495r1144b3558],
76	Cordiology	NNP	ORGANIZATION	Cordiology	dep	110	SENT_22	[p1l1175t3495r1539b3578],
77	,	,	O	,	_	0	SENT_22	[p1l1175t3495r1539b3578],
78	University	NNP	ORGANIZATION	University	dep	110	SENT_22	[p1l1582t3501r1868b3578],
79	Hospital	NNP	ORGANIZATION	Hospital	dep	110	SENT_22	[p1l1903t3495r2147b3578],
80	Groningen	NNP	ORGANIZATION	Groningen	dep	110	SENT_22	[p1l17t3584r362b3662],
81	,	,	O	,	_	0	SENT_22	[p1l17t3584r362b3662],
82	Groningen	NNP	ORGANIZATION	Groningen	dep	110	SENT_22	[p1l392t3584r737b3662],
83	,	,	O	,	_	0	SENT_22	[p1l392t3584r737b3662],
84	The	DT	O	the	dep	110	SENT_22	[p1l765t3579r872b3643],
85	Netherlonds	NNS	LOCATION	netherlond	dep	110	SENT_22	[p1l899t3579r1287b3655],
86	;	:	O	;	_	0	SENT_22	[p1l899t3579r1287b3655],
87	lnteruniversitory	JJ	O	lnteruniversitory	dep	110	SENT_22	[p1l1320t3585r1781b3663],
88	Cordiology	NNP	ORGANIZATION	Cordiology	dep	110	SENT_22	[p1l1804t3579r2153b3663],
89	Institute	NNP	ORGANIZATION	Institute	dep	110	SENT_22	[p1l20t3669r231b3727],
90	(	VBP	O	(	dep	110	SENT_22	[p1l263t3668r460b3739],
91	ICIN	NN	O	icin	dep	110	SENT_22	[p1l263t3668r460b3739],
92	)	NN	O	)	dep	110	SENT_22	[p1l263t3668r460b3739],
93	,	,	O	,	_	0	SENT_22	[p1l263t3668r460b3739],
94	Utrecht	NNP	ORGANIZATION	Utrecht	dep	110	SENT_22	[p1l499t3664r721b3739],
95	,	,	O	,	_	0	SENT_22	[p1l499t3664r721b3739],
96	The	DT	O	the	dep	110	SENT_22	[p1l755t3664r861b3727],
97	Netherlonds	NNS	LOCATION	netherlond	dep	110	SENT_22	[p1l895t3664r1281b3739],
98	;	:	O	;	_	0	SENT_22	[p1l895t3664r1281b3739],
99	ond	JJ	O	ond	dep	110	SENT_22	[p1l1316t3664r1430b3727],
100	Centre	NNP	ORGANIZATION	Centre	dep	110	SENT_22	[p1l1463t3669r1664b3727],
101	for	IN	ORGANIZATION	for	dep	110	SENT_22	[p1l1692t3663r1770b3727],
102	Genetics	NNP	ORGANIZATION	Genetics	dep	110	SENT_22	[p1l1798t3669r2066b3727],
103	of	IN	ORGANIZATION	of	dep	110	SENT_22	[p1l2096t3663r2153b3727],
104	Cordiovosculor	NNP	ORGANIZATION	Cordiovosculor	dep	110	SENT_22	[p1l17t3748r484b3812],
105	Disorders	NNPS	ORGANIZATION	Disorders	dep	110	SENT_22	[p1l526t3748r821b3823],
106	,	,	O	,	_	0	SENT_22	[p1l526t3748r821b3823],
107	London	NNP	LOCATION	London	dep	110	SENT_22	[p1l870t3748r1102b3823],
108	,	,	O	,	_	0	SENT_22	[p1l870t3748r1102b3823],
109	United	NNP	LOCATION	United	dep	110	SENT_22	[p1l1150t3748r1340b3811],
110	Kingdom	NNP	LOCATION	Kingdom	_	0	SENT_22	[p1l1386t3748r1672b3830],
111	.	.	O	.	_	0	SENT_22	[p1l1386t3748r1672b3830],

1	The	DT	O	the	det	2	SENT_23	[p1l1716t3748r1822b3811],
2	REGRESS	NNS	O	regress	_	0	SENT_23	[p1l1866t3753r2150b3811],

1	Study	NNP	O	Study	nn	2	SENT_24	[p2l18t8r183b91],
2	wos	NNS	O	wo	nsubj	3	SENT_24	[p2l216t35r340b72],
3	sponsored	VBN	O	sponsor	_	0	SENT_24	[p2l378t8r689b91],
4	by	IN	O	by	_	0	SENT_24	[p2l733t8r804b91],
5	Bristol	NNP	LOCATION	Bristol	prep_by	3	SENT_24	[p2l843t8r1219b91],
6	-	:	O	-	_	0	SENT_24	[p2l843t8r1219b91],
7	/	:	O	/	punct	8	SENT_24	[p2l843t8r1219b91],
8	\	CD	NUMBER	\	dep	3	SENT_24	[p2l843t8r1219b91],
9	/	:	O	/	punct	11	SENT_24	[p2l843t8r1219b91],
10	\	CD	NUMBER	\	num	11	SENT_24	[p2l843t8r1219b91],
11	yers	NNS	O	yer	dep	8	SENT_24	[p2l843t8r1219b91],
12	Squibb	NNP	ORGANIZATION	Squibb	nn	13	SENT_24	[p2l1258t8r1472b91],
13	Co	NNP	ORGANIZATION	Co	dep	11	SENT_24	[p2l1510t13r1619b83],
14	,	,	O	,	_	0	SENT_24	[p2l1510t13r1619b83],
15	Princeton	NNP	ORGANIZATION	Princeton	appos	11	SENT_24	[p2l1667t13r1954b83],
16	,	,	O	,	_	0	SENT_24	[p2l1667t13r1954b83],
17	New	NNP	LOCATION	New	nn	18	SENT_24	[p2l2001t13r2153b72],
18	Jersey	NNP	LOCATION	Jersey	appos	8	SENT_24	[p2l6t98r206b176],
19	.	.	O	.	_	0	SENT_24	[p2l6t98r206b176],

1	A.	NN	O	a.	_	0	SENT_25	[p2l257t97r410b157],
2	/	:	O	/	punct	3	SENT_25	[p2l257t97r410b157],
3	\	CD	NUMBER	\	dep	1	SENT_25	[p2l257t97r410b157],
4	/	:	O	/	punct	3	SENT_25	[p2l257t97r410b157],
5	\	CD	NUMBER	\	dep	3	SENT_25	[p2l257t97r410b157],
6	.	.	O	.	_	0	SENT_25	[p2l257t97r410b157],

1	Henney	NNP	PERSON	Henney	dep	14	SENT_26	[p2l465t98r713b176],
2	,	,	O	,	_	0	SENT_26	[p2l465t98r713b176],
3	S.E.	NNP	PERSON	S.E.	nn	8	SENT_26	[p2l766t98r880b156],
4	Humphries	NNP	PERSON	Humphries	nn	8	SENT_26	[p2l936t93r1272b176],
5	,	,	O	,	_	0	SENT_26	[p2l936t93r1272b176],
6	ond	JJ	O	ond	amod	8	SENT_26	[p2l1324t93r1437b156],
7	S.	NNP	O	S.	nn	8	SENT_26	[p2l1488t97r1541b156],
8	Ye	NNP	O	Ye	appos	1	SENT_26	[p2l1591t98r1668b156],
9	were	VBD	O	be	cop	10	SENT_26	[p2l1713t118r1864b157],
10	pcrrtiolly	JJ	O	pcrrtiolly	rcmod	8	SENT_26	[p2l1913t93r2152b176],
11	supported	VBN	O	support	partmod	8	SENT_26	[p2l16t177r314b260],
12	by	IN	O	by	_	0	SENT_26	[p2l346t177r417b260],
13	gronts	NNS	O	gront	agent	11	SENT_26	[p2l440t192r621b259],
14	trom	VBP	O	trom	_	0	SENT_26	[p2l646t176r773b240],
15	the	DT	O	the	det	18	SENT_26	[p2l801t177r888b240],
16	British	JJ	O	british	amod	18	SENT_26	[p2l916t177r1084b240],
17	Heort	NNP	LOCATION	Heort	nn	18	SENT_26	[p2l1116t182r1281b240],
18	Foundotion	NN	LOCATION	foundotion	nsubj	14	SENT_26	[p2l1308t177r1658b252],
19	,	,	O	,	_	0	SENT_26	[p2l1308t177r1658b252],
20	London	NNP	LOCATION	London	appos	18	SENT_26	[p2l1693t177r1924b252],
21	,	,	O	,	_	0	SENT_26	[p2l1693t177r1924b252],
22	United	NNP	LOCATION	United	nn	23	SENT_26	[p2l1958t177r2147b240],
23	Kingdom	NNP	LOCATION	Kingdom	appos	20	SENT_26	[p2l20t261r307b344],
24	.	.	O	.	_	0	SENT_26	[p2l20t261r307b344],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_27	[p2l347t266r688b345],
2	received	VBD	O	receive	_	0	SENT_27	[p2l724t261r976b326],
3	May	NNP	DATE	May	tmod	2	SENT_27	[p2l1013t266r1156b345],
4	28	CD	DATE	28	num	3	SENT_27	[p2l1193t266r1296b336],
5	,	,	DATE	,	_	0	SENT_27	[p2l1193t266r1296b336],
6	1998	CD	DATE	1998	num	3	SENT_27	[p2l1349t266r1536b336],
7	;	:	O	;	_	0	SENT_27	[p2l1349t266r1536b336],
8	revised	VBN	O	revise	csubj	12	SENT_27	[p2l1581t261r1787b326],
9	monuscript	JJ	O	monuscript	dobj	8	SENT_27	[p2l1829t274r2153b345],
10	received	VBN	O	receive	partmod	9	SENT_27	[p2l20t346r273b410],
11	ond	NN	O	ond	dobj	10	SENT_27	[p2l305t346r418b409],
12	occepted	VBD	O	occept	parataxis	2	SENT_27	[p2l451t346r733b429],
13	November	NNP	DATE	November	tmod	12	SENT_27	[p2l769t346r1093b410],
14	5	CD	DATE	5	num	13	SENT_27	[p2l1122t351r1180b421],
15	,	,	DATE	,	_	0	SENT_27	[p2l1122t351r1180b421],
16	1998	CD	DATE	1998	num	13	SENT_27	[p2l1228t351r1415b409],
17	.	.	O	.	_	0	SENT_27	[p2l1228t351r1415b409],

1	Address	NN	O	address	nsubj	2	SENT_28	[p2l141t430r386b493],
2	tor	NN	O	tor	_	0	SENT_28	[p2l414t430r492b493],
3	reprints	VBZ	O	reprint	rcmod	2	SENT_28	[p2l522t443r752b513],
4	:	:	O	:	_	0	SENT_28	[p2l522t443r752b513],
5	/	:	O	/	punct	6	SENT_28	[p2l785t430r1018b494],
6	\	CD	NUMBER	\	dep	2	SENT_28	[p2l785t430r1018b494],
7	/	:	O	/	punct	11	SENT_28	[p2l785t430r1018b494],
8	\	CD	NUMBER	\	num	10	SENT_28	[p2l785t430r1018b494],
9	onie	NN	O	onie	nn	10	SENT_28	[p2l785t430r1018b494],
10	|	NN	O	|	dep	11	SENT_28	[p2l785t430r1018b494],
11	<	JJR	O	<	dep	6	SENT_28	[p2l785t430r1018b494],
12	P.	FW	O	p.	dep	6	SENT_28	[p2l1048t435r1183b494],
13	/	:	O	/	punct	14	SENT_28	[p2l1048t435r1183b494],
14	\	CD	NUMBER	\	dep	12	SENT_28	[p2l1048t435r1183b494],
15	/	:	O	/	punct	14	SENT_28	[p2l1048t435r1183b494],
16	\	CD	NUMBER	\	dep	6	SENT_28	[p2l1048t435r1183b494],
17	.	.	O	.	_	0	SENT_28	[p2l1048t435r1183b494],

1	de	IN	O	de	_	0	SENT_29	[p2l1217t430r1293b493],
2	/	:	O	/	punct	3	SENT_29	[p2l1320t434r1501b505],
3	\	CD	NUMBER	\	dep	1	SENT_29	[p2l1320t434r1501b505],
4	/	:	O	/	punct	3	SENT_29	[p2l1320t434r1501b505],
5	\	CD	NUMBER	\	num	6	SENT_29	[p2l1320t434r1501b505],
6	oot	NN	O	oot	dep	1	SENT_29	[p2l1320t434r1501b505],
7	,	,	O	,	_	0	SENT_29	[p2l1320t434r1501b505],
8	PhD	NN	O	phd	appos	6	SENT_29	[p2l1540t430r1670b505],
9	,	,	O	,	_	0	SENT_29	[p2l1540t430r1670b505],
10	Goubius	NNP	O	Goubius	nn	12	SENT_29	[p2l1705t430r1962b493],
11	Loborotory	NNP	O	Loborotory	nn	12	SENT_29	[p2l1995t430r2153b493, p2l20t547r190b615],
12	TNO-PG	NNP	O	TNO-PG	appos	6	SENT_29	[p2l215t537r502b607],
13	,	,	O	,	_	0	SENT_29	[p2l215t537r502b607],
14	PO	NNP	O	PO	nn	15	SENT_29	[p2l543t537r634b595],
15	Box	NNP	O	Box	appos	6	SENT_29	[p2l668t538r778b595],
16	2215	CD	DATE	2215	num	15	SENT_29	[p2l810t537r1006b607],
17	,	,	DATE	,	_	0	SENT_29	[p2l810t537r1006b607],
18	2301	CD	DATE	2301	num	15	SENT_29	[p2l1046t537r1207b595],
19	CE	NNP	ORGANIZATION	CE	nn	20	SENT_29	[p2l1255t537r1341b595],
20	Leiden	NNP	ORGANIZATION	Leiden	dep	15	SENT_29	[p2l1377t532r1584b607],
21	,	,	O	,	_	0	SENT_29	[p2l1377t532r1584b607],
22	The	DT	LOCATION	the	det	23	SENT_29	[p2l1618t532r1724b595],
23	Netherlands	NNP	LOCATION	Netherlands	appos	6	SENT_29	[p2l1758t532r2144b596],
24	.	.	O	.	_	0	SENT_29	[p2l1758t532r2144b596],

1	Email	VB	O	email	_	0	SENT_30	[p2l20t615r211b678],
2	:	:	O	:	_	0	SENT_30	[p2l20t615r211b678],
3	m.demoot@pg.tno.n	NN	O	m.demoot@pg.tno.n	nn	4	SENT_30	[p2l249t615r907b698],
4	|	NN	O	|	dobj	1	SENT_30	[p2l249t615r907b698],
5	.	.	O	.	_	0	SENT_30	[p2l249t615r907b698],

1	852	CD	NUMBER	852	number	2	SENT_31	[p2l18t864r158b932],
2	©	CD	NUMBER	©	num	3	SENT_31	[p2l274t879r484b931],
3	1999	CD	DATE	1999	npadvmod	4	SENT_31	[p2l274t879r484b931],
4	by	IN	O	by	dep	8	SENT_31	[p2l514t875r580b947],
5	Excerptci	NNP	ORGANIZATION	Excerptci	nn	6	SENT_31	[p2l606t880r844b947],
6	Mediccr	NNP	ORGANIZATION	Mediccr	pobj	4	SENT_31	[p2l871t875r1102b941],
7	,	,	ORGANIZATION	,	_	0	SENT_31	[p2l871t875r1102b941],
8	Inc.	NNP	ORGANIZATION	Inc.	_	0	SENT_31	[p2l1134t880r1225b931],
9	.	.	O	.	_	0	SENT_31	[p2l1134t880r1225b931],

1	All	DT	O	all	det	2	SENT_32	[p2l274t958r345b1013],
2	rights	NNS	O	rights	nsubj	3	SENT_32	[p2l375t958r523b1030],
3	reserved	VBN	O	reserve	_	0	SENT_32	[p2l551t958r801b1015],
4	.	.	O	.	_	0	SENT_32	[p2l551t958r801b1015],

1	sin	NN	O	sin	nsubj	20	SENT_33	[p2l11t1199r193b1268],
2	—	CD	NUMBER	—	num	3	SENT_33	[p2l11t1199r193b1268],
3	l	NN	O	l	tmod	20	SENT_33	[p2l11t1199r193b1268],
4	gene	NN	O	gene	nn	6	SENT_33	[p2l228t1221r409b1288],
5	{	CD	NUMBER	{	num	6	SENT_33	[p2l443t1199r551b1285],
6	l6l2	NN	O	l6l2	nsubj	20	SENT_33	[p2l573t1199r1234b1285],
7	(	CD	NUMBER	(	num	8	SENT_33	[p2l573t1199r1234b1285],
8	5A/6A	NN	O	5a/6a	dep	6	SENT_33	[p2l573t1199r1234b1285],
9	)	CD	NUMBER	)	number	10	SENT_33	[p2l573t1199r1234b1285],
10	}	CD	NUMBER	}	dep	6	SENT_33	[p2l573t1199r1234b1285],
11	.12	CD	NUMBER	.12	dep	10	SENT_33	[p2l573t1199r1234b1285],
12	In	IN	O	in	_	0	SENT_33	[p2l1259t1201r1339b1267],
13	a	DT	O	a	det	15	SENT_33	[p2l1365t1221r1405b1268],
14	preliminary	JJ	O	preliminary	amod	15	SENT_33	[p2l1427t1199r1885b1288],
15	study	NN	O	study	prep_in	20	SENT_33	[p2l1913t1199r2142b1288],
16	,	,	O	,	_	0	SENT_33	[p2l1913t1199r2142b1288],
17	Ye	NNP	O	Ye	appos	15	SENT_33	[p2l8t1302r120b1369],
18	et	FW	O	et	nn	19	SENT_33	[p2l168t1311r237b1369],
19	al13	FW	O	al13	dep	17	SENT_33	[p2l284t1300r417b1369],
20	found	VBD	O	find	_	0	SENT_33	[p2l468t1300r695b1369],
21	an	DT	O	a	det	22	SENT_33	[p2l743t1322r832b1369],
22	association	NN	O	association	dobj	20	SENT_33	[p2l880t1300r1314b1369],
23	between	IN	O	between	_	0	SENT_33	[p2l1359t1301r1686b1370],
24	the	DT	O	the	det	26	SENT_33	[p2l1732t1301r1849b1369],
25	angiographic	JJ	O	angiographic	amod	26	SENT_33	[p2l1898t1301r2143b1390, p2l9t1405r299b1494],
26	progression	NN	O	progression	prep_between	22	SENT_33	[p2l349t1405r808b1494],
27	of	IN	O	of	_	0	SENT_33	[p2l859t1405r943b1474],
28	the	DT	O	the	det	29	SENT_33	[p2l986t1405r1103b1474],
29	disease	NN	O	disease	prep_of	26	SENT_33	[p2l1155t1405r1436b1474],
30	and	CC	O	and	_	0	SENT_33	[p2l1487t1405r1626b1474],
31	this	DT	O	this	det	33	SENT_33	[p2l1674t1405r1812b1474],
32	genetic	JJ	O	genetic	amod	33	SENT_33	[p2l1865t1405r2144b1494],
33	variant	NN	O	variant	prep_of	26	SENT_33	[p2l8t1508r298b1577],
34	.	.	O	.	_	0	SENT_33	[p2l8t1508r298b1577],

1	Therefore	RB	O	therefore	advmod	4	SENT_34	[p2l338t1508r745b1589],
2	,	,	O	,	_	0	SENT_34	[p2l338t1508r745b1589],
3	we	PRP	O	we	nsubj	4	SENT_34	[p2l784t1530r895b1577],
4	studied	VBD	O	study	_	0	SENT_34	[p2l934t1508r1213b1577],
5	whether	IN	O	whether	complm	13	SENT_34	[p2l1247t1508r1564b1577],
6	this	DT	O	this	det	9	SENT_34	[p2l1596t1508r1734b1577],
7	stromely	JJ	O	stromely	amod	9	SENT_34	[p2l1774t1508r2143b1597],
8	—	NN	O	—	nn	9	SENT_34	[p2l1774t1508r2143b1597],
9	sin-1	NN	O	sin-1	nsubjpass	13	SENT_34	[p2l11t1609r193b1678],
10	genetic	JJ	O	genetic	amod	11	SENT_34	[p2l238t1609r518b1699],
11	variant	NN	O	variant	dep	9	SENT_34	[p2l554t1609r826b1679],
12	is	VBZ	O	be	auxpass	13	SENT_34	[p2l860t1610r921b1678],
13	associated	VBN	O	associate	ccomp	4	SENT_34	[p2l960t1609r1361b1678],
14	with	IN	O	with	_	0	SENT_34	[p2l1395t1609r1568b1679],
15	risk	NN	O	risk	prep_with	13	SENT_34	[p2l1601t1609r1750b1678],
16	of	IN	O	of	_	0	SENT_34	[p2l1784t1609r1868b1678],
17	occurrence	NN	O	occurrence	prep_of	15	SENT_34	[p2l1898t1631r2143b1678, p2l7t1736r218b1783],
18	of	IN	O	of	_	0	SENT_34	[p2l278t1714r363b1783],
19	clinical	JJ	O	clinical	amod	20	SENT_34	[p2l416t1714r701b1783],
20	events	NNS	O	event	prep_of	17	SENT_34	[p2l761t1724r1007b1783],
21	or	CC	O	or	_	0	SENT_34	[p2l1069t1736r1149b1783],
22	requirement	NN	O	requirement	conj_or	20	SENT_34	[p2l1204t1714r1681b1803],
23	for	IN	O	for	_	0	SENT_34	[p2l1738t1714r1851b1783],
24	repeat	NN	O	repeat	nn	25	SENT_34	[p2l1907t1724r2148b1803],
25	angioplasty	NN	O	angioplasty	prep_for	13	SENT_34	[p2l10t1817r459b1906],
26	due	JJ	O	due	_	0	SENT_34	[p2l492t1817r630b1886],
27	to	TO	O	to	_	0	SENT_34	[p2l661t1827r734b1886],
28	clinical	JJ	O	clinical	amod	29	SENT_34	[p2l768t1817r1054b1886],
29	restenosis	NN	O	restenosis	prep_due_to	25	SENT_34	[p2l1084t1817r1491b1886],
30	.	.	O	.	_	0	SENT_34	[p2l1084t1817r1491b1886],

1	We	PRP	O	we	nsubj	2	SENT_35	[p2l1526t1819r1661b1886],
2	studied	VBD	O	study	_	0	SENT_35	[p2l1696t1817r1976b1886],
3	this	DT	O	this	dobj	2	SENT_35	[p2l2005t1817r2143b1886],
4	by	IN	O	by	_	0	SENT_35	[p2l7t1919r103b2008],
5	performing	VBG	O	perform	prepc_by	2	SENT_35	[p2l148t1918r589b2008],
6	associative	JJ	O	associative	amod	7	SENT_35	[p2l638t1918r1065b1987],
7	studies	NNS	O	study	dobj	5	SENT_35	[p2l1114t1919r1380b1987],
8	in	IN	O	in	_	0	SENT_35	[p2l1428t1918r1502b1986],
9	the	DT	O	the	det	11	SENT_35	[p2l1547t1919r1664b1987],
10	Regression	NN	O	regression	nn	11	SENT_35	[p2l1711t1918r2146b2008],
11	Growth	NN	O	growth	prep_in	5	SENT_35	[p2l9t2023r307b2092],
12	Evaluation	NN	O	evaluation	nn	14	SENT_35	[p2l340t2023r765b2092],
13	Statin	NN	O	statin	nn	14	SENT_35	[p2l803t2023r1028b2092],
14	Study	NN	O	study	dep	22	SENT_35	[p2l1065t2023r1289b2112],
15	(	CD	NUMBER	(	num	16	SENT_35	[p2l1327t2024r1817b2108],
16	REGRESS	NNP	O	REGRESS	dep	14	SENT_35	[p2l1327t2024r1817b2108],
17	)	CD	NUMBER	)	num	16	SENT_35	[p2l1327t2024r1817b2108],
18	trial	NN	O	trial	dep	22	SENT_35	[p2l1854t2023r2070b2104],
19	,4	CD	NUMBER	,4	num	18	SENT_35	[p2l1854t2023r2070b2104],
20	a	DT	O	a	det	22	SENT_35	[p2l2107t2045r2147b2092],
21	multicenter	NN	O	multicenter	nn	22	SENT_35	[p2l8t2126r456b2195],
22	study	NN	O	study	dep	5	SENT_35	[p2l507t2126r714b2215],
23	on	IN	O	on	_	0	SENT_35	[p2l765t2148r860b2195],
24	the	DT	O	the	det	25	SENT_35	[p2l909t2126r1027b2195],
25	effect	NN	O	effect	prep_on	22	SENT_35	[p2l1078t2126r1300b2195],
26	of	IN	O	of	_	0	SENT_35	[p2l1350t2126r1435b2195],
27	2-year	JJ	DURATION	2-year	amod	28	SENT_35	[p2l1479t2126r1728b2215],
28	treatment	NN	O	treatment	prep_of	25	SENT_35	[p2l1776t2136r2147b2195],
29	with	IN	O	with	_	0	SENT_35	[p2l8t2228r181b2297],
30	pravastatin	NN	O	pravastatin	prep_with	5	SENT_35	[p2l225t2227r657b2317],
31	on	IN	O	on	_	0	SENT_35	[p2l704t2249r799b2296],
32	progression	NN	O	progression	prep_on	30	SENT_35	[p2l844t2227r1303b2317],
33	of	IN	O	of	_	0	SENT_35	[p2l1351t2227r1435b2296],
34	coronary	JJ	O	coronary	amod	35	SENT_35	[p2l1476t2249r1822b2317],
35	atherosclerosis	NN	O	atherosclerosis	prep_of	32	SENT_35	[p2l1871t2228r2143b2296, p2l11t2331r364b2400],
36	.	.	O	.	_	0	SENT_35	[p2l1871t2228r2143b2296, p2l11t2331r364b2400],

1	METHODS	NNS	O	method	_	0	SENT_36	[p2l8t2569r562b2655],

1	Study	NNP	O	Study	dep	6	SENT_37	[p2l135t2675r351b2775],
2	design	NN	O	design	dep	6	SENT_37	[p2l403t2675r676b2775],
3	:	:	O	:	_	0	SENT_37	[p2l403t2675r676b2775],
4	The	DT	O	the	det	6	SENT_37	[p2l736t2684r885b2752],
5	REGRESS	NNP	O	REGRESS	nn	6	SENT_37	[p2l942t2684r1368b2753],
6	study	NN	O	study	_	0	SENT_37	[p2l1432t2684r1638b2773],
7	and	CC	O	and	_	0	SENT_37	[p2l1698t2684r1836b2752],
8	design	NN	O	design	conj_and	6	SENT_37	[p2l1892t2684r2146b2773],
9	have	VBP	O	have	aux	11	SENT_37	[p2l7t2787r191b2856],
10	been	VBN	O	be	auxpass	11	SENT_37	[p2l216t2787r400b2856],
11	described	VBN	O	describe	dep	6	SENT_37	[p2l427t2787r803b2856],
12	elsewhere	RB	O	elsewhere	advmod	16	SENT_37	[p2l828t2787r1279b2856],
13	.4	CD	NUMBER	.4	pobj	12	SENT_37	[p2l828t2787r1279b2856],
14	Brieﬂy	NNP	O	Brieﬂy	nn	16	SENT_37	[p2l1305t2787r1597b2876],
15	,	,	O	,	_	0	SENT_37	[p2l1305t2787r1597b2876],
16	REGRESS	NNP	O	REGRESS	dobj	11	SENT_37	[p2l1627t2788r2052b2857],
17	is	VBZ	O	be	cop	20	SENT_37	[p2l2083t2787r2143b2856],
18	a	DT	O	a	det	20	SENT_37	[p2l10t2912r50b2959],
19	double	JJ	O	double	amod	20	SENT_37	[p2l85t2890r606b2971],
20	—	NN	O	—	rcmod	16	SENT_37	[p2l85t2890r606b2971],
21	blind	JJ	O	blind	amod	16	SENT_37	[p2l85t2890r606b2971],
22	,	,	O	,	_	0	SENT_37	[p2l85t2890r606b2971],
23	randomized	VBN	O	randomize	partmod	16	SENT_37	[p2l643t2890r1128b2971],
24	,	,	O	,	_	0	SENT_37	[p2l643t2890r1128b2971],
25	placebo	NN	O	placebo	nn	26	SENT_37	[p2l1165t2890r1924b2979],
26	—	NN	O	—	appos	16	SENT_37	[p2l1165t2890r1924b2979],
27	controlled	VBN	O	control	partmod	26	SENT_37	[p2l1165t2890r1924b2979],
28	,	,	O	,	_	0	SENT_37	[p2l1165t2890r1924b2979],
29	multicenter	JJ	O	multicenter	amod	30	SENT_37	[p2l1963t2890r2143b2959, p2l8t2993r302b3062],
30	study	NN	O	study	appos	16	SENT_37	[p2l340t2993r547b3082],
31	to	TO	O	to	aux	32	SENT_37	[p2l582t3003r655b3062],
32	assess	VB	O	assess	infmod	30	SENT_37	[p2l694t3014r928b3062],
33	the	DT	O	the	det	34	SENT_37	[p2l966t2993r1083b3062],
34	effect	NN	O	effect	dobj	32	SENT_37	[p2l1120t2993r1342b3062],
35	of	IN	O	of	_	0	SENT_37	[p2l1378t2993r1463b3062],
36	2-year	JJ	DURATION	2-year	amod	37	SENT_37	[p2l1493t2993r1742b3082],
37	treatment	NN	O	treatment	prep_of	34	SENT_37	[p2l1776t3003r2147b3062],
38	with	IN	O	with	_	0	SENT_37	[p2l8t3096r181b3165],
39	the	DT	O	the	det	42	SENT_37	[p2l214t3096r332b3165],
40	3	CD	NUMBER	3	num	42	SENT_37	[p2l369t3096r1902b3185],
41	—	NN	O	—	nn	42	SENT_37	[p2l369t3096r1902b3185],
42	hydroXy	NN	O	hydroxy	prep_with	32	SENT_37	[p2l369t3096r1902b3185],
43	—	CD	NUMBER	—	number	44	SENT_37	[p2l369t3096r1902b3185],
44	3	CD	NUMBER	3	dep	6	SENT_37	[p2l369t3096r1902b3185],
45	—	NN	O	—	nn	52	SENT_37	[p2l369t3096r1902b3185],
46	methylglutaryl	NN	O	methylglutaryl	nn	52	SENT_37	[p2l369t3096r1902b3185],
47	—	NN	O	—	nn	52	SENT_37	[p2l369t3096r1902b3185],
48	coenzyme	NN	O	coenzyme	nn	52	SENT_37	[p2l369t3096r1902b3185],
49	A	NN	O	a	nn	52	SENT_37	[p2l1937t3097r2005b3164],
50	reductase	NN	O	reductase	nn	52	SENT_37	[p2l2038t3118r2143b3165, p2l9t3199r300b3268],
51	inhibitor	NN	O	inhibitor	nn	52	SENT_37	[p2l343t3199r682b3268],
52	pravastatin	NN	O	pravastatin	dep	44	SENT_37	[p2l721t3199r1173b3288],
53	,	,	O	,	_	0	SENT_37	[p2l721t3199r1173b3288],
54	on	IN	O	on	_	0	SENT_37	[p2l1220t3221r1315b3268],
55	progression	NN	O	progression	prep_on	6	SENT_37	[p2l1356t3199r1815b3288],
56	and	CC	O	and	_	0	SENT_37	[p2l1859t3199r1998b3268],
57	regression	NN	O	regression	conj_and	55	SENT_37	[p2l2038t3220r2143b3268, p2l9t3302r334b3391],
58	of	IN	O	of	_	0	SENT_37	[p2l397t3302r481b3371],
59	angiographically	RB	O	angiographically	advmod	60	SENT_37	[p2l538t3302r1195b3391],
60	documented	VBN	O	document	amod	62	SENT_37	[p2l1258t3302r1738b3371],
61	coronary	JJ	O	coronary	amod	62	SENT_37	[p2l1799t3323r2145b3391],
62	atherosclerosis	NN	O	atherosclerosis	prep_of	55	SENT_37	[p2l10t3405r589b3474],
63	in	IN	O	in	_	0	SENT_37	[p2l647t3405r721b3473],
64	885	CD	NUMBER	885	num	66	SENT_37	[p2l781t3405r917b3475],
65	male	JJ	O	male	amod	66	SENT_37	[p2l978t3405r1166b3474],
66	patients	NNS	O	patient	prep_in	6	SENT_37	[p2l1221t3405r1524b3494],
67	with	IN	O	with	_	0	SENT_37	[p2l1583t3405r1755b3474],
68	a	DT	O	a	det	71	SENT_37	[p2l1813t3427r1853b3474],
69	serum	NN	O	serum	nn	71	SENT_37	[p2l1911t3427r2147b3474],
70	cholesterol	NN	O	cholesterol	nn	71	SENT_37	[p2l9t3507r437b3575],
71	level	NN	O	level	prep_with	66	SENT_37	[p2l469t3507r657b3575],
72	between	IN	O	between	_	0	SENT_37	[p2l687t3507r1014b3575],
73	4.0	CD	NUMBER	4.0	num	77	SENT_37	[p2l1044t3507r1164b3576],
74	and	CC	NUMBER	and	_	0	SENT_37	[p2l1198t3507r1336b3575],
75	8.0	CD	NUMBER	8.0	conj_and	73	SENT_37	[p2l1370t3507r1486b3576],
76	mmol/L	NN	O	mmol/l	nn	77	SENT_37	[p2l1517t3507r1832b3576],
77	(	NN	O	(	prep_between	71	SENT_37	[p2l1866t3507r2036b3591],
78	155	CD	NUMBER	155	number	80	SENT_37	[p2l1866t3507r2036b3591],
79	to	TO	O	to	dep	80	SENT_37	[p2l2071t3517r2144b3575],
80	310	CD	NUMBER	310	num	82	SENT_37	[p2l10t3610r152b3679],
81	mg/dl	NN	O	mg/dl	nn	82	SENT_37	[p2l190t3610r470b3699],
82	)	NN	O	)	dep	77	SENT_37	[p2l190t3610r470b3699],
83	.	.	O	.	_	0	SENT_37	[p2l190t3610r470b3699],

1	After	IN	O	after	_	0	SENT_38	[p2l512t3610r719b3679],
2	inclusion	NN	O	inclusion	prep_after	10	SENT_38	[p2l754t3610r1112b3679],
3	in	IN	O	in	_	0	SENT_38	[p2l1149t3610r1224b3678],
4	the	DT	O	the	det	5	SENT_38	[p2l1260t3610r1378b3679],
5	study	NN	O	study	prep_in	2	SENT_38	[p2l1419t3610r1647b3699],
6	,	,	O	,	_	0	SENT_38	[p2l1419t3610r1647b3699],
7	the	DT	O	the	det	8	SENT_38	[p2l1687t3610r1805b3679],
8	patients	NNS	O	patient	nsubjpass	10	SENT_38	[p2l1841t3610r2144b3699],
9	were	VBD	O	be	auxpass	10	SENT_38	[p2l8t3735r196b3782],
10	divided	VBN	O	divide	_	0	SENT_38	[p2l227t3713r520b3782],
11	into	IN	O	into	_	0	SENT_38	[p2l548t3713r697b3782],
12	1	CD	TIME	1	prep_into	10	SENT_38	[p2l737t3714r765b3781],
13	of	IN	TIME	of	_	0	SENT_38	[p2l804t3713r889b3782],
14	3	CD	TIME	3	num	15	SENT_38	[p2l914t3714r953b3783],
15	arms	NNS	O	arm	prep_of	12	SENT_38	[p2l989t3735r1173b3782],
16	according	VBG	O	accord	_	0	SENT_38	[p2l1207t3713r1590b3802],
17	to	TO	O	to	prepc_according_to	10	SENT_38	[p2l1620t3724r1693b3782],
18	the	DT	O	the	det	19	SENT_38	[p2l1723t3713r1840b3782],
19	type	NN	O	type	pobj	10	SENT_38	[p2l1870t3724r2036b3802],
20	of	IN	O	of	_	0	SENT_38	[p2l2067t3713r2152b3782],
21	primary	JJ	O	primary	amod	22	SENT_38	[p3l7t14r316b103],
22	management	NN	O	management	prep_of	19	SENT_38	[p3l351t24r853b103],
23	elected	VBN	O	elect	partmod	22	SENT_38	[p3l887t14r1163b83],
24	at	IN	O	at	_	0	SENT_38	[p3l1198t24r1266b83],
25	the	DT	O	the	det	27	SENT_38	[p3l1298t14r1415b83],
26	participating	VBG	O	participate	amod	27	SENT_38	[p3l1449t14r1944b103],
27	center	NN	O	center	prep_at	23	SENT_38	[p3l1980t35r2143b83, p3l8t127r130b186],
28	:	:	O	:	_	0	SENT_38	[p3l1980t35r2143b83, p3l8t127r130b186],
29	a	DT	O	a	det	33	SENT_38	[p3l171t138r211b186],
30	percutaneous	JJ	O	percutaneous	amod	31	SENT_38	[p3l241t127r757b206],
31	transluminal	JJ	O	transluminal	amod	33	SENT_38	[p3l791t117r1281b186],
32	coronary	JJ	O	coronary	amod	33	SENT_38	[p3l1315t138r1661b206],
33	angioplasty	NN	O	angioplasty	dobj	23	SENT_38	[p3l1696t117r2145b206],

1	0002-9149/99	CD	DURATION	0002-9149/99	nsubj	5	SENT_39	[p3l1141t375r1799b443],
2	/	:	O	/	punct	3	SENT_39	[p3l1141t375r1799b443],
3	$	$	MONEY	$	dep	1	SENT_39	[p3l1141t375r1799b443],
4	-	:	O	-	_	0	SENT_39	[p3l1141t375r1799b443],
5	see	VB	O	see	_	0	SENT_39	[p3l1141t375r1799b443],
6	Front	NN	O	front	nn	8	SENT_39	[p3l1825t377r1950b433],
7	matter	NN	O	matter	nn	8	SENT_39	[p3l1976t390r2148b434],
8	PH	NN	O	ph	dobj	5	SENT_39	[p3l1320t466r1375b517],
9	S0002-9l	NN	O	s0002-9l	dep	8	SENT_39	[p3l1404t466r1679b518],
10	4-9	CD	NUMBER	4-9	num	9	SENT_39	[p3l1696t465r1960b533],
11	(	CD	NUMBER	(	number	12	SENT_39	[p3l1696t465r1960b533],
12	98	CD	NUMBER	98	num	16	SENT_39	[p3l1696t465r1960b533],
13	)	NN	O	)	nn	16	SENT_39	[p3l1696t465r1960b533],
14	Ol	NN	O	ol	nn	16	SENT_39	[p3l1696t465r1960b533],
15	O73-X	NN	O	o73-x	nn	16	SENT_39	[p3l1978t466r2147b518],
16	arm	NN	O	arm	dep	9	SENT_39	[p3l10t575r179b634],
17	,	,	O	,	_	0	SENT_39	[p3l10t575r179b634],
18	a	DT	O	a	det	20	SENT_39	[p3l211t575r252b622],
19	coronary	JJ	O	coronary	amod	20	SENT_39	[p3l276t575r623b642],
20	artery	NN	O	artery	dobj	5	SENT_39	[p3l651t564r876b642],
21	bypass	NN	O	bypass	nn	23	SENT_39	[p3l901t553r1165b642],
22	graft	NN	O	graft	nn	23	SENT_39	[p3l1195t553r1379b642],
23	arm	NN	O	arm	dep	20	SENT_39	[p3l1405t575r1574b634],
24	,	,	O	,	_	0	SENT_39	[p3l1405t575r1574b634],
25	and	CC	O	and	_	0	SENT_39	[p3l1606t553r1745b622],
26	a	DT	O	a	det	29	SENT_39	[p3l1772t575r1812b622],
27	medical	JJ	O	medical	amod	29	SENT_39	[p3l1837t553r2145b622],
28	management	NN	O	management	nn	29	SENT_39	[p3l8t668r511b746],
29	arm	NN	O	arm	dobj	5	SENT_39	[p3l564t679r732b726],
30	.	.	O	.	_	0	SENT_39	[p3l564t679r732b726],

1	In	IN	O	in	_	0	SENT_40	[p3l790t659r869b725],
2	each	DT	O	each	det	3	SENT_40	[p3l923t657r1100b726],
3	arm	NN	O	arm	prep_in	8	SENT_40	[p3l1155t679r1324b738],
4	,	,	O	,	_	0	SENT_40	[p3l1155t679r1324b738],
5	patients	NNS	O	patient	nsubjpass	8	SENT_40	[p3l1379t657r1682b746],
6	were	VBD	O	be	auxpass	8	SENT_40	[p3l1737t679r1926b726],
7	then	RB	O	then	advmod	8	SENT_40	[p3l1979t657r2146b726],
8	randomized	VBN	O	randomize	_	0	SENT_40	[p3l7t759r471b828],
9	to	TO	O	to	aux	10	SENT_40	[p3l497t770r570b828],
10	receive	VB	O	receive	xcomp	8	SENT_40	[p3l597t759r879b828],
11	pravastatin	NN	O	pravastatin	nn	13	SENT_40	[p3l905t759r1336b849],
12	40	CD	NUMBER	40	num	13	SENT_40	[p3l1362t760r1458b829],
13	mg	NN	O	mg	dobj	10	SENT_40	[p3l1485t781r1608b849],
14	once	RB	DATE	once	advmod	15	SENT_40	[p3l1637t781r1818b828],
15	daily	JJ	SET	daily	advmod	13	SENT_40	[p3l1846t759r2039b849],
16	or	CC	O	or	_	0	SENT_40	[p3l2068t781r2148b828],
17	placebo	NN	O	placebo	conj_or	13	SENT_40	[p3l7t865r331b954],
18	.	.	O	.	_	0	SENT_40	[p3l7t865r331b954],

1	Coronary	JJ	O	coronary	amod	2	SENT_41	[p3l135t970r504b1058],
2	arteriograms	NNS	O	arteriogram	nsubjpass	4	SENT_41	[p3l540t969r1030b1058],
3	were	VBD	O	be	auxpass	4	SENT_41	[p3l1066t991r1254b1038],
4	analyzed	VBN	O	analyze	_	0	SENT_41	[p3l1290t969r1636b1058],
5	by	IN	O	by	_	0	SENT_41	[p3l1667t969r1764b1058],
6	quantitative	JJ	O	quantitative	amod	8	SENT_41	[p3l1798t969r2143b1058, p3l8t1073r153b1142],
7	computer	NN	O	computer	nn	8	SENT_41	[p3l191t1084r561b1162],
8	analysis	NN	O	analysis	agent	4	SENT_41	[p3l598t1073r909b1162],
9	(	CD	NUMBER	(	num	12	SENT_41	[p3l951t1073r1577b1158],
10	Cardiovascular	NNP	O	Cardiovascular	nn	12	SENT_41	[p3l951t1073r1577b1158],
11	Measurement	NNP	O	Measurement	nn	12	SENT_41	[p3l1612t1075r2148b1142],
12	System	NNP	O	System	dep	4	SENT_41	[p3l10t1177r316b1266],
13	,	,	O	,	_	0	SENT_41	[p3l10t1177r316b1266],
14	MEDIS	NNP	LOCATION	MEDIS	appos	12	SENT_41	[p3l352t1177r677b1258],
15	,	,	O	,	_	0	SENT_41	[p3l352t1177r677b1258],
16	Nuenen	NNP	LOCATION	Nuenen	appos	12	SENT_41	[p3l712t1178r1037b1258],
17	,	,	O	,	_	0	SENT_41	[p3l712t1178r1037b1258],
18	The	DT	LOCATION	the	det	20	SENT_41	[p3l1073t1177r1223b1246],
19	Netherlands	NNP	LOCATION	Netherlands	nn	20	SENT_41	[p3l1255t1177r1781b1262],
20	)	NN	O	)	appos	12	SENT_41	[p3l1255t1177r1781b1262],
21	.	.	O	.	_	0	SENT_41	[p3l1255t1177r1781b1262],

1	To	TO	O	to	aux	2	SENT_42	[p3l1818t1178r1924b1246],
2	standardize	VB	O	standardize	_	0	SENT_42	[p3l1960t1187r2143b1246, p3l9t1280r295b1349],
3	vasomotor	NN	O	vasomotor	nn	4	SENT_42	[p3l331t1290r747b1349],
4	tone	NN	O	tone	dobj	2	SENT_42	[p3l781t1290r948b1349],
5	5	CD	DURATION	5	number	7	SENT_42	[p3l986t1280r1027b1349],
6	to	TO	DURATION	to	dep	7	SENT_42	[p3l1067t1290r1140b1349],
7	10	CD	DURATION	10	num	8	SENT_42	[p3l1187t1280r1273b1349],
8	minutes	NNS	NUMBER	minute	npadvmod	2	SENT_42	[p3l1309t1280r1617b1349],
9	before	IN	O	before	_	0	SENT_42	[p3l1654t1280r1904b1349],
10	coronary	JJ	O	coronary	prep_before	2	SENT_42	[p3l1941t1302r2143b1349, p3l8t1407r180b1474],

1	angiography	NN	O	angiography	nsubjpass	10	SENT_43	[p3l211t1385r720b1474],
2	,	,	O	,	_	0	SENT_43	[p3l211t1385r720b1474],
3	5	CD	NUMBER	5	number	5	SENT_43	[p3l755t1385r795b1454],
4	to	TO	O	to	dep	5	SENT_43	[p3l828t1395r902b1454],
5	10	CD	NUMBER	10	appos	1	SENT_43	[p3l941t1386r1027b1454],
6	mg	NN	O	mg	nn	8	SENT_43	[p3l1057t1407r1179b1474],
7	isosorbide	NN	O	isosorbide	nn	8	SENT_43	[p3l1209t1385r1611b1454],
8	dinitrate	NN	O	dinitrate	dep	5	SENT_43	[p3l1642t1385r1966b1454],
9	was	VBD	O	be	auxpass	10	SENT_43	[p3l1996t1407r2143b1454],
10	administered	VBN	O	administer	_	0	SENT_43	[p3l10t1489r515b1558],
11	sublingually	RB	O	sublingually	advmod	10	SENT_43	[p3l560t1489r1062b1578],
12	.	.	O	.	_	0	SENT_43	[p3l560t1489r1062b1578],

1	Primary	JJ	O	primary	amod	3	SENT_44	[p3l1109t1489r1423b1578],
2	end	NN	O	end	nn	3	SENT_44	[p3l1467t1489r1607b1558],
3	points	NNS	O	point	nsubj	4	SENT_44	[p3l1647t1489r1885b1578],
4	were	VBD	O	be	_	0	SENT_44	[p3l1930t1511r2139b1558],
5	:	:	O	:	_	0	SENT_44	[p3l1930t1511r2139b1558],
6	(	CD	NUMBER	(	number	7	SENT_44	[p3l11t1592r117b1676],
7	1	CD	NUMBER	1	num	9	SENT_44	[p3l11t1592r117b1676],
8	)	NN	O	)	nn	9	SENT_44	[p3l11t1592r117b1676],
9	change	NN	O	change	dep	16	SENT_44	[p3l152t1592r427b1681],
10	in	IN	O	in	_	0	SENT_44	[p3l458t1591r532b1659],
11	average	JJ	O	average	amod	13	SENT_44	[p3l565t1613r867b1681],
12	mean	JJ	O	mean	amod	13	SENT_44	[p3l898t1613r1109b1660],
13	segment	NN	O	segment	prep_in	9	SENT_44	[p3l1143t1602r1467b1681],
14	diameter	NN	O	diameter	dep	16	SENT_44	[p3l1497t1591r1840b1660],
15	(	CD	NUMBER	(	num	14	SENT_44	[p3l1872t1592r2143b1677],
16	MSD	NN	O	msd	dep	25	SENT_44	[p3l1872t1592r2143b1677],
17	)	CD	NUMBER	)	num	16	SENT_44	[p3l1872t1592r2143b1677],
18	per	IN	O	per	_	0	SENT_44	[p3l7t1718r133b1786],
19	patient	NN	O	patient	prep_per	16	SENT_44	[p3l175t1697r463b1786],
20	,	,	O	,	_	0	SENT_44	[p3l175t1697r463b1786],
21	and	CC	O	and	_	0	SENT_44	[p3l514t1697r653b1766],
22	(	NN	O	(	prep_per	16	SENT_44	[p3l701t1697r807b1782],
23	2	CD	NUMBER	2	number	24	SENT_44	[p3l701t1697r807b1782],
24	)	CD	NUMBER	)	num	25	SENT_44	[p3l701t1697r807b1782],
25	change	NN	O	change	dep	30	SENT_44	[p3l856t1697r1131b1786],
26	in	IN	O	in	_	0	SENT_44	[p3l1177t1697r1251b1765],
27	average	JJ	O	average	amod	29	SENT_44	[p3l1298t1718r1600b1786],
28	minimal	JJ	O	minimal	amod	29	SENT_44	[p3l1646t1697r1971b1766],
29	obstruction	NN	O	obstruction	prep_in	25	SENT_44	[p3l2019t1697r2143b1766, p3l11t1801r350b1870],
30	diameter	NN	O	diameter	dep	32	SENT_44	[p3l381t1801r724b1870],
31	(	CD	NUMBER	(	num	30	SENT_44	[p3l755t1801r1041b1886],
32	MOD	NN	O	mod	dep	4	SENT_44	[p3l755t1801r1041b1886],
33	)	CD	NUMBER	)	num	32	SENT_44	[p3l755t1801r1041b1886],
34	per	IN	O	per	dep	32	SENT_44	[p3l1074t1822r1199b1890],
35	patient	NN	O	patient	pobj	34	SENT_44	[p3l1226t1801r1512b1890],
36	.	.	O	.	_	0	SENT_44	[p3l1226t1801r1512b1890],

1	If	IN	O	if	mark	8	SENT_45	[p3l1547t1801r1617b1869],
2	a	DT	O	a	det	3	SENT_45	[p3l1642t1823r1682b1870],
3	segment	NN	O	segment	nsubjpass	8	SENT_45	[p3l1714t1811r2038b1890],
4	or	CC	O	or	_	0	SENT_45	[p3l2067t1823r2148b1870],
5	lesion	NN	O	lesion	conj_or	3	SENT_45	[p3l8t1905r241b1974],
6	was	VBD	O	be	auxpass	8	SENT_45	[p3l279t1927r426b1974],
7	adequately	RB	O	adequately	advmod	8	SENT_45	[p3l469t1905r890b1994],
8	visualized	VBN	O	visualize	advcl	37	SENT_45	[p3l929t1905r1327b1974],
9	in	IN	O	in	_	0	SENT_45	[p3l1364t1905r1438b1973],
10	2	CD	NUMBER	2	number	11	SENT_45	[p3l1477t1906r1521b1973],
11	(	CD	NUMBER	(	prep_in	8	SENT_45	[p3l1564t1905r1995b1994],
12	preferably	RB	O	preferably	advmod	8	SENT_45	[p3l1564t1905r1995b1994],
13	orthogonal	JJ	O	orthogonal	amod	15	SENT_45	[p3l2035t1927r2143b1974, p3l8t2009r380b2098],
14	)	NN	O	)	nn	15	SENT_45	[p3l2035t1927r2143b1974, p3l8t2009r380b2098],
15	projections	NNS	O	projection	tmod	8	SENT_45	[p3l409t2009r843b2098],
16	and	CC	O	and	_	0	SENT_45	[p3l875t2009r1013b2078],
17	free	JJ	O	free	advmod	15	SENT_45	[p3l1040t2009r1190b2078],
18	of	IN	O	of	_	0	SENT_45	[p3l1219t2009r1304b2078],
19	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_45	[p3l1328t2009r1734b2098],
20	foreshort	NN	O	foreshort	prep_of	17	SENT_45	[p3l1760t2009r2143b2078],
21	—	NN	O	—	tmod	8	SENT_45	[p3l1760t2009r2143b2078],
22	ening	VBG	O	ene	xcomp	8	SENT_45	[p3l9t2111r223b2201],
23	in	IN	O	in	prep	22	SENT_45	[p3l255t2111r329b2180],
24	both	CC	O	both	prep	22	SENT_45	[p3l359t2112r533b2180],
25	views	NNS	O	view	dep	24	SENT_45	[p3l564t2112r812b2193],
26	,	,	O	,	_	0	SENT_45	[p3l564t2112r812b2193],
27	the	DT	O	the	det	29	SENT_45	[p3l846t2111r964b2180],
28	average	JJ	O	average	amod	29	SENT_45	[p3l997t2133r1298b2201],
29	values	NNS	O	value	nsubjpass	37	SENT_45	[p3l1330t2112r1577b2181],
30	of	IN	O	of	_	0	SENT_45	[p3l1611t2111r1696b2180],
31	the	DT	O	the	det	32	SENT_45	[p3l1720t2112r1838b2180],
32	parameters	NNS	O	parameter	prep_of	29	SENT_45	[p3l1868t2133r2143b2201, p3l9t2227r189b2286],
33	in	IN	O	in	_	0	SENT_45	[p3l221t2217r295b2285],
34	both	DT	O	both	det	35	SENT_45	[p3l323t2217r497b2286],
35	projections	NNS	O	projection	prep_in	32	SENT_45	[p3l526t2217r960b2306],
36	were	VBD	O	be	auxpass	37	SENT_45	[p3l993t2238r1180b2286],
37	calculated	VBN	O	calculate	_	0	SENT_45	[p3l1211t2217r1627b2286],
38	.	.	O	.	_	0	SENT_45	[p3l1211t2217r1627b2286],

1	To	TO	O	to	dep	110	SENT_46	[p3l1662t2218r1767b2286],
2	calculate	VB	O	calculate	dep	110	SENT_46	[p3l1799t2217r2145b2286],
3	average	JJ	O	average	dep	110	SENT_46	[p3l10t2343r311b2410],
4	MSD	NN	O	msd	dep	110	SENT_46	[p3l353t2321r563b2390],
5	and	CC	O	and	dep	110	SENT_46	[p3l608t2321r747b2390],
6	MOD	NN	O	mod	dep	110	SENT_46	[p3l788t2321r1013b2390],
7	per	IN	O	per	dep	110	SENT_46	[p3l1057t2343r1182b2410],
8	patient	NN	O	patient	dep	110	SENT_46	[p3l1221t2321r1509b2410],
9	,	,	O	,	_	0	SENT_46	[p3l1221t2321r1509b2410],
10	the	DT	O	the	dep	110	SENT_46	[p3l1555t2321r1672b2390],
11	MSDs	NNS	O	msd	dep	110	SENT_46	[p3l1715t2321r1962b2390],
12	and	CC	O	and	dep	110	SENT_46	[p3l2008t2321r2147b2390],
13	MODS	NNS	O	mod	dep	110	SENT_46	[p3l7t2425r271b2494],
14	of	IN	O	of	dep	110	SENT_46	[p3l301t2425r386b2494],
15	all	DT	O	all	dep	110	SENT_46	[p3l407t2425r501b2494],
16	qualifying	VBG	O	qualify	dep	110	SENT_46	[p3l528t2425r929b2514],
17	segments	NNS	O	segment	dep	110	SENT_46	[p3l959t2435r1318b2514],
18	or	CC	O	or	dep	110	SENT_46	[p3l1347t2447r1428b2494],
19	obstructions	NNS	O	obstruction	dep	110	SENT_46	[p3l1453t2425r1929b2494],
20	were	VBD	O	be	dep	110	SENT_46	[p3l1958t2447r2146b2494],
21	added	VBN	O	add	dep	110	SENT_46	[p3l10t2529r242b2598],
22	and	CC	O	and	dep	110	SENT_46	[p3l300t2529r439b2598],
23	divided	VBN	O	divide	dep	110	SENT_46	[p3l496t2529r789b2598],
24	by	IN	O	by	dep	110	SENT_46	[p3l844t2529r941b2618],
25	the	DT	O	the	dep	110	SENT_46	[p3l998t2529r1116b2598],
26	number	NN	O	number	dep	110	SENT_46	[p3l1174t2529r1474b2598],
27	of	IN	O	of	dep	110	SENT_46	[p3l1531t2529r1616b2598],
28	contributing	VBG	O	contribute	dep	110	SENT_46	[p3l1667t2529r2144b2618],
29	segments	NNS	O	segment	dep	110	SENT_46	[p3l11t2644r370b2722],
30	or	CC	O	or	dep	110	SENT_46	[p3l441t2655r521b2702],
31	obstructionsf	NN	O	obstructionsf	dep	110	SENT_46	[p3l587t2633r1125b2702],
32	‘	CD	NUMBER	‘	dep	110	SENT_46	[p3l587t2633r1125b2702],
33	The	DT	O	the	dep	110	SENT_46	[p3l1192t2633r1342b2702],
34	following	VBG	O	follow	dep	110	SENT_46	[p3l1411t2633r1790b2722],
35	clinical	JJ	O	clinical	dep	110	SENT_46	[p3l1859t2633r2145b2702],
36	events	NNS	O	event	dep	110	SENT_46	[p3l9t2746r255b2805],
37	(	JJ	O	(	dep	110	SENT_46	[p3l303t2735r718b2825],
38	according	VBG	O	accord	dep	110	SENT_46	[p3l303t2735r718b2825],
39	to	TO	O	to	dep	110	SENT_46	[p3l761t2746r834b2804],
40	prespeciﬁed	JJ	O	prespeciﬁed	dep	110	SENT_46	[p3l877t2735r1353b2825],
41	criteria	NNS	O	criterion	dep	110	SENT_46	[p3l1396t2735r1701b2820],
42	)	CD	NUMBER	)	dep	110	SENT_46	[p3l1396t2735r1701b2820],
43	were	VBD	O	be	dep	110	SENT_46	[p3l1748t2757r1936b2805],
44	analyzed	VBN	O	analyze	dep	110	SENT_46	[p3l1981t2757r2143b2804, p3l8t2841r239b2930],
45	:	:	O	:	_	0	SENT_46	[p3l1981t2757r2143b2804, p3l8t2841r239b2930],
46	(	CD	NUMBER	(	dep	110	SENT_46	[p3l276t2841r382b2926],
47	1	CD	NUMBER	1	dep	110	SENT_46	[p3l276t2841r382b2926],
48	)	NN	O	)	dep	110	SENT_46	[p3l276t2841r382b2926],
49	myocardial	JJ	O	myocardial	dep	110	SENT_46	[p3l413t2841r853b2930],
50	infarction	NN	O	infarction	dep	110	SENT_46	[p3l881t2841r1262b2910],
51	(	CD	NUMBER	(	dep	110	SENT_46	[p3l1292t2841r1494b2926],
52	fatal	JJ	O	fatal	dep	110	SENT_46	[p3l1292t2841r1494b2926],
53	or	CC	O	or	dep	110	SENT_46	[p3l1523t2862r1603b2910],
54	nonfatal	JJ	O	nonfatal	dep	110	SENT_46	[p3l1628t2841r2002b2926],
55	)	NN	O	)	dep	110	SENT_46	[p3l1628t2841r2002b2926],
56	,	,	O	,	_	0	SENT_46	[p3l1628t2841r2002b2926],
57	(	NN	O	(	dep	110	SENT_46	[p3l2037t2841r2143b2926],
58	2	CD	NUMBER	2	dep	110	SENT_46	[p3l2037t2841r2143b2926],
59	)	CD	NUMBER	)	dep	110	SENT_46	[p3l2037t2841r2143b2926],
60	coronary	JJ	O	coronary	dep	110	SENT_46	[p3l9t2967r354b3034],
61	heart	NN	O	heart	dep	110	SENT_46	[p3l393t2945r589b3014],
62	disease	NN	O	disease	dep	110	SENT_46	[p3l627t2945r907b3014],
63	death	NN	O	death	dep	110	SENT_46	[p3l946t2945r1156b3014],
64	(	CD	NUMBER	(	dep	110	SENT_46	[p3l1197t2945r1429b3030],
65	other	JJ	O	other	dep	110	SENT_46	[p3l1197t2945r1429b3030],
66	than	IN	O	than	dep	110	SENT_46	[p3l1465t2945r1632b3014],
67	known	JJ	O	known	dep	110	SENT_46	[p3l1669t2945r1936b3014],
68	fatal	JJ	O	fatal	dep	110	SENT_46	[p3l1974t2945r2145b3014],
69	myocardial	JJ	O	myocardial	dep	110	SENT_46	[p3l8t3049r448b3138],
70	infarction	NN	O	infarction	dep	110	SENT_46	[p3l493t3049r927b3134],
71	)	NN	O	)	dep	110	SENT_46	[p3l493t3049r927b3134],
72	,	,	O	,	_	0	SENT_46	[p3l493t3049r927b3134],
73	(	CD	NUMBER	(	dep	110	SENT_46	[p3l979t3050r1085b3134],
74	3	CD	NUMBER	3	dep	110	SENT_46	[p3l979t3050r1085b3134],
75	)	NN	O	)	dep	110	SENT_46	[p3l979t3050r1085b3134],
76	symptom	NN	O	symptom	dep	110	SENT_46	[p3l1136t3049r1781b3138],
77	—	NN	O	—	dep	110	SENT_46	[p3l1136t3049r1781b3138],
78	driven	VBN	O	drive	dep	110	SENT_46	[p3l1136t3049r1781b3138],
79	percuta	NN	O	percuta	dep	110	SENT_46	[p3l1825t3059r2143b3138],
80	—	NN	O	—	dep	110	SENT_46	[p3l1825t3059r2143b3138],
81	neous	JJ	O	neous	dep	110	SENT_46	[p3l8t3175r233b3222],
82	transluminal	JJ	O	transluminal	dep	110	SENT_46	[p3l274t3153r763b3222],
83	coronary	JJ	O	coronary	dep	110	SENT_46	[p3l803t3175r1150b3242],
84	angioplasty	NN	O	angioplasty	dep	110	SENT_46	[p3l1191t3153r1641b3242],
85	or	CC	O	or	dep	110	SENT_46	[p3l1681t3175r1761b3222],
86	coronary	JJ	O	coronary	dep	110	SENT_46	[p3l1799t3175r2145b3242],
87	artery	NN	O	artery	dep	110	SENT_46	[p3l10t3266r234b3345],
88	bypass	NN	O	bypass	dep	110	SENT_46	[p3l279t3256r543b3345],
89	graft	NN	O	graft	dep	110	SENT_46	[p3l593t3255r776b3345],
90	surgery	NN	O	surgery	dep	110	SENT_46	[p3l824t3277r1134b3345],
91	,	,	O	,	_	0	SENT_46	[p3l824t3277r1134b3345],
92	(	CD	NUMBER	(	dep	110	SENT_46	[p3l1186t3256r1293b3341],
93	4	CD	NUMBER	4	dep	110	SENT_46	[p3l1186t3256r1293b3341],
94	)	NN	O	)	dep	110	SENT_46	[p3l1186t3256r1293b3341],
95	stroke	NN	O	stroke	dep	110	SENT_46	[p3l1344t3256r1579b3324],
96	and	CC	O	and	dep	110	SENT_46	[p3l1626t3256r1765b3324],
97	transient	JJ	O	transient	dep	110	SENT_46	[p3l1809t3256r2148b3324],
98	ischemic	JJ	O	ischemic	dep	110	SENT_46	[p3l8t3360r354b3428],
99	attack	NN	O	attack	dep	110	SENT_46	[p3l393t3360r645b3441],
100	,	,	O	,	_	0	SENT_46	[p3l393t3360r645b3441],
101	and	CC	O	and	dep	110	SENT_46	[p3l686t3360r824b3428],
102	(	NN	O	(	dep	110	SENT_46	[p3l862t3360r968b3444],
103	5	CD	NUMBER	5	dep	110	SENT_46	[p3l862t3360r968b3444],
104	)	NN	O	)	dep	110	SENT_46	[p3l862t3360r968b3444],
105	death	NN	O	death	dep	110	SENT_46	[p3l1008t3360r1218b3428],
106	(	CD	NUMBER	(	dep	110	SENT_46	[p3l1256t3360r1382b3444],
107	all	DT	O	all	dep	110	SENT_46	[p3l1256t3360r1382b3444],
108	other	JJ	O	other	dep	110	SENT_46	[p3l1419t3360r1619b3428],
109	causes	NNS	O	cause	dep	110	SENT_46	[p3l1654t3361r1960b3444],
110	)	VBP	O	)	_	0	SENT_46	[p3l1654t3361r1960b3444],
111	.	.	O	.	_	0	SENT_46	[p3l1654t3361r1960b3444],

1	The	DT	O	the	det	2	SENT_47	[p3l134t3464r284b3533],
2	study	NN	O	study	nsubjpass	4	SENT_47	[p3l317t3464r524b3553],
3	was	VBD	O	be	auxpass	4	SENT_47	[p3l554t3486r701b3533],
4	conducted	VBN	O	conduct	_	0	SENT_47	[p3l733t3464r1136b3533],
5	under	IN	O	under	_	0	SENT_47	[p3l1163t3464r1387b3533],
6	the	DT	O	the	det	7	SENT_47	[p3l1414t3464r1531b3533],
7	auspices	NNS	O	auspices	prep_under	4	SENT_47	[p3l1562t3464r1889b3553],
8	of	IN	O	of	_	0	SENT_47	[p3l1922t3464r2006b3533],
9	the	DT	O	the	det	12	SENT_47	[p3l2028t3464r2145b3533],
10	Interuniversity	NNP	ORGANIZATION	Interuniversity	nn	12	SENT_47	[p3l8t3568r585b3657],
11	Cardiology	NNP	ORGANIZATION	Cardiology	nn	12	SENT_47	[p3l612t3568r1051b3657],
12	Institute	NNP	ORGANIZATION	Institute	prep_of	7	SENT_47	[p3l1078t3568r1398b3637],
13	of	IN	O	of	_	0	SENT_47	[p3l1425t3568r1510b3637],
14	the	DT	O	the	det	18	SENT_47	[p3l1529t3568r1646b3637],
15	Netherlands	NNP	LOCATION	Netherlands	nn	18	SENT_47	[p3l1672t3568r2143b3637],
16	(	CD	NUMBER	(	num	18	SENT_47	[p3l11t3672r294b3755],
17	ICIN	NN	O	icin	nn	18	SENT_47	[p3l11t3672r294b3755],
18	)	NN	O	)	prep_of	12	SENT_47	[p3l11t3672r294b3755],
19	,	,	O	,	_	0	SENT_47	[p3l11t3672r294b3755],
20	Utrecht	NNP	ORGANIZATION	Utrecht	appos	18	SENT_47	[p3l355t3671r669b3752],
21	,	,	O	,	_	0	SENT_47	[p3l355t3671r669b3752],
22	The	DT	LOCATION	the	det	23	SENT_47	[p3l729t3671r879b3739],
23	Netherlands	NNP	LOCATION	Netherlands	appos	20	SENT_47	[p3l936t3671r1430b3740],
24	.	.	O	.	_	0	SENT_47	[p3l936t3671r1430b3740],

1	Written	VBN	O	write	csubjpass	4	SENT_48	[p3l1491t3671r1791b3740],
2	consent	NN	O	consent	dobj	1	SENT_48	[p3l1848t3681r2147b3739],
3	was	VBD	O	be	auxpass	4	SENT_48	[p4l8t39r156b86],
4	obtained	VBN	O	obtain	_	0	SENT_48	[p4l212t17r549b86],
5	from	IN	O	from	_	0	SENT_48	[p4l601t17r791b86],
6	the	DT	O	the	det	7	SENT_48	[p4l842t17r959b86],
7	patients	NNS	O	patient	prep_from	4	SENT_48	[p4l1011t17r1314b106],
8	and	CC	O	and	_	0	SENT_48	[p4l1371t17r1509b86],
9	the	DT	O	the	det	10	SENT_48	[p4l1561t17r1678b86],
10	study	NN	O	study	nsubjpass	12	SENT_48	[p4l1735t17r1941b106],
11	was	VBD	O	be	auxpass	12	SENT_48	[p4l1995t39r2143b86],
12	performed	VBN	O	perform	conj_and	4	SENT_48	[p4l7t119r416b209],
13	in	IN	O	in	_	0	SENT_48	[p4l446t120r521b188],
14	accordance	NN	O	accordance	prep_in	12	SENT_48	[p4l553t120r992b188],
15	with	IN	O	with	_	0	SENT_48	[p4l1023t119r1196b189],
16	the	DT	O	the	det	17	SENT_48	[p4l1226t120r1343b188],
17	Declaration	NN	O	declaration	prep_with	12	SENT_48	[p4l1375t120r1832b188],
18	of	IN	O	of	_	0	SENT_48	[p4l1864t119r1949b188],
19	Helsinki	NNP	LOCATION	Helsinki	prep_of	17	SENT_48	[p4l1974t120r2143b188, p4l11t224r217b293],
20	.	.	O	.	_	0	SENT_48	[p4l1974t120r2143b188, p4l11t224r217b293],

1	Patients	NNS	O	patient	dep	18	SENT_49	[p4l138t327r430b398],
2	and	CC	O	and	_	0	SENT_49	[p4l456t320r600b398],
3	controls	NNS	O	control	dep	18	SENT_49	[p4l629t320r948b399],
4	:	:	O	:	_	0	SENT_49	[p4l629t320r948b399],
5	In	IN	O	in	_	0	SENT_49	[p4l978t331r1057b397],
6	the	DT	O	the	det	7	SENT_49	[p4l1083t329r1201b398],
7	substudy	NN	O	substudy	prep_in	18	SENT_49	[p4l1231t329r1575b418],
8	reported	VBN	O	report	partmod	7	SENT_49	[p4l1601t329r1929b418],
9	here	RB	O	here	advmod	8	SENT_49	[p4l1954t329r2142b410],
10	,	,	O	,	_	0	SENT_49	[p4l1954t329r2142b410],
11	the	DT	O	the	det	13	SENT_49	[p4l8t433r125b502],
12	baseline	NN	O	baseline	nn	13	SENT_49	[p4l184t433r505b502],
13	data	NNS	O	datum	nsubj	18	SENT_49	[p4l566t433r728b502],
14	of	IN	O	of	_	0	SENT_49	[p4l786t433r871b502],
15	the	DT	O	the	det	17	SENT_49	[p4l924t433r1041b502],
16	above	JJ	O	above	amod	17	SENT_49	[p4l1103t433r1784b502],
17	—	NN	O	—	prep_of	13	SENT_49	[p4l1103t433r1784b502],
18	mentioned	VBD	O	mention	_	0	SENT_49	[p4l1103t433r1784b502],
19	patients	NNS	O	patient	nsubjpass	21	SENT_49	[p4l1841t433r2143b522],
20	were	VBD	O	be	auxpass	21	SENT_49	[p4l8t559r196b606],
21	evaluated	VBN	O	evaluate	ccomp	18	SENT_49	[p4l226t537r620b606],
22	.	.	O	.	_	0	SENT_49	[p4l226t537r620b606],

1	Desoxyribonucleic	JJ	MISC	desoxyribonucleic	amod	3	SENT_50	[p4l653t537r1394b626],
2	acid	NN	O	acid	nn	3	SENT_50	[p4l1425t537r1586b606],
3	samples	NNS	O	sample	nsubj	5	SENT_50	[p4l1617t537r1926b626],
4	were	VBD	O	be	cop	5	SENT_50	[p4l1957t559r2145b606],
5	available	JJ	O	available	_	0	SENT_50	[p4l10t639r360b709],
6	from	IN	O	from	_	0	SENT_50	[p4l401t639r591b708],
7	only	RB	O	only	quantmod	8	SENT_50	[p4l630t640r801b729],
8	496	CD	NUMBER	496	num	9	SENT_50	[p4l841t639r985b709],
9	patients	NNS	O	patient	prep_from	5	SENT_50	[p4l1024t639r1327b729],
10	due	JJ	O	due	_	0	SENT_50	[p4l1370t640r1509b708],
11	to	TO	O	to	_	0	SENT_50	[p4l1548t650r1621b708],
12	shortages	NNS	O	shortage	prep_due_to	9	SENT_50	[p4l1665t639r2029b729],
13	in	IN	O	in	_	0	SENT_50	[p4l2071t639r2145b708],
14	stocks	NNS	O	stock	prep_in	12	SENT_50	[p4l11t745r271b814],
15	.	.	O	.	_	0	SENT_50	[p4l11t745r271b814],

1	Information	NN	O	information	nsubjpass	12	SENT_51	[p4l309t745r777b814],
2	on	IN	O	on	_	0	SENT_51	[p4l810t766r905b814],
3	smoking	NN	O	smoking	nn	6	SENT_51	[p4l940t745r1272b834],
4	and	CC	O	and	_	0	SENT_51	[p4l1307t745r1446b814],
5	family	NN	O	family	nn	6	SENT_51	[p4l1477t745r1731b834],
6	history	NN	O	history	prep_on	1	SENT_51	[p4l1763t745r2034b834],
7	of	IN	O	of	_	0	SENT_51	[p4l2068t745r2152b814],
8	coronary	JJ	O	coronary	amod	10	SENT_51	[p4l9t871r354b938],
9	heart	NN	O	heart	nn	10	SENT_51	[p4l384t849r581b918],
10	disease	NN	O	disease	prep_of	6	SENT_51	[p4l610t849r890b918],
11	was	VBD	O	be	auxpass	12	SENT_51	[p4l921t871r1069b918],
12	obtained	VBN	O	obtain	_	0	SENT_51	[p4l1102t849r1439b918],
13	by	IN	O	by	_	0	SENT_51	[p4l1466t849r1562b938],
14	questionnaire	NN	O	questionnaire	agent	12	SENT_51	[p4l1593t849r2141b938],
15	.	.	O	.	_	0	SENT_51	[p4l1593t849r2141b938],

1	The	DT	O	the	det	3	SENT_52	[p4l8t953r158b1022],
2	smoking	NN	O	smoking	nn	3	SENT_52	[p4l220t953r552b1042],
3	information	NN	O	information	nsubj	4	SENT_52	[p4l612t953r1075b1022],
4	consisted	VBD	O	consist	_	0	SENT_52	[p4l1134t953r1498b1022],
5	of	IN	O	of	_	0	SENT_52	[p4l1557t953r1642b1022],
6	the	DT	O	the	det	9	SENT_52	[p4l1693t953r1811b1022],
7	current	JJ	DATE	current	amod	9	SENT_52	[p4l1870t963r2148b1022],
8	smoking	NN	O	smoking	nn	9	SENT_52	[p4l11t1057r344b1146],
9	status	NN	O	status	prep_of	4	SENT_52	[p4l386t1067r602b1126],
10	and	CC	O	and	_	0	SENT_52	[p4l644t1057r783b1126],
11	the	DT	O	the	det	12	SENT_52	[p4l820t1057r937b1126],
12	number	NN	O	number	nsubj	15	SENT_52	[p4l976t1057r1276b1126],
13	of	IN	O	of	_	0	SENT_52	[p4l1313t1057r1398b1126],
14	cigarettes	NNS	O	cigarette	prep_of	12	SENT_52	[p4l1430t1057r1802b1146],
15	smoked	VBD	O	smoke	conj_and	4	SENT_52	[p4l1845t1057r2147b1126],
16	per	IN	O	per	_	0	SENT_52	[p4l7t1183r133b1250],
17	day	NN	DURATION	day	prep_per	15	SENT_52	[p4l174t1161r332b1250],
18	.	.	O	.	_	0	SENT_52	[p4l174t1161r332b1250],

1	The	DT	O	the	det	3	SENT_53	[p4l378t1161r529b1230],
2	family	NN	O	family	nn	3	SENT_53	[p4l570t1161r824b1250],
3	history	NN	O	history	nsubjpass	5	SENT_53	[p4l865t1161r1137b1250],
4	was	VBD	O	be	auxpass	5	SENT_53	[p4l1179t1183r1327b1231],
5	considered	VBN	O	consider	_	0	SENT_53	[p4l1372t1161r1796b1230],
6	positive	JJ	O	positive	acomp	5	SENT_53	[p4l1835t1161r2146b1250],
7	when	WRB	O	when	advmod	14	SENT_53	[p4l8t1264r219b1333],
8	a	DT	O	a	det	11	SENT_53	[p4l257t1285r298b1332],
9	ﬁrst	JJ	O	ﬁrst	amod	11	SENT_53	[p4l334t1263r778b1353],
10	—	NN	O	—	nn	11	SENT_53	[p4l334t1263r778b1353],
11	degree	NN	O	degree	nsubj	14	SENT_53	[p4l334t1263r778b1353],
12	relative	JJ	O	relative	advmod	14	SENT_53	[p4l814t1263r1107b1333],
13	had	VBD	O	have	aux	14	SENT_53	[p4l1144t1264r1285b1332],
14	had	VBN	O	have	advcl	5	SENT_53	[p4l1319t1263r1460b1332],
15	a	DT	O	a	det	17	SENT_53	[p4l1498t1285r1539b1332],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_53	[p4l1574t1263r2148b1333],
17	event	NN	O	event	dobj	14	SENT_53	[p4l9t1379r220b1438],
18	before	IN	O	before	_	0	SENT_53	[p4l251t1369r501b1438],
19	the	DT	O	the	det	20	SENT_53	[p4l534t1369r652b1438],
20	age	NN	O	age	prep_before	14	SENT_53	[p4l688t1390r819b1458],
21	of	IN	O	of	_	0	SENT_53	[p4l855t1369r939b1438],
22	60	CD	NUMBER	60	prep_of	20	SENT_53	[p4l968t1369r1082b1438],
23	.	.	O	.	_	0	SENT_53	[p4l968t1369r1082b1438],

1	From	IN	O	from	_	0	SENT_54	[p4l1120t1370r1333b1438],
2	the	DT	O	the	det	4	SENT_54	[p4l1364t1369r1482b1438],
3	coronary	JJ	O	coronary	amod	4	SENT_54	[p4l1517t1390r1863b1458],
4	angiograms	NN	O	angiogram	pobj	1	SENT_54	[p4l1899t1369r2143b1458, p4l9t1495r244b1562],
5	at	IN	O	at	_	0	SENT_54	[p4l293t1483r361b1542],
6	baseline	NN	O	baseline	prep_at	4	SENT_54	[p4l404t1473r725b1542],
7	and	CC	O	and	_	0	SENT_54	[p4l773t1473r912b1542],
8	after	IN	O	after	mark	20	SENT_54	[p4l959t1473r1136b1542],
9	24	CD	DURATION	24	num	10	SENT_54	[p4l1181t1473r1275b1541],
10	months	NNS	NUMBER	month	nsubjpass	20	SENT_54	[p4l1321t1473r1630b1554],
11	,	,	O	,	_	0	SENT_54	[p4l1321t1473r1630b1554],
12	the	DT	O	the	det	14	SENT_54	[p4l1679t1473r1796b1542],
13	average	JJ	O	average	amod	14	SENT_54	[p4l1844t1495r2145b1562],
14	MSD	NN	O	msd	nsubjpass	20	SENT_54	[p4l7t1578r217b1646],
15	and	CC	O	and	_	0	SENT_54	[p4l256t1577r395b1646],
16	the	DT	O	the	det	18	SENT_54	[p4l429t1577r547b1646],
17	average	JJ	O	average	amod	18	SENT_54	[p4l585t1599r886b1666],
18	MOD	NN	O	mod	conj_and	10	SENT_54	[p4l922t1578r1147b1646],
19	were	VBD	O	be	auxpass	20	SENT_54	[p4l1185t1599r1373b1646],
20	calculated	VBN	O	calculate	conj_and	1	SENT_54	[p4l1410t1577r1866b1646],
21	.4	NN	NUMBER	.4	dobj	20	SENT_54	[p4l1410t1577r1866b1646],

1	Detection	NN	O	detection	_	0	SENT_55	[p4l138t1678r482b1749],
2	of	IN	O	of	_	0	SENT_55	[p4l512t1671r587b1749],
3	stromelysin	NN	O	stromelysin	nn	4	SENT_55	[p4l613t1672r1040b1771],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_55	[p4l1074t1672r1640b1771],
5	:	:	O	:	_	0	SENT_55	[p4l1074t1672r1640b1771],
6	The	DT	O	the	det	8	SENT_55	[p4l1670t1680r1820b1749],
7	stromelysin	NN	O	stromelysin	nn	8	SENT_55	[p4l1851t1691r2143b1749, p4l8t1782r197b1872],
8	genotype	NN	O	genotype	dep	1	SENT_55	[p4l243t1793r600b1872],
9	was	VBD	O	be	auxpass	10	SENT_55	[p4l645t1804r793b1852],
10	analyzed	VBN	O	analyze	rcmod	8	SENT_55	[p4l842t1783r1189b1872],
11	as	IN	O	as	mark	34	SENT_55	[p4l1235t1804r1310b1851],
12	described	VBN	O	describe	csubj	34	SENT_55	[p4l1358t1782r1733b1851],
13	previously	RB	DATE	previously	advmod	21	SENT_55	[p4l1775t1783r2143b1872, p4l8t1886r177b1976],
14	.14	CD	NUMBER	.14	num	19	SENT_55	[p4l1775t1783r2143b1872, p4l8t1886r177b1976],
15	Brieﬂy	NNP	O	Brieﬂy	nn	19	SENT_55	[p4l202t1887r494b1976],
16	,	,	O	,	_	0	SENT_55	[p4l202t1887r494b1976],
17	genomic	JJ	O	genomic	amod	19	SENT_55	[p4l523t1887r857b1976],
18	desoxyribonucleid	JJ	O	desoxyribonucleid	amod	19	SENT_55	[p4l884t1887r1610b1976],
19	acid	NN	O	acid	nsubjpass	21	SENT_55	[p4l1636t1887r1796b1956],
20	was	VBD	O	be	auxpass	21	SENT_55	[p4l1821t1908r1968b1956],
21	ampliﬁed	VBN	O	ampliﬁed	ccomp	12	SENT_55	[p4l1997t1908r2143b1956, p4l7t1992r258b2081],
22	in	IN	O	in	_	0	SENT_55	[p4l298t1992r372b2060],
23	a	DT	O	a	det	26	SENT_55	[p4l415t2014r456b2061],
24	polymerase	NN	O	polymerase	nn	26	SENT_55	[p4l494t1992r947b2081],
25	chain	NN	O	chain	nn	26	SENT_55	[p4l988t1992r1199b2061],
26	reaction	NN	O	reaction	prep_in	21	SENT_55	[p4l1238t1992r1554b2061],
27	using	VBG	O	use	xcomp	21	SENT_55	[p4l1594t1992r1805b2081],
28	speciﬁc	JJ	O	speciﬁc	amod	33	SENT_55	[p4l1851t1992r2144b2081],
29	polymerase	NN	O	polymerase	nn	33	SENT_55	[p4l7t2096r706b2185],
30	—	NN	O	—	nn	33	SENT_55	[p4l7t2096r706b2185],
31	chain	NN	O	chain	nn	33	SENT_55	[p4l7t2096r706b2185],
32	reaction	NN	O	reaction	nn	33	SENT_55	[p4l761t2096r1077b2165],
33	primers	NNS	O	primer	dobj	27	SENT_55	[p4l1131t2096r1429b2185],
34	(	VBP	O	(	advcl	10	SENT_55	[p4l1491t2096r1831b2181],
35	forward	RB	O	forward	advmod	36	SENT_55	[p4l1491t2096r1831b2181],
36	primer	NN	O	primer	nsubj	38	SENT_55	[p4l1885t2096r2148b2185],
37	was	VBD	O	be	cop	38	SENT_55	[p4l8t2222r156b2269],
38	ﬂuorophor	JJ	O	ﬂuorophor	ccomp	34	SENT_55	[p4l227t2200r640b2289],
39	labeled	VBN	O	label	partmod	8	SENT_55	[p4l706t2200r1040b2285],
40	)	NN	O	)	dobj	39	SENT_55	[p4l706t2200r1040b2285],
41	.	.	O	.	_	0	SENT_55	[p4l706t2200r1040b2285],

1	Ampliﬁed	JJ	O	ampliﬁed	amod	2	SENT_56	[p4l1112t2200r1510b2289],
2	samples	NNS	O	sample	nsubjpass	4	SENT_56	[p4l1579t2200r1888b2289],
3	were	VBD	O	be	auxpass	4	SENT_56	[p4l1958t2222r2146b2269],
4	loaded	VBN	O	load	_	0	SENT_56	[p4l8t2304r269b2373],
5	on	IN	O	on	_	0	SENT_56	[p4l307t2326r401b2373],
6	a	DT	O	a	det	8	SENT_56	[p4l441t2326r482b2373],
7	6	CD	PERCENT	6	number	8	SENT_56	[p4l519t2304r642b2374],
8	%	NN	PERCENT	%	prep_on	4	SENT_56	[p4l519t2304r642b2374],
9	denaturing	VBG	O	denature	xcomp	4	SENT_56	[p4l685t2304r1102b2393],
10	polyacrylamide	NN	O	polyacrylamide	nn	11	SENT_56	[p4l1139t2304r1750b2393],
11	gel	NN	O	gel	dobj	9	SENT_56	[p4l1790t2304r1906b2393],
12	in	IN	O	in	_	0	SENT_56	[p4l1944t2304r2018b2372],
13	an	DT	O	a	det	17	SENT_56	[p4l2057t2326r2146b2373],
14	ABI	NNP	MISC	ABI	nn	17	SENT_56	[p4l8t2407r175b2475],
15	Prism	NN	MISC	prism	nn	17	SENT_56	[p4l211t2406r440b2475],
16	377	CD	NUMBER	377	num	17	SENT_56	[p4l477t2407r616b2476],
17	Sequencing	NN	O	sequencing	prep_in	9	SENT_56	[p4l658t2407r1111b2496],
18	apparatus	NN	O	apparatus	nn	21	SENT_56	[p4l1151t2417r1521b2496],
19	(	CD	NUMBER	(	num	21	SENT_56	[p4l1563t2407r1848b2491],
20	Perkin	NNP	PERSON	Perkin	nn	21	SENT_56	[p4l1563t2407r1848b2491],
21	Elmer	NNP	PERSON	Elmer	dep	17	SENT_56	[p4l1883t2407r2142b2488],
22	,	,	O	,	_	0	SENT_56	[p4l1883t2407r2142b2488],
23	Nieuwerkerk	NNP	O	Nieuwerkerk	appos	17	SENT_56	[p4l7t2511r522b2579],
24	aan	FW	O	aan	dep	23	SENT_56	[p4l578t2532r710b2579],
25	de	FW	O	de	nn	26	SENT_56	[p4l768t2511r857b2579],
26	Ilssel	FW	O	ilssel	tmod	9	SENT_56	[p4l914t2511r1140b2592],
27	,	,	O	,	_	0	SENT_56	[p4l914t2511r1140b2592],
28	The	DT	LOCATION	the	det	30	SENT_56	[p4l1201t2511r1351b2579],
29	Netherlands	NNP	LOCATION	Netherlands	nn	30	SENT_56	[p4l1407t2511r1934b2595],
30	)	NN	O	)	appos	26	SENT_56	[p4l1407t2511r1934b2595],
31	.	.	O	.	_	0	SENT_56	[p4l1407t2511r1934b2595],

1	The	DT	O	the	det	3	SENT_57	[p4l1995t2511r2145b2579],
2	ﬂuorescense	NN	O	ﬂuorescense	nn	3	SENT_57	[p4l9t2615r492b2684],
3	intensity	NN	O	intensity	nsubjpass	16	SENT_57	[p4l530t2615r866b2704],
4	and	CC	O	and	_	0	SENT_57	[p4l906t2615r1045b2684],
5	emission	NN	O	emission	nsubjpass	16	SENT_57	[p4l1082t2615r1429b2684],
6	from	IN	O	from	_	0	SENT_57	[p4l1466t2615r1656b2684],
7	the	DT	O	the	det	10	SENT_57	[p4l1692t2615r1810b2684],
8	internal	JJ	O	internal	amod	10	SENT_57	[p4l1848t2615r2145b2684],
9	size	NN	O	size	nn	10	SENT_57	[p4l11t2719r158b2788],
10	standard	NN	O	standard	prep_from	3	SENT_57	[p4l192t2719r521b2788],
11	and	CC	O	and	_	0	SENT_57	[p4l552t2719r691b2788],
12	stromelysin	NN	O	stromelysin	nn	13	SENT_57	[p4l723t2719r1250b2808],
13	—	NN	O	—	conj_and	10	SENT_57	[p4l723t2719r1250b2808],
14	l	NN	O	l	tmod	16	SENT_57	[p4l723t2719r1250b2808],
15	were	VBD	O	be	auxpass	16	SENT_57	[p4l1290t2741r1478b2788],
16	collected	VBN	O	collect	_	0	SENT_57	[p4l1509t2719r1862b2788],
17	during	IN	O	during	_	0	SENT_57	[p4l1893t2719r2145b2808],
18	the	DT	O	the	det	19	SENT_57	[p4l8t2823r125b2892],
19	electrophoresis	NN	O	electrophoresis	prep_during	16	SENT_57	[p4l155t2823r768b2912],
20	.	.	O	.	_	0	SENT_57	[p4l155t2823r768b2912],

1	Analysis	NN	O	analysis	nsubjpass	5	SENT_58	[p4l801t2823r1142b2912],
2	and	CC	O	and	_	0	SENT_58	[p4l1175t2823r1313b2892],
3	genotyping	NN	O	genotyping	nsubjpass	5	SENT_58	[p4l1342t2823r1781b2912],
4	was	VBD	O	be	auxpass	5	SENT_58	[p4l1811t2845r1958b2892],
5	performed	VBN	O	perform	_	0	SENT_58	[p4l1988t2845r2143b2912, p4l8t2925r291b2994],
6	using	VBG	O	use	xcomp	5	SENT_58	[p4l328t2926r539b3015],
7	GeneScan	NNP	O	GeneScan	dobj	6	SENT_58	[p4l581t2926r977b2995],
8	2.1	CD	NUMBER	2.1	num	7	SENT_58	[p4l1017t2926r1128b2994],
9	and	CC	O	and	_	0	SENT_58	[p4l1178t2926r1316b2994],
10	Genotyper	NNP	O	Genotyper	dobj	6	SENT_58	[p4l1357t2926r1770b3015],
11	2.0	CD	NUMBER	2.0	num	10	SENT_58	[p4l1809t2926r1928b2995],
12	software	NN	O	software	nn	16	SENT_58	[p4l1971t2925r2143b2994, p4l8t3051r196b3098],
13	(	CD	NUMBER	(	num	16	SENT_58	[p4l235t3030r520b3114],
14	Perkin	NNP	PERSON	Perkin	nn	16	SENT_58	[p4l235t3030r520b3114],
15	Elmer	NNP	PERSON	Elmer	nn	16	SENT_58	[p4l554t3030r846b3114],
16	)	NNP	O	)	dep	10	SENT_58	[p4l554t3030r846b3114],
17	.	.	O	.	_	0	SENT_58	[p4l554t3030r846b3114],

1	Statistical	JJ	O	statistical	amod	2	SENT_59	[p4l135t3125r491b3203],
2	analysis	NN	O	analysis	_	0	SENT_59	[p4l525t3125r858b3224],
3	:	:	O	:	_	0	SENT_59	[p4l525t3125r858b3224],
4	Patients	NNS	O	patient	nsubjpass	2	SENT_59	[p4l892t3133r1200b3202],
5	with	IN	O	with	_	0	SENT_59	[p4l1235t3133r1407b3202],
6	the	DT	O	the	det	7	SENT_59	[p4l1439t3133r1556b3202],
7	5A5A	NN	O	5a5a	prep_with	4	SENT_59	[p4l1590t3133r1848b3214],
8	,	,	O	,	_	0	SENT_59	[p4l1590t3133r1848b3214],
9	5A6A	NN	O	5a6a	conj_and	7	SENT_59	[p4l1885t3133r2142b3214],
10	,	,	O	,	_	0	SENT_59	[p4l1885t3133r2142b3214],
11	and	CC	O	and	_	0	SENT_59	[p4l10t3236r148b3305],
12	6A6A	NN	O	6a6a	nn	13	SENT_59	[p4l206t3236r443b3305],
13	genotypes	NNS	O	genotype	conj_and	7	SENT_59	[p4l501t3246r895b3325],
14	of	IN	O	of	_	0	SENT_59	[p4l956t3236r1041b3305],
15	the	DT	O	the	det	17	SENT_59	[p4l1092t3236r1209b3305],
16	stromelysin	NN	O	stromelysin	nn	17	SENT_59	[p4l1270t3236r1724b3325],
17	polymorphism	NN	O	polymorphism	prep_of	13	SENT_59	[p4l1780t3236r2143b3325, p4l7t3339r247b3428],
18	were	VBD	O	be	auxpass	2	SENT_59	[p4l278t3361r466b3408],
19	compared	VBN	O	compare	_	0	SENT_59	[p4l499t3339r885b3428],
20	with	IN	O	with	_	0	SENT_59	[p4l916t3339r1088b3408],
21	each	DT	O	each	det	22	SENT_59	[p4l1120t3339r1298b3408],
22	other	JJ	O	other	prep_compared_with	2	SENT_59	[p4l1330t3339r1530b3408],
23	with	IN	O	with	_	0	SENT_59	[p4l1560t3339r1733b3408],
24	respect	NN	O	respect	_	0	SENT_59	[p4l1763t3350r2042b3428],
25	to	TO	O	to	_	0	SENT_59	[p4l2072t3350r2145b3408],
26	relevant	JJ	O	relevant	amod	28	SENT_59	[p4l7t3442r324b3511],
27	baseline	NN	O	baseline	nn	28	SENT_59	[p4l376t3442r697b3511],
28	characteristics	NNS	O	characteristic	prep_with_respect_to	2	SENT_59	[p4l754t3442r1334b3523],
29	,	,	O	,	_	0	SENT_59	[p4l754t3442r1334b3523],
30	changes	NNS	O	change	conj_and	2	SENT_59	[p4l1394t3442r1706b3531],
31	of	IN	O	of	_	0	SENT_59	[p4l1764t3442r1849b3511],
32	angiographic	JJ	O	angiographic	amod	33	SENT_59	[p4l1898t3442r2143b3531, p4l9t3545r299b3634],
33	parameters	NNS	O	parameter	prep_of	30	SENT_59	[p4l341t3555r793b3634],
34	,	,	O	,	_	0	SENT_59	[p4l341t3555r793b3634],
35	and	CC	O	and	_	0	SENT_59	[p4l840t3545r978b3614],
36	differences	NNS	O	difference	conj_and	2	SENT_59	[p4l1020t3545r1452b3614],
37	in	IN	O	in	_	0	SENT_59	[p4l1496t3545r1570b3613],
38	the	DT	O	the	det	39	SENT_59	[p4l1611t3545r1729b3614],
39	incidence	NN	O	incidence	prep_in	36	SENT_59	[p4l1771t3545r2145b3614],
40	of	IN	O	of	_	0	SENT_59	[p4l9t3648r94b3717],
41	clinical	JJ	O	clinical	amod	42	SENT_59	[p4l116t3648r403b3717],
42	events	NNS	O	event	prep_of	39	SENT_59	[p4l432t3658r700b3717],
43	.	.	O	.	_	0	SENT_59	[p4l432t3658r700b3717],

1	Differences	NNS	O	difference	nsubjpass	8	SENT_60	[p4l733t3648r1188b3717],
2	with	IN	O	with	_	0	SENT_60	[p4l1218t3648r1391b3717],
3	respect	NN	O	respect	_	0	SENT_60	[p4l1417t3659r1697b3737],
4	to	TO	O	to	_	0	SENT_60	[p4l1723t3659r1796b3717],
5	baseline	NN	O	baseline	nn	6	SENT_60	[p4l1824t3648r2145b3717],
6	parameters	NNS	O	parameter	prep_with_respect_to	1	SENT_60	[p5l7t24r435b103],
7	were	VBD	O	be	auxpass	8	SENT_60	[p5l463t36r652b83],
8	analyzed	VBN	O	analyze	_	0	SENT_60	[p5l679t14r1026b103],
9	with	IN	O	with	_	0	SENT_60	[p5l1051t14r1223b83],
10	1-way	JJ	O	1-way	amod	11	SENT_60	[p5l1257t15r1491b103],
11	analysis	NN	O	analysis	prep_with	8	SENT_60	[p5l1519t14r1830b103],
12	of	IN	O	of	_	0	SENT_60	[p5l1859t14r1943b83],
13	variance	NN	O	variance	prep_of	11	SENT_60	[p5l1962t14r2143b83, p5l10t138r207b198],
14	,	,	O	,	_	0	SENT_60	[p5l1962t14r2143b83, p5l10t138r207b198],
15	Kruskal-Wallis	NN	PERSON	kruskal-walli	nn	16	SENT_60	[p5l266t117r861b186],
16	test	NN	O	test	prep_of	11	SENT_60	[p5l916t127r1072b198],
17	,	,	O	,	_	0	SENT_60	[p5l916t127r1072b198],
18	or	CC	O	or	_	0	SENT_60	[p5l1130t138r1210b186],
19	chi-square	JJ	O	chi-square	amod	20	SENT_60	[p5l1263t117r1669b206],
20	test	NN	O	test	conj_or	13	SENT_60	[p5l1723t127r1878b198],
21	,	,	O	,	_	0	SENT_60	[p5l1723t127r1878b198],
22	when	WRB	O	when	dep	23	SENT_60	[p5l1935t117r2146b186],
23	appropriate	JJ	O	appropriate	dep	8	SENT_60	[p5l10t220r474b309],
24	.	.	O	.	_	0	SENT_60	[p5l10t220r474b309],

1	The	DT	O	the	det	2	SENT_61	[p5l516t220r666b289],
2	changes	NNS	O	change	nsubjpass	7	SENT_61	[p5l704t220r1016b309],
3	in	IN	O	in	_	0	SENT_61	[p5l1056t220r1130b288],
4	angiographic	JJ	O	angiographic	amod	5	SENT_61	[p5l1169t220r1677b309],
5	parameters	NNS	O	parameter	prep_in	2	SENT_61	[p5l1715t230r2143b309],
6	were	VBD	O	be	auxpass	7	SENT_61	[p5l8t345r196b392],
7	analyzed	VBN	O	analyze	_	0	SENT_61	[p5l244t323r591b412],
8	with	IN	O	with	_	0	SENT_61	[p5l636t323r808b392],
9	2-way	JJ	O	2-way	amod	11	SENT_61	[p5l855t323r1096b412],
10	covariance	NN	O	covariance	nn	11	SENT_61	[p5l1144t323r1566b392],
11	analysis	NN	O	analysis	prep_with	7	SENT_61	[p5l1614t323r1925b412],
12	with	IN	O	with	_	0	SENT_61	[p5l1974t323r2146b392],
13	randomized	VBN	O	randomize	prepc_with	7	SENT_61	[p5l7t426r471b495],
14	therapy	NN	O	therapy	nn	16	SENT_61	[p5l523t426r815b515],
15	(	CD	NUMBER	(	num	16	SENT_61	[p5l872t426r1205b515],
16	placebo	NN	O	placebo	dobj	13	SENT_61	[p5l872t426r1205b515],
17	or	CC	O	or	_	0	SENT_61	[p5l1260t447r1340b495],
18	pravastatin	NN	O	pravastatin	nn	19	SENT_61	[p5l1390t426r1851b515],
19	)	NN	O	)	dobj	13	SENT_61	[p5l1390t426r1851b515],
20	and	CC	O	and	_	0	SENT_61	[p5l1908t426r2047b495],
21	3	CD	NUMBER	3	num	23	SENT_61	[p5l2101t426r2141b495],
22	possible	JJ	O	possible	amod	23	SENT_61	[p5l7t529r328b618],
23	genotypes	NNS	O	genotype	conj_and	16	SENT_61	[p5l368t540r762b618],
24	of	IN	O	of	_	0	SENT_61	[p5l804t529r889b598],
25	the	DT	O	the	det	27	SENT_61	[p5l921t529r1038b598],
26	stromelysin	NN	O	stromelysin	nn	27	SENT_61	[p5l1081t529r1535b618],
27	polymorphism	NN	O	polymorphism	prep_of	23	SENT_61	[p5l1572t529r2147b618],
28	as	IN	O	as	_	0	SENT_61	[p5l10t653r85b700],
29	ﬁxed	JJ	O	ﬁxed	amod	30	SENT_61	[p5l123t631r317b700],
30	factors	NNS	O	factor	prep_as	13	SENT_61	[p5l350t631r612b700],
31	and	CC	O	and	_	0	SENT_61	[p5l651t631r789b700],
32	the	DT	O	the	det	34	SENT_61	[p5l822t631r940b700],
33	baseline	NN	O	baseline	nn	34	SENT_61	[p5l972t631r1294b700],
34	values	NNS	O	value	prepc_with	7	SENT_61	[p5l1328t631r1575b700],
35	as	IN	O	as	_	0	SENT_61	[p5l1613t653r1688b700],
36	covariates	NNS	O	covariate	prep_as	34	SENT_61	[p5l1725t631r2141b700],
37	.	.	O	.	_	0	SENT_61	[p5l1725t631r2141b700],

1	Time	NNP	O	Time	nsubjpass	7	SENT_62	[p5l8t735r212b804],
2	to	TO	O	to	aux	3	SENT_62	[p5l251t745r324b804],
3	ﬁrst	VB	O	ﬁrst	infmod	1	SENT_62	[p5l365t735r516b804],
4	clinical	JJ	O	clinical	amod	5	SENT_62	[p5l553t735r840b804],
5	event	NN	O	event	dobj	3	SENT_62	[p5l879t745r1091b804],
6	was	VBD	O	be	auxpass	7	SENT_62	[p5l1128t756r1276b804],
7	analyzed	VBN	O	analyze	_	0	SENT_62	[p5l1318t735r1665b824],
8	with	IN	O	with	_	0	SENT_62	[p5l1703t735r1875b804],
9	Cox	NN	PERSON	cox	poss	11	SENT_62	[p5l1914t735r2144b804],
10	’s	POS	O	’s	_	0	SENT_62	[p5l1914t735r2144b804],
11	model	NN	O	model	prep_with	7	SENT_62	[p5l8t838r271b907],
12	.	.	O	.	_	0	SENT_62	[p5l8t838r271b907],

1	The	DT	O	the	det	3	SENT_63	[p5l307t838r457b907],
2	differential	JJ	O	differential	amod	3	SENT_63	[p5l489t838r923b907],
3	effect	NN	O	effect	nsubjpass	15	SENT_63	[p5l954t838r1177b907],
4	of	IN	O	of	_	0	SENT_63	[p5l1207t838r1291b907],
5	pravastatin	NN	O	pravastatin	nn	6	SENT_63	[p5l1314t838r1745b927],
6	treatment	NN	O	treatment	prep_of	3	SENT_63	[p5l1776t849r2147b907],
7	on	IN	O	on	_	0	SENT_63	[p5l9t963r104b1010],
8	patients	NNS	O	patient	prep_on	6	SENT_63	[p5l152t941r455b1030],
9	with	IN	O	with	_	0	SENT_63	[p5l508t941r681b1010],
10	and	CC	O	and	_	0	SENT_63	[p5l732t941r870b1010],
11	without	IN	O	without	_	0	SENT_63	[p5l920t941r1219b1010],
12	the	DT	O	the	det	13	SENT_63	[p5l1267t941r1385b1010],
13	variation	NN	O	variation	prep_without	8	SENT_63	[p5l1436t941r1784b1010],
14	was	VBD	O	be	auxpass	15	SENT_63	[p5l1834t963r1982b1010],
15	assessed	VBN	O	assess	_	0	SENT_63	[p5l2036t963r2143b1010, p5l11t1043r258b1112],
16	with	IN	O	with	_	0	SENT_63	[p5l291t1043r464b1112],
17	the	DT	O	the	det	18	SENT_63	[p5l497t1043r614b1112],
18	test	NN	O	test	prep_with	15	SENT_63	[p5l649t1053r785b1112],
19	for	IN	O	for	_	0	SENT_63	[p5l818t1043r931b1112],
20	interaction	NN	O	interaction	prep_for	18	SENT_63	[p5l963t1043r1383b1112],
21	between	IN	O	between	_	0	SENT_63	[p5l1415t1043r1742b1112],
22	treatment	NN	O	treatment	prep_between	20	SENT_63	[p5l1775t1053r2147b1112],
23	and	CC	O	and	_	0	SENT_63	[p5l10t1147r148b1216],
24	genotype	NN	O	genotype	prep_between	20	SENT_63	[p5l196t1158r574b1236],
25	.	.	O	.	_	0	SENT_63	[p5l196t1158r574b1236],

1	A	DT	O	a	det	3	SENT_64	[p5l626t1148r695b1215],
2	p	NN	O	p	nn	3	SENT_64	[p5l741t1169r788b1236],
3	value	NN	O	value	nsubjpass	8	SENT_64	[p5l837t1147r1047b1216],
4	of	IN	O	of	_	0	SENT_64	[p5l1097t1147r1182b1216],
5	£	CD	MONEY	£	num	6	SENT_64	[p5l1230t1147r1471b1217],
6	0.05	CD	MONEY	0.05	prep_of	3	SENT_64	[p5l1230t1147r1471b1217],
7	was	VBD	O	be	auxpass	8	SENT_64	[p5l1523t1169r1671b1216],
8	considered	VBN	O	consider	_	0	SENT_64	[p5l1722t1147r2146b1216],
9	signiﬁcant	NN	O	signiﬁcant	dobj	8	SENT_64	[p5l11t1250r435b1339],
10	.	.	O	.	_	0	SENT_64	[p5l11t1250r435b1339],

1	RESULTS	NNS	O	result	_	0	SENT_65	[p5l13t1444r461b1531],

1	Genotype	NN	O	genotype	nn	2	SENT_66	[p5l134t1557r506b1650],
2	distribution	NN	O	distribution	nsubj	14	SENT_66	[p5l550t1551r976b1628],
3	and	CC	O	and	_	0	SENT_66	[p5l1022t1551r1166b1628],
4	allele	NN	O	allele	nn	5	SENT_66	[p5l1213t1551r1415b1628],
5	frequencies	NNS	O	frequency	conj_and	2	SENT_66	[p5l1458t1550r1915b1650],
6	:	:	O	:	_	0	SENT_66	[p5l1458t1550r1915b1650],
7	Desoxyribonucleid	JJ	O	desoxyribonucleid	amod	9	SENT_66	[p5l1962t1561r2143b1628, p5l9t1662r603b1751],
8	acid	NN	O	acid	nn	9	SENT_66	[p5l644t1662r805b1731],
9	samples	NNS	O	sample	nsubj	14	SENT_66	[p5l847t1662r1156b1751],
10	from	IN	O	from	_	0	SENT_66	[p5l1199t1662r1389b1731],
11	494	CD	NUMBER	494	num	12	SENT_66	[p5l1427t1662r1572b1732],
12	patients	NNS	O	patient	prep_from	9	SENT_66	[p5l1611t1662r1914b1751],
13	were	VBD	O	be	cop	14	SENT_66	[p5l1957t1683r2145b1731],
14	available	JJ	O	available	_	0	SENT_66	[p5l10t1765r361b1834],
15	for	IN	O	for	_	0	SENT_66	[p5l405t1765r519b1834],
16	analysis	NN	O	analysis	prep_for	14	SENT_66	[p5l562t1765r873b1854],
17	of	IN	O	of	_	0	SENT_66	[p5l920t1765r1005b1834],
18	the	DT	O	the	det	23	SENT_66	[p5l1042t1765r1160b1834],
19	stromelysin	NN	O	stromelysin	nn	23	SENT_66	[p5l1207t1765r1734b1854],
20	—	NN	O	—	nn	23	SENT_66	[p5l1207t1765r1734b1854],
21	l	NN	O	l	nn	23	SENT_66	[p5l1207t1765r1734b1854],
22	promoter	NN	O	promoter	nn	23	SENT_66	[p5l1786t1776r2147b1854],
23	variant	NN	O	variant	prep_of	16	SENT_66	[p5l8t1867r280b1936],
24	and	CC	O	and	_	0	SENT_66	[p5l316t1867r454b1936],
25	evaluation	NN	O	evaluation	prep_for	14	SENT_66	[p5l489t1867r896b1936],
26	of	IN	O	of	_	0	SENT_66	[p5l932t1867r1017b1936],
27	the	DT	O	the	det	28	SENT_66	[p5l1044t1867r1162b1936],
28	association	NN	O	association	prep_of	25	SENT_66	[p5l1199t1867r1633b1936],
29	between	IN	O	between	_	0	SENT_66	[p5l1666t1867r1993b1936],
30	the	DT	O	the	det	32	SENT_66	[p5l2028t1867r2145b1936],
31	stromelysin-1	NN	O	stromelysin-1	nn	32	SENT_66	[p5l11t1971r538b2060],
32	polymorphism	NN	O	polymorphism	prep_between	28	SENT_66	[p5l577t1971r1152b2060],
33	and	CC	O	and	_	0	SENT_66	[p5l1183t1971r1322b2040],
34	disease	NN	O	disease	nn	35	SENT_66	[p5l1352t1971r1633b2040],
35	progression	NN	O	progression	prep_between	28	SENT_66	[p5l1663t1971r2141b2060],
36	.	.	O	.	_	0	SENT_66	[p5l1663t1971r2141b2060],

1	Two	CD	NUMBER	two	number	2	SENT_67	[p5l8t2076r184b2144],
2	hundred	CD	NUMBER	hundred	num	3	SENT_67	[p5l241t2074r563b2143],
3	forty-nine	CD	NUMBER	forty-nine	nsubj	7	SENT_67	[p5l617t2074r1009b2163],
4	of	IN	O	of	_	0	SENT_67	[p5l1066t2074r1151b2143],
5	these	DT	O	these	det	6	SENT_67	[p5l1200t2074r1399b2143],
6	patients	NNS	O	patient	prep_of	3	SENT_67	[p5l1453t2074r1757b2163],
7	received	VBD	O	receive	_	0	SENT_67	[p5l1814t2074r2146b2143],
8	placebo	NN	O	placebo	dobj	7	SENT_67	[p5l7t2177r310b2266],
9	and	CC	O	and	_	0	SENT_67	[p5l344t2177r482b2246],
10	245	CD	NUMBER	245	num	11	SENT_67	[p5l512t2177r651b2246],
11	pravastatin	NN	O	pravastatin	conj_and	8	SENT_67	[p5l684t2177r1135b2266],
12	.	.	O	.	_	0	SENT_67	[p5l684t2177r1135b2266],

1	The	DT	O	the	det	2	SENT_68	[p5l1170t2177r1320b2246],
2	frequency	NN	O	frequency	nsubj	12	SENT_68	[p5l1351t2177r1741b2266],
3	of	IN	O	of	_	0	SENT_68	[p5l1772t2177r1857b2246],
4	the	DT	O	the	det	6	SENT_68	[p5l1880t2177r1998b2246],
5	6A	NN	O	6a	nn	6	SENT_68	[p5l2029t2177r2145b2246],
6	allele	NN	O	allele	prep_of	2	SENT_68	[p5l10t2279r218b2348],
7	in	IN	O	in	_	0	SENT_68	[p5l253t2279r327b2347],
8	the	DT	O	the	det	11	SENT_68	[p5l362t2279r479b2348],
9	total	JJ	O	total	amod	11	SENT_68	[p5l514t2279r686b2348],
10	patient	NN	O	patient	nn	11	SENT_68	[p5l720t2279r989b2368],
11	group	NN	O	group	prep_in	6	SENT_68	[p5l1023t2300r1248b2368],
12	was	VBD	O	be	_	0	SENT_68	[p5l1284t2300r1432b2348],
13	0.51	CD	PERCENT	0.51	num	18	SENT_68	[p5l1469t2278r1629b2348],
14	(	CD	PERCENT	(	number	15	SENT_68	[p5l1676t2278r1880b2364],
15	95	CD	PERCENT	95	dep	16	SENT_68	[p5l1676t2278r1880b2364],
16	%	NN	PERCENT	%	dep	18	SENT_68	[p5l1676t2278r1880b2364],
17	conﬁdence	NN	O	conﬁdence	nn	18	SENT_68	[p5l1920t2279r2143b2348, p5l9t2383r235b2452],
18	intervals	NNS	O	interval	nsubj	19	SENT_68	[p5l267t2383r601b2452],
19	0.48	CD	NUMBER	0.48	xcomp	12	SENT_68	[p5l636t2384r801b2453],
20	to	TO	O	to	_	0	SENT_68	[p5l837t2394r910b2452],
21	0.54	CD	NUMBER	0.54	num	22	SENT_68	[p5l943t2383r1166b2468],
22	)	CD	NUMBER	)	prep_to	19	SENT_68	[p5l943t2383r1166b2468],
23	,	,	O	,	_	0	SENT_68	[p5l943t2383r1166b2468],
24	and	CC	O	and	_	0	SENT_68	[p5l1204t2383r1342b2452],
25	the	DT	O	the	det	27	SENT_68	[p5l1373t2383r1491b2452],
26	genotype	NN	O	genotype	nn	27	SENT_68	[p5l1524t2394r1881b2472],
27	distribution	NN	O	distribution	nsubj	29	SENT_68	[p5l1914t2383r2143b2452, p5l7t2486r257b2555],
28	was	VBD	O	be	cop	29	SENT_68	[p5l305t2508r453b2555],
29	consistent	JJ	O	consistent	conj_and	12	SENT_68	[p5l504t2486r896b2555],
30	with	IN	O	with	_	0	SENT_68	[p5l943t2486r1116b2555],
31	a	DT	O	a	det	32	SENT_68	[p5l1165t2508r1206b2555],
32	sample	NN	O	sample	prep_with	29	SENT_68	[p5l1255t2486r1528b2575],
33	drawn	VBN	O	draw	partmod	32	SENT_68	[p5l1577t2486r1820b2555],
34	from	IN	O	from	_	0	SENT_68	[p5l1868t2486r2058b2555],
35	a	DT	O	a	det	36	SENT_68	[p5l2107t2508r2148b2555],
36	population	NN	O	population	prep_from	33	SENT_68	[p5l7t2589r427b2678],
37	in	IN	O	in	_	0	SENT_68	[p5l462t2589r537b2657],
38	Hardy	NNP	LOCATION	Hardy	prep_in	36	SENT_68	[p5l572t2589r1236b2678],
39	.	.	O	.	_	0	SENT_68	[p5l572t2589r1236b2678],

1	—	NN	O	—	_	0	SENT_69	[p5l572t2589r1236b2678],
2	.	.	O	.	_	0	SENT_69	[p5l572t2589r1236b2678],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_70	[p5l572t2589r1236b2678],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_70	[p5l1273t2589r1749b2678],
3	.	.	O	.	_	0	SENT_70	[p5l1273t2589r1749b2678],

1	Baseline	NN	O	baseline	nn	3	SENT_71	[p5l138t2684r450b2761],
2	patient	NN	O	patient	nn	3	SENT_71	[p5l490t2690r753b2783],
3	characteristics	NNS	O	characteristic	_	0	SENT_71	[p5l788t2684r1347b2762],
4	:	:	O	:	_	0	SENT_71	[p5l788t2684r1347b2762],
5	The	DT	O	the	det	6	SENT_71	[p5l1388t2692r1538b2761],
6	distribution	NN	O	distribution	dep	3	SENT_71	[p5l1578t2692r2029b2761],
7	of	IN	O	of	_	0	SENT_71	[p5l2068t2692r2152b2761],
8	the	DT	O	the	det	9	SENT_71	[p5l8t2795r125b2864],
9	patient	NN	O	patient	prep_of	6	SENT_71	[p5l158t2795r426b2884],
10	baseline	NN	O	baseline	nn	11	SENT_71	[p5l458t2795r779b2864],
11	characteristics	NNS	O	characteristic	nsubj	28	SENT_71	[p5l814t2795r1395b2876],
12	,	,	O	,	_	0	SENT_71	[p5l814t2795r1395b2876],
13	such	JJ	O	such	_	0	SENT_71	[p5l1436t2795r1611b2864],
14	as	IN	O	as	_	0	SENT_71	[p5l1647t2817r1722b2864],
15	age	NN	O	age	prep_such_as	11	SENT_71	[p5l1760t2817r1913b2884],
16	,	,	O	,	_	0	SENT_71	[p5l1760t2817r1913b2884],
17	body	NN	O	body	nn	19	SENT_71	[p5l1950t2795r2144b2884],
18	mass	NN	O	mass	nn	19	SENT_71	[p5l8t2919r200b2967],
19	index	NN	O	index	prep_such_as	11	SENT_71	[p5l262t2898r499b2979],
20	,	,	O	,	_	0	SENT_71	[p5l262t2898r499b2979],
21	smoking	NN	O	smoking	nn	22	SENT_71	[p5l566t2898r898b2987],
22	habits	NNS	O	habit	prep_such_as	11	SENT_71	[p5l959t2898r1213b2979],
23	,	,	O	,	_	0	SENT_71	[p5l959t2898r1213b2979],
24	and	CC	O	and	_	0	SENT_71	[p5l1279t2898r1417b2967],
25	medication	NN	O	medication	conj_and	15	SENT_71	[p5l1476t2898r1931b2979],
26	,	,	O	,	_	0	SENT_71	[p5l1476t2898r1931b2979],
27	was	VBD	O	be	cop	28	SENT_71	[p5l1996t2919r2143b2967],
28	comparable	JJ	O	comparable	rcmod	9	SENT_71	[p5l9t3001r464b3090],
29	for	IN	O	for	_	0	SENT_71	[p5l498t3001r611b3070],
30	the	DT	O	the	det	32	SENT_71	[p5l642t3001r759b3070],
31	3	CD	NUMBER	3	num	32	SENT_71	[p5l795t3002r834b3071],
32	stromelysins	NNS	O	stromelysin	prep_for	28	SENT_71	[p5l875t3001r1387b3090],
33	.	.	O	.	_	0	SENT_71	[p5l875t3001r1387b3090],

1	The	DT	O	the	det	2	SENT_72	[p5l1424t3001r1574b3070],
2	levels	NNS	O	level	nsubj	19	SENT_72	[p5l1608t3001r1832b3070],
3	of	IN	O	of	_	0	SENT_72	[p5l1868t3001r1953b3070],
4	triglycerides	NNS	O	triglyceride	prep_of	2	SENT_72	[p5l1979t3001r2143b3090, p5l8t3104r382b3193],
5	,	,	O	,	_	0	SENT_72	[p5l1979t3001r2143b3090, p5l8t3104r382b3193],
6	and	CC	O	and	_	0	SENT_72	[p5l415t3104r553b3173],
7	total	NN	O	total	prep_of	2	SENT_72	[p5l579t3104r772b3185],
8	,	,	O	,	_	0	SENT_72	[p5l579t3104r772b3185],
9	high	JJ	O	high	amod	10	SENT_72	[p5l802t3104r1029b3193],
10	—	NN	O	—	conj_and	4	SENT_72	[p5l802t3104r1029b3193],
11	,	,	O	,	_	0	SENT_72	[p5l802t3104r1029b3193],
12	and	CC	O	and	_	0	SENT_72	[p5l1062t3104r1200b3173],
13	low	JJ	O	low	amod	17	SENT_72	[p5l1227t3104r1688b3193],
14	—	NN	O	—	nn	17	SENT_72	[p5l1227t3104r1688b3193],
15	density	NN	O	density	nn	17	SENT_72	[p5l1227t3104r1688b3193],
16	lipoprotein	NN	O	lipoprotein	nn	17	SENT_72	[p5l1716t3104r2146b3193],
17	cholesterol	NN	O	cholesterol	conj_and	4	SENT_72	[p5l9t3207r437b3276],
18	were	VBD	O	be	cop	19	SENT_72	[p5l480t3228r668b3276],
19	comparable	JJ	O	comparable	_	0	SENT_72	[p5l711t3207r1167b3296],
20	for	IN	O	for	_	0	SENT_72	[p5l1210t3207r1323b3276],
21	the	DT	O	the	det	23	SENT_72	[p5l1363t3207r1481b3276],
22	stromelysin	NN	O	stromelysin	nn	23	SENT_72	[p5l1527t3207r1981b3296],
23	genotypes	NNS	O	genotype	prep_for	19	SENT_72	[p5l2023t3228r2143b3296, p5l8t3321r333b3399],
24	,	,	O	,	_	0	SENT_72	[p5l2023t3228r2143b3296, p5l8t3321r333b3399],
25	and	CC	O	and	_	0	SENT_72	[p5l379t3310r517b3379],
26	no	DT	O	no	det	30	SENT_72	[p5l557t3332r652b3379],
27	genotype	NN	O	genotype	nn	30	SENT_72	[p5l695t3310r1385b3399],
28	—	NN	O	—	nn	30	SENT_72	[p5l695t3310r1385b3399],
29	speciﬁc	NN	O	speciﬁc	nn	30	SENT_72	[p5l695t3310r1385b3399],
30	inﬂuence	NN	O	inﬂuence	nsubjpass	32	SENT_72	[p5l1427t3310r1785b3379],
31	was	VBD	O	be	auxpass	32	SENT_72	[p5l1826t3332r1974b3379],
32	observed	VBN	O	observe	conj_and	19	SENT_72	[p5l2018t3310r2143b3379, p5l11t3413r263b3482],
33	on	IN	O	on	_	0	SENT_72	[p5l292t3435r387b3482],
34	the	DT	O	the	det	36	SENT_72	[p5l415t3413r532b3482],
35	baseline	NN	O	baseline	nn	36	SENT_72	[p5l560t3413r881b3482],
36	severity	NN	O	severity	prep_on	32	SENT_72	[p5l914t3413r1218b3502],
37	of	IN	O	of	_	0	SENT_72	[p5l1249t3413r1334b3482],
38	coronary	JJ	O	coronary	amod	39	SENT_72	[p5l1356t3435r1702b3502],
39	disease	NN	O	disease	prep_of	36	SENT_72	[p5l1733t3413r2035b3494],
40	,	,	O	,	_	0	SENT_72	[p5l1733t3413r2035b3494],
41	as	IN	O	as	mark	42	SENT_72	[p5l2069t3435r2144b3482],
42	represented	VBN	O	represent	advcl	32	SENT_72	[p5l7t3516r460b3605],
43	by	IN	O	by	_	0	SENT_72	[p5l501t3516r597b3605],
44	MOD	NNP	O	MOD	prep_by	42	SENT_72	[p5l640t3516r888b3597],
45	,	,	O	,	_	0	SENT_72	[p5l640t3516r888b3597],
46	MSD	NNP	O	MSD	prep_by	42	SENT_72	[p5l934t3516r1166b3597],
47	,	,	O	,	_	0	SENT_72	[p5l934t3516r1166b3597],
48	and	CC	O	and	_	0	SENT_72	[p5l1215t3516r1353b3585],
49	extent	NN	O	extent	conj_and	44	SENT_72	[p5l1396t3526r1635b3585],
50	of	IN	O	of	_	0	SENT_72	[p5l1677t3516r1761b3585],
51	coronary	JJ	O	coronary	amod	53	SENT_72	[p5l1798t3537r2144b3605],
52	artery	NN	O	artery	nn	53	SENT_72	[p5l10t3630r234b3708],
53	disease	NN	O	disease	prep_of	49	SENT_72	[p5l272t3619r572b3688],
54	.	.	O	.	_	0	SENT_72	[p5l272t3619r572b3688],

1	Effect	NN	O	effect	_	0	SENT_73	[p5l138t3712r339b3790],
2	of	IN	O	of	_	0	SENT_73	[p5l369t3712r444b3790],
3	genotype	NN	O	genotype	nn	6	SENT_73	[p5l475t3730r831b3812],
4	and	CC	O	and	_	0	SENT_73	[p5l863t3713r1007b3790],
5	pravastatin	NN	O	pravastatin	conj_and	3	SENT_73	[p5l1046t3719r1472b3812],
6	treatment	NN	O	treatment	prep_of	1	SENT_73	[p5l1508t3730r1874b3790],
7	on	IN	O	on	_	0	SENT_73	[p5l1904t3743r1995b3790],
8	the	DT	O	the	det	9	SENT_73	[p5l2031t3713r2146b3790],
9	occurrence	NN	O	occurrence	prep_on	1	SENT_73	[p6l8t39r418b86],
10	of	IN	O	of	_	0	SENT_73	[p6l455t7r531b86],
11	clinical	JJ	O	clinical	amod	12	SENT_73	[p6l567t8r824b86],
12	events	NNS	O	event	prep_of	9	SENT_73	[p6l864t25r1127b86],
13	:	:	O	:	_	0	SENT_73	[p6l864t25r1127b86],
14	After	IN	O	after	_	0	SENT_73	[p6l1168t17r1375b86],
15	2	CD	DURATION	2	num	16	SENT_73	[p6l1414t17r1458b85],
16	years	NNS	NUMBER	year	prep_after	33	SENT_73	[p6l1497t38r1700b106],
17	of	IN	O	of	_	0	SENT_73	[p6l1742t17r1827b86],
18	followup	NN	O	followup	prep_of	16	SENT_73	[p6l1859t17r2143b86, p6l7t143r124b210],
19	,	,	O	,	_	0	SENT_73	[p6l1859t17r2143b86, p6l7t143r124b210],
20	nearly	RB	O	nearly	quantmod	23	SENT_73	[p6l168t121r411b210],
21	twice	RB	O	twice	quantmod	23	SENT_73	[p6l452t121r662b190],
22	as	IN	O	as	quantmod	23	SENT_73	[p6l705t143r780b190],
23	many	JJ	O	many	num	25	SENT_73	[p6l822t143r1038b210],
24	clinical	JJ	O	clinical	amod	25	SENT_73	[p6l1079t121r1365b190],
25	events	NNS	O	event	nsubjpass	33	SENT_73	[p6l1406t132r1653b190],
26	(	VBP	O	(	rcmod	25	SENT_73	[p6l1698t122r1919b206],
27	most	RBS	O	most	nsubj	31	SENT_73	[p6l1698t122r1919b206],
28	were	VBD	O	be	cop	31	SENT_73	[p6l1957t143r2145b190],
29	clinical	JJ	O	clinical	amod	31	SENT_73	[p6l9t224r295b293],
30	restenosis	NN	O	restenosis	nn	31	SENT_73	[p6l360t224r777b309],
31	)	NN	O	)	ccomp	26	SENT_73	[p6l360t224r777b309],
32	were	VBD	O	be	auxpass	33	SENT_73	[p6l846t246r1034b293],
33	observed	VBN	O	observe	dep	1	SENT_73	[p6l1102t224r1454b293],
34	in	IN	O	in	_	0	SENT_73	[p6l1519t224r1593b292],
35	the	DT	O	the	det	37	SENT_73	[p6l1658t224r1776b293],
36	placebo	NN	O	placebo	nn	37	SENT_73	[p6l1841t224r2144b313],
37	group	NN	O	group	prep_in	33	SENT_73	[p6l9t347r234b415],
38	in	IN	O	in	_	0	SENT_73	[p6l275t326r349b394],
39	those	DT	O	those	det	40	SENT_73	[p6l388t326r593b395],
40	patients	NNS	O	patient	prep_in	37	SENT_73	[p6l632t326r935b415],
41	with	IN	O	with	_	0	SENT_73	[p6l977t326r1149b395],
42	6A6A	NN	O	6a6a	nn	45	SENT_73	[p6l1191t326r1427b395],
43	and	CC	O	and	_	0	SENT_73	[p6l1468t326r1607b395],
44	5A6A	NN	O	5a6a	conj_and	42	SENT_73	[p6l1647t325r1884b395],
45	genotypes	NNS	O	genotype	prep_with	40	SENT_73	[p6l1925t347r2142b415, p6l8t441r211b519],
46	compared	VBN	O	compare	_	0	SENT_73	[p6l260t430r646b519],
47	with	IN	O	with	prepc_compared_with	33	SENT_73	[p6l691t430r863b499],
48	those	DT	O	those	det	49	SENT_73	[p6l909t430r1114b499],
49	homozygous	JJ	O	homozygous	pobj	33	SENT_73	[p6l1159t430r1659b519],
50	for	IN	O	for	_	0	SENT_73	[p6l1707t430r1821b499],
51	the	DT	O	the	det	53	SENT_73	[p6l1864t430r1982b499],
52	5A	NN	O	5a	nn	53	SENT_73	[p6l2029t430r2146b500],
53	allele	NN	O	allele	prep_for	49	SENT_73	[p6l10t533r242b614],
54	;	:	O	;	_	0	SENT_73	[p6l10t533r242b614],
55	clinical	JJ	O	clinical	amod	56	SENT_73	[p6l293t533r579b602],
56	events	NNS	O	event	nsubj	63	SENT_73	[p6l627t543r873b602],
57	in	IN	O	in	_	0	SENT_73	[p6l922t533r996b601],
58	the	DT	O	the	det	60	SENT_73	[p6l1042t533r1160b602],
59	pravastatin	NN	O	pravastatin	nn	60	SENT_73	[p6l1205t533r1637b622],
60	group	NN	O	group	prep_in	56	SENT_73	[p6l1684t555r1909b622],
61	were	VBD	O	be	cop	63	SENT_73	[p6l1957t555r2145b602],
62	substantially	RB	O	substantially	advmod	63	SENT_73	[p6l11t635r503b724],
63	lower	JJR	O	lower	dep	53	SENT_73	[p6l553t635r776b704],
64	for	IN	O	for	mark	69	SENT_73	[p6l824t635r938b704],
65	5A6A	NN	O	5a6a	nn	68	SENT_73	[p6l987t635r1224b704],
66	and	CC	O	and	_	0	SENT_73	[p6l1274t635r1413b704],
67	6A6A	NN	O	6a6a	conj_and	65	SENT_73	[p6l1463t635r1700b704],
68	genotypes	NNS	O	genotype	nsubj	69	SENT_73	[p6l1750t645r2143b724],
69	(	VBP	O	(	ccomp	63	SENT_73	[p6l11t739r262b824],
70	Table	NNP	O	Table	dobj	69	SENT_73	[p6l11t739r262b824],
71	1	CD	NUMBER	1	number	72	SENT_73	[p6l296t740r378b824],
72	)	CD	NUMBER	)	num	49	SENT_73	[p6l296t740r378b824],
73	.	.	O	.	_	0	SENT_73	[p6l296t740r378b824],

1	Thus	RB	O	thus	advmod	7	SENT_74	[p6l417t739r632b821],
2	,	,	O	,	_	0	SENT_74	[p6l417t739r632b821],
3	the	DT	O	the	det	4	SENT_74	[p6l669t739r787b808],
4	response	NN	O	response	nsubj	7	SENT_74	[p6l819t761r1162b828],
5	to	TO	O	to	_	0	SENT_74	[p6l1196t749r1269b808],
6	medication	NN	O	medication	prep_to	4	SENT_74	[p6l1304t739r1739b808],
7	showed	VBD	O	show	_	0	SENT_74	[p6l1776t739r2072b808],
8	a	DT	O	a	det	12	SENT_74	[p6l2106t761r2147b808],
9	genotype	NN	O	genotype	nn	12	SENT_74	[p6l9t842r699b931],
10	—	NN	O	—	nn	12	SENT_74	[p6l9t842r699b931],
11	speciﬁc	NN	O	speciﬁc	nn	12	SENT_74	[p6l9t842r699b931],
12	effect	NN	O	effect	nsubj	19	SENT_74	[p6l738t842r960b911],
13	beneﬁting	VBG	O	beneﬁting	partmod	12	SENT_74	[p6l995t842r1386b931],
14	heterozygotes	NNS	O	heterozygote	dobj	13	SENT_74	[p6l1424t842r1967b931],
15	and	CC	O	and	_	0	SENT_74	[p6l2008t842r2146b911],
16	6A	NN	O	6a	nn	17	SENT_74	[p6l9t945r126b1014],
17	homozygotes	NNS	O	homozygote	conj_and	14	SENT_74	[p6l174t945r695b1034],
18	only	RB	O	only	advmod	13	SENT_74	[p6l748t945r919b1034],
19	(	VBP	O	(	ccomp	7	SENT_74	[p6l972t945r1047b1034],
20	p	NN	O	p	dobj	19	SENT_74	[p6l972t945r1047b1034],
21	=	JJ	O	=	advmod	19	SENT_74	[p6l1107t969r1166b991],
22	0.04	CD	NUMBER	0.04	num	23	SENT_74	[p6l1227t945r1448b1030],
23	)	NN	O	)	dep	21	SENT_74	[p6l1227t945r1448b1030],
24	.	.	O	.	_	0	SENT_74	[p6l1227t945r1448b1030],

1	This	DT	O	this	det	2	SENT_75	[p6l1503t945r1672b1014],
2	effect	NN	O	effect	nsubjpass	4	SENT_75	[p6l1725t945r1947b1014],
3	was	VBD	O	be	auxpass	4	SENT_75	[p6l1995t966r2143b1014],
4	emphasized	VBN	O	emphasize	_	0	SENT_75	[p6l9t1048r471b1137],
5	by	IN	O	by	_	0	SENT_75	[p6l508t1048r604b1137],
6	the	DT	O	the	det	7	SENT_75	[p6l643t1048r761b1117],
7	calculation	NN	O	calculation	agent	4	SENT_75	[p6l801t1048r1230b1117],
8	of	IN	O	of	_	0	SENT_75	[p6l1270t1048r1355b1117],
9	survival	NN	O	survival	nn	10	SENT_75	[p6l1390t1048r1701b1117],
10	curves	NNS	O	curve	prep_of	7	SENT_75	[p6l1741t1070r1992b1117],
11	for	IN	O	for	_	0	SENT_75	[p6l2034t1048r2148b1117],
12	each	DT	O	each	det	13	SENT_75	[p6l9t1151r186b1220],
13	genotype	NN	O	genotype	prep_for	4	SENT_75	[p6l217t1161r574b1240],
14	separately	RB	O	separately	advmod	13	SENT_75	[p6l608t1151r1001b1240],
15	in	IN	O	in	_	0	SENT_75	[p6l1032t1151r1106b1219],
16	the	DT	O	the	det	17	SENT_75	[p6l1136t1151r1253b1220],
17	placebo	NN	O	placebo	prep_in	13	SENT_75	[p6l1282t1151r1586b1240],
18	and	CC	O	and	_	0	SENT_75	[p6l1619t1151r1758b1220],
19	pravastatin	NN	O	pravastatin	nn	20	SENT_75	[p6l1786t1161r2143b1240, p6l8t1254r109b1323],
20	groups	NNS	O	group	prep_in	13	SENT_75	[p6l153t1275r416b1343],
21	(	CD	NUMBER	(	num	22	SENT_75	[p6l464t1254r748b1343],
22	Figure	NN	O	figure	dep	20	SENT_75	[p6l464t1254r748b1343],
23	1	CD	NUMBER	1	num	24	SENT_75	[p6l801t1254r868b1339],
24	)	NN	O	)	dep	20	SENT_75	[p6l801t1254r868b1339],
25	and	CC	O	and	_	0	SENT_75	[p6l916t1254r1055b1323],
26	by	IN	O	by	_	0	SENT_75	[p6l1096t1254r1192b1343],
27	calculating	VBG	O	calculate	prepc_by	13	SENT_75	[p6l1237t1254r1664b1343],
28	risk	NN	O	risk	nn	29	SENT_75	[p6l1708t1254r1856b1323],
29	differences	NNS	O	difference	dobj	27	SENT_75	[p6l1898t1254r2143b1323, p6l9t1378r221b1425],
30	and	CC	O	and	_	0	SENT_75	[p6l257t1356r396b1425],
31	odds	NNS	O	odds	nn	32	SENT_75	[p6l428t1356r608b1425],
32	ratios	NNS	O	ratio	dobj	27	SENT_75	[p6l640t1356r855b1425],
33	for	IN	O	for	_	0	SENT_75	[p6l890t1356r1003b1425],
34	treatment	NN	O	treatment	nn	35	SENT_75	[p6l1033t1367r1404b1425],
35	effect	NN	O	effect	prep_for	27	SENT_75	[p6l1435t1356r1658b1425],
36	within	IN	O	within	_	0	SENT_75	[p6l1688t1356r1937b1425],
37	each	DT	O	each	det	38	SENT_75	[p6l1969t1356r2146b1425],
38	genotype	NN	O	genotype	prep_within	35	SENT_75	[p6l9t1470r366b1549],
39	class	NN	O	class	nn	41	SENT_75	[p6l411t1460r597b1529],
40	(	CD	NUMBER	(	num	41	SENT_75	[p6l647t1460r898b1545],
41	Table	NNP	O	Table	dep	13	SENT_75	[p6l647t1460r898b1545],
42	11	CD	NUMBER	11	number	43	SENT_75	[p6l942t1461r1057b1545],
43	)	CD	NUMBER	)	dep	41	SENT_75	[p6l942t1461r1057b1545],
44	.	.	O	.	_	0	SENT_75	[p6l942t1461r1057b1545],

1	These	DT	O	these	det	2	SENT_76	[p6l1107t1460r1339b1529],
2	data	NNS	O	datum	nsubj	3	SENT_76	[p6l1385t1460r1547b1529],
3	show	VBP	O	show	_	0	SENT_76	[p6l1593t1460r1794b1529],
4	that	IN	O	that	complm	13	SENT_76	[p6l1838t1460r1985b1529],
5	the	DT	O	the	det	7	SENT_76	[p6l2028t1460r2145b1529],
6	main	JJ	O	main	amod	7	SENT_76	[p6l8t1563r202b1632],
7	effect	NN	O	effect	nsubj	13	SENT_76	[p6l242t1563r464b1632],
8	of	IN	O	of	_	0	SENT_76	[p6l503t1563r588b1632],
9	pravastatin	NN	O	pravastatin	prep_of	7	SENT_76	[p6l619t1563r1050b1652],
10	is	VBZ	O	be	cop	13	SENT_76	[p6l1089t1563r1150b1632],
11	a	DT	O	a	det	13	SENT_76	[p6l1193t1584r1234b1632],
12	great	JJ	O	great	amod	13	SENT_76	[p6l1272t1573r1467b1652],
13	improvement	NN	O	improvement	ccomp	3	SENT_76	[p6l1504t1563r2029b1652],
14	of	IN	O	of	_	0	SENT_76	[p6l2068t1563r2152b1632],
15	the	DT	O	the	det	16	SENT_76	[p6l8t1665r125b1734],
16	chances	NNS	O	chance	prep_of	13	SENT_76	[p6l170t1665r476b1734],
17	of	IN	O	of	_	0	SENT_76	[p6l524t1665r609b1734],
18	event	NN	O	event	dep	21	SENT_76	[p6l647t1665r1042b1734],
19	—	CD	NUMBER	—	num	18	SENT_76	[p6l647t1665r1042b1734],
20	free	JJ	O	free	amod	21	SENT_76	[p6l647t1665r1042b1734],
21	survival	NN	O	survival	prep_of	16	SENT_76	[p6l1090t1665r1401b1735],
22	in	IN	O	in	_	0	SENT_76	[p6l1445t1665r1519b1733],
23	the	DT	O	the	det	24	SENT_76	[p6l1563t1665r1680b1734],
24	5A6A	NN	O	5a6a	prep_in	21	SENT_76	[p6l1726t1665r1963b1735],
25	and	CC	O	and	cc	21	SENT_76	[p6l2008t1665r2147b1734],

1	6A6A	NN	O	6a6a	nn	2	SENT_77	[p6l9t1769r246b1838],
2	genotypes	NNS	O	genotype	nsubj	3	SENT_77	[p6l283t1779r676b1858],
3	(	VBP	O	(	_	0	SENT_77	[p6l717t1770r792b1858],
4	p	NN	O	p	dobj	3	SENT_77	[p6l717t1770r792b1858],
5	=	JJ	O	=	advmod	3	SENT_77	[p6l839t1793r898b1816],
6	0.038	CD	NUMBER	0.038	num	7	SENT_77	[p6l944t1769r1215b1854],
7	)	NN	O	)	dep	5	SENT_77	[p6l944t1769r1215b1854],
8	.	.	O	.	_	0	SENT_77	[p6l944t1769r1215b1854],

1	No	DT	O	no	det	2	SENT_78	[p6l134t1873r251b1941],
2	association	NN	O	association	nsubjpass	4	SENT_78	[p6l289t1872r722b1941],
3	was	VBD	O	be	auxpass	4	SENT_78	[p6l757t1893r904b1941],
4	observed	VBN	O	observe	_	0	SENT_78	[p6l942t1872r1295b1941],
5	between	IN	O	between	_	0	SENT_78	[p6l1327t1872r1654b1941],
6	stromelysin	NN	O	stromelysin	prep_between	4	SENT_78	[p6l1692t1872r2146b1961],

1	CORONARY	JJ	O	coronary	amod	3	SENT_79	[p6l378t2038r559b2064],
2	ARTERY	NN	O	artery	nn	3	SENT_79	[p6l570t2038r674b2064],
3	DISEASE/PRAVASTAT	NN	O	disease/pravastat	_	0	SENT_79	[p6l688t2036r1026b2068],
4	/	:	O	/	punct	14	SENT_79	[p6l688t2036r1026b2068],
5	/	:	O	/	punct	6	SENT_79	[p6l688t2036r1026b2068],
6	\	CD	NUMBER	\	dep	14	SENT_79	[p6l688t2036r1026b2068],
7	I	PRP	O	I	dep	6	SENT_79	[p6l688t2036r1026b2068],
8	AND	CC	O	and	_	0	SENT_79	[p6l1036t2038r1106b2064],
9	STRO	NN	O	stro	dep	14	SENT_79	[p6l1120t2038r1323b2064],
10	/	:	O	/	punct	11	SENT_79	[p6l1120t2038r1323b2064],
11	\	CD	NUMBER	\	dep	9	SENT_79	[p6l1120t2038r1323b2064],
12	/	:	O	/	punct	11	SENT_79	[p6l1120t2038r1323b2064],
13	\	CD	NUMBER	\	dep	6	SENT_79	[p6l1120t2038r1323b2064],
14	ELYS	NNS	O	ely	dep	3	SENT_79	[p6l1120t2038r1323b2064],
15	|	VBD	O	|	rcmod	14	SENT_79	[p6l1120t2038r1323b2064],
16	N	NN	O	n	prep	14	SENT_79	[p6l1120t2038r1323b2064],
17	GENE	NN	O	gene	nn	18	SENT_79	[p6l1338t2038r1424b2064],
18	POLY	NN	O	poly	dep	16	SENT_79	[p6l1440t2038r1680b2064],
19	/	:	O	/	punct	14	SENT_79	[p6l1440t2038r1680b2064],
20	\	CD	NUMBER	\	dep	3	SENT_79	[p6l1440t2038r1680b2064],
21	/	:	O	/	punct	24	SENT_79	[p6l1440t2038r1680b2064],
22	\	CD	NUMBER	\	num	23	SENT_79	[p6l1440t2038r1680b2064],
23	ORPH	NN	O	orph	nsubj	24	SENT_79	[p6l1440t2038r1680b2064],
24	|	VBD	O	|	dep	20	SENT_79	[p6l1440t2038r1680b2064],
25	Sl	NNP	O	Sl	dobj	24	SENT_79	[p6l1440t2038r1680b2064],
26	\	CD	NUMBER	\	num	25	SENT_79	[p6l1440t2038r1680b2064],
27	/	:	O	/	punct	24	SENT_79	[p6l1440t2038r1680b2064],
28	\	CD	NUMBER	\	num	29	SENT_79	[p6l1440t2038r1680b2064],
29	853	CD	NUMBER	853	dep	3	SENT_79	[p6l1719t2034r1781b2065],

1	TABLE	NN	O	table	nn	3	SENT_80	[p6l129t2169r214b2196],
2	I	CD	NUMBER	i	num	3	SENT_80	[p6l228t2170r233b2196],
3	Change	NNP	O	Change	_	0	SENT_80	[p6l256t2168r369b2204],
4	in	IN	O	in	_	0	SENT_80	[p6l384t2172r405b2196],
5	Angio	NNP	LOCATION	Angio	nn	7	SENT_80	[p6l419t2169r506b2204],
6	phic	JJ	O	phic	amod	7	SENT_80	[p6l559t2168r616b2204],
7	Parameters	NNS	O	parameter	prep_in	3	SENT_80	[p6l631t2170r787b2196],
8	and	CC	O	and	_	0	SENT_80	[p6l800t2168r853b2196],
9	Clinical	JJ	O	clinical	amod	10	SENT_80	[p6l867t2168r973b2196],
10	Events	NNS	O	event	prep_in	3	SENT_80	[p6l989t2170r1075b2196],
11	in	IN	O	in	dep	3	SENT_80	[p6l1090t2172r1111b2196],
12	Patients	NNS	O	patient	pobj	11	SENT_80	[p6l1127t2170r1233b2196],
13	Randomized	VBN	O	randomize	partmod	12	SENT_80	[p6l1247t2168r1424b2196],
14	to	TO	O	to	_	0	SENT_80	[p6l1438t2174r1463b2196],
15	Placebo	NNP	O	Placebo	prep_to	13	SENT_80	[p6l1477t2168r1589b2196],
16	or	CC	O	or	_	0	SENT_80	[p6l1602t2179r1630b2196],
17	Pravastatin	NNP	O	Pravastatin	nn	18	SENT_80	[p6l1644t2170r1796b2196],
18	Treatment	NN	O	treatment	prep_to	13	SENT_80	[p6l1810t2170r1957b2201],
19	,	,	O	,	_	0	SENT_80	[p6l1810t2170r1957b2201],
20	According	VBG	O	accord	_	0	SENT_80	[p6l129t2205r277b2242],
21	to	TO	O	to	prepc_according_to	13	SENT_80	[p6l291t2211r316b2234],
22	Stromelysin	NNP	O	Stromelysin	nn	23	SENT_80	[p6l329t2205r489b2242],
23	notypes	NNS	O	notype	pobj	13	SENT_80	[p6l549t2211r657b2242],

1	Placebo	NNP	O	Placebo	nn	2	SENT_81	[p6l826t2269r930b2296],
2	Pravastatin	NNP	O	Pravastatin	_	0	SENT_81	[p6l1525t2272r1668b2296],

1	Stromelysin	NNP	O	Stromelysin	nn	3	SENT_82	[p6l658t2332r808b2366],
2	Genotype	NNP	O	Genotype	nn	3	SENT_82	[p6l821t2334r953b2366],
3	Stromelysin	NNP	O	Stromelysin	_	0	SENT_82	[p6l1391t2332r1541b2366],
4	Genotype	NN	O	genotype	dep	3	SENT_82	[p6l1554t2334r1686b2366],

1	5A5A	NN	O	5a5a	nn	8	SENT_83	[p6l556t2396r637b2421],
2	5A6A	NN	O	5a6a	nn	8	SENT_83	[p6l765t2396r846b2421],
3	6A6A	NN	O	6a6a	nn	8	SENT_83	[p6l974t2396r1055b2421],
4	5A5A	NN	O	5a5a	nn	8	SENT_83	[p6l1315t2396r1396b2421],
5	5A6A	NN	O	5a6a	nn	8	SENT_83	[p6l1498t2396r1579b2421],
6	6A6A	NN	O	6a6a	nn	8	SENT_83	[p6l1681t2396r1762b2421],
7	p	NN	O	p	nn	8	SENT_83	[p6l1864t2405r1879b2429],
8	p	NN	O	p	dep	28	SENT_83	[p6l1977t2405r1993b2429],
9	(	CD	NUMBER	(	num	10	SENT_83	[p6l539t2433r559b2465],
10	n	NN	O	n	dep	8	SENT_83	[p6l539t2433r559b2465],
11	=	JJ	O	=	quantmod	13	SENT_83	[p6l575t2444r595b2452],
12	66	CD	NUMBER	66	number	13	SENT_83	[p6l610t2433r653b2465],
13	)	CD	NUMBER	)	num	24	SENT_83	[p6l610t2433r653b2465],
14	(	NN	O	(	nn	24	SENT_83	[p6l738t2433r759b2465],
15	n	NN	O	n	nn	24	SENT_83	[p6l738t2433r759b2465],
16	=	JJ	O	=	amod	24	SENT_83	[p6l775t2444r794b2452],
17	121	CD	NUMBER	121	number	18	SENT_83	[p6l813t2433r872b2465],
18	)	CD	NUMBER	)	num	24	SENT_83	[p6l813t2433r872b2465],
19	(	NN	O	(	nn	24	SENT_83	[p6l957t2433r978b2465],
20	n	NN	O	n	nn	24	SENT_83	[p6l957t2433r978b2465],
21	=	JJ	O	=	amod	24	SENT_83	[p6l994t2444r1013b2452],
22	62	CD	NUMBER	62	num	24	SENT_83	[p6l1028t2433r1072b2465],
23	)	NN	O	)	nn	24	SENT_83	[p6l1028t2433r1072b2465],
24	p	NN	O	p	dep	10	SENT_83	[p6l1131t2443r1146b2466],
25	Value	NN	O	value	dep	28	SENT_83	[p6l1158t2432r1250b2459],
26	*	CD	NUMBER	*	num	25	SENT_83	[p6l1158t2432r1250b2459],
27	(	NN	O	(	nn	28	SENT_83	[p6l1298t2433r1319b2465],
28	n	NN	O	n	_	0	SENT_83	[p6l1298t2433r1319b2465],
29	=	JJ	O	=	quantmod	31	SENT_83	[p6l1335t2444r1354b2452],
30	53	CD	NUMBER	53	number	31	SENT_83	[p6l1368t2433r1412b2465],
31	)	CD	NUMBER	)	num	38	SENT_83	[p6l1368t2433r1412b2465],
32	(	NN	O	(	nn	38	SENT_83	[p6l1471t2433r1492b2465],
33	n	NN	O	n	nn	38	SENT_83	[p6l1471t2433r1492b2465],
34	=	JJ	O	=	amod	38	SENT_83	[p6l1508t2444r1527b2452],
35	127	CD	NUMBER	127	number	36	SENT_83	[p6l1546t2433r1605b2465],
36	)	CD	NUMBER	)	num	38	SENT_83	[p6l1546t2433r1605b2465],
37	(	NN	O	(	nn	38	SENT_83	[p6l1664t2433r1685b2465],
38	n	NN	O	n	dep	28	SENT_83	[p6l1664t2433r1685b2465],
39	=	JJ	O	=	quantmod	41	SENT_83	[p6l1701t2444r1720b2452],
40	65	CD	NUMBER	65	number	41	SENT_83	[p6l1735t2433r1779b2465],
41	)	CD	NUMBER	)	num	44	SENT_83	[p6l1735t2433r1779b2465],
42	Value	NNP	O	Value	nn	44	SENT_83	[p6l1823t2432r1915b2459],
43	*	CD	NUMBER	*	num	44	SENT_83	[p6l1823t2432r1915b2459],
44	Value1	NN	O	value1	dep	38	SENT_83	[p6l1939t2431r2028b2459],

1	Total	JJ	O	total	amod	3	SENT_84	[p6l129t2494r192b2521],
2	cholesterol	NN	O	cholesterol	nn	3	SENT_84	[p6l205t2494r346b2521],
3	decrease	NN	O	decrease	dep	8	SENT_84	[p6l360t2494r480b2521],
4	-0.11	CD	NUMBER	-0.11	num	5	SENT_84	[p6l505t2496r588b2521],
5	(	CD	NUMBER	(	dep	3	SENT_84	[p6l608t2496r688b2528],
6	0.64	CD	NUMBER	0.64	num	7	SENT_84	[p6l608t2496r688b2528],
7	)	NN	O	)	dep	8	SENT_84	[p6l608t2496r688b2528],
8	-0.16	CD	NUMBER	-0.16	dep	15	SENT_84	[p6l715t2496r803b2521],
9	(	CD	NUMBER	(	number	10	SENT_84	[p6l817t2496r897b2528],
10	0.55	CD	NUMBER	0.55	num	11	SENT_84	[p6l817t2496r897b2528],
11	)	NN	O	)	dep	8	SENT_84	[p6l817t2496r897b2528],
12	-0.14	CD	NUMBER	-0.14	num	13	SENT_84	[p6l924t2496r1012b2521],
13	(	CD	NUMBER	(	dep	11	SENT_84	[p6l1026t2496r1106b2528],
14	0.80	CD	NUMBER	0.80	num	15	SENT_84	[p6l1026t2496r1106b2528],
15	)	NN	O	)	dep	24	SENT_84	[p6l1026t2496r1106b2528],
16	0.97	CD	NUMBER	0.97	num	18	SENT_84	[p6l1149t2496r1215b2521],
17	1.27	CD	NUMBER	1.27	num	18	SENT_84	[p6l1279t2496r1341b2521],
18	(	NN	O	(	dep	15	SENT_84	[p6l1354t2496r1434b2528],
19	0.67	CD	NUMBER	0.67	number	20	SENT_84	[p6l1354t2496r1434b2528],
20	)	CD	NUMBER	)	num	22	SENT_84	[p6l1354t2496r1434b2528],
21	1.37	CD	NUMBER	1.37	number	22	SENT_84	[p6l1462t2496r1524b2521],
22	(	CD	NUMBER	(	dep	18	SENT_84	[p6l1537t2496r1617b2528],
23	0.67	CD	NUMBER	0.67	num	24	SENT_84	[p6l1537t2496r1617b2528],
24	)	NN	O	)	dep	29	SENT_84	[p6l1537t2496r1617b2528],
25	1.15	CD	NUMBER	1.15	number	26	SENT_84	[p6l1645t2497r1705b2521],
26	(	CD	NUMBER	(	dep	24	SENT_84	[p6l1720t2496r1800b2528],
27	0.70	CD	NUMBER	0.70	num	28	SENT_84	[p6l1720t2496r1800b2528],
28	)	NN	O	)	dep	26	SENT_84	[p6l1720t2496r1800b2528],
29	0.91	CD	NUMBER	0.91	_	0	SENT_84	[p6l1838t2496r1897b2521],
30	0.88	CD	NUMBER	0.88	num	32	SENT_84	[p6l1942t2496r2006b2521],
31	(	NN	O	(	nn	32	SENT_84	[p6l170t2532r294b2565],
32	mmol/L	NN	O	mmol/l	nsubj	35	SENT_84	[p6l170t2532r294b2565],
33	)	CD	NUMBER	)	dep	32	SENT_84	[p6l170t2532r294b2565],
34	:	:	O	:	_	0	SENT_84	[p6l170t2532r294b2565],
35	mean	VB	O	mean	rcmod	29	SENT_84	[p6l309t2543r380b2559],
36	(	JJ	O	(	amod	37	SENT_84	[p6l395t2533r446b2565],
37	SD	NN	O	sd	dobj	35	SENT_84	[p6l395t2533r446b2565],
38	)	CD	NUMBER	)	num	39	SENT_84	[p6l395t2533r446b2565],
39	MSD	NNP	O	MSD	dep	37	SENT_84	[p6l130t2571r195b2596],
40	de	IN	O	de	amod	37	SENT_84	[p6l207t2569r240b2596],
41	rease	NN	O	rease	nn	44	SENT_84	[p6l258t2580r328b2596],
42	(	CD	NUMBER	(	num	44	SENT_84	[p6l342t2571r412b2603],
43	mm	NN	O	mm	nn	44	SENT_84	[p6l342t2571r412b2603],
44	)	NN	O	)	dep	37	SENT_84	[p6l342t2571r412b2603],
45	:	:	O	:	_	0	SENT_84	[p6l342t2571r412b2603],
46	0.09	CD	NUMBER	0.09	number	47	SENT_84	[p6l529t2571r594b2596],
47	(	CD	NUMBER	(	dep	44	SENT_84	[p6l608t2571r688b2603],
48	0.19	CD	NUMBER	0.19	num	49	SENT_84	[p6l608t2571r688b2603],
49	)	NN	O	)	dep	57	SENT_84	[p6l608t2571r688b2603],
50	0.09	CD	NUMBER	0.09	number	51	SENT_84	[p6l738t2571r803b2596],
51	(	CD	NUMBER	(	dep	49	SENT_84	[p6l817t2571r897b2603],
52	0.20	CD	NUMBER	0.20	dep	51	SENT_84	[p6l817t2571r897b2603],
53	)	NN	O	)	dep	57	SENT_84	[p6l817t2571r897b2603],
54	0.08	CD	NUMBER	0.08	num	53	SENT_84	[p6l947t2571r1011b2596],
55	(	CD	NUMBER	(	num	57	SENT_84	[p6l1026t2571r1106b2603],
56	0.15	CD	NUMBER	0.15	num	57	SENT_84	[p6l1026t2571r1106b2603],
57	)	NN	O	)	dep	60	SENT_84	[p6l1026t2571r1106b2603],
58	0.94	CD	NUMBER	0.94	num	59	SENT_84	[p6l1149t2571r1214b2596],
59	0.03	CD	NUMBER	0.03	dep	57	SENT_84	[p6l1275t2571r1338b2596],
60	(	NN	O	(	dep	63	SENT_84	[p6l1354t2571r1434b2603],
61	0.13	CD	NUMBER	0.13	num	60	SENT_84	[p6l1354t2571r1434b2603],
62	)	CD	NUMBER	)	num	63	SENT_84	[p6l1354t2571r1434b2603],
63	0.07	CD	NUMBER	0.07	dep	68	SENT_84	[p6l1458t2571r1524b2596],
64	(	NN	O	(	dep	63	SENT_84	[p6l1537t2571r1617b2603],
65	0.17	CD	NUMBER	0.17	num	64	SENT_84	[p6l1537t2571r1617b2603],
66	)	CD	NUMBER	)	number	67	SENT_84	[p6l1537t2571r1617b2603],
67	0.08	CD	NUMBER	0.08	dep	64	SENT_84	[p6l1641t2571r1705b2596],
68	(	NN	O	(	dep	44	SENT_84	[p6l1720t2571r1800b2603],
69	0.15	CD	NUMBER	0.15	num	68	SENT_84	[p6l1720t2571r1800b2603],
70	)	CD	NUMBER	)	number	71	SENT_84	[p6l1720t2571r1800b2603],
71	0.38	CD	NUMBER	0.38	num	44	SENT_84	[p6l1838t2571r1902b2596],
72	0.71	CD	NUMBER	0.71	num	73	SENT_84	[p6l1942t2571r2001b2596],
73	mean	NN	O	mean	dep	44	SENT_84	[p6l169t2618r240b2633],

1	MOD	NN	O	mod	nn	2	SENT_85	[p6l130t2646r204b2671],
2	decrease	NN	O	decrease	dep	25	SENT_85	[p6l217t2644r338b2671],
3	(	CD	NUMBER	(	num	5	SENT_85	[p6l352t2646r421b2678],
4	mm	NN	O	mm	nn	5	SENT_85	[p6l352t2646r421b2678],
5	)	NN	O	)	dep	2	SENT_85	[p6l352t2646r421b2678],
6	:	:	O	:	_	0	SENT_85	[p6l352t2646r421b2678],
7	0.06	CD	NUMBER	0.06	number	8	SENT_85	[p6l529t2646r594b2671],
8	(	CD	NUMBER	(	dep	5	SENT_85	[p6l608t2646r688b2678],
9	0.24	CD	NUMBER	0.24	num	10	SENT_85	[p6l608t2646r688b2678],
10	)	NN	O	)	dep	14	SENT_85	[p6l608t2646r688b2678],
11	0.08	CD	NUMBER	0.08	dep	10	SENT_85	[p6l738t2646r802b2671],
12	(	CD	NUMBER	(	dep	14	SENT_85	[p6l817t2646r897b2678],
13	0.19	CD	NUMBER	0.19	num	14	SENT_85	[p6l817t2646r897b2678],
14	)	NN	O	)	dep	5	SENT_85	[p6l817t2646r897b2678],
15	0.12	CD	NUMBER	0.12	number	16	SENT_85	[p6l947t2646r1011b2671],
16	(	CD	NUMBER	(	dep	14	SENT_85	[p6l1026t2646r1106b2678],
17	0.25	CD	NUMBER	0.25	num	18	SENT_85	[p6l1026t2646r1106b2678],
18	)	NN	O	)	dep	16	SENT_85	[p6l1026t2646r1106b2678],
19	0.19	CD	NUMBER	0.19	num	20	SENT_85	[p6l1149t2646r1214b2671],
20	0.02	CD	NUMBER	0.02	dep	5	SENT_85	[p6l1275t2646r1339b2671],
21	(	NN	O	(	dep	25	SENT_85	[p6l1354t2646r1434b2678],
22	0.16	CD	NUMBER	0.16	num	21	SENT_85	[p6l1354t2646r1434b2678],
23	)	CD	NUMBER	)	num	25	SENT_85	[p6l1354t2646r1434b2678],
24	0.05	CD	NUMBER	0.05	num	25	SENT_85	[p6l1458t2646r1522b2671],
25	(	NN	O	(	dep	29	SENT_85	[p6l1537t2646r1617b2678],
26	0.21	CD	NUMBER	0.21	number	27	SENT_85	[p6l1537t2646r1617b2678],
27	)	CD	NUMBER	)	dep	25	SENT_85	[p6l1537t2646r1617b2678],
28	0.03	CD	NUMBER	0.03	dep	27	SENT_85	[p6l1641t2646r1705b2671],
29	(	NN	O	(	dep	31	SENT_85	[p6l1720t2646r1800b2678],
30	0.25	CD	NUMBER	0.25	num	29	SENT_85	[p6l1720t2646r1800b2678],
31	)	CD	NUMBER	)	dep	33	SENT_85	[p6l1720t2646r1800b2678],
32	0.23	CD	NUMBER	0.23	num	33	SENT_85	[p6l1838t2646r1902b2671],
33	0.55	CD	NUMBER	0.55	_	0	SENT_85	[p6l1942t2646r2006b2671],

1	dian	NN	O	dian	_	0	SENT_86	[p6l208t2682r266b2709],
2	(	CD	NUMBER	(	num	4	SENT_86	[p6l281t2683r345b2715],
3	IQR	NN	O	iqr	nn	4	SENT_86	[p6l281t2683r345b2715],
4	)	NN	O	)	dep	1	SENT_86	[p6l281t2683r345b2715],

1	C	NN	O	c	nsubj	5	SENT_87	[p6l130t2721r165b2746],
2	’	CD	NUMBER	’	num	4	SENT_87	[p6l130t2721r165b2746],
3	ical	JJ	O	ical	amod	4	SENT_87	[p6l186t2719r230b2746],
4	events	NNS	O	event	dep	1	SENT_87	[p6l243t2725r325b2746],
5	(	VBP	O	(	_	0	SENT_87	[p6l339t2720r457b2754],
6	yes/no	JJ	O	yes/no	amod	7	SENT_87	[p6l339t2720r457b2754],
7	)	NN	O	)	dobj	5	SENT_87	[p6l339t2720r457b2754],
8	:	:	O	:	_	0	SENT_87	[p6l339t2720r457b2754],
9	8	CD	PERCENT	8	number	10	SENT_87	[p6l543t2721r558b2746],
10	(	CD	PERCENT	(	dep	7	SENT_87	[p6l573t2721r648b2753],
11	12	CD	PERCENT	12	num	12	SENT_87	[p6l573t2721r648b2753],
12	%	NN	PERCENT	%	dep	20	SENT_87	[p6l573t2721r648b2753],
13	)	CD	NUMBER	)	number	14	SENT_87	[p6l573t2721r648b2753],
14	32	CD	NUMBER	32	num	15	SENT_87	[p6l742t2721r777b2746],
15	(	NN	O	(	dep	12	SENT_87	[p6l791t2721r867b2753],
16	26	CD	PERCENT	26	number	17	SENT_87	[p6l791t2721r867b2753],
17	%	NN	PERCENT	%	amod	15	SENT_87	[p6l791t2721r867b2753],
18	)	CD	NUMBER	)	dep	20	SENT_87	[p6l791t2721r867b2753],
19	16	CD	NUMBER	16	num	20	SENT_87	[p6l955t2721r987b2746],
20	(	NN	O	(	dep	7	SENT_87	[p6l1000t2721r1076b2753],
21	26	CD	PERCENT	26	num	22	SENT_87	[p6l1000t2721r1076b2753],
22	%	NN	PERCENT	%	dep	20	SENT_87	[p6l1000t2721r1076b2753],
23	)	CD	NUMBER	)	number	24	SENT_87	[p6l1000t2721r1076b2753],
24	0.047	CD	NUMBER	0.047	num	22	SENT_87	[p6l1149t2721r1234b2746],
25	9	CD	NUMBER	9	num	26	SENT_87	[p6l1301t2721r1318b2746],
26	(	NN	O	(	dep	22	SENT_87	[p6l1332t2721r1408b2753],
27	17	CD	PERCENT	17	num	28	SENT_87	[p6l1332t2721r1408b2753],
28	%	NN	PERCENT	%	dep	7	SENT_87	[p6l1332t2721r1408b2753],
29	)	CD	PERCENT	)	number	30	SENT_87	[p6l1332t2721r1408b2753],
30	12	CD	PERCENT	12	num	28	SENT_87	[p6l1488t2721r1519b2746],
31	(	CD	PERCENT	(	num	33	SENT_87	[p6l1534t2721r1591b2753],
32	9	CD	PERCENT	9	num	33	SENT_87	[p6l1534t2721r1591b2753],
33	%	NN	PERCENT	%	dep	44	SENT_87	[p6l1534t2721r1591b2753],
34	)	CD	NUMBER	)	number	35	SENT_87	[p6l1534t2721r1591b2753],
35	9	CD	NUMBER	9	num	36	SENT_87	[p6l1667t2721r1684b2746],
36	(	NN	O	(	dep	33	SENT_87	[p6l1698t2721r1774b2753],
37	14	CD	PERCENT	14	num	38	SENT_87	[p6l1698t2721r1774b2753],
38	%	NN	PERCENT	%	dep	36	SENT_87	[p6l1698t2721r1774b2753],
39	)	CD	NUMBER	)	number	40	SENT_87	[p6l1698t2721r1774b2753],
40	0.34	CD	NUMBER	0.34	num	38	SENT_87	[p6l1838t2721r1903b2746],
41	0.038	CD	NUMBER	0.038	num	42	SENT_87	[p6l1942t2721r2026b2746],
42	n	NN	O	n	dep	44	SENT_87	[p6l169t2768r181b2783],
43	(	CD	PERCENT	(	num	44	SENT_87	[p6l196t2758r234b2790],
44	%	NN	PERCENT	%	dep	7	SENT_87	[p6l196t2758r234b2790],
45	)	CD	NUMBER	)	dep	44	SENT_87	[p6l196t2758r234b2790],

1	*	NN	O	*	nn	2	SENT_88	[p6l153t2825r163b2835],
2	alue	NN	O	alue	nsubj	6	SENT_88	[p6l209t2823r257b2846],
3	of	IN	O	of	_	0	SENT_88	[p6l267t2823r290b2846],
4	covariance	NN	O	covariance	nn	5	SENT_88	[p6l299t2826r427b2846],
5	analysis	NN	O	analysis	prep_of	2	SENT_88	[p6l437t2823r530b2853],
6	adjusted	VBN	O	adjust	_	0	SENT_88	[p6l540t2823r637b2853],
7	for	IN	O	for	_	0	SENT_88	[p6l648t2823r679b2846],
8	baseline	NN	O	baseline	nn	9	SENT_88	[p6l690t2823r786b2846],
9	values	NNS	O	value	prep_for	6	SENT_88	[p6l795t2823r874b2850],
10	,	,	O	,	_	0	SENT_88	[p6l795t2823r874b2850],
11	or	CC	O	or	_	0	SENT_88	[p6l886t2832r910b2846],
12	chi-square	JJ	O	chi-square	amod	13	SENT_88	[p6l920t2823r1037b2853],
13	test	NN	O	test	prep_for	6	SENT_88	[p6l1048t2828r1091b2850],
14	,	,	O	,	_	0	SENT_88	[p6l1048t2828r1091b2850],
15	where	WRB	O	where	dep	16	SENT_88	[p6l1102t2823r1174b2846],
16	appropriate	JJ	O	appropriate	dep	6	SENT_88	[p6l1184t2826r1328b2853],
17	.	.	O	.	_	0	SENT_88	[p6l1184t2826r1328b2853],

1	a	DT	O	a	det	2	SENT_89	[p6l180t2870r193b2883],
2	ue	NN	O	ue	nsubj	20	SENT_89	[p6l203t2870r228b2883],
3	of	IN	O	of	_	0	SENT_89	[p6l238t2860r260b2883],
4	the	DT	O	the	det	5	SENT_89	[p6l268t2860r301b2883],
5	interaction	NN	O	interaction	prep_of	2	SENT_89	[p6l312t2864r431b2883],
6	between	IN	O	between	_	0	SENT_89	[p6l442t2860r538b2884],
7	the	DT	O	the	det	9	SENT_89	[p6l548t2860r581b2883],
8	stromelysin	NN	O	stromelysin	nn	9	SENT_89	[p6l591t2860r716b2890],
9	polymorphism	NN	O	polymorphism	prep_between	5	SENT_89	[p6l727t2860r888b2890],
10	and	CC	O	and	_	0	SENT_89	[p6l898t2860r942b2883],
11	medication	NN	O	medication	nn	13	SENT_89	[p6l953t2860r1078b2883],
12	(	CD	NUMBER	(	num	13	SENT_89	[p6l1090t2860r1190b2890],
13	placebo	NN	O	placebo	prep_of	2	SENT_89	[p6l1090t2860r1190b2890],
14	vs	CC	O	vs	_	0	SENT_89	[p6l1199t2870r1221b2883],
15	pravastatin	NN	O	pravastatin	nn	16	SENT_89	[p6l1231t2862r1365b2890],
16	)	NN	O	)	conj_vs	13	SENT_89	[p6l1231t2862r1365b2890],
17	of	IN	O	of	_	0	SENT_89	[p6l1375t2860r1398b2883],
18	covariance	NN	O	covariance	nn	19	SENT_89	[p6l1406t2864r1534b2883],
19	analysis	NN	O	analysis	prep_of	16	SENT_89	[p6l1543t2860r1635b2890],
20	adjusted	VBN	O	adjust	_	0	SENT_89	[p6l1644t2860r1741b2890],
21	for	IN	O	for	_	0	SENT_89	[p6l1751t2860r1782b2883],
22	the	DT	O	the	det	25	SENT_89	[p6l1791t2860r1824b2883],
23	relevant	JJ	O	relevant	amod	25	SENT_89	[p6l1834t2860r1926b2884],
24	baseline	NN	O	baseline	nn	25	SENT_89	[p6l1935t2860r2030b2883],
25	values	NNS	O	value	prep_for	20	SENT_89	[p6l129t2898r202b2921],
26	or	CC	O	or	_	0	SENT_89	[p6l212t2907r236b2921],
27	logistic	JJ	O	logistic	amod	28	SENT_89	[p6l246t2898r325b2928],
28	regression	NN	O	regression	conj_or	25	SENT_89	[p6l337t2901r462b2928],
29	,	,	O	,	_	0	SENT_89	[p6l337t2901r462b2928],
30	where	WRB	O	where	dep	31	SENT_89	[p6l473t2898r544b2921],
31	appropriate	JJ	O	appropriate	dep	20	SENT_89	[p6l555t2901r699b2928],
32	.	.	O	.	_	0	SENT_89	[p6l555t2901r699b2928],

1	IQR	NN	O	iqr	_	0	SENT_90	[p6l152t2937r194b2958],
2	=	JJ	O	=	amod	4	SENT_90	[p6l207t2946r223b2952],
3	interquartile	JJ	O	interquartile	amod	4	SENT_90	[p6l237t2935r374b2965],
4	range	NN	O	range	dep	1	SENT_90	[p6l385t2945r458b2965],
5	.	.	O	.	_	0	SENT_90	[p6l385t2945r458b2965],

1	3	CD	NUMBER	3	number	2	SENT_91	[p7l248t157r280b206],
2	3	CD	NUMBER	3	_	0	SENT_91	[p7l284t157r316b206],
3	f	SYM	O	f	dep	2	SENT_91	[p7l401t175r437b214],
4	u	FW	O	u	dep	2	SENT_91	[p7l474t176r491b208],

1	`	``	O	`	_	0	SENT_92	[p7l482t297r676b444],
2	k	NN	O	k	_	0	SENT_92	[p7l482t297r676b444],
3	*	CD	NUMBER	*	num	4	SENT_92	[p7l482t297r676b444],
4	1.	CD	NUMBER	1.	dep	2	SENT_92	[p7l510t429r823b569],
5	,	,	O	,	_	0	SENT_92	[p7l510t429r823b569],
6	_	CD	NUMBER	_	num	7	SENT_92	[p7l510t429r823b569],
7	s	NNS	O	s	npadvmod	8	SENT_92	[p7l510t429r823b569],
8	_	RB	O	_	advmod	2	SENT_92	[p7l510t429r823b569],
9	,	,	O	,	_	0	SENT_92	[p7l510t429r823b569],
10	,	,	O	,	_	0	SENT_92	[p7l510t429r823b569],
11	,	,	O	,	_	0	SENT_92	[p7l510t429r823b569],
12	_	NN	O	_	dep	2	SENT_92	[p7l510t429r823b569],
13	,	,	O	,	_	0	SENT_92	[p7l510t429r823b569],
14	:	:	O	:	_	0	SENT_92	[p7l510t429r823b569],
15	"	''	O	"	punct	2	SENT_92	[p7l749t593r984b768],

1	~	NN	O	~	_	0	SENT_93	[p7l749t593r984b768],
2	.1	CD	NUMBER	.1	dep	1	SENT_93	[p7l749t593r984b768],
3	"	``	O	"	punct	2	SENT_93	[p7l749t593r984b768],
4	a	DT	O	a	det	5	SENT_93	[p7l749t593r984b768],
5	=	JJ	O	=	dep	2	SENT_93	[p7l749t593r984b768],

1	-	:	O	-	_	0	SENT_94	[p7l921t732r1092b821],
2	‘	NN	O	‘	_	0	SENT_94	[p7l921t732r1092b821],
3	ray	NN	O	ray	dep	2	SENT_94	[p7l921t732r1092b821],
4	-	:	O	-	_	0	SENT_94	[p7l1121t790r1148b828],
5	:	:	O	:	_	0	SENT_94	[p7l1121t790r1148b828],

1	to	TO	O	to	_	0	SENT_95	[p7l232t475r279b525],
2	<	JJR	O	<	pobj	1	SENT_95	[p7l283t476r315b525],
3	3	CD	NUMBER	3	num	5	SENT_95	[p7l283t476r315b525],
4	bo	NN	O	bo	nn	5	SENT_95	[p7l231t794r278b843],
5	c	NN	O	c	npadvmod	6	SENT_95	[p7l282t794r314b843],
6	>	JJR	O	>	amod	2	SENT_95	[p7l282t794r314b843],

1	....	NN	O	....	nn	2	SENT_96	[p7l1285t938r1603b1008],
2	L	NN	O	l	_	0	SENT_96	[p7l1285t938r1603b1008],
3	,	,	O	,	_	0	SENT_96	[p7l1285t938r1603b1008],
4	"	``	O	"	punct	5	SENT_96	[p7l1285t938r1603b1008],
5	u	NN	O	u	appos	2	SENT_96	[p7l1285t938r1603b1008],
6	'	''	O	'	_	0	SENT_96	[p7l1493t991r1523b1008],

1	‘	NN	O	‘	nn	2	SENT_97	[p7l1534t991r1577b1034],
2	I.	NN	O	i.	_	0	SENT_97	[p7l1534t991r1577b1034],
3	i.	NN	O	i.	dep	2	SENT_97	[p7l1586t975r2023b1035],
4	'	''	O	'	_	0	SENT_97	[p7l1586t975r2023b1035],
5	.	.	O	.	_	0	SENT_97	[p7l1586t975r2023b1035],

1	t.	NN	O	t.	_	0	SENT_98	[p7l1586t975r2023b1035],
2	'	''	O	'	_	0	SENT_98	[p7l1586t975r2023b1035],
3	.	.	O	.	_	0	SENT_98	[p7l1586t975r2023b1035],

1	L	NN	O	l	advmod	2	SENT_99	[p7l1586t975r2023b1035],
2	"	''	O	"	_	0	SENT_99	[p7l1586t975r2023b1035],
3	-	:	O	-	_	0	SENT_99	[p7l1586t975r2023b1035],
4	"	``	O	"	punct	2	SENT_99	[p7l1586t975r2023b1035],
5	-	:	O	-	_	0	SENT_99	[p7l1586t975r2023b1035],
6	"	``	O	"	punct	2	SENT_99	[p7l1586t975r2023b1035],
7	-	:	O	-	_	0	SENT_99	[p7l1586t975r2023b1035],
8	'	''	O	'	_	0	SENT_99	[p7l1586t975r2023b1035],
9	£	CD	NUMBER	£	dep	2	SENT_99	[p7l1586t975r2023b1035],
10	.	.	O	.	_	0	SENT_99	[p7l1586t975r2023b1035],
11	'	''	O	'	_	0	SENT_99	[p7l1586t975r2023b1035],

1	.	.	O	.	_	0	SENT_100	[p7l1586t975r2023b1035],

1	L	NN	O	l	_	0	SENT_101	[p7l1586t975r2023b1035],
2	"	''	O	"	punct	1	SENT_101	[p7l1586t975r2023b1035],
3	-	:	O	-	_	0	SENT_101	[p7l1586t975r2023b1035],
4	"	``	O	"	dep	1	SENT_101	[p7l1586t975r2023b1035],
5	-	:	O	-	_	0	SENT_101	[p7l1586t975r2023b1035],
6	'	''	DATE	'	_	0	SENT_101	[p7l1586t975r2023b1035],
7	3	CD	DATE	3	dep	4	SENT_101	[p7l1586t975r2023b1035],

1	proportion	NN	O	proportion	_	0	SENT_102	[p7l85t833r145b1128],
2	of	IN	O	of	_	0	SENT_102	[p7l84t753r133b808],
3	patients	NNS	O	patient	prep_of	1	SENT_102	[p7l85t508r145b734],
4	event-free	RB	O	event-free	advmod	3	SENT_102	[p7l86t191r134b484],

1	A	DT	O	a	_	0	SENT_103	[p7l230t1085r277b1133],
2	:	:	O	:	_	0	SENT_103	[p7l230t1085r277b1133],
3	O	NN	O	o	dep	1	SENT_103	[p7l281t1084r313b1134],

1	months	NNS	DURATION	month	_	0	SENT_104	[p7l1194t1306r1403b1354],
2	since	IN	O	since	_	0	SENT_104	[p7l1426t1306r1576b1355],
3	randomisation	NN	O	randomisation	prep_since	1	SENT_104	[p7l1600t1306r2013b1355],

1	Hannah	NNP	PERSON	Hannah	_	0	SENT_105	[p7l764t2000r1254b2049],
2	!	.	O	!	_	0	SENT_105	[p7l764t2000r1254b2049],

1	-	:	O	-	_	0	SENT_106	[p7l764t2000r1254b2049],
2	tutu	NN	O	tutu	_	0	SENT_106	[p7l764t2000r1254b2049],
3	!	.	O	!	_	0	SENT_106	[p7l764t2000r1254b2049],

1	-	:	O	-	_	0	SENT_107	[p7l1265t2014r1321b2052],
2	.	.	O	.	_	0	SENT_107	[p7l1265t2014r1321b2052],

1	‘	NN	O	‘	dep	4	SENT_108	[p7l1229t2057r1249b2077],
2	II	CD	NUMBER	ii	dep	1	SENT_108	[p7l1258t2061r1290b2077],
3	g	NN	O	g	dep	4	SENT_108	[p7l1299t2061r1496b2114],
4	*	CD	NUMBER	*	dep	7	SENT_108	[p7l1299t2061r1496b2114],
5	I	PRP	O	I	dep	4	SENT_108	[p7l1505t2061r1535b2101],
6	:	:	O	:	_	0	SENT_108	[p7l1505t2061r1535b2101],
7	I	PRP	O	I	_	0	SENT_108	[p7l1517t2110r1537b2130],

1	hC	NN	O	hc	_	0	SENT_109	[p7l1695t2250r2018b2283],
2	.	.	O	.	_	0	SENT_109	[p7l1695t2250r2018b2283],

1	—	NN	O	—	_	0	SENT_110	[p7l1695t2250r2018b2283],
2	.	.	O	.	_	0	SENT_110	[p7l1695t2250r2018b2283],

1	ZCZ	NN	O	zcz	_	0	SENT_111	[p7l1695t2250r2018b2283],

1	months	NNS	DURATION	month	_	0	SENT_112	[p7l1190t2845r1399b2894],
2	since	IN	O	since	_	0	SENT_112	[p7l1423t2846r1573b2894],
3	randomisation	NN	O	randomisation	prep_since	1	SENT_112	[p7l1597t2846r2009b2895],

1	FIGURE	NN	O	figure	_	0	SENT_113	[p7l9t3222r238b3281],
2	1	CD	NUMBER	1	dep	1	SENT_113	[p7l275t3223r326b3281],
3	.	.	O	.	_	0	SENT_113	[p7l275t3223r326b3281],

1	Clinical	JJ	O	clinical	_	0	SENT_114	[p7l355t3216r582b3281],
2	event-free	RB	O	event-free	advmod	4	SENT_114	[p7l611t3216r928b3281],
3	survival	NN	O	survival	nn	4	SENT_114	[p7l956t3216r1199b3281],
4	curves	NNS	O	curve	rcmod	1	SENT_114	[p7l1228t3242r1428b3281],
5	for	IN	O	for	_	0	SENT_114	[p7l1455t3216r1545b3281],
6	each	DT	O	each	det	12	SENT_114	[p7l1570t3216r1716b3281],
7	stromel	NN	O	stromel	nn	12	SENT_114	[p7l1745t3216r1974b3281],
8	sin	NN	O	sin	nn	12	SENT_114	[p7l2018t3221r2102b3281],
9	genotype	NN	O	genotype	nn	12	SENT_114	[p7l6t3314r302b3383],
10	(	CD	NUMBER	(	num	12	SENT_114	[p7l333t3300r504b3377],
11	solid	JJ	O	solid	amod	12	SENT_114	[p7l333t3300r504b3377],
12	line	NN	O	line	prep_for	4	SENT_114	[p7l526t3300r654b3365],
13	:	:	O	:	_	0	SENT_114	[p7l526t3300r654b3365],
14	5A5A	NN	O	5a5a	dep	12	SENT_114	[p7l685t3305r889b3375],
15	;	:	O	;	_	0	SENT_114	[p7l685t3305r889b3375],
16	dotted	VBN	O	dot	amod	17	SENT_114	[p7l918t3300r1123b3364],
17	line	NN	O	line	prep_for	4	SENT_114	[p7l1145t3300r1273b3365],
18	:	:	O	:	_	0	SENT_114	[p7l1145t3300r1273b3365],
19	5A6A	NN	O	5a6a	conj_and	12	SENT_114	[p7l1304t3305r1507b3375],
20	,	,	O	,	_	0	SENT_114	[p7l1304t3305r1507b3375],
21	and	CC	O	and	_	0	SENT_114	[p7l1535t3300r1655b3364],
22	hatched	VBD	O	hatch	amod	23	SENT_114	[p7l1686t3300r1942b3364],
23	ine	NN	O	ine	prep_for	4	SENT_114	[p7l1982t3305r2092b3365],
24	:	:	O	:	_	0	SENT_114	[p7l1982t3305r2092b3365],
25	6A6A	NN	O	6a6a	dep	4	SENT_114	[p7l7t3385r207b3460],
26	)	CD	NUMBER	)	num	25	SENT_114	[p7l7t3385r207b3460],
27	in	IN	O	in	_	0	SENT_114	[p7l240t3388r292b3447],
28	(	CD	NUMBER	(	prep_in	25	SENT_114	[p7l328t3385r410b3460],
29	A	DT	O	a	det	30	SENT_114	[p7l328t3385r410b3460],
30	)	NN	O	)	dep	1	SENT_114	[p7l328t3385r410b3460],
31	the	DT	O	the	det	35	SENT_114	[p7l436t3383r532b3448],
32	placebo	NN	O	placebo	nn	35	SENT_114	[p7l561t3383r809b3466],
33	and	CC	O	and	_	0	SENT_114	[p7l836t3383r956b3448],
34	(	NN	O	(	conj_and	32	SENT_114	[p7l991t3385r1065b3460],
35	B	NN	O	b	nsubj	36	SENT_114	[p7l991t3385r1065b3460],
36	)	VBD	O	)	rcmod	30	SENT_114	[p7l991t3385r1065b3460],
37	the	DT	O	the	det	39	SENT_114	[p7l1091t3383r1187b3448],
38	pravastatin	NN	O	pravastatin	nn	39	SENT_114	[p7l1215t3388r1570b3466],
39	groups	NNS	O	group	dobj	36	SENT_114	[p7l1599t3409r1839b3466],
40	,	,	O	,	_	0	SENT_114	[p7l1599t3409r1839b3466],
41	adjusted	VBN	O	adjust	partmod	39	SENT_114	[p7l1867t3383r1972b3448, p7l8t3467r191b3550],
42	for	IN	O	for	_	0	SENT_114	[p7l219t3466r310b3531],
43	baseline	NN	O	baseline	nn	44	SENT_114	[p7l337t3466r598b3531],
44	medication	NN	O	medication	prep_for	41	SENT_114	[p7l627t3466r992b3532],
45	.	.	O	.	_	0	SENT_114	[p7l627t3466r992b3532],

1	genotype	NN	O	genotype	nsubj	22	SENT_115	[p8l8t100r361b178],
2	and	CC	O	and	_	0	SENT_115	[p8l394t90r531b158],
3	changes	NNS	O	change	nsubj	22	SENT_115	[p8l561t90r869b178],
4	in	IN	O	in	_	0	SENT_115	[p8l902t90r975b157],
5	lipid	NN	O	lipid	nn	6	SENT_115	[p8l1006t90r1182b178],
6	levels	NNS	O	level	prep_in	1	SENT_115	[p8l1212t90r1434b158],
7	between	IN	O	between	_	0	SENT_115	[p8l1466t90r1789b158],
8	patients	NNS	O	patient	prep_between	6	SENT_115	[p8l1819t90r2118b178],
9	with	IN	O	with	_	0	SENT_115	[p8l7t190r178b259],
10	placebo	NN	O	placebo	prep_with	8	SENT_115	[p8l207t191r507b279],
11	and	CC	O	and	_	0	SENT_115	[p8l541t191r678b258],
12	pravastatin	NN	O	pravastatin	conj_and	10	SENT_115	[p8l707t190r1154b279],
13	,	,	O	,	_	0	SENT_115	[p8l707t190r1154b279],
14	which	WDT	O	which	nsubj	15	SENT_115	[p8l1189t190r1424b259],
15	indicates	VBZ	O	indicate	rcmod	6	SENT_115	[p8l1455t190r1796b258],
16	that	IN	O	that	complm	19	SENT_115	[p8l1829t190r1974b258],
17	the	DT	O	the	det	18	SENT_115	[p8l2004t191r2119b258],
18	associations	NNS	O	association	nsubj	19	SENT_115	[p8l9t292r473b360],
19	described	VBN	O	describe	ccomp	15	SENT_115	[p8l551t292r922b360],
20	above	IN	O	above	prep	19	SENT_115	[p8l998t292r1226b360],
21	are	VBP	O	be	cop	22	SENT_115	[p8l1303t314r1417b360],
22	independent	JJ	O	independent	_	0	SENT_115	[p8l1493t292r1968b380],
23	of	IN	O	of	_	0	SENT_115	[p8l2043t292r2126b360],
24	changes	NNS	O	change	prep_of	22	SENT_115	[p8l8t393r316b481],
25	in	IN	O	in	_	0	SENT_115	[p8l342t393r416b460],
26	lipid	NN	O	lipid	nn	27	SENT_115	[p8l440t393r616b481],
27	levels	NNS	O	level	prep_in	24	SENT_115	[p8l641t393r884b461],
28	.	.	O	.	_	0	SENT_115	[p8l641t393r884b461],

1	Thus	RB	O	thus	dep	4	SENT_116	[p8l913t393r1126b473],
2	,	,	O	,	_	0	SENT_116	[p8l913t393r1126b473],
3	the	DT	O	the	nsubj	4	SENT_116	[p8l1154t393r1270b461],
4	observed	VBN	O	observe	_	0	SENT_116	[p8l1296t393r1645b461],
5	interactions	NNS	O	interaction	dobj	4	SENT_116	[p8l1668t393r2118b461],
6	between	IN	O	between	_	0	SENT_116	[p8l6t494r329b562],
7	stromelysin	NN	O	stromelysin	nn	8	SENT_116	[p8l388t493r837b582],
8	genotype	NN	O	genotype	prep_between	5	SENT_116	[p8l893t504r1246b582],
9	and	CC	O	and	_	0	SENT_116	[p8l1304t494r1441b561],
10	medication	NN	O	medication	prep_between	5	SENT_116	[p8l1496t493r1927b561],
11	and	CC	O	and	advmod	8	SENT_116	[p8l1984t493r2121b561],

1	854	CD	NUMBER	854	_	0	SENT_117	[p8l9t745r149b812],
2	THE	DT	O	the	det	4	SENT_117	[p8l234t754r354b811],
3	AMERICAN	NNP	MISC	AMERICAN	nn	4	SENT_117	[p8l396t753r758b812],
4	JOURNAL	NNP	O	JOURNAL	dep	1	SENT_117	[p8l792t753r1100b822],
5	OF	IN	O	of	_	0	SENT_117	[p8l1139t753r1229b811],
6	CARD	NNP	O	CARD	prep_of	4	SENT_117	[p8l1273t753r1766b811],
7	|	CD	NUMBER	|	num	6	SENT_117	[p8l1273t753r1766b811],
8	OLOGY	NNP	O	OLOGY	dep	1	SENT_117	[p8l1273t753r1766b811],
9	®	CD	NUMBER	®	num	8	SENT_117	[p8l1273t753r1766b811],
10	VOL	NNP	O	VOL	dep	8	SENT_117	[p8l1880t753r2023b812],
11	.	.	O	.	_	0	SENT_117	[p8l1880t753r2023b812],

1	83	CD	NUMBER	83	_	0	SENT_118	[p8l2075t753r2153b811],

1	TABLE	NN	O	table	_	0	SENT_119	[p8l63t1051r254b1110],
2	II	CD	NUMBER	ii	num	3	SENT_119	[p8l286t1052r317b1110],
3	Frequency	NN	O	frequency	dep	1	SENT_119	[p8l373t1052r702b1130],
4	of	IN	O	of	_	0	SENT_119	[p8l729t1046r790b1111],
5	Events	NNS	O	event	prep_of	3	SENT_119	[p8l820t1052r1014b1111],
6	and	CC	O	and	_	0	SENT_119	[p8l1044t1047r1163b1111],
7	Odds	NNS	O	odds	nn	8	SENT_119	[p8l1196t1047r1372b1111],
8	Ratio	NN	O	ratio	prep_of	3	SENT_119	[p8l1405t1052r1562b1111],
9	of	IN	O	of	_	0	SENT_119	[p8l1591t1046r1653b1111],
10	Events	NNS	O	event	prep_of	3	SENT_119	[p8l1682t1052r1877b1111],
11	in	IN	O	in	_	0	SENT_119	[p8l1909t1056r1958b1110],
12	the	DT	O	the	det	16	SENT_119	[p8l1990t1047r2083b1111],
13	Placebo	NNP	O	Placebo	nn	16	SENT_119	[p8l69t1132r321b1195],
14	and	CC	O	and	_	0	SENT_119	[p8l350t1132r470b1195],
15	Pravastatin	NNP	O	Pravastatin	nn	16	SENT_119	[p8l505t1137r848b1196],
16	Groups	NNS	O	group	prep_in	10	SENT_119	[p8l880t1136r1117b1214],

1	Odds	NNS	O	odds	_	0	SENT_120	[p8l1647t1276r1812b1336],
2	Ratio	NNP	O	Ratio	nn	5	SENT_120	[p8l1844t1281r1990b1336],
3	Genotype	NNP	O	Genotype	nn	5	SENT_120	[p8l66t1366r363b1439],
4	Placebo	NNP	O	Placebo	nn	5	SENT_120	[p8l553t1361r788b1421],
5	Pravastatin	NNP	O	Pravastatin	dep	1	SENT_120	[p8l1076t1366r1398b1422],
6	(	CD	PERCENT	(	number	7	SENT_120	[p8l1687t1364r1843b1437],
7	95	CD	PERCENT	95	num	8	SENT_120	[p8l1687t1364r1843b1437],
8	%	NN	PERCENT	%	dep	5	SENT_120	[p8l1687t1364r1843b1437],
9	CI	NN	O	ci	nn	10	SENT_120	[p8l1870t1364r1949b1437],
10	)	NN	O	)	dep	1	SENT_120	[p8l1870t1364r1949b1437],

1	5A5A	NN	O	5a5a	_	0	SENT_121	[p8l65t1505r249b1562],
2	8	CD	NUMBER	8	dep	1	SENT_121	[p8l497t1503r927b1578],
3	/	:	O	/	punct	4	SENT_121	[p8l497t1503r927b1578],
4	éé	NN	O	éé	dep	2	SENT_121	[p8l497t1503r927b1578],
5	(	CD	PERCENT	(	number	6	SENT_121	[p8l497t1503r927b1578],
6	12.1	CD	PERCENT	12.1	dep	7	SENT_121	[p8l497t1503r927b1578],
7	%	NN	PERCENT	%	dep	2	SENT_121	[p8l497t1503r927b1578],
8	)	CD	NUMBER	)	number	9	SENT_121	[p8l497t1503r927b1578],
9	9/53	CD	NUMBER	9/53	num	10	SENT_121	[p8l1063t1502r1224b1572],
10	(	NN	O	(	dep	1	SENT_121	[p8l1259t1505r1495b1578],
11	17.0	CD	PERCENT	17.0	num	12	SENT_121	[p8l1259t1505r1495b1578],
12	%	NN	PERCENT	%	dep	10	SENT_121	[p8l1259t1505r1495b1578],
13	)	CD	NUMBER	)	number	14	SENT_121	[p8l1259t1505r1495b1578],
14	1.48	CD	NUMBER	1.48	dep	1	SENT_121	[p8l1553t1505r1688b1562],
15	(	CD	NUMBER	(	num	16	SENT_121	[p8l1722t1505r2089b1578],
16	O.	NNP	O	O.	dep	14	SENT_121	[p8l1722t1505r2089b1578],
17	53	CD	NUMBER	53	num	16	SENT_121	[p8l1722t1505r2089b1578],
18	—	CD	NUMBER	—	number	19	SENT_121	[p8l1722t1505r2089b1578],
19	4.15	CD	NUMBER	4.15	dep	1	SENT_121	[p8l1722t1505r2089b1578],
20	)	NN	O	)	nn	21	SENT_121	[p8l1722t1505r2089b1578],
21	5A6A	NN	O	5a6a	dep	19	SENT_121	[p8l65t1590r249b1647],
22	32/121	CD	PERCENT	32/121	number	23	SENT_121	[p8l409t1587r645b1657],
23	(	CD	PERCENT	(	dep	1	SENT_121	[p8l691t1590r927b1663],
24	26.4	CD	PERCENT	26.4	num	25	SENT_121	[p8l691t1590r927b1663],
25	%	NN	PERCENT	%	dep	23	SENT_121	[p8l691t1590r927b1663],
26	)	CD	NUMBER	)	number	27	SENT_121	[p8l691t1590r927b1663],
27	12/127	CD	NUMBER	12/127	num	28	SENT_121	[p8l984t1587r1451b1663],
28	(	NN	O	(	dep	1	SENT_121	[p8l984t1587r1451b1663],
29	9.4	CD	PERCENT	9.4	number	30	SENT_121	[p8l984t1587r1451b1663],
30	%	NN	PERCENT	%	amod	28	SENT_121	[p8l984t1587r1451b1663],
31	)	CD	NUMBER	)	num	32	SENT_121	[p8l984t1587r1451b1663],
32	O.	NNP	O	O.	dep	1	SENT_121	[p8l1544t1589r2089b1663],
33	29	CD	NUMBER	29	num	32	SENT_121	[p8l1544t1589r2089b1663],
34	(	CD	NUMBER	(	num	35	SENT_121	[p8l1544t1589r2089b1663],
35	O.	NNP	O	O.	dep	32	SENT_121	[p8l1544t1589r2089b1663],
36	14	CD	NUMBER	14	num	35	SENT_121	[p8l1544t1589r2089b1663],
37	.	.	O	.	_	0	SENT_121	[p8l1544t1589r2089b1663],

1	—	NN	O	—	_	0	SENT_122	[p8l1544t1589r2089b1663],
2	.	.	O	.	_	0	SENT_122	[p8l1544t1589r2089b1663],

1	O.	NNP	O	O.	dep	15	SENT_123	[p8l1544t1589r2089b1663],
2	60	CD	NUMBER	60	number	3	SENT_123	[p8l1544t1589r2089b1663],
3	)	CD	NUMBER	)	dep	1	SENT_123	[p8l1544t1589r2089b1663],
4	6A6A	NN	O	6a6a	dep	3	SENT_123	[p8l67t1675r249b1732],
5	16/62	CD	PERCENT	16/62	num	4	SENT_123	[p8l460t1672r657b1741],
6	(	CD	PERCENT	(	number	7	SENT_123	[p8l691t1675r927b1747],
7	25.8	CD	PERCENT	25.8	num	8	SENT_123	[p8l691t1675r927b1747],
8	%	NN	PERCENT	%	dep	3	SENT_123	[p8l691t1675r927b1747],
9	)	CD	NUMBER	)	number	10	SENT_123	[p8l691t1675r927b1747],
10	9/65	CD	NUMBER	9/65	num	11	SENT_123	[p8l1063t1672r1225b1741],
11	(	NN	O	(	dep	8	SENT_123	[p8l1259t1675r1495b1747],
12	13.8	CD	PERCENT	13.8	num	13	SENT_123	[p8l1259t1675r1495b1747],
13	%	NN	PERCENT	%	dep	15	SENT_123	[p8l1259t1675r1495b1747],
14	)	CD	NUMBER	)	num	15	SENT_123	[p8l1259t1675r1495b1747],
15	O.	NNP	O	O.	_	0	SENT_123	[p8l1544t1674r2089b1747],
16	46	CD	NUMBER	46	num	15	SENT_123	[p8l1544t1674r2089b1747],
17	(	CD	NUMBER	(	num	18	SENT_123	[p8l1544t1674r2089b1747],
18	O.	NNP	O	O.	dep	15	SENT_123	[p8l1544t1674r2089b1747],
19	19	CD	NUMBER	19	num	18	SENT_123	[p8l1544t1674r2089b1747],
20	—	CD	NUMBER	—	number	21	SENT_123	[p8l1544t1674r2089b1747],
21	1.14	CD	NUMBER	1.14	num	22	SENT_123	[p8l1544t1674r2089b1747],
22	)	NN	O	)	dep	18	SENT_123	[p8l1544t1674r2089b1747],

1	CI	NN	O	ci	_	0	SENT_124	[p8l113t1824r165b1873],
2	=	JJ	O	=	amod	4	SENT_124	[p8l197t1844r234b1859],
3	confidence	NN	O	confidence	nn	4	SENT_124	[p8l263t1820r547b1873],
4	interval	NN	O	interval	dep	1	SENT_124	[p8l573t1821r774b1873],
5	.	.	O	.	_	0	SENT_124	[p8l573t1821r774b1873],

1	their	PRP$	O	they	poss	2	SENT_125	[p8l9t2097r189b2166],
2	impact	NN	O	impact	nsubj	11	SENT_125	[p8l219t2097r486b2186],
3	on	IN	O	on	_	0	SENT_125	[p8l517t2119r612b2166],
4	measurements	NNS	O	measurement	prep_on	2	SENT_125	[p8l643t2107r1203b2166],
5	of	IN	O	of	_	0	SENT_125	[p8l1238t2097r1323b2166],
6	disease	NN	O	disease	prep_of	4	SENT_125	[p8l1349t2097r1630b2166],
7	in	IN	O	in	_	0	SENT_125	[p8l1662t2097r1736b2165],
8	this	DT	O	this	det	9	SENT_125	[p8l1767t2097r1905b2166],
9	study	NN	O	study	prep_in	6	SENT_125	[p8l1942t2097r2149b2186],
10	may	MD	O	may	aux	11	SENT_125	[p8l9t2221r175b2289],
11	operate	VB	O	operate	_	0	SENT_125	[p8l203t2210r489b2289],
12	through	IN	O	through	_	0	SENT_125	[p8l515t2200r820b2289],
13	mechanisms	NNS	O	mechanism	prep_through	11	SENT_125	[p8l845t2200r1328b2269],
14	that	WDT	O	that	nsubj	16	SENT_125	[p8l1356t2200r1503b2269],
15	are	VBP	O	be	cop	16	SENT_125	[p8l1529t2221r1644b2269],
16	independent	JJ	O	independent	rcmod	13	SENT_125	[p8l1670t2200r2151b2289],
17	of	IN	O	of	_	0	SENT_125	[p8l10t2303r95b2372],
18	the	DT	O	the	det	19	SENT_125	[p8l124t2303r242b2372],
19	effect	NN	O	effect	prep_of	16	SENT_125	[p8l279t2303r501b2372],
20	of	IN	O	of	_	0	SENT_125	[p8l536t2303r621b2372],
21	pravastatin	NN	O	pravastatin	prep_of	19	SENT_125	[p8l649t2303r1081b2392],
22	on	IN	O	on	_	0	SENT_125	[p8l1117t2325r1212b2372],
23	lipid	NN	O	lipid	nn	24	SENT_125	[p8l1248t2303r1427b2392],
24	metabolism	NN	O	metabolism	prep_on	16	SENT_125	[p8l1462t2303r1940b2372],
25	.	.	O	.	_	0	SENT_125	[p8l1462t2303r1940b2372],

1	Effect	NN	O	effect	nsubjpass	19	SENT_126	[p8l139t2396r341b2474],
2	of	IN	O	of	_	0	SENT_126	[p8l371t2396r446b2474],
3	genotype	NN	O	genotype	nn	6	SENT_126	[p8l477t2414r833b2496],
4	and	CC	O	and	_	0	SENT_126	[p8l866t2397r1010b2474],
5	pravastatin	NN	O	pravastatin	conj_and	3	SENT_126	[p8l1049t2403r1475b2496],
6	treatment	NN	O	treatment	prep_of	1	SENT_126	[p8l1511t2414r1878b2474],
7	on	IN	O	on	_	0	SENT_126	[p8l1908t2427r2000b2474],
8	the	DT	O	the	det	9	SENT_126	[p8l2036t2397r2151b2474],
9	incidence	NN	O	incidence	prep_on	6	SENT_126	[p8l11t2498r364b2577],
10	of	IN	O	of	_	0	SENT_126	[p8l402t2497r477b2576],
11	repeat	NN	O	repeat	nn	12	SENT_126	[p8l516t2515r762b2599],
12	angioplasties	NNS	O	angioplasty	prep_of	9	SENT_126	[p8l797t2498r1325b2599],
13	:	:	O	:	_	0	SENT_126	[p8l797t2498r1325b2599],
14	Percutaneous	JJ	O	percutaneous	amod	9	SENT_126	[p8l1366t2509r1888b2576],
15	transluminal	JJ	O	transluminal	amod	17	SENT_126	[p8l1928t2517r2148b2576, p8l9t2611r307b2680],
16	coronary	JJ	O	coronary	amod	17	SENT_126	[p8l354t2633r701b2700],
17	angiographies	NNS	O	angiography	dep	9	SENT_126	[p8l749t2611r1296b2700],
18	were	VBD	O	be	auxpass	19	SENT_126	[p8l1344t2633r1532b2680],
19	performed	VBN	O	perform	_	0	SENT_126	[p8l1577t2611r1987b2700],
20	according	VBG	O	accord	_	0	SENT_126	[p8l2034t2633r2147b2680, p8l10t2714r307b2803],
21	to	TO	O	to	prepc_according_to	19	SENT_126	[p8l340t2724r413b2783],
22	the	DT	O	the	det	24	SENT_126	[p8l447t2714r565b2783],
23	randomization	NN	O	randomization	nn	24	SENT_126	[p8l596t2714r1165b2783],
24	arm	NN	O	arm	pobj	19	SENT_126	[p8l1199t2736r1350b2783],
25	during	IN	O	during	_	0	SENT_126	[p8l1382t2714r1634b2803],
26	the	DT	O	the	det	28	SENT_126	[p8l1668t2714r1786b2783],
27	randomization	NN	O	randomization	nn	28	SENT_126	[p8l1817t2714r2147b2783, p8l9t2816r275b2885],
28	period	NN	O	period	prep_during	24	SENT_126	[p8l326t2816r578b2905],
29	in	IN	O	in	_	0	SENT_126	[p8l629t2816r703b2884],
30	the	DT	O	the	det	32	SENT_126	[p8l755t2816r873b2885],
31	REGRESS	NNP	O	REGRESS	nn	32	SENT_126	[p8l925t2816r1351b2885],
32	study	NN	O	study	prep_in	28	SENT_126	[p8l1411t2815r1678b2905],
33	.4	CD	NUMBER	.4	nsubj	55	SENT_126	[p8l1411t2815r1678b2905],
34	In	IN	O	in	_	0	SENT_126	[p8l1731t2818r1810b2884],
35	general	JJ	O	general	prep_in	33	SENT_126	[p8l1864t2816r2150b2905],
36	these	DT	O	these	det	37	SENT_126	[p8l9t2920r209b2989],
37	procedures	NNS	O	procedure	nsubj	38	SENT_126	[p8l252t2920r682b3009],
38	took	VBD	O	take	rcmod	35	SENT_126	[p8l728t2920r903b2989],
39	place	NN	O	place	nsubj	45	SENT_126	[p8l943t2920r1150b3009],
40	in	IN	O	in	_	0	SENT_126	[p8l1195t2920r1269b2988],
41	patients	NNS	O	patient	prep_in	39	SENT_126	[p8l1311t2920r1615b3009],
42	with	IN	O	with	_	0	SENT_126	[p8l1662t2920r1835b2989],
43	Braun	NNP	PERSON	Braun	nn	44	SENT_126	[p8l1879t2922r2147b2989],
44	—	NNP	O	—	prep_with	41	SENT_126	[p8l1879t2922r2147b2989],
45	wald	VBD	O	wald	ccomp	38	SENT_126	[p8l9t3023r199b3092],
46	class	NN	O	class	nn	49	SENT_126	[p8l226t3023r412b3092],
47	III/IV	NN	O	iii/iv	nn	49	SENT_126	[p8l441t3023r668b3092],
48	angina	NN	O	angina	nn	49	SENT_126	[p8l698t3023r958b3112],
49	pectoris	NN	O	pectoris	dobj	45	SENT_126	[p8l982t3023r1291b3112],
50	after	IN	O	after	_	0	SENT_126	[p8l1322t3023r1500b3092],
51	initial	JJ	O	initial	amod	52	SENT_126	[p8l1526t3023r1753b3092],
52	reduction	NN	O	reduction	prep_after	45	SENT_126	[p8l1779t3023r2151b3092],
53	to	TO	O	to	_	0	SENT_126	[p8l9t3136r82b3195],
54	angina	NN	O	angina	prep_to	45	SENT_126	[p8l125t3126r385b3215],
55	classed	VBD	O	class	rcmod	24	SENT_126	[p8l424t3126r707b3195],
56	I	PRP	O	I	dobj	55	SENT_126	[p8l746t3127r776b3194],
57	to	TO	O	to	_	0	SENT_126	[p8l816t3136r889b3195],
58	11	CD	NUMBER	11	prep_to	55	SENT_126	[p8l930t3127r993b3194],
59	after	IN	O	after	_	0	SENT_126	[p8l1035t3126r1213b3195],
60	the	DT	O	the	det	61	SENT_126	[p8l1251t3126r1368b3195],
61	arm	NN	O	arm	prep_after	55	SENT_126	[p8l1411t3126r1988b3195],
62	—	CD	NUMBER	—	num	61	SENT_126	[p8l1411t3126r1988b3195],
63	scheduled	VBN	O	schedule	partmod	61	SENT_126	[p8l1411t3126r1988b3195],
64	angioplasty	NN	O	angioplasty	dobj	63	SENT_126	[p8l2029t3147r2148b3195, p8l10t3229r388b3318],
65	.	.	O	.	_	0	SENT_126	[p8l2029t3147r2148b3195, p8l10t3229r388b3318],

1	The	DT	O	the	det	3	SENT_127	[p8l454t3229r604b3298],
2	repeat	NN	O	repeat	nn	3	SENT_127	[p8l663t3240r904b3318],
3	angioplasties	NNS	O	angioplasty	nsubj	5	SENT_127	[p8l965t3229r1474b3318],
4	were	VBD	O	be	cop	5	SENT_127	[p8l1537t3251r1725b3298],
5	symptom	NN	O	symptom	_	0	SENT_127	[p8l1789t3240r2152b3318],
6	driven	VBN	O	drive	partmod	5	SENT_127	[p8l10t3332r259b3401],
7	with	IN	O	with	_	0	SENT_127	[p8l308t3332r481b3401],
8	a	DT	O	a	det	10	SENT_127	[p8l531t3354r572b3401],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_127	[p8l623t3332r1029b3421],
10	stenosis	NN	O	stenosis	prep_with	6	SENT_127	[p8l1080t3332r1385b3401],
11	at	IN	O	at	_	0	SENT_127	[p8l1438t3342r1506b3401],
12	the	DT	O	the	det	14	SENT_127	[p8l1553t3332r1671b3401],
13	target	NN	O	target	nn	14	SENT_127	[p8l1720t3342r1944b3421],
14	site	NN	O	site	prep_at	10	SENT_127	[p8l1994t3332r2145b3401],
15	.	.	O	.	_	0	SENT_127	[p8l1994t3332r2145b3401],

1	Results	NNS	O	result	nsubjpass	26	SENT_128	[p8l9t3435r295b3504],
2	with	IN	O	with	_	0	SENT_128	[p8l340t3435r512b3504],
3	regard	NN	O	regard	_	0	SENT_128	[p8l552t3435r804b3524],
4	to	TO	O	to	_	0	SENT_128	[p8l844t3445r918b3504],
5	the	DT	O	the	det	6	SENT_128	[p8l960t3435r1078b3504],
6	need	NN	O	need	prep_with_regard_to	1	SENT_128	[p8l1120t3435r1305b3504],
7	for	IN	O	for	_	0	SENT_128	[p8l1346t3435r1460b3504],
8	symptom	NN	O	symptom	nn	9	SENT_128	[p8l1503t3435r2150b3524],
9	—	NN	O	—	prep_for	6	SENT_128	[p8l1503t3435r2150b3524],
10	driven	VBN	O	drive	partmod	9	SENT_128	[p8l1503t3435r2150b3524],
11	repeat	NN	O	repeat	nn	12	SENT_128	[p8l8t3549r249b3627],
12	angioplasty	NN	O	angioplasty	dobj	10	SENT_128	[p8l298t3538r747b3627],
13	of	IN	O	of	_	0	SENT_128	[p8l798t3538r882b3607],
14	the	DT	O	the	det	16	SENT_128	[p8l924t3538r1042b3607],
15	target	NN	O	target	nn	16	SENT_128	[p8l1090t3549r1314b3627],
16	lesion	NN	O	lesion	prep_of	12	SENT_128	[p8l1361t3538r1594b3607],
17	according	VBG	O	accord	_	0	SENT_128	[p8l1643t3538r2027b3627],
18	to	TO	O	to	prepc_according_to	10	SENT_128	[p8l2076t3548r2149b3607],
19	genotype	NN	O	genotype	nn	24	SENT_128	[p8l10t3651r368b3730],
20	and	CC	O	and	_	0	SENT_128	[p8l416t3641r555b3710],
21	placebo	NN	O	placebo	nn	24	SENT_128	[p8l598t3641r902b3730],
22	and/or	JJ	O	and/or	amod	24	SENT_128	[p8l951t3641r1201b3710],
23	pravastatin	NN	O	pravastatin	nn	24	SENT_128	[p8l1243t3641r1675b3730],
24	groups	NNS	O	group	pobj	10	SENT_128	[p8l1722t3663r1984b3730],
25	are	VBP	O	be	auxpass	26	SENT_128	[p8l2034t3663r2150b3710],
26	listed	VBN	O	list	_	0	SENT_128	[p8l9t3744r221b3813],
27	in	IN	O	in	_	0	SENT_128	[p8l253t3744r327b3812],
28	Table	NNP	O	Table	nn	29	SENT_128	[p8l360t3744r582b3813],
29	III	NNP	O	III	prep_in	26	SENT_128	[p8l615t3745r730b3813],
30	.	.	O	.	_	0	SENT_128	[p8l615t3745r730b3813],

1	In	IN	O	in	_	0	SENT_129	[p8l768t3745r848b3812],
2	the	DT	O	the	det	6	SENT_129	[p8l880t3744r998b3813],
3	placebo	NN	O	placebo	nn	6	SENT_129	[p8l1030t3744r1334b3833],
4	group	NN	O	group	nn	6	SENT_129	[p8l1370t3765r1595b3833],
5	repeat	NN	O	repeat	nn	6	SENT_129	[p8l1628t3754r1869b3833],
6	angio	NN	O	angio	pobj	1	SENT_129	[p8l1902t3744r2147b3833, p8l3t987r2156b1932],

1	plasties	NNS	O	plasty	nsubj	4	SENT_130	[p9l8t20r300b109],
2	were	VBD	O	be	cop	4	SENT_130	[p9l343t42r532b89],
3	more	RBR	O	more	advmod	4	SENT_130	[p9l572t42r772b89],
4	frequent	JJ	O	frequent	_	0	SENT_130	[p9l814t20r1141b109],
5	in	IN	O	in	_	0	SENT_130	[p9l1180t20r1254b88],
6	the	DT	O	the	det	10	SENT_130	[p9l1294t20r1412b89],
7	5A6A	NN	O	5a6a	nn	10	SENT_130	[p9l1454t20r1691b90],
8	and	CC	O	and	_	0	SENT_130	[p9l1733t20r1872b89],
9	6A6A	NN	O	6a6a	nn	10	SENT_130	[p9l1914t20r2151b90],
10	group	NN	O	group	prep_in	4	SENT_130	[p9l10t145r235b212],
11	compared	VBN	O	compare	_	0	SENT_130	[p9l262t123r649b212],
12	with	IN	O	with	prepc_compared_with	4	SENT_130	[p9l674t123r846b192],
13	the	DT	O	the	det	15	SENT_130	[p9l871t123r989b192],
14	5A5A	NN	O	5a5a	nn	15	SENT_130	[p9l1016t123r1253b192],
15	group	NN	O	group	pobj	4	SENT_130	[p9l1279t145r1525b212],
16	.	.	O	.	_	0	SENT_130	[p9l1279t145r1525b212],

1	This	DT	O	this	det	2	SENT_131	[p9l1555t123r1726b192],
2	difference	NN	O	difference	nsubjpass	5	SENT_131	[p9l1754t123r2150b192],
3	was	VBD	O	be	auxpass	5	SENT_131	[p9l9t247r157b295],
4	not	RB	O	not	neg	5	SENT_131	[p9l185t236r311b295],
5	observed	VBN	O	observe	_	0	SENT_131	[p9l336t226r690b295],
6	in	IN	O	in	_	0	SENT_131	[p9l714t226r789b294],
7	the	DT	O	the	det	9	SENT_131	[p9l814t226r932b295],
8	pravastatin	NN	O	pravastatin	nn	9	SENT_131	[p9l957t226r1389b315],
9	group	NN	O	group	prep_in	5	SENT_131	[p9l1416t247r1661b315],
10	.	.	O	.	_	0	SENT_131	[p9l1416t247r1661b315],

1	Differences	NNS	O	difference	nsubj	15	SENT_132	[p9l1693t226r2148b295],
2	in	IN	O	in	_	0	SENT_132	[p9l9t329r83b397],
3	the	DT	O	the	det	4	SENT_132	[p9l113t329r230b398],
4	risk	NN	O	risk	prep_in	1	SENT_132	[p9l259t329r408b398],
5	of	IN	O	of	_	0	SENT_132	[p9l436t329r521b398],
6	repeat	NN	O	repeat	nn	7	SENT_132	[p9l543t340r784b418],
7	angioplasty	NN	O	angioplasty	prep_of	4	SENT_132	[p9l814t329r1264b418],
8	between	IN	O	between	_	0	SENT_132	[p9l1292t329r1620b398],
9	genotypes	NNS	O	genotype	prep_between	7	SENT_132	[p9l1651t340r2045b418],
10	in	IN	O	in	_	0	SENT_132	[p9l2076t329r2151b397],
11	the	DT	O	the	det	13	SENT_132	[p9l9t432r127b501],
12	placebo	NN	O	placebo	nn	13	SENT_132	[p9l175t432r479b521],
13	group	NN	O	group	prep_in	9	SENT_132	[p9l531t454r756b521],
14	were	VBD	O	be	cop	15	SENT_132	[p9l807t454r996b501],
15	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_132	[p9l1049t432r1455b521],
16	when	WRB	O	when	advmod	17	SENT_132	[p9l1504t432r1714b501],
17	compared	VBN	O	compare	advcl	15	SENT_132	[p9l1765t432r2151b521],
18	with	IN	O	with	_	0	SENT_132	[p9l9t535r182b604],
19	the	DT	O	the	det	23	SENT_132	[p9l226t535r343b604],
20	pravastatin	NN	O	pravastatin	nn	23	SENT_132	[p9l387t535r819b624],
21	group	NN	O	group	nn	23	SENT_132	[p9l864t556r1089b624],
22	(	CD	NUMBER	(	num	23	SENT_132	[p9l1138t536r1213b624],
23	p	NN	O	p	prep_with	17	SENT_132	[p9l1138t536r1213b624],
24	=	JJ	O	=	amod	26	SENT_132	[p9l1268t559r1327b582],
25	0.002	CD	NUMBER	0.002	tmod	24	SENT_132	[p9l1383t535r1654b620],
26	)	NN	O	)	dobj	17	SENT_132	[p9l1383t535r1654b620],
27	.	.	O	.	_	0	SENT_132	[p9l1383t535r1654b620],

1	Medication	NN	O	medication	nsubj	3	SENT_133	[p9l1703t535r2151b604],
2	again	RB	O	again	advmod	3	SENT_133	[p9l11t638r220b727],
3	exerted	VBD	O	exert	_	0	SENT_133	[p9l247t638r535b707],
4	its	PRP$	O	its	poss	5	SENT_133	[p9l560t638r649b707],
5	inﬂuence	NN	O	inﬂuence	nsubj	18	SENT_133	[p9l677t638r1036b707],
6	in	IN	O	in	_	0	SENT_133	[p9l1063t638r1137b706],
7	a	DT	O	a	det	11	SENT_133	[p9l1165t660r1206b707],
8	genotype	NN	O	genotype	nn	11	SENT_133	[p9l1231t638r1922b727],
9	—	NN	O	—	nn	11	SENT_133	[p9l1231t638r1922b727],
10	speciﬁc	NN	O	speciﬁc	nn	11	SENT_133	[p9l1231t638r1922b727],
11	manner	NN	O	manner	prep_in	5	SENT_133	[p9l1950t660r2148b707, p9l9t763r153b810],
12	:	:	O	:	_	0	SENT_133	[p9l1950t660r2148b707, p9l9t763r153b810],
13	in	IN	O	in	_	0	SENT_133	[p9l210t741r285b809],
14	heterozygotes	NNS	O	heterozygote	prep_in	5	SENT_133	[p9l334t741r878b830],
15	and	CC	O	and	_	0	SENT_133	[p9l933t741r1072b810],
16	the	DT	O	the	det	17	SENT_133	[p9l1121t741r1239b810],
17	6A	NN	O	6a	prep_in	5	SENT_133	[p9l1292t741r1408b810],
18	homozygotes	VBZ	O	homozygote	ccomp	3	SENT_133	[p9l1458t741r1980b830],
19	the	DT	O	the	det	20	SENT_133	[p9l2032t741r2150b810],
20	data	NNS	O	datum	nsubj	21	SENT_133	[p9l10t844r172b913],
21	indicated	VBD	O	indicate	ccomp	18	SENT_133	[p9l197t844r557b913],
22	that	IN	O	that	complm	24	SENT_133	[p9l582t844r729b913],
23	pravastatin	NN	O	pravastatin	nsubj	24	SENT_133	[p9l752t844r1184b933],
24	reduced	VBD	O	reduce	ccomp	21	SENT_133	[p9l1209t844r1521b913],
25	the	DT	O	the	det	26	SENT_133	[p9l1546t844r1663b913],
26	risk	NN	O	risk	dobj	24	SENT_133	[p9l1688t844r1837b913],
27	of	IN	O	of	_	0	SENT_133	[p9l1862t844r1947b913],
28	need	NN	O	need	prep_of	26	SENT_133	[p9l1967t844r2151b913],
29	for	IN	O	for	_	0	SENT_133	[p9l9t947r123b1016],
30	a	DT	O	a	det	32	SENT_133	[p9l164t969r205b1016],
31	repeat	NN	O	repeat	nn	32	SENT_133	[p9l242t958r483b1036],
32	angioplasty	NN	O	angioplasty	prep_for	24	SENT_133	[p9l524t947r974b1036],
33	in	IN	O	in	_	0	SENT_133	[p9l1015t947r1089b1015],
34	patients	NNS	O	patient	prep_in	24	SENT_133	[p9l1128t947r1432b1036],
35	with	IN	O	with	_	0	SENT_133	[p9l1475t947r1648b1016],
36	these	DT	O	these	det	37	SENT_133	[p9l1688t947r1887b1016],
37	genotypes	NNS	O	genotype	prep_with	34	SENT_133	[p9l1930t969r2148b1036, p9l9t1060r238b1139],
38	;	:	O	;	_	0	SENT_133	[p9l1930t969r2148b1036, p9l9t1060r238b1139],
39	in	IN	O	in	_	0	SENT_133	[p9l269t1050r343b1118],
40	the	DT	O	the	det	41	SENT_133	[p9l370t1050r488b1119],
41	case	NN	O	case	prep_in	50	SENT_133	[p9l516t1072r682b1119],
42	of	IN	O	of	_	0	SENT_133	[p9l711t1050r796b1119],
43	5A	NN	O	5a	nn	44	SENT_133	[p9l818t1050r934b1119],
44	homozygotes	NNS	O	homozygote	prep_of	41	SENT_133	[p9l961t1050r1506b1139],
45	,	,	O	,	_	0	SENT_133	[p9l961t1050r1506b1139],
46	this	DT	O	this	nsubj	50	SENT_133	[p9l1537t1050r1675b1119],
47	was	VBD	O	be	cop	50	SENT_133	[p9l1705t1072r1852b1119],
48	not	RB	O	not	neg	50	SENT_133	[p9l1882t1060r2007b1119],
49	the	DT	O	the	det	50	SENT_133	[p9l2032t1050r2150b1119],
50	case	NN	O	case	parataxis	3	SENT_133	[p9l10t1153r196b1200],
51	.	.	O	.	_	0	SENT_133	[p9l10t1153r196b1200],

1	MARCH	NN	DATE	march	nn	2	SENT_134	[p9l48t1369r304b1429],
2	l5	NN	O	l5	_	0	SENT_134	[p9l361t1370r455b1439],
3	,	,	O	,	_	0	SENT_134	[p9l361t1370r455b1439],
4	W99	NN	O	w99	appos	2	SENT_134	[p9l516t1369r684b1428],

1	TABLE	NN	O	table	nn	3	SENT_135	[p9l63t1668r254b1727],
2	III	CD	NUMBER	iii	num	3	SENT_135	[p9l286t1669r336b1727],
3	Frequency	NN	O	frequency	_	0	SENT_135	[p9l392t1669r721b1747],
4	of	IN	O	of	_	0	SENT_135	[p9l748t1663r810b1728],
5	Symptom-Driven	NNP	O	Symptom-Driven	nn	7	SENT_135	[p9l837t1668r1352b1747],
6	Repeat	NN	O	repeat	nn	7	SENT_135	[p9l1388t1669r1607b1747],
7	Angioplasty	NNP	O	Angioplasty	prep_of	3	SENT_135	[p9l1632t1664r2019b1747],
8	in	IN	O	in	_	0	SENT_135	[p9l69t1758r118b1811],
9	Patients	NNPS	O	Patients	prep_in	7	SENT_135	[p9l154t1754r392b1812],
10	Where	WRB	O	where	advmod	14	SENT_135	[p9l421t1749r642b1813],
11	Planned	NNP	O	Planned	nn	12	SENT_135	[p9l675t1749r925b1812],
12	Angioplasty	NNP	O	Angioplasty	nsubj	14	SENT_135	[p9l955t1749r1342b1831],
13	Was	VBD	O	be	cop	14	SENT_135	[p9l1368t1752r1520b1813],
14	Performed	NNP	O	Performed	dep	3	SENT_135	[p9l1553t1748r1873b1812],
15	When	WRB	O	when	advmod	16	SENT_135	[p9l65t1833r259b1898],
16	Entering	VBG	O	enter	advcl	14	SENT_135	[p9l295t1838r549b1915],
17	the	DT	O	the	det	18	SENT_135	[p9l582t1833r675b1897],
18	Study	NN	O	study	dobj	16	SENT_135	[p9l705t1833r881b1916],
19	for	IN	O	for	_	0	SENT_135	[p9l909t1832r994b1897],
20	Each	DT	O	each	det	21	SENT_135	[p9l1025t1833r1173b1897],
21	Genotype	NN	O	genotype	prep_for	16	SENT_135	[p9l1206t1837r1522b1916],
22	in	IN	O	in	_	0	SENT_135	[p9l1555t1842r1604b1896],
23	the	DT	O	the	det	27	SENT_135	[p9l1636t1833r1728b1897],
24	Placebo	NNP	O	Placebo	nn	27	SENT_135	[p9l1761t1833r2012b1897],
25	and	CC	O	and	_	0	SENT_135	[p9l67t1918r185b1981],
26	Pravastatin	NNP	O	Pravastatin	nn	27	SENT_135	[p9l221t1923r564b1982],
27	Groups	NNS	O	group	prep_in	21	SENT_135	[p9l597t1922r833b2000],

1	Placebo	NNP	O	Placebo	nn	2	SENT_136	[p9l626t2062r862b2122],
2	Pravastatin	NNP	O	Pravastatin	_	0	SENT_136	[p9l1336t2068r1657b2123],

1	P	NN	O	p	_	0	SENT_137	[p9l979t2228r1012b2281],
2	P	NN	O	p	nn	3	SENT_137	[p9l1749t2228r1783b2281],
3	P	NN	O	p	dep	1	SENT_137	[p9l1977t2228r2011b2281],

1	Genotype	NN	O	genotype	_	0	SENT_138	[p9l66t2292r363b2366],
2	Reangioplasty	NNP	O	Reangioplasty	nn	8	SENT_138	[p9l416t2288r841b2366],
3	Value	NNP	O	Value	nn	8	SENT_138	[p9l887t2288r1095b2349],
4	*	NNP	O	*	nn	8	SENT_138	[p9l887t2288r1095b2349],
5	Reangioplasty	NNP	O	Reangioplasty	nn	8	SENT_138	[p9l1170t2288r1595b2366],
6	Value	NNP	O	Value	nn	8	SENT_138	[p9l1658t2288r1865b2349],
7	*	NNP	O	*	nn	8	SENT_138	[p9l1658t2288r1865b2349],
8	Value	NNP	O	Value	dep	1	SENT_138	[p9l1891t2286r2091b2350],
9	*	IN	O	*	amod	8	SENT_138	[p9l1891t2286r2091b2350],

1	5A5A	NN	O	5a5a	dep	13	SENT_139	[p9l65t2432r249b2489],
2	2/18	CD	PERCENT	2/18	num	1	SENT_139	[p9l430t2429r592b2499],
3	(	CD	PERCENT	(	number	4	SENT_139	[p9l625t2432r861b2505],
4	11.1	CD	PERCENT	11.1	num	5	SENT_139	[p9l625t2432r861b2505],
5	%	NN	PERCENT	%	dep	1	SENT_139	[p9l625t2432r861b2505],
6	)	CD	NUMBER	)	number	7	SENT_139	[p9l625t2432r861b2505],
7	5/18	CD	NUMBER	5/18	dep	8	SENT_139	[p9l1122t2429r1286b2499],
8	(	NN	O	(	dep	5	SENT_139	[p9l1319t2432r1490b2505],
9	28	CD	PERCENT	28	number	10	SENT_139	[p9l1319t2432r1490b2505],
10	%	NN	PERCENT	%	amod	5	SENT_139	[p9l1319t2432r1490b2505],
11	)	CD	NUMBER	)	num	12	SENT_139	[p9l1319t2432r1490b2505],
12	5A6A	NN	O	5a6a	dep	13	SENT_139	[p9l66t2517r249b2574],
13	18/48	CD	PERCENT	18/48	dep	21	SENT_139	[p9l395t2514r592b2584],
14	(	CD	PERCENT	(	num	16	SENT_139	[p9l625t2517r861b2590],
15	37.5	CD	PERCENT	37.5	num	16	SENT_139	[p9l625t2517r861b2590],
16	%	NN	PERCENT	%	dep	13	SENT_139	[p9l625t2517r861b2590],
17	)	CD	NUMBER	)	number	18	SENT_139	[p9l625t2517r861b2590],
18	0/38	CD	NUMBER	0/38	num	20	SENT_139	[p9l1123t2514r1286b2584],
19	(	NN	O	(	nn	20	SENT_139	[p9l1319t2517r1447b2589],
20	o	NN	PERCENT	o	dep	16	SENT_139	[p9l1319t2517r1447b2589],
21	%	NN	PERCENT	%	dep	23	SENT_139	[p9l1319t2517r1447b2589],
22	)	CD	NUMBER	)	num	21	SENT_139	[p9l1319t2517r1447b2589],
23	6A6A	NN	O	6a6a	dep	27	SENT_139	[p9l67t2602r249b2658],
24	8/20	CD	PERCENT	8/20	num	23	SENT_139	[p9l432t2599r595b2668],
25	(	CD	PERCENT	(	num	27	SENT_139	[p9l625t2601r861b2674],
26	40.0	CD	PERCENT	40.0	num	27	SENT_139	[p9l625t2601r861b2674],
27	%	NN	PERCENT	%	dep	33	SENT_139	[p9l625t2601r861b2674],
28	)	CD	NUMBER	)	number	29	SENT_139	[p9l625t2601r861b2674],
29	0.09	CD	NUMBER	0.09	dep	27	SENT_139	[p9l921t2603r1067b2658],
30	3/20	CD	NUMBER	3/20	num	31	SENT_139	[p9l1125t2599r1555b2674],
31	(	NN	O	(	dep	29	SENT_139	[p9l1125t2599r1555b2674],
32	15.0	CD	PERCENT	15.0	num	33	SENT_139	[p9l1125t2599r1555b2674],
33	%	NN	PERCENT	%	dep	34	SENT_139	[p9l1125t2599r1555b2674],
34	)	CD	NUMBER	)	dep	36	SENT_139	[p9l1125t2599r1555b2674],
35	0.005	CD	NUMBER	0.005	num	36	SENT_139	[p9l1669t2603r1857b2658],
36	0.002	CD	NUMBER	0.002	_	0	SENT_139	[p9l1898t2603r2085b2658],

1	*	NN	O	*	nn	3	SENT_140	[p9l117t2752r181b2814],
2	p	NN	O	p	nn	3	SENT_140	[p9l117t2752r181b2814],
3	Value	NN	O	value	_	0	SENT_140	[p9l200t2747r348b2801],
4	For	IN	O	for	dep	3	SENT_140	[p9l369t2746r438b2799],
5	the	DT	O	the	det	7	SENT_140	[p9l457t2747r533b2799],
6	chi-square	JJ	O	chi-square	amod	7	SENT_140	[p9l553t2747r819b2814],
7	test	NN	O	test	pobj	4	SENT_140	[p9l839t2759r924b2799],
8	for	IN	O	for	_	0	SENT_140	[p9l942t2746r1012b2799],
9	the	DT	O	the	det	10	SENT_140	[p9l1031t2747r1106b2799],
10	difference	NN	O	difference	prep_for	7	SENT_140	[p9l1127t2746r1385b2799],
11	between	IN	O	between	_	0	SENT_140	[p9l1408t2747r1624b2800],
12	patients	NNS	O	patient	prep_between	10	SENT_140	[p9l1649t2755r1847b2814],
13	with	IN	O	with	_	0	SENT_140	[p9l1867t2747r1972b2800],
14	and	CC	O	and	_	0	SENT_140	[p9l1995t2747r2092b2799],
15	without	IN	O	without	_	0	SENT_140	[p9l64t2832r254b2884],
16	a	DT	O	a	det	18	SENT_140	[p9l276t2853r305b2884],
17	repeat	NN	O	repeat	nn	18	SENT_140	[p9l334t2843r499b2899],
18	antioplasty	NN	O	antioplasty	prep_with	12	SENT_140	[p9l521t2832r819b2899],
19	.	.	O	.	_	0	SENT_140	[p9l521t2832r819b2899],

1	lp	NN	O	lp	nn	2	SENT_141	[p9l115t2909r172b2983],
2	Value	NN	O	value	_	0	SENT_141	[p9l209t2916r357b2970],
3	of	IN	O	of	_	0	SENT_141	[p9l395t2916r445b2968],
4	the	DT	O	the	det	5	SENT_141	[p9l480t2916r556b2968],
5	interaction	NN	O	interaction	prep_of	2	SENT_141	[p9l596t2924r864b2968],
6	between	IN	O	between	_	0	SENT_141	[p9l907t2916r1122b2969],
7	the	DT	O	the	det	9	SENT_141	[p9l1162t2916r1238b2968],
8	stromelysin	NN	O	stromelysin	nn	9	SENT_141	[p9l1276t2916r1559b2983],
9	polymorphism	NN	O	polymorphism	prep_between	5	SENT_141	[p9l1602t2916r1964b2984],
10	and	CC	O	and	_	0	SENT_141	[p9l2005t2916r2101b2968],
11	medication	NN	O	medication	nn	13	SENT_141	[p9l68t3001r351b3053],
12	(	CD	NUMBER	(	num	13	SENT_141	[p9l393t3001r618b3068],
13	placebo	NN	O	placebo	conj_and	9	SENT_141	[p9l393t3001r618b3068],
14	vs	CC	O	vs	_	0	SENT_141	[p9l651t3022r702b3053],
15	pravastatin	NN	O	pravastatin	conj_vs	5	SENT_141	[p9l739t3003r1040b3068],
16	)	CD	NUMBER	)	number	17	SENT_141	[p9l739t3003r1040b3068],
17	(	CD	NUMBER	(	num	18	SENT_141	[p9l1082t3003r1255b3067],
18	5A6A	NN	O	5a6a	dep	15	SENT_141	[p9l1082t3003r1255b3067],
19	and	CC	O	and	_	0	SENT_141	[p9l1288t3001r1385b3053],
20	6A6A	NN	O	6a6a	conj_and	5	SENT_141	[p9l1423t3004r1581b3053],
21	combined	VBN	O	combine	partmod	20	SENT_141	[p9l1615t3001r1870b3053],
22	for	IN	O	for	_	0	SENT_141	[p9l1907t3000r1977b3053],
23	this	DT	O	this	det	25	SENT_141	[p9l2010t3001r2094b3053],
24	analysis	NN	O	analysis	nn	25	SENT_141	[p9l66t3086r307b3153],
25	)	NN	O	)	prep_for	21	SENT_141	[p9l66t3086r307b3153],
26	.	.	O	.	_	0	SENT_141	[p9l66t3086r307b3153],
27	'	''	O	'	_	0	SENT_141	[p10l71t162r137b245],

1	8	CD	NUMBER	8	num	2	SENT_142	[p10l71t162r137b245],
2	‘	CD	NUMBER	‘	_	0	SENT_142	[p10l71t162r137b245],
3	.5	CD	NUMBER	.5	number	4	SENT_142	[p10l71t248r136b332],
4	E	NN	PERCENT	e	num	5	SENT_142	[p10l95t359r129b445],
5	%	NN	PERCENT	%	dep	2	SENT_142	[p10l95t449r143b516],
6	O	NN	O	o	nn	7	SENT_142	[p10l95t538r129b572],
7	E	NN	O	e	dep	2	SENT_142	[p10l88t575r129b650],
8	53	CD	NUMBER	53	number	9	SENT_142	[p10l89t672r129b758],
9	‘	CD	NUMBER	‘	dep	7	SENT_142	[p10l89t672r129b758],
10	“	NN	O	“	dep	9	SENT_142	[p10l73t760r130b817],
11	:3	CD	NUMBER	:3	num	10	SENT_142	[p10l73t760r130b817],

1	E	NN	O	e	_	0	SENT_143	[p10l74t869r130b953],
2	:1	CD	NUMBER	:1	num	3	SENT_143	[p10l76t976r130b1033],
3	o	NN	O	o	dep	1	SENT_143	[p10l76t1036r130b1092],
4	2	CD	NUMBER	2	dep	3	SENT_143	[p10l74t1096r129b1165],

1	Baseline	NN	O	baseline	nn	2	SENT_144	[p10l1416t1380r1682b1437],
2	MOD	NN	O	mod	_	0	SENT_144	[p10l1704t1382r1894b1435],
3	(	CD	NUMBER	(	num	5	SENT_144	[p10l1919t1379r2085b1442],
4	mm	NN	O	mm	nn	5	SENT_144	[p10l1919t1379r2085b1442],
5	)	NN	O	)	dep	2	SENT_144	[p10l1919t1379r2085b1442],

1	FIGURE	NN	O	figure	_	0	SENT_145	[p10l11t1561r243b1621],
2	2	CD	NUMBER	2	dep	1	SENT_145	[p10l273t1561r332b1621],
3	.	.	O	.	_	0	SENT_145	[p10l273t1561r332b1621],

1	Relation	NN	O	relation	nsubj	18	SENT_146	[p10l365t1556r619b1621],
2	between	IN	O	between	_	0	SENT_146	[p10l651t1556r920b1621],
3	baseline	NN	O	baseline	nn	4	SENT_146	[p10l951t1556r1216b1621],
4	MOD	NN	O	mod	prep_between	1	SENT_146	[p10l1243t1561r1412b1621],
5	and	CC	O	and	_	0	SENT_146	[p10l1439t1556r1560b1621],
6	lesion	NN	O	lesion	nn	7	SENT_146	[p10l1591t1556r1772b1621],
7	rogression	NN	O	rogression	prep_between	1	SENT_146	[p10l1846t1581r2072b1640, p10l9t1645r136b1706],
8	for	IN	O	for	_	0	SENT_146	[p10l165t1639r257b1706],
9	each	DT	O	each	det	14	SENT_146	[p10l282t1640r430b1706],
10	stromelysin	NN	O	stromelysin	nn	14	SENT_146	[p10l460t1640r821b1724],
11	genotype	NN	O	genotype	nn	14	SENT_146	[p10l851t1654r1150b1724],
12	(	CD	NUMBER	(	num	14	SENT_146	[p10l1182t1640r1355b1718],
13	solid	JJ	O	solid	amod	14	SENT_146	[p10l1182t1640r1355b1718],
14	line	NN	O	line	prep_for	4	SENT_146	[p10l1377t1640r1507b1706],
15	:	:	O	:	_	0	SENT_146	[p10l1377t1640r1507b1706],
16	5A5A	NN	O	5a5a	dep	14	SENT_146	[p10l1538t1646r1745b1716],
17	;	:	O	;	_	0	SENT_146	[p10l1538t1646r1745b1716],
18	otted	VBN	O	ott	_	0	SENT_146	[p10l1817t1640r1982b1706],
19	line	NN	O	line	dobj	18	SENT_146	[p10l2004t1640r2134b1706],
20	:	:	O	:	_	0	SENT_146	[p10l2004t1640r2134b1706],
21	5A6A	NN	O	5a6a	dep	19	SENT_146	[p10l10t1730r217b1801],
22	;	:	O	;	_	0	SENT_146	[p10l10t1730r217b1801],
23	and	CC	O	and	_	0	SENT_146	[p10l244t1725r365b1790],
24	hatched	VBD	O	hatch	conj_and	18	SENT_146	[p10l397t1725r657b1790],
25	line	NN	O	line	dobj	24	SENT_146	[p10l678t1725r808b1791],
26	:	:	O	:	_	0	SENT_146	[p10l678t1725r808b1791],
27	6A6A	NN	O	6a6a	nn	28	SENT_146	[p10l838t1726r1041b1802],
28	)	NN	O	)	dep	25	SENT_146	[p10l838t1726r1041b1802],
29	in	IN	O	in	_	0	SENT_146	[p10l1074t1730r1128b1789],
30	the	DT	O	the	det	32	SENT_146	[p10l1157t1725r1254b1790],
31	placebo	NN	O	placebo	nn	32	SENT_146	[p10l1283t1725r1535b1809],
32	group	NN	O	group	prep_in	28	SENT_146	[p10l1562t1750r1774b1809],
33	,	,	O	,	_	0	SENT_146	[p10l1562t1750r1774b1809],
34	adjusted	VBN	O	adjust	partmod	28	SENT_146	[p10l1802t1725r2074b1809],
35	for	IN	O	for	_	0	SENT_146	[p10l8t1808r100b1875],
36	baseline	NN	O	baseline	nn	37	SENT_146	[p10l128t1809r392b1875],
37	medication	NN	O	medication	prep_for	34	SENT_146	[p10l422t1809r791b1875],
38	.	.	O	.	_	0	SENT_146	[p10l422t1809r791b1875],

1	Comparison	NN	O	comparison	nsubj	42	SENT_147	[p10l136t2052r595b2146],
2	of	IN	O	of	_	0	SENT_147	[p10l622t2044r697b2123],
3	measurements	NNS	O	measurement	prep_of	1	SENT_147	[p10l722t2062r1270b2123],
4	of	IN	O	of	_	0	SENT_147	[p10l1295t2044r1370b2123],
5	disease	NN	O	disease	nn	6	SENT_147	[p10l1392t2045r1677b2123],
6	progression	NN	O	progression	prep_of	3	SENT_147	[p10l1703t2052r2148b2146],
7	according	VBG	O	accord	_	0	SENT_147	[p10l9t2149r382b2248],
8	to	TO	O	to	prepc_according_to	3	SENT_147	[p10l437t2166r508b2227],
9	genotype	NN	O	genotype	pobj	3	SENT_147	[p10l559t2166r937b2248],
10	:	:	O	:	_	0	SENT_147	[p10l559t2166r937b2248],
11	The	DT	O	the	det	12	SENT_147	[p10l992t2158r1142b2226],
12	patients	NNS	O	patient	dep	3	SENT_147	[p10l1194t2157r1497b2247],
13	in	IN	O	in	_	0	SENT_147	[p10l1551t2157r1625b2225],
14	the	DT	O	the	det	17	SENT_147	[p10l1677t2158r1794b2226],
15	placebo	NN	O	placebo	nn	17	SENT_147	[p10l1845t2158r2149b2247],
16	treatment	NN	O	treatment	nn	17	SENT_147	[p10l9t2271r381b2330],
17	group	NN	O	group	prep_in	12	SENT_147	[p10l429t2283r654b2350],
18	who	WP	O	who	nsubj	20	SENT_147	[p10l703t2261r869b2330],
19	were	VBD	O	be	cop	20	SENT_147	[p10l919t2283r1107b2330],
20	homozygous	JJ	O	homozygous	rcmod	12	SENT_147	[p10l1155t2261r1655b2350],
21	for	IN	O	for	mark	25	SENT_147	[p10l1706t2261r1820b2330],
22	the	DT	O	the	det	24	SENT_147	[p10l1866t2261r1984b2330],
23	6A	NN	O	6a	nn	24	SENT_147	[p10l2034t2261r2151b2330],
24	allele	NN	O	allele	nsubj	25	SENT_147	[p10l11t2364r219b2433],
25	had	VBD	O	have	advcl	20	SENT_147	[p10l268t2364r409b2433],
26	a	DT	O	a	det	29	SENT_147	[p10l459t2385r500b2433],
27	slightly	RB	O	slightly	advmod	28	SENT_147	[p10l550t2364r840b2453],
28	greater	JJR	O	greater	amod	29	SENT_147	[p10l890t2374r1162b2453],
29	progression	NN	O	progression	dobj	25	SENT_147	[p10l1207t2364r1667b2453],
30	of	IN	O	of	_	0	SENT_147	[p10l1716t2364r1801b2433],
31	disease	NN	O	disease	prep_of	29	SENT_147	[p10l1844t2364r2147b2445],
32	,	,	O	,	_	0	SENT_147	[p10l1844t2364r2147b2445],
33	assessed	VBN	O	assess	partmod	3	SENT_147	[p10l11t2466r341b2534],
34	as	IN	O	as	_	0	SENT_147	[p10l383t2487r457b2534],
35	a	DT	O	a	det	36	SENT_147	[p10l502t2487r543b2534],
36	reduction	NN	O	reduction	prep_as	33	SENT_147	[p10l579t2465r951b2534],
37	in	IN	O	in	_	0	SENT_147	[p10l991t2465r1065b2534],
38	MOD	NNP	O	MOD	prep_in	36	SENT_147	[p10l1104t2466r1330b2535],
39	in	IN	O	in	_	0	SENT_147	[p10l1372t2466r1446b2533],
40	coronary	JJ	O	coronary	amod	41	SENT_147	[p10l1486t2487r1833b2555],
41	Vessels	NNS	O	vessel	prep_in	33	SENT_147	[p10l1874t2466r2148b2535],
42	(	VBP	O	(	_	0	SENT_147	[p10l12t2570r263b2655],
43	Table	NNP	O	Table	dobj	42	SENT_147	[p10l12t2570r263b2655],
44	I	PRP	O	I	nsubj	45	SENT_147	[p10l313t2571r395b2655],
45	)	VBP	O	)	rcmod	43	SENT_147	[p10l313t2571r395b2655],
46	.	.	O	.	_	0	SENT_147	[p10l313t2571r395b2655],

1	Figure	NN	O	figure	nsubj	3	SENT_148	[p10l449t2570r704b2659],
2	2	CD	NUMBER	2	num	1	SENT_148	[p10l754t2571r798b2638],
3	shows	VBZ	O	show	_	0	SENT_148	[p10l852t2570r1090b2639],
4	that	IN	O	that	complm	24	SENT_148	[p10l1141t2570r1288b2639],
5	the	DT	O	the	det	6	SENT_148	[p10l1335t2570r1453b2639],
6	extent	NN	O	extent	dobj	10	SENT_148	[p10l1503t2580r1742b2639],
7	to	TO	O	to	_	0	SENT_148	[p10l1789t2581r1862b2639],
8	which	WDT	O	which	prep_to	6	SENT_148	[p10l1913t2570r2151b2639],
9	lesions	NNS	O	lesion	nsubj	10	SENT_148	[p10l9t2673r278b2742],
10	progressed	VBD	O	progress	dep	24	SENT_148	[p10l311t2673r738b2762],
11	over	IN	O	over	_	0	SENT_148	[p10l771t2694r944b2742],
12	the	DT	DURATION	the	det	14	SENT_148	[p10l974t2673r1092b2742],
13	2	CD	DURATION	2	num	14	SENT_148	[p10l1125t2673r1170b2741],
14	years	NNS	NUMBER	year	prep_over	10	SENT_148	[p10l1202t2694r1406b2762],
15	of	IN	O	of	_	0	SENT_148	[p10l1441t2673r1526b2742],
16	the	DT	O	the	det	17	SENT_148	[p10l1551t2673r1669b2742],
17	trial	NN	O	trial	prep_of	14	SENT_148	[p10l1701t2673r1857b2742],
18	(	CD	NUMBER	(	num	21	SENT_148	[p10l1893t2673r2148b2758],
19	MOD	NN	O	mod	nn	21	SENT_148	[p10l1893t2673r2148b2758],
20	loss	NN	O	loss	nn	21	SENT_148	[p10l9t2775r190b2860],
21	)	NN	O	)	nsubj	24	SENT_148	[p10l9t2775r190b2860],
22	was	VBD	O	be	cop	24	SENT_148	[p10l239t2796r386b2844],
23	directly	RB	O	directly	advmod	24	SENT_148	[p10l436t2774r733b2864],
24	related	JJ	O	related	ccomp	3	SENT_148	[p10l778t2775r1045b2843],
25	not	RB	O	not	neg	26	SENT_148	[p10l1090t2785r1215b2843],
26	only	RB	O	only	preconj	24	SENT_148	[p10l1260t2775r1431b2864],
27	to	TO	O	to	_	0	SENT_148	[p10l1477t2785r1550b2843],
28	genotype	NN	O	genotype	prep_to	24	SENT_148	[p10l1598t2785r1977b2864],
29	,	,	O	,	_	0	SENT_148	[p10l1598t2785r1977b2864],
30	but	CC	O	but	_	0	SENT_148	[p10l2025t2774r2151b2843],
31	also	RB	O	also	_	0	SENT_148	[p10l11t2879r164b2948],
32	to	TO	O	to	_	0	SENT_148	[p10l197t2889r271b2948],
33	the	DT	O	the	det	34	SENT_148	[p10l304t2879r421b2948],
34	severity	NN	O	severity	prep_to	24	SENT_148	[p10l458t2879r763b2968],
35	of	IN	O	of	_	0	SENT_148	[p10l798t2879r883b2948],
36	the	DT	O	the	det	37	SENT_148	[p10l908t2879r1026b2948],
37	disease	NN	O	disease	prep_of	34	SENT_148	[p10l1060t2879r1341b2948],
38	at	IN	O	at	_	0	SENT_148	[p10l1375t2889r1444b2948],
39	baseline	NN	O	baseline	prep_at	24	SENT_148	[p10l1473t2879r1816b2948],
40	:	:	O	:	_	0	SENT_148	[p10l1473t2879r1816b2948],
41	the	DT	O	the	det	43	SENT_148	[p10l1855t2879r1973b2948],
42	less	RBR	O	less	advmod	43	SENT_148	[p10l2005t2879r2148b2948],
43	severe	JJ	O	severe	dep	45	SENT_148	[p10l12t3003r258b3051],
44	the	DT	O	the	det	45	SENT_148	[p10l301t2982r418b3051],
45	lesion	NN	O	lesion	dep	3	SENT_148	[p10l462t2982r695b3051],
46	to	TO	O	to	aux	47	SENT_148	[p10l737t2992r810b3051],
47	begin	VB	O	begin	infmod	45	SENT_148	[p10l853t2982r1071b3071],
48	with	IN	O	with	prep	47	SENT_148	[p10l1114t2982r1307b3063],
49	,	,	O	,	_	0	SENT_148	[p10l1114t2982r1307b3063],
50	the	DT	O	the	det	51	SENT_148	[p10l1353t2982r1471b3051],
51	greater	JJR	O	greater	dep	53	SENT_148	[p10l1515t2992r1787b3071],
52	the	DT	O	the	det	53	SENT_148	[p10l1828t2982r1945b3051],
53	progression	NN	O	progression	dep	45	SENT_148	[p10l1987t3003r2147b3071, p10l10t3084r356b3173],
54	,	,	O	,	_	0	SENT_148	[p10l1987t3003r2147b3071, p10l10t3084r356b3173],
55	with	IN	O	with	_	0	SENT_148	[p10l405t3083r578b3152],
56	the	DT	O	the	det	66	SENT_148	[p10l622t3084r740b3152],
57	fastest	JJS	O	fastest	amod	66	SENT_148	[p10l786t3083r1036b3152],
58	being	VBG	O	be	auxpass	59	SENT_148	[p10l1079t3083r1295b3173],
59	observed	VBN	O	observe	dep	57	SENT_148	[p10l1343t3084r1696b3153],
60	in	IN	O	in	_	0	SENT_148	[p10l1740t3084r1814b3151],
61	6A	NN	O	6a	nn	62	SENT_148	[p10l1861t3083r1977b3153],
62	homozygotes	NNS	O	homozygote	prep_in	59	SENT_148	[p10l2021t3084r2148b3152, p10l9t3198r431b3277],
63	(	CD	NUMBER	(	num	64	SENT_148	[p10l471t3188r821b3273],
64	baseline	NN	O	baseline	npadvmod	65	SENT_148	[p10l471t3188r821b3273],
65	MOD-genotype	JJ	MISC	mod-genotype	amod	66	SENT_148	[p10l855t3189r1477b3277],
66	interaction	NN	O	interaction	prep_with	45	SENT_148	[p10l1512t3188r1952b3269],
67	,	,	O	,	_	0	SENT_148	[p10l1512t3188r1952b3269],
68	p	NN	O	p	appos	66	SENT_148	[p10l1989t3210r2036b3277],
69	=	JJ	O	=	amod	71	SENT_148	[p10l2081t3213r2140b3235],
70	0.003	CD	NUMBER	0.003	tmod	69	SENT_148	[p10l10t3290r281b3375],
71	)	NN	O	)	dep	68	SENT_148	[p10l10t3290r281b3375],
72	.	.	O	.	_	0	SENT_148	[p10l10t3290r281b3375],

1	DISCUSSION	NN	O	discussion	_	0	SENT_149	[p10l14t3496r704b3582],

1	In	IN	O	in	_	0	SENT_150	[p11l136t23r216b89],
2	this	DT	O	this	det	3	SENT_150	[p11l250t21r387b90],
3	study	NN	O	study	prep_in	7	SENT_150	[p11l428t21r657b111],
4	,	,	O	,	_	0	SENT_150	[p11l428t21r657b111],
5	we	PRP	O	we	nsubj	7	SENT_150	[p11l695t43r807b91],
6	were	VBD	O	be	cop	7	SENT_150	[p11l843t43r1031b91],
7	able	JJ	O	able	_	0	SENT_150	[p11l1068t22r1227b90],
8	to	TO	O	to	aux	9	SENT_150	[p11l1262t32r1335b90],
9	identify	VB	O	identify	xcomp	7	SENT_150	[p11l1371t21r1675b111],
10	a	DT	O	a	det	11	SENT_150	[p11l1712t43r1753b90],
11	subgroup	NN	O	subgroup	dobj	9	SENT_150	[p11l1789t22r2149b111],
12	of	IN	O	of	_	0	SENT_150	[p11l10t126r95b195],
13	patients	NNS	O	patient	prep_of	11	SENT_150	[p11l146t126r449b215],
14	with	IN	O	with	_	0	SENT_150	[p11l510t126r683b195],
15	coronary	JJ	O	coronary	amod	17	SENT_150	[p11l741t148r1088b215],
16	artery	NN	O	artery	nn	17	SENT_150	[p11l1149t137r1374b215],
17	disease	NN	O	disease	prep_with	9	SENT_150	[p11l1434t126r1715b195],
18	in	IN	O	in	_	0	SENT_150	[p11l1774t126r1848b194],
19	whom	WP	O	whom	det	20	SENT_150	[p11l1906t126r2152b195],
20	treatment	NN	O	treatment	rel	31	SENT_150	[p11l9t239r381b298],
21	with	IN	O	with	_	0	SENT_150	[p11l406t229r579b298],
22	the	DT	O	the	det	24	SENT_150	[p11l605t229r723b298],
23	lipid	NN	O	lipid	nn	24	SENT_150	[p11l749t229r1310b318],
24	—	NN	O	—	prep_with	20	SENT_150	[p11l749t229r1310b318],
25	lowering	VBG	O	lower	csubj	31	SENT_150	[p11l749t229r1310b318],
26	drug	NN	O	drug	nn	27	SENT_150	[p11l1339t229r1515b318],
27	pravastatin	NN	O	pravastatin	dobj	25	SENT_150	[p11l1541t229r1973b318],
28	was	VBD	O	be	cop	31	SENT_150	[p11l2000t251r2148b298],
29	apparently	RB	O	apparently	advmod	31	SENT_150	[p11l11t331r422b420],
30	especially	RB	O	especially	advmod	31	SENT_150	[p11l461t331r851b420],
31	beneﬁcial	JJ	O	beneﬁcial	rcmod	17	SENT_150	[p11l888t330r1290b399],
32	.	.	O	.	_	0	SENT_150	[p11l888t330r1290b399],

1	The	DT	O	the	det	2	SENT_151	[p11l1333t331r1483b399],
2	subgroups	NNS	O	subgroup	nsubjpass	4	SENT_151	[p11l1524t331r1922b420],
3	were	VBD	O	be	auxpass	4	SENT_151	[p11l1962t352r2150b400],
4	identiﬁed	VBN	O	identiﬁed	_	0	SENT_151	[p11l9t435r380b504],
5	using	VBG	O	use	xcomp	4	SENT_151	[p11l420t435r630b524],
6	the	DT	O	the	det	9	SENT_151	[p11l672t435r790b504],
7	functional	JJ	O	functional	amod	9	SENT_151	[p11l832t435r1229b504],
8	SA/6A	NN	O	sa/6a	nn	9	SENT_151	[p11l1272t435r1536b505],
9	polymorphism	NN	O	polymorphism	dobj	5	SENT_151	[p11l1576t435r2152b524],
10	in	IN	O	in	_	0	SENT_151	[p11l9t538r83b606],
11	the	DT	O	the	det	12	SENT_151	[p11l125t538r243b607],
12	promoter	NN	O	promoter	prep_in	5	SENT_151	[p11l285t548r648b627],
13	of	IN	O	of	_	0	SENT_151	[p11l690t538r775b607],
14	the	DT	O	the	det	16	SENT_151	[p11l811t538r928b607],
15	stromelysin-1	NN	O	stromelysin-1	nn	16	SENT_151	[p11l975t538r1503b627],
16	gene	NN	O	gene	prep_of	12	SENT_151	[p11l1556t560r1759b627],
17	,	,	O	,	_	0	SENT_151	[p11l1556t560r1759b627],
18	which	WDT	O	which	nsubjpass	20	SENT_151	[p11l1807t538r2045b607],
19	is	VBZ	O	be	auxpass	20	SENT_151	[p11l2088t538r2148b607],
20	associated	VBN	O	associate	rcmod	16	SENT_151	[p11l11t639r413b708],
21	with	IN	O	with	_	0	SENT_151	[p11l445t640r618b709],
22	variation	NN	O	variation	prep_with	20	SENT_151	[p11l650t639r998b709],
23	in	IN	O	in	_	0	SENT_151	[p11l1030t640r1105b707],
24	the	DT	O	the	det	25	SENT_151	[p11l1136t640r1254b708],
25	expression	NN	O	expression	prep_in	20	SENT_151	[p11l1288t640r1707b729],
26	of	IN	O	of	_	0	SENT_151	[p11l1740t639r1825b708],
27	stromelysin-l	JJ	O	stromelysin-l	amod	28	SENT_151	[p11l1855t650r2147b708, p11l9t744r375b833],
28	.12	CD	NUMBER	.12	prep_of	25	SENT_151	[p11l1855t650r2147b708, p11l9t744r375b833],
29	In	IN	O	in	_	0	SENT_151	[p11l409t746r489b812],
30	the	DT	O	the	det	31	SENT_151	[p11l522t744r639b813],
31	subgroups	NNS	O	subgroup	prep_in	40	SENT_151	[p11l677t744r1097b833],
32	,	,	O	,	_	0	SENT_151	[p11l677t744r1097b833],
33	speciﬁc	NN	O	speciﬁc	nn	34	SENT_151	[p11l1138t744r1431b833],
34	genotypes	NNS	O	genotype	nsubjpass	40	SENT_151	[p11l1468t755r1862b833],
35	of	IN	O	of	_	0	SENT_151	[p11l1899t744r1984b813],
36	this	DT	O	this	det	38	SENT_151	[p11l2010t744r2148b813],
37	functional	JJ	O	functional	amod	38	SENT_151	[p11l9t847r406b916],
38	polymorphism	NN	O	polymorphism	prep_of	34	SENT_151	[p11l463t847r1039b936],
39	were	VBD	O	be	auxpass	40	SENT_151	[p11l1096t869r1283b916],
40	associated	VBN	O	associate	ccomp	20	SENT_151	[p11l1344t847r1746b916],
41	with	IN	O	with	_	0	SENT_151	[p11l1803t847r1975b916],
42	the	DT	O	the	det	43	SENT_151	[p11l2032t847r2150b916],
43	development	NN	O	development	prep_with	40	SENT_151	[p11l10t949r518b1038],
44	of	IN	O	of	_	0	SENT_151	[p11l566t948r651b1017],
45	clinical	JJ	O	clinical	amod	47	SENT_151	[p11l694t948r980b1017],
46	coronary	JJ	O	coronary	amod	47	SENT_151	[p11l1030t970r1377b1038],
47	events	NNS	O	event	prep_of	43	SENT_151	[p11l1426t959r1673b1018],
48	in	IN	O	in	_	0	SENT_151	[p11l1724t949r1798b1016],
49	patients	NNS	O	patient	prep_in	40	SENT_151	[p11l1845t948r2148b1038],
50	receiving	VBG	O	receive	partmod	49	SENT_151	[p11l14t1053r377b1142],
51	placebo	NN	O	placebo	dobj	50	SENT_151	[p11l423t1053r748b1142],
52	,	,	O	,	_	0	SENT_151	[p11l423t1053r748b1142],
53	whereas	IN	O	whereas	mark	62	SENT_151	[p11l798t1053r1114b1122],
54	the	DT	O	the	det	56	SENT_151	[p11l1162t1053r1280b1122],
55	deleterious	JJ	O	deleterious	amod	56	SENT_151	[p11l1327t1053r1752b1122],
56	effect	NN	O	effect	nsubjpass	62	SENT_151	[p11l1801t1053r2023b1122],
57	of	IN	O	of	_	0	SENT_151	[p11l2069t1053r2153b1122],
58	the	DT	O	the	det	59	SENT_151	[p11l15t1156r132b1225],
59	polymorphism	NN	O	polymorphism	prep_of	56	SENT_151	[p11l178t1156r751b1245],
60	was	VBD	O	be	auxpass	62	SENT_151	[p11l796t1177r943b1225],
61	not	RB	O	not	neg	62	SENT_151	[p11l992t1166r1116b1225],
62	observed	VBN	O	observe	advcl	5	SENT_151	[p11l1163t1156r1515b1225],
63	in	IN	O	in	_	0	SENT_151	[p11l1560t1156r1634b1224],
64	the	DT	O	the	det	65	SENT_151	[p11l1680t1156r1797b1225],
65	patients	NNS	O	patient	nsubj	66	SENT_151	[p11l1843t1156r2144b1245],
66	receiving	VBG	O	receive	prepc_in	62	SENT_151	[p11l14t1259r377b1348],
67	pravastatin	NN	O	pravastatin	dobj	66	SENT_151	[p11l415t1259r864b1348],
68	.	.	O	.	_	0	SENT_151	[p11l415t1259r864b1348],

1	Until	IN	O	until	prep	6	SENT_152	[p11l908t1259r1107b1329],
2	now	RB	DATE	now	pobj	1	SENT_152	[p11l1146t1281r1334b1340],
3	,	,	O	,	_	0	SENT_152	[p11l1146t1281r1334b1340],
4	it	PRP	O	it	nsubj	6	SENT_152	[p11l1376t1259r1430b1328],
5	had	VBD	O	have	aux	6	SENT_152	[p11l1466t1259r1607b1328],
6	proved	VBN	O	prove	_	0	SENT_152	[p11l1643t1259r1915b1348],
7	difﬁcult	NN	O	difﬁcult	dobj	6	SENT_152	[p11l1954t1259r2144b1328, p11l16t1362r161b1431],
8	to	TO	O	to	aux	9	SENT_152	[p11l204t1372r277b1431],
9	identify	VB	O	identify	xcomp	6	SENT_152	[p11l323t1362r625b1451],
10	such	JJ	O	such	amod	14	SENT_152	[p11l675t1362r849b1431],
11	high	JJ	O	high	amod	14	SENT_152	[p11l893t1362r1248b1451],
12	—	NN	O	—	nn	14	SENT_152	[p11l893t1362r1248b1451],
13	risk	NN	O	risk	nn	14	SENT_152	[p11l893t1362r1248b1451],
14	groups	NNS	O	group	dobj	9	SENT_152	[p11l1292t1384r1553b1451],
15	of	IN	O	of	_	0	SENT_152	[p11l1602t1362r1687b1431],
16	patients	NNS	O	patient	prep_of	14	SENT_152	[p11l1724t1362r2026b1451],
17	in	IN	O	in	_	0	SENT_152	[p11l2073t1362r2147b1430],
18	those	DT	O	those	prep_in	16	SENT_152	[p11l15t1465r219b1534],
19	with	IN	O	with	_	0	SENT_152	[p11l245t1465r417b1534],
20	unremarkable	JJ	O	unremarkable	amod	22	SENT_152	[p11l441t1465r979b1534],
21	lipoprotein	NN	O	lipoprotein	nn	22	SENT_152	[p11l1005t1465r1433b1554],
22	disturbances	NNS	O	disturbance	prep_with	18	SENT_152	[p11l1459t1465r1967b1534],
23	.	.	O	.	_	0	SENT_152	[p11l1459t1465r1967b1534],

1	The	DT	O	the	det	3	SENT_153	[p11l1997t1465r2146b1534],
2	REGRESS	NNP	O	REGRESS	nn	3	SENT_153	[p11l15t1569r439b1638],
3	trial	NN	O	trial	nsubjpass	5	SENT_153	[p11l473t1568r628b1637],
4	was	VBD	O	be	auxpass	5	SENT_153	[p11l658t1590r806b1637],
5	designed	VBN	O	design	_	0	SENT_153	[p11l838t1568r1185b1657],
6	as	IN	O	as	_	0	SENT_153	[p11l1216t1590r1290b1637],
7	a	DT	O	a	det	8	SENT_153	[p11l1324t1590r1365b1637],
8	study	NN	O	study	prep_as	5	SENT_153	[p11l1396t1568r1602b1657],
9	of	IN	O	of	_	0	SENT_153	[p11l1634t1568r1718b1637],
10	the	DT	O	the	det	11	SENT_153	[p11l1740t1568r1858b1637],
11	effects	NNS	O	effect	prep_of	8	SENT_153	[p11l1888t1568r2144b1637],
12	of	IN	O	of	_	0	SENT_153	[p11l16t1671r101b1740],
13	pravastatin	NN	O	pravastatin	prep_of	11	SENT_153	[p11l149t1671r579b1760],
14	on	IN	O	on	_	0	SENT_153	[p11l637t1693r731b1740],
15	the	DT	O	the	det	16	SENT_153	[p11l787t1671r905b1740],
16	progression	NN	O	progression	prep_on	5	SENT_153	[p11l960t1671r1417b1760],
17	or	CC	O	or	_	0	SENT_153	[p11l1475t1693r1555b1740],
18	regression	NN	O	regression	prep_on	5	SENT_153	[p11l1609t1671r2011b1760],
19	of	IN	O	of	_	0	SENT_153	[p11l2069t1671r2153b1740],
20	coronary	JJ	O	coronary	amod	22	SENT_153	[p11l16t1795r361b1863],
21	artery	NN	O	artery	nn	22	SENT_153	[p11l402t1784r626b1863],
22	disease	NN	O	disease	prep_of	16	SENT_153	[p11l667t1774r947b1843],
23	over	IN	O	over	_	0	SENT_153	[p11l987t1795r1160b1843],
24	2	CD	DURATION	2	num	25	SENT_153	[p11l1199t1774r1243b1842],
25	years	NNS	NUMBER	year	prep_over	16	SENT_153	[p11l1282t1795r1508b1863],
26	,	,	O	,	_	0	SENT_153	[p11l1282t1795r1508b1863],
27	using	VBG	O	use	partmod	16	SENT_153	[p11l1550t1774r1760b1863],
28	quantitative	JJ	O	quantitative	amod	29	SENT_153	[p11l1801t1774r2144b1863, p11l15t1877r159b1946],
29	angiography	NN	O	angiography	dobj	27	SENT_153	[p11l187t1877r695b1966],
30	,	,	O	,	_	0	SENT_153	[p11l187t1877r695b1966],
31	in	IN	O	in	_	0	SENT_153	[p11l724t1877r798b1945],
32	a	DT	O	a	det	33	SENT_153	[p11l826t1899r866b1946],
33	cohort	NN	O	cohort	prep_in	16	SENT_153	[p11l891t1877r1141b1946],
34	of	IN	O	of	_	0	SENT_153	[p11l1166t1877r1250b1946],
35	patients	NNS	O	patient	nn	36	SENT_153	[p11l1268t1877r1570b1966],
36	representative	NN	O	representative	prep_of	33	SENT_153	[p11l1597t1877r2146b1966],
37	of	IN	O	of	_	0	SENT_153	[p11l16t1980r101b2049],
38	most	JJS	O	most	prep_of	36	SENT_153	[p11l146t1990r335b2049],
39	of	IN	O	of	_	0	SENT_153	[p11l387t1980r472b2049],
40	the	DT	O	the	det	42	SENT_153	[p11l517t1980r634b2049],
41	cardiology	NN	O	cardiology	nn	42	SENT_153	[p11l687t1980r1103b2069],
42	patients	NNS	O	patient	prep_of	38	SENT_153	[p11l1154t1980r1456b2069],
43	seen	VBN	O	see	partmod	42	SENT_153	[p11l1514t2002r1682b2049],
44	in	IN	O	in	_	0	SENT_153	[p11l1734t1980r1808b2048],
45	clinical	JJ	O	clinical	amod	47	SENT_153	[p11l1861t1980r2146b2049],
46	practice	NN	O	practice	nn	47	SENT_153	[p11l14t2081r383b2171],
47	.4	NN	NUMBER	.4	prep_in	43	SENT_153	[p11l14t2081r383b2171],

1	Stromelysin	NNP	O	Stromelysin	nn	3	SENT_154	[p11l144t2186r614b2275],
2	genotype	NN	O	genotype	nn	3	SENT_154	[p11l661t2197r1017b2275],
3	analysis	NN	O	analysis	nsubj	7	SENT_154	[p11l1065t2186r1375b2275],
4	in	IN	O	in	_	0	SENT_154	[p11l1424t2186r1498b2254],
5	REGRESS	NNP	O	REGRESS	prep_in	3	SENT_154	[p11l1544t2187r1968b2256],
6	has	VBZ	O	have	aux	7	SENT_154	[p11l2018t2186r2145b2255],
7	shed	VBN	O	shed	_	0	SENT_154	[p11l18t2289r193b2358],
8	some	DT	O	some	det	11	SENT_154	[p11l226t2311r427b2358],
9	interesting	JJ	O	interesting	amod	11	SENT_154	[p11l458t2289r869b2378],
10	new	JJ	O	new	amod	11	SENT_154	[p11l901t2311r1061b2358],
11	data	NNS	O	datum	dobj	7	SENT_154	[p11l1094t2289r1256b2358],
12	not	RB	O	not	neg	11	SENT_154	[p11l1284t2299r1409b2358],
13	just	RB	O	just	advmod	11	SENT_154	[p11l1429t2289r1579b2378],
14	on	IN	O	on	_	0	SENT_154	[p11l1609t2311r1704b2358],
15	the	DT	O	the	det	16	SENT_154	[p11l1734t2289r1851b2358],
16	impact	NN	O	impact	prep_on	11	SENT_154	[p11l1882t2289r2149b2378],
17	of	IN	O	of	_	0	SENT_154	[p11l16t2392r101b2461],
18	this	DT	O	this	det	22	SENT_154	[p11l125t2392r262b2461],
19	common	JJ	O	common	amod	20	SENT_154	[p11l297t2413r637b2461],
20	functional	JJ	O	functional	amod	22	SENT_154	[p11l669t2392r1064b2461],
21	genetic	JJ	O	genetic	amod	22	SENT_154	[p11l1097t2392r1375b2481],
22	variant	NN	O	variant	prep_of	16	SENT_154	[p11l1409t2392r1680b2461],
23	on	IN	O	on	_	0	SENT_154	[p11l1711t2413r1806b2461],
24	the	DT	O	the	det	25	SENT_154	[p11l1836t2392r1953b2461],
25	progression	NN	O	progression	prep_on	22	SENT_154	[p11l1984t2413r2144b2481, p11l16t2495r340b2584],
26	of	IN	O	of	_	0	SENT_154	[p11l380t2495r464b2564],
27	atherosclerosis	NN	O	atherosclerosis	prep_of	25	SENT_154	[p11l498t2495r1075b2564],
28	but	CC	O	but	advmod	11	SENT_154	[p11l1115t2495r1260b2577],
29	,	,	O	,	_	0	SENT_154	[p11l1115t2495r1260b2577],
30	perhaps	RB	O	perhaps	dep	11	SENT_154	[p11l1301t2495r1603b2584],
31	more	RBR	O	more	advmod	32	SENT_154	[p11l1644t2517r1843b2564],
32	importantly	RB	O	importantly	dep	30	SENT_154	[p11l1882t2495r2144b2584, p11l15t2598r257b2687],
33	,	,	O	,	_	0	SENT_154	[p11l1882t2495r2144b2584, p11l15t2598r257b2687],
34	also	RB	O	also	advmod	7	SENT_154	[p11l302t2598r455b2667],
35	on	IN	O	on	_	0	SENT_154	[p11l497t2620r591b2667],
36	the	DT	O	the	det	37	SENT_154	[p11l631t2598r748b2667],
37	interaction	NN	O	interaction	prep_on	7	SENT_154	[p11l788t2598r1206b2667],
38	between	IN	O	between	_	0	SENT_154	[p11l1245t2598r1571b2667],
39	genotype	NN	O	genotype	prep_between	37	SENT_154	[p11l1611t2608r1968b2687],
40	and	CC	O	and	_	0	SENT_154	[p11l2010t2598r2148b2667],
41	medication	NN	O	medication	prep_between	37	SENT_154	[p11l15t2701r449b2770],
42	in	IN	O	in	_	0	SENT_154	[p11l487t2701r561b2769],
43	determining	VBG	O	determine	prepc_in	7	SENT_154	[p11l600t2701r1070b2790],
44	the	DT	O	the	det	45	SENT_154	[p11l1109t2701r1226b2770],
45	course	NN	O	course	dobj	43	SENT_154	[p11l1266t2722r1518b2770],
46	of	IN	O	of	_	0	SENT_154	[p11l1559t2701r1643b2770],
47	disease	NN	O	disease	prep_of	45	SENT_154	[p11l1675t2701r1976b2770],
48	.	.	O	.	_	0	SENT_154	[p11l1675t2701r1976b2770],

1	Although	IN	O	although	mark	4	SENT_155	[p11l2018t2701r2144b2769, p11l15t2804r285b2893],
2	pravastatin	NN	O	pravastatin	nn	3	SENT_155	[p11l321t2804r751b2893],
3	treatment	NN	O	treatment	nsubj	4	SENT_155	[p11l788t2815r1159b2873],
4	had	VBD	O	have	advcl	17	SENT_155	[p11l1193t2804r1334b2873],
5	a	DT	O	a	det	7	SENT_155	[p11l1372t2826r1413b2873],
6	detectable	JJ	O	detectable	amod	7	SENT_155	[p11l1450t2804r1844b2873],
7	beneﬁt	NN	O	beneﬁt	dobj	4	SENT_155	[p11l1880t2804r2148b2873],
8	overall	NN	O	overall	advmod	7	SENT_155	[p11l16t2907r285b2976],
9	in	IN	O	in	_	0	SENT_155	[p11l327t2907r401b2975],
10	terms	NNS	O	term	prep_in	8	SENT_155	[p11l442t2917r656b2976],
11	of	IN	O	of	_	0	SENT_155	[p11l701t2907r786b2976],
12	improved	VBN	O	improve	amod	14	SENT_155	[p11l821t2907r1196b2996],
13	angiographic	JJ	O	angiographic	amod	14	SENT_155	[p11l1239t2907r1746b2996],
14	measurements	NNS	O	measurement	prep_of	10	SENT_155	[p11l1789t2929r2144b2976, p11l15t3020r268b3091],
15	,	,	O	,	_	0	SENT_155	[p11l1789t2929r2144b2976, p11l15t3020r268b3091],
16	it	PRP	O	it	nsubj	17	SENT_155	[p11l301t3010r354b3078],
17	had	VBD	O	have	_	0	SENT_155	[p11l381t3010r522b3079],
18	no	DT	O	no	det	19	SENT_155	[p11l551t3031r645b3078],
19	effect	NN	O	effect	dobj	17	SENT_155	[p11l676t3010r898b3078],
20	on	IN	O	on	_	0	SENT_155	[p11l927t3031r1021b3078],
21	the	DT	O	the	det	22	SENT_155	[p11l1050t3010r1167b3078],
22	risk	NN	O	risk	prep_on	19	SENT_155	[p11l1196t3010r1344b3078],
23	of	IN	O	of	_	0	SENT_155	[p11l1372t3010r1457b3078],
24	clinical	JJ	O	clinical	amod	25	SENT_155	[p11l1480t3010r1766b3079],
25	events	NNS	O	event	prep_of	22	SENT_155	[p11l1796t3020r2042b3079],
26	in	IN	O	in	prep	17	SENT_155	[p11l2073t3010r2147b3078],

1	5A	NN	O	5a	nn	2	SENT_156	[p12l16t18r132b88],
2	homozygotes	NNS	O	homozygote	_	0	SENT_156	[p12l168t18r711b107],
3	,	,	O	,	_	0	SENT_156	[p12l168t18r711b107],
4	whereas	IN	O	whereas	mark	6	SENT_156	[p12l752t18r1068b88],
5	it	PRP	O	it	nsubj	6	SENT_156	[p12l1107t18r1160b87],
6	halved	VBD	O	halve	dep	2	SENT_156	[p12l1195t18r1455b87],
7	it	PRP	O	it	dobj	6	SENT_156	[p12l1491t18r1544b87],
8	in	IN	O	in	_	0	SENT_156	[p12l1580t18r1653b86],
9	other	JJ	O	other	amod	10	SENT_156	[p12l1691t18r1891b87],
10	genotypes	NNS	O	genotype	prep_in	6	SENT_156	[p12l1926t40r2144b107, p12l15t131r239b210],
11	.	.	O	.	_	0	SENT_156	[p12l1926t40r2144b107, p12l15t131r239b210],

1	It	PRP	O	it	nsubjpass	4	SENT_157	[p12l272t123r331b190],
2	must	MD	O	must	aux	4	SENT_157	[p12l358t131r548b190],
3	be	VB	O	be	auxpass	4	SENT_157	[p12l573t121r664b190],
4	stated	VBN	O	state	_	0	SENT_157	[p12l696t121r920b190],
5	however	RB	O	however	advmod	4	SENT_157	[p12l947t121r1304b202],
6	,	,	O	,	_	0	SENT_157	[p12l947t121r1304b202],
7	that	IN	O	that	complm	17	SENT_157	[p12l1336t121r1482b190],
8	the	DT	O	the	det	10	SENT_157	[p12l1509t121r1626b190],
9	baseline	NN	O	baseline	nn	10	SENT_157	[p12l1653t121r1973b190],
10	risk	NN	O	risk	nsubj	17	SENT_157	[p12l2001t121r2149b190],
11	in	IN	O	in	_	0	SENT_157	[p12l15t223r88b291],
12	the	DT	O	the	det	14	SENT_157	[p12l135t223r252b292],
13	5A5A	NN	O	5a5a	nn	14	SENT_157	[p12l301t222r538b292],
14	group	NN	O	group	prep_in	10	SENT_157	[p12l586t244r810b312],
15	was	VBD	O	be	cop	17	SENT_157	[p12l858t244r1006b292],
16	already	RB	O	already	advmod	17	SENT_157	[p12l1057t223r1341b312],
17	lower	JJR	O	lower	ccomp	4	SENT_157	[p12l1389t223r1612b292],
18	than	IN	O	than	prep	17	SENT_157	[p12l1656t223r1824b292],
19	for	IN	O	for	pcomp	18	SENT_157	[p12l1871t223r1984b292],
20	the	DT	O	the	det	24	SENT_157	[p12l2028t223r2146b292],
21	5A6A	NN	O	5a6a	nn	24	SENT_157	[p12l16t327r252b397],
22	and	CC	O	and	_	0	SENT_157	[p12l307t327r445b396],
23	6A6A	NN	O	6a6a	nn	24	SENT_157	[p12l499t327r735b397],
24	groups	NNS	O	group	pobj	19	SENT_157	[p12l789t349r1072b416],
25	.	.	O	.	_	0	SENT_157	[p12l789t349r1072b416],

1	In	IN	O	in	_	0	SENT_158	[p12l1131t329r1210b395],
2	this	DT	O	this	det	3	SENT_158	[p12l1263t327r1400b396],
3	case	NN	O	case	prep_in	12	SENT_158	[p12l1456t349r1643b409],
4	,	,	O	,	_	0	SENT_158	[p12l1456t349r1643b409],
5	the	DT	O	the	det	6	SENT_158	[p12l1699t327r1816b396],
6	risk	NN	O	risk	nsubjpass	12	SENT_158	[p12l1869t327r2017b396],
7	of	IN	O	of	_	0	SENT_158	[p12l2069t327r2153b396],
8	clinical	JJ	O	clinical	amod	9	SENT_158	[p12l16t430r301b499],
9	restenosis	NN	O	restenosis	prep_of	6	SENT_158	[p12l350t430r733b499],
10	was	VBD	O	be	auxpass	12	SENT_158	[p12l785t452r932b499],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_158	[p12l987t430r1467b519],
12	reduced	VBN	O	reduce	_	0	SENT_158	[p12l1515t430r1826b499],
13	in	IN	O	in	_	0	SENT_158	[p12l1874t430r1948b498],
14	heterozygotes	NNS	O	heterozygote	prep_in	12	SENT_158	[p12l1996t430r2144b499, p12l16t543r435b622],
15	and	CC	O	and	_	0	SENT_158	[p12l481t533r619b602],
16	6A	NN	O	6a	nn	17	SENT_158	[p12l661t533r777b602],
17	homozygotes	NNS	O	homozygote	conj_and	14	SENT_158	[p12l817t533r1336b622],
18	treated	VBN	O	treat	partmod	14	SENT_158	[p12l1380t533r1645b602],
19	with	IN	O	with	_	0	SENT_158	[p12l1686t533r1858b602],
20	pravastatin	NN	O	pravastatin	prep_with	18	SENT_158	[p12l1898t554r2144b622, p12l18t636r246b718],
21	,	,	O	,	_	0	SENT_158	[p12l1898t554r2144b622, p12l18t636r246b718],
22	whereas	IN	O	whereas	mark	26	SENT_158	[p12l275t636r592b705],
23	no	DT	O	no	det	24	SENT_158	[p12l619t658r714b705],
24	effect	NN	O	effect	nsubjpass	26	SENT_158	[p12l741t636r963b705],
25	was	VBD	O	be	auxpass	26	SENT_158	[p12l987t658r1134b705],
26	seen	VBN	O	see	advcl	12	SENT_158	[p12l1165t658r1334b705],
27	in	IN	O	in	_	0	SENT_158	[p12l1359t636r1433b704],
28	SA	NNP	O	SA	nn	29	SENT_158	[p12l1460t636r1576b706],
29	homozygotes	NNS	O	homozygote	prep_in	26	SENT_158	[p12l1600t636r2142b725],
30	.	.	O	.	_	0	SENT_158	[p12l1600t636r2142b725],

1	Thus	RB	O	thus	advmod	4	SENT_159	[p12l15t739r230b820],
2	,	,	O	,	_	0	SENT_159	[p12l15t739r230b820],
3	it	PRP	O	it	nsubj	4	SENT_159	[p12l273t739r327b808],
4	appears	VBZ	O	appear	_	0	SENT_159	[p12l368t761r661b828],
5	that	IN	O	that	complm	12	SENT_159	[p12l704t739r850b808],
6	treatment	NN	O	treatment	nsubj	12	SENT_159	[p12l889t749r1259b808],
7	with	IN	O	with	_	0	SENT_159	[p12l1299t739r1471b808],
8	pravastatin	NN	O	pravastatin	prep_with	6	SENT_159	[p12l1510t739r1940b828],
9	may	MD	O	may	aux	12	SENT_159	[p12l1980t761r2146b828],
10	be	VB	O	be	cop	12	SENT_159	[p12l14t842r104b911],
11	especially	RB	O	especially	advmod	12	SENT_159	[p12l137t842r526b931],
12	beneﬁcial	JJ	O	beneﬁcial	ccomp	4	SENT_159	[p12l557t842r938b911],
13	in	IN	O	in	_	0	SENT_159	[p12l970t842r1044b910],
14	subsets	NNS	O	subset	prep_in	12	SENT_159	[p12l1079t842r1354b911],
15	of	IN	O	of	_	0	SENT_159	[p12l1390t842r1474b911],
16	patients	NNS	O	patient	prep_of	14	SENT_159	[p12l1498t842r1823b931],
17	,	,	O	,	_	0	SENT_159	[p12l1498t842r1823b931],
18	and	CC	O	and	_	0	SENT_159	[p12l1861t842r1999b911],
19	the	DT	O	the	det	21	SENT_159	[p12l2029t842r2146b911],
20	stromelysin	NN	O	stromelysin	nn	21	SENT_159	[p12l18t945r471b1034],
21	genotype	NN	O	genotype	nsubj	25	SENT_159	[p12l523t956r879b1034],
22	may	MD	O	may	aux	25	SENT_159	[p12l931t967r1097b1034],
23	be	VB	O	be	cop	25	SENT_159	[p12l1147t945r1238b1014],
24	a	DT	O	a	det	25	SENT_159	[p12l1291t967r1332b1014],
25	determinant	NN	O	determinant	conj_and	4	SENT_159	[p12l1382t945r1850b1014],
26	of	IN	O	of	_	0	SENT_159	[p12l1901t945r1985b1014],
27	the	DT	O	the	det	28	SENT_159	[p12l2029t945r2147b1014],
28	response	NN	O	response	prep_of	25	SENT_159	[p12l14t1070r376b1137],
29	.	.	O	.	_	0	SENT_159	[p12l14t1070r376b1137],

1	Several	JJ	O	several	amod	2	SENT_160	[p12l417t1048r706b1117],
2	studies	NNS	O	study	nsubj	5	SENT_160	[p12l744t1048r1009b1117],
3	have	VBP	O	have	aux	5	SENT_160	[p12l1044t1048r1228b1117],
4	already	RB	O	already	advmod	5	SENT_160	[p12l1264t1048r1548b1137],
5	suggested	VBN	O	suggest	_	0	SENT_160	[p12l1586t1048r1969b1137],
6	that	IN	O	that	complm	15	SENT_160	[p12l2002t1048r2148b1117],
7	the	DT	O	the	det	8	SENT_160	[p12l15t1151r132b1220],
8	effects	NNS	O	effect	nsubj	15	SENT_160	[p12l179t1151r434b1220],
9	of	IN	O	of	_	0	SENT_160	[p12l484t1151r569b1220],
10	lipid	NN	O	lipid	nn	13	SENT_160	[p12l608t1151r1166b1240],
11	—	NN	O	—	nn	13	SENT_160	[p12l608t1151r1166b1240],
12	1owering	VBG	O	1ower	amod	13	SENT_160	[p12l608t1151r1166b1240],
13	drugs	NNS	O	drug	prep_of	8	SENT_160	[p12l1214t1151r1426b1240],
14	are	VBP	O	be	cop	15	SENT_160	[p12l1476t1172r1591b1220],
15	broader	JJR	O	broader	ccomp	5	SENT_160	[p12l1636t1151r1937b1220],
16	than	IN	O	than	_	0	SENT_160	[p12l1980t1151r2147b1220],
17	just	RB	O	just	_	0	SENT_160	[p12l6t1254r156b1343],
18	lipid	NN	O	lipid	nn	19	SENT_160	[p12l206t1254r384b1343],
19	lowering	NN	O	lowering	conj_just	15	SENT_160	[p12l436t1254r802b1343],
20	.	.	O	.	_	0	SENT_160	[p12l436t1254r802b1343],

1	For	IN	O	for	_	0	SENT_161	[p12l858t1256r994b1323],
2	example	NN	O	example	prep_for	16	SENT_161	[p12l1045t1254r1396b1343],
3	,	,	O	,	_	0	SENT_161	[p12l1045t1254r1396b1343],
4	the	DT	O	the	det	9	SENT_161	[p12l1451t1254r1568b1323],
5	rejection	NN	O	rejection	nn	9	SENT_161	[p12l1619t1254r2147b1343],
6	—	CD	NUMBER	—	num	9	SENT_161	[p12l1619t1254r2147b1343],
7	free	JJ	O	free	amod	9	SENT_161	[p12l1619t1254r2147b1343],
8	survival	NN	O	survival	nn	9	SENT_161	[p12l18t1357r328b1426],
9	period	NN	O	period	nsubjpass	16	SENT_161	[p12l368t1357r618b1446],
10	after	IN	O	after	_	0	SENT_161	[p12l660t1357r837b1426],
11	a	DT	O	a	det	13	SENT_161	[p12l877t1379r917b1426],
12	heart	NN	O	heart	nn	13	SENT_161	[p12l955t1357r1151b1426],
13	transplantation	NN	O	transplantation	prep_after	9	SENT_161	[p12l1190t1357r1772b1446],
14	was	VBD	O	be	auxpass	16	SENT_161	[p12l1812t1379r1960b1426],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_161	[p12l2006t1357r2144b1446, p12l15t1460r383b1549],
16	prolonged	VBN	O	prolong	_	0	SENT_161	[p12l411t1460r809b1549],
17	in	IN	O	in	_	0	SENT_161	[p12l837t1460r911b1528],
18	patients	NNS	O	patient	prep_in	16	SENT_161	[p12l939t1460r1241b1549],
19	randomized	VBN	O	randomize	partmod	18	SENT_161	[p12l1271t1460r1735b1529],
20	to	TO	O	to	aux	21	SENT_161	[p12l1763t1470r1835b1529],
21	receive	VB	O	receive	xcomp	19	SENT_161	[p12l1865t1460r2146b1529],
22	pravastatin	NN	O	pravastatin	dobj	21	SENT_161	[p12l14t1563r463b1652],
23	.	.	O	.	_	0	SENT_161	[p12l14t1563r463b1652],

1	15	CD	NUMBER	15	_	0	SENT_162	[p12l477t1563r535b1606],

1	This	DT	O	this	det	2	SENT_163	[p12l141t1666r311b1735],
2	study	NN	O	study	nsubj	3	SENT_163	[p12l346t1666r552b1755],
3	shows	VBZ	O	show	_	0	SENT_163	[p12l587t1666r824b1735],
4	that	IN	O	that	complm	6	SENT_163	[p12l856t1666r1003b1735],
5	there	EX	O	there	expl	6	SENT_163	[p12l1030t1666r1224b1735],
6	is	VBZ	O	be	ccomp	3	SENT_163	[p12l1254t1666r1315b1735],
7	a	DT	O	a	det	9	SENT_163	[p12l1349t1688r1389b1735],
8	measurable	JJ	O	measurable	amod	9	SENT_163	[p12l1418t1666r1862b1735],
9	risk	NN	O	risk	nsubj	6	SENT_163	[p12l1891t1666r2040b1735],
10	of	IN	O	of	_	0	SENT_163	[p12l2068t1666r2153b1735],
11	disease	NN	O	disease	nn	12	SENT_163	[p12l16t1769r295b1838],
12	progression	NN	O	progression	prep_of	9	SENT_163	[p12l344t1769r802b1858],
13	associated	VBN	O	associate	partmod	12	SENT_163	[p12l853t1769r1253b1838],
14	with	IN	O	with	_	0	SENT_163	[p12l1302t1769r1474b1838],
15	the	DT	O	the	det	18	SENT_163	[p12l1523t1769r1641b1838],
16	stromelysin	NN	O	stromelysin	nn	18	SENT_163	[p12l1694t1769r2147b1858],
17	promoter	NN	O	promoter	nn	18	SENT_163	[p12l14t1883r374b1961],
18	variant	NN	O	variant	prep_with	13	SENT_163	[p12l413t1872r703b1941],
19	.	.	O	.	_	0	SENT_163	[p12l413t1872r703b1941],

1	In	IN	O	in	_	0	SENT_164	[p12l748t1874r827b1940],
2	patients	NNS	O	patient	prep_in	16	SENT_164	[p12l866t1872r1169b1961],
3	who	WP	O	who	nsubj	5	SENT_164	[p12l1212t1872r1377b1941],
4	were	VBD	O	be	cop	5	SENT_164	[p12l1419t1894r1606b1941],
5	homozygous	JJ	O	homozygous	rcmod	2	SENT_164	[p12l1646t1872r2144b1961],
6	for	IN	O	for	_	0	SENT_164	[p12l15t1975r129b2044],
7	the	DT	O	the	det	9	SENT_164	[p12l153t1975r270b2044],
8	6A	NN	O	6a	nn	9	SENT_164	[p12l298t1975r414b2044],
9	allele	NN	O	allele	prep_for	5	SENT_164	[p12l442t1975r671b2056],
10	,	,	O	,	_	0	SENT_164	[p12l442t1975r671b2056],
11	lesion	NN	O	lesion	nn	12	SENT_164	[p12l701t1975r933b2044],
12	growth	NN	O	growth	nsubj	16	SENT_164	[p12l961t1975r1235b2064],
13	was	VBD	O	be	cop	16	SENT_164	[p12l1262t1997r1409b2044],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_164	[p12l1441t1975r1920b2064],
15	more	RBR	O	more	advmod	16	SENT_164	[p12l1947t1997r2146b2044],
16	rapid	JJ	O	rapid	_	0	SENT_164	[p12l14t2078r215b2167],
17	and	CC	O	and	_	0	SENT_164	[p12l257t2078r395b2147],
18	the	DT	O	the	det	19	SENT_164	[p12l435t2078r552b2147],
19	risk	NN	O	risk	nsubj	27	SENT_164	[p12l593t2078r741b2147],
20	of	IN	O	of	_	0	SENT_164	[p12l782t2078r866b2147],
21	new	JJ	O	new	amod	23	SENT_164	[p12l901t2099r1061b2147],
22	lesion	NN	O	lesion	nn	23	SENT_164	[p12l1104t2078r1335b2147],
23	formation	NN	O	formation	prep_of	19	SENT_164	[p12l1377t2078r1762b2147],
24	was	VBD	O	be	cop	27	SENT_164	[p12l1803t2099r1951b2147],
25	2.3	CD	NUMBER	2.3	number	26	SENT_164	[p12l1996t2078r2144b2147, p12l15t2181r171b2250],
26	fold	JJ	O	fold	amod	27	SENT_164	[p12l1996t2078r2144b2147, p12l15t2181r171b2250],
27	greater	JJR	O	greater	conj_and	16	SENT_164	[p12l203t2192r474b2270],
28	than	IN	O	than	advmod	27	SENT_164	[p12l503t2181r670b2250],
29	for	IN	O	for	_	0	SENT_164	[p12l701t2181r814b2250],
30	SA	NNP	O	SA	nn	31	SENT_164	[p12l845t2181r961b2251],
31	homozygotes	NNS	O	homozygote	prep_for	28	SENT_164	[p12l991t2181r1533b2270],
32	.	.	O	.	_	0	SENT_164	[p12l991t2181r1533b2270],

1	This	DT	O	this	nsubj	2	SENT_165	[p12l1569t2181r1739b2250],
2	compares	VBZ	O	compare	_	0	SENT_165	[p12l1773t2203r2144b2270],
3	favorably	RB	O	favorably	advmod	2	SENT_165	[p12l15t2284r388b2373],
4	with	IN	O	with	_	0	SENT_165	[p12l424t2284r596b2353],
5	the	DT	O	the	det	7	SENT_165	[p12l630t2284r747b2353],
6	e4	NN	O	e4	nn	7	SENT_165	[p12l783t2284r871b2353],
7	allele	NN	O	allele	prep_with	2	SENT_165	[p12l909t2284r1117b2353],
8	of	IN	O	of	_	0	SENT_165	[p12l1153t2284r1238b2353],
9	apolipoprotein	NN	O	apolipoprotein	prep_of	7	SENT_165	[p12l1268t2284r1930b2373],
10	.	.	O	.	_	0	SENT_165	[p12l1268t2284r1930b2373],

1	—	NN	O	—	_	0	SENT_166	[p12l1268t2284r1930b2373],
2	.	.	O	.	_	0	SENT_166	[p12l1268t2284r1930b2373],

1	E	NN	O	e	nsubj	3	SENT_167	[p12l1268t2284r1930b2373],
2	(	CD	NUMBER	(	num	1	SENT_167	[p12l1967t2285r2144b2369, p12l14t2386r166b2455],
3	carried	VBN	O	carry	_	0	SENT_167	[p12l1967t2285r2144b2369, p12l14t2386r166b2455],
4	by	IN	O	by	_	0	SENT_167	[p12l214t2386r310b2475],
5	ll	CD	PERCENT	ll	num	6	SENT_167	[p12l370t2386r534b2455],
6	%	NN	PERCENT	%	prep_by	3	SENT_167	[p12l370t2386r534b2455],
7	of	IN	O	of	_	0	SENT_167	[p12l590t2386r674b2455],
8	the	DT	O	the	det	11	SENT_167	[p12l717t2386r835b2455],
9	population	NN	O	population	nn	11	SENT_167	[p12l884t2385r1427b2475],
10	“	CD	NUMBER	“	num	11	SENT_167	[p12l884t2385r1427b2475],
11	)	NN	O	)	prep_of	6	SENT_167	[p12l884t2385r1427b2475],
12	,	,	O	,	_	0	SENT_167	[p12l884t2385r1427b2475],
13	which	WDT	O	which	nsubjpass	16	SENT_167	[p12l1482t2386r1719b2455],
14	is	VBZ	O	be	auxpass	16	SENT_167	[p12l1769t2386r1829b2455],
15	clearly	RB	O	clearly	advmod	16	SENT_167	[p12l1883t2386r2146b2475],
16	associated	VBN	O	associate	rcmod	11	SENT_167	[p12l17t2490r417b2559],
17	with	IN	O	with	_	0	SENT_167	[p12l462t2490r634b2559],
18	changes	NNS	O	change	prep_with	16	SENT_167	[p12l679t2490r990b2579],
19	in	IN	O	in	_	0	SENT_167	[p12l1037t2490r1112b2558],
20	lipid	NN	O	lipid	nn	21	SENT_167	[p12l1157t2490r1335b2579],
21	proﬁles	NNS	O	proﬁles	prep_in	18	SENT_167	[p12l1378t2490r1692b2579],
22	,	,	O	,	_	0	SENT_167	[p12l1378t2490r1692b2579],
23	but	CC	O	but	_	0	SENT_167	[p12l1740t2490r1866b2559],
24	which	WDT	O	which	nsubj	25	SENT_167	[p12l1910t2490r2147b2559],
25	carries	VBZ	O	carry	conj_but	16	SENT_167	[p12l16t2593r272b2662],
26	a	DT	O	a	det	28	SENT_167	[p12l317t2615r357b2662],
27	relative	JJ	O	relative	amod	28	SENT_167	[p12l395t2593r688b2662],
28	risk	NN	O	risk	dobj	25	SENT_167	[p12l728t2593r876b2662],
29	of	IN	O	of	_	0	SENT_167	[p12l916t2593r1000b2662],
30	only	RB	O	only	quantmod	31	SENT_167	[p12l1035t2593r1205b2682],
31	1.3	CD	NUMBER	1.3	prep_of	28	SENT_167	[p12l1256t2593r1362b2662],
32	for	IN	O	for	_	0	SENT_167	[p12l1408t2593r1522b2662],
33	myocardial	JJ	O	myocardial	amod	34	SENT_167	[p12l1561t2593r1999b2682],
34	infarction	NN	O	infarction	prep_for	31	SENT_167	[p12l2041t2593r2144b2661, p12l15t2695r411b2764],
35	.	.	O	.	_	0	SENT_167	[p12l2041t2593r2144b2661, p12l15t2695r411b2764],

1	”	NN	O	”	dep	46	SENT_168	[p12l2041t2593r2144b2661, p12l15t2695r411b2764],
2	These	DT	O	these	det	3	SENT_168	[p12l460t2695r691b2764],
3	data	NNS	O	datum	nsubj	24	SENT_168	[p12l740t2695r921b2776],
4	,	,	O	,	_	0	SENT_168	[p12l740t2695r921b2776],
5	together	RB	O	together	_	0	SENT_168	[p12l972t2695r1294b2784],
6	with	IN	O	with	_	0	SENT_168	[p12l1339t2695r1511b2764],
7	the	DT	O	the	det	10	SENT_168	[p12l1558t2695r1675b2764],
8	far	RB	O	far	advmod	9	SENT_168	[p12l1724t2695r1832b2764],
9	greater	JJR	O	greater	amod	10	SENT_168	[p12l1878t2705r2149b2784],
10	incidence	NN	O	incidence	prep_together_with	13	SENT_168	[p12l15t2799r388b2868],
11	of	IN	O	of	_	0	SENT_168	[p12l421t2799r505b2868],
12	restenosis	NN	O	restenosis	prep_of	10	SENT_168	[p12l529t2799r912b2868],
13	leading	VBG	O	lead	partmod	3	SENT_168	[p12l946t2799r1231b2888],
14	to	TO	O	to	aux	15	SENT_168	[p12l1263t2810r1336b2868],
15	repeat	VB	O	repeat	xcomp	13	SENT_168	[p12l1367t2810r1607b2888],
16	angioplasties	NNS	O	angioplasty	dobj	15	SENT_168	[p12l1638t2799r2144b2888],
17	in	IN	O	in	_	0	SENT_168	[p12l15t2902r88b2970],
18	6A	NN	O	6a	nn	19	SENT_168	[p12l124t2902r240b2971],
19	homozygotes	NNS	O	homozygote	prep_in	15	SENT_168	[p12l273t2902r793b2991],
20	and	CC	O	and	_	0	SENT_168	[p12l832t2902r970b2971],
21	heterozygotes	NNS	O	heterozygote	prep_in	15	SENT_168	[p12l1002t2902r1567b2991],
22	,	,	O	,	_	0	SENT_168	[p12l1002t2902r1567b2991],
23	are	VBP	O	be	cop	24	SENT_168	[p12l1607t2924r1722b2971],
24	consistent	JJ	O	consistent	rcmod	1	SENT_168	[p12l1757t2902r2148b2971],
25	with	IN	O	with	_	0	SENT_168	[p12l15t3005r187b3074],
26	the	DT	O	the	det	27	SENT_168	[p12l216t3005r333b3074],
27	model	NN	O	model	prep_with	24	SENT_168	[p12l363t3005r606b3074],
28	that	IN	O	that	complm	34	SENT_168	[p12l635t3005r781b3074],
29	the	DT	O	the	det	31	SENT_168	[p12l809t3005r926b3074],
30	reduced	VBN	O	reduce	amod	31	SENT_168	[p12l955t3005r1266b3074],
31	expression	NN	O	expression	nsubj	34	SENT_168	[p12l1295t3005r1712b3094],
32	of	IN	O	of	_	0	SENT_168	[p12l1742t3005r1827b3074],
33	stromelysin	NN	O	stromelysin	prep_of	31	SENT_168	[p12l1853t3015r2144b3074, p12l15t3108r203b3197],
34	driven	VBN	O	drive	ccomp	24	SENT_168	[p12l253t3108r501b3177],
35	by	IN	O	by	_	0	SENT_168	[p12l548t3108r644b3197],
36	the	DT	O	the	det	38	SENT_168	[p12l693t3108r811b3177],
37	6A	NN	O	6a	nn	38	SENT_168	[p12l861t3108r977b3178],
38	allele	NN	O	allele	prep_by	34	SENT_168	[p12l1028t3108r1257b3190],
39	,	,	O	,	_	0	SENT_168	[p12l1028t3108r1257b3190],
40	during	IN	O	during	_	0	SENT_168	[p12l1310t3108r1562b3197],
41	active	JJ	O	active	amod	43	SENT_168	[p12l1614t3108r1843b3177],
42	matrix	NN	O	matrix	nn	43	SENT_168	[p12l1892t3108r2146b3177],
43	remodeling	NN	O	remodeling	prep_during	46	SENT_168	[p12l14t3211r480b3300],
44	,	,	O	,	_	0	SENT_168	[p12l14t3211r480b3300],
45	could	MD	O	could	aux	46	SENT_168	[p12l518t3211r734b3280],
46	result	VB	O	result	_	0	SENT_168	[p12l764t3211r983b3280],
47	in	IN	O	in	_	0	SENT_168	[p12l1014t3211r1088b3279],
48	greater	JJR	O	greater	amod	49	SENT_168	[p12l1121t3221r1392b3300],
49	deposition	NN	O	deposition	prep_in	46	SENT_168	[p12l1424t3211r1831b3300],
50	of	IN	O	of	_	0	SENT_168	[p12l1864t3211r1949b3280],
51	connective	JJ	O	connective	amod	52	SENT_168	[p12l1975t3233r2144b3280, p12l15t3314r295b3383],
52	tissue	NN	O	tissue	prep_of	49	SENT_168	[p12l334t3314r555b3383],
53	and	CC	O	and	_	0	SENT_168	[p12l596t3314r754b3395],
54	,	,	O	,	_	0	SENT_168	[p12l596t3314r754b3395],
55	hence	RB	O	hence	dep	52	SENT_168	[p12l796t3314r1044b3395],
56	,	,	O	,	_	0	SENT_168	[p12l796t3314r1044b3395],
57	larger	JJR	O	larger	amod	58	SENT_168	[p12l1087t3314r1314b3403],
58	lesions	NNS	O	lesion	conj_and	52	SENT_168	[p12l1351t3314r1641b3383],
59	.	.	O	.	_	0	SENT_168	[p12l1351t3314r1641b3383],

1	The	DT	O	the	det	2	SENT_169	[p12l1684t3314r1834b3383],
2	data	NNS	O	datum	nsubj	10	SENT_169	[p12l1874t3314r2036b3383],
3	in	IN	O	in	_	0	SENT_169	[p12l2073t3314r2147b3382],
4	this	DT	O	this	det	5	SENT_169	[p12l15t3417r152b3486],
5	paper	NN	O	paper	prep_in	2	SENT_169	[p12l178t3439r397b3506],
6	are	VBP	O	be	cop	7	SENT_169	[p12l423t3439r537b3486],
7	consistent	JJ	O	consistent	_	0	SENT_169	[p12l564t3417r955b3486],
8	with	IN	O	with	prep	7	SENT_169	[p12l979t3417r1151b3486],
9	and	CC	O	and	_	0	SENT_169	[p12l1178t3417r1316b3486],
10	expand	VB	O	expand	conj_and	7	SENT_169	[p12l1342t3417r1623b3506],
11	considerably	RB	O	considerably	advmod	14	SENT_169	[p12l1648t3417r2146b3506],
12	the	DT	O	the	det	14	SENT_169	[p12l15t3520r132b3589],
13	preliminary	JJ	O	preliminary	amod	14	SENT_169	[p12l164t3520r620b3609],
14	results	NNS	O	result	dobj	10	SENT_169	[p12l653t3520r906b3589],
15	arising	VBG	O	arise	xcomp	10	SENT_169	[p12l943t3520r1205b3609],
16	from	IN	O	from	_	0	SENT_169	[p12l1240t3520r1429b3589],
17	the	DT	O	the	det	25	SENT_169	[p12l1461t3520r1578b3589],
18	much	JJ	O	much	amod	25	SENT_169	[p12l1611t3520r1827b3589],
19	smaller	JJR	O	smaller	dep	18	SENT_169	[p12l1863t3520r2149b3589],
20	St.	NNP	LOCATION	St.	nn	25	SENT_169	[p12l17t3623r109b3692],
21	Thomas	NNP	LOCATION	Thomas	nn	25	SENT_169	[p12l143t3623r468b3692],
22	’	NNP	O	’	nn	25	SENT_169	[p12l143t3623r468b3692],
23	Atherosclerosis	NNP	O	Atherosclerosis	nn	25	SENT_169	[p12l505t3623r1084b3692],
24	Regression	NN	O	regression	nn	25	SENT_169	[p12l1115t3623r1531b3712],
25	study	NN	O	study	prep_from	15	SENT_169	[p12l1562t3623r1760b3712],
26	(	CD	NUMBER	(	num	27	SENT_169	[p12l1792t3623r2143b3708],
27	STARS	NNS	O	star	dep	25	SENT_169	[p12l1792t3623r2143b3708],
28	)	CD	NUMBER	)	num	29	SENT_169	[p12l1792t3623r2143b3708],
29	study	NN	O	study	dobj	15	SENT_169	[p12l18t3726r236b3815],
30	,	,	O	,	_	0	SENT_169	[p12l18t3726r236b3815],
31	which	WDT	O	which	nsubjpass	33	SENT_169	[p12l264t3726r494b3795],
32	was	VBD	O	be	auxpass	33	SENT_169	[p12l518t3748r662b3795],
33	conducted	VBN	O	conduct	rcmod	29	SENT_169	[p12l689t3726r1075b3795],
34	over	IN	O	over	_	0	SENT_169	[p12l1100t3748r1267b3795],
35	a	DT	O	a	det	36	SENT_169	[p12l1291t3748r1332b3795],
36	period	NN	O	period	prep_over	33	SENT_169	[p12l1353t3726r1594b3815],
37	of	IN	O	of	_	0	SENT_169	[p12l1618t3726r1701b3795],
38	3	CD	DURATION	3	num	39	SENT_169	[p12l1721t3727r1760b3796],
39	years	NNS	NUMBER	year	prep_of	36	SENT_169	[p12l1789t3748r1984b3815],
40	and	CC	O	and	_	0	SENT_169	[p12l2013t3726r2147b3795],
41	included	VBD	O	include	conj_and	7	SENT_169	[p13l15t14r338b83],
42	patients	NNS	O	patient	dobj	41	SENT_169	[p13l372t14r660b103],
43	with	IN	O	with	_	0	SENT_169	[p13l699t14r865b83],
44	higher	JJR	O	higher	amod	46	SENT_169	[p13l900t14r1141b103],
45	cholesterol	NN	O	cholesterol	nn	46	SENT_169	[p13l1176t14r1584b83],
46	levels	NNS	O	level	prep_with	41	SENT_169	[p13l1620t14r1854b83],
47	.	.	O	.	_	0	SENT_169	[p13l1620t14r1854b83],

1	13	CD	NUMBER	13	nsubj	4	SENT_170	[p13l1868t14r1924b56],
2	Both	CC	O	both	dep	1	SENT_170	[p13l1964t14r2147b83],
3	studies	NNS	O	study	conj	1	SENT_170	[p13l18t117r271b186],
4	agree	VBP	O	agree	_	0	SENT_170	[p13l316t138r516b206],
5	that	IN	O	that	complm	15	SENT_170	[p13l557t117r697b186],
6	genotype	NN	O	genotype	nn	9	SENT_170	[p13l738t117r1397b206],
7	—	NN	O	—	nn	9	SENT_170	[p13l738t117r1397b206],
8	speciﬁc	NN	O	speciﬁc	nn	9	SENT_170	[p13l738t117r1397b206],
9	differences	NNS	O	difference	nsubj	15	SENT_170	[p13l1440t117r1851b186],
10	in	IN	O	in	_	0	SENT_170	[p13l1894t117r1966b185],
11	dis	NN	O	di	nn	14	SENT_170	[p13l2008t117r2143b186],
12	—	CD	NUMBER	—	num	14	SENT_170	[p13l2008t117r2143b186],
13	ease	NN	O	ease	nn	14	SENT_170	[p13l16t242r175b289],
14	progression	NN	O	progression	prep_in	9	SENT_170	[p13l206t220r643b309],
15	exist	VBP	O	exist	ccomp	4	SENT_170	[p13l675t220r867b289],
16	.	.	O	.	_	0	SENT_170	[p13l675t220r867b289],

1	The	DT	O	the	det	2	SENT_171	[p13l141t323r291b392],
2	data	NNS	O	datum	nsubj	6	SENT_171	[p13l332t323r494b392],
3	presented	VBN	O	present	partmod	2	SENT_171	[p13l530t323r906b412],
4	here	RB	O	here	advmod	3	SENT_171	[p13l944t323r1111b392],
5	may	MD	O	may	aux	6	SENT_171	[p13l1151t345r1316b412],
6	appear	VB	O	appear	ccomp	15	SENT_171	[p13l1359t345r1618b412],
7	to	TO	O	to	aux	9	SENT_171	[p13l1655t333r1728b392],
8	be	VB	O	be	cop	9	SENT_171	[p13l1767t323r1859b392],
9	inconsistent	JJ	O	inconsistent	xcomp	6	SENT_171	[p13l1898t323r2144b392, p13l18t426r265b495],
10	with	IN	O	with	_	0	SENT_171	[p13l329t426r501b495],
11	our	PRP$	O	we	poss	13	SENT_171	[p13l567t447r696b495],
12	previous	JJ	O	previous	amod	13	SENT_171	[p13l757t426r1092b515],
13	work	NN	O	work	prep_with	9	SENT_171	[p13l1160t426r1380b507],
14	,	,	O	,	_	0	SENT_171	[p13l1160t426r1380b507],
15	supported	VBD	O	support	_	0	SENT_171	[p13l1452t426r1834b515],
16	subseCORONARY	NN	O	subsecoronary	nsubj	15	SENT_171	[p13l1902t426r2144b495, p13l378t592r559b618],

1	ARTERY	NN	O	artery	nn	2	SENT_172	[p13l570t592r674b618],
2	DISEASE/PRAVASTAT	NN	O	disease/pravastat	_	0	SENT_172	[p13l688t590r1026b622],
3	/	:	O	/	punct	13	SENT_172	[p13l688t590r1026b622],
4	/	:	O	/	punct	5	SENT_172	[p13l688t590r1026b622],
5	\	CD	NUMBER	\	dep	13	SENT_172	[p13l688t590r1026b622],
6	I	PRP	O	I	dep	5	SENT_172	[p13l688t590r1026b622],
7	AND	CC	O	and	_	0	SENT_172	[p13l1036t592r1106b618],
8	STRO	NN	O	stro	conj_and	5	SENT_172	[p13l1120t592r1323b618],
9	/	:	O	/	punct	10	SENT_172	[p13l1120t592r1323b618],
10	\	CD	NUMBER	\	dep	8	SENT_172	[p13l1120t592r1323b618],
11	/	:	O	/	punct	10	SENT_172	[p13l1120t592r1323b618],
12	\	CD	NUMBER	\	dep	5	SENT_172	[p13l1120t592r1323b618],
13	ELYS	NNS	O	ely	dep	2	SENT_172	[p13l1120t592r1323b618],
14	|	VBD	O	|	rcmod	13	SENT_172	[p13l1120t592r1323b618],
15	N	NN	O	n	prep	13	SENT_172	[p13l1120t592r1323b618],
16	GENE	NN	O	gene	nn	17	SENT_172	[p13l1338t592r1424b618],
17	POLY	NN	O	poly	dep	15	SENT_172	[p13l1440t592r1680b618],
18	/	:	O	/	punct	13	SENT_172	[p13l1440t592r1680b618],
19	\	CD	NUMBER	\	dep	2	SENT_172	[p13l1440t592r1680b618],
20	/	:	O	/	punct	23	SENT_172	[p13l1440t592r1680b618],
21	\	CD	NUMBER	\	num	22	SENT_172	[p13l1440t592r1680b618],
22	ORPH	NN	O	orph	nsubj	23	SENT_172	[p13l1440t592r1680b618],
23	|	VBD	O	|	dep	19	SENT_172	[p13l1440t592r1680b618],
24	Sl	NNP	O	Sl	dobj	23	SENT_172	[p13l1440t592r1680b618],
25	\	CD	NUMBER	\	num	24	SENT_172	[p13l1440t592r1680b618],
26	/	:	O	/	punct	23	SENT_172	[p13l1440t592r1680b618],
27	\	CD	NUMBER	\	num	28	SENT_172	[p13l1440t592r1680b618],
28	855	CD	NUMBER	855	dep	2	SENT_172	[p13l1719t588r1781b619],

1	quently	RB	O	quently	_	0	SENT_173	[p13l8t789r296b877],
2	by	IN	O	by	_	0	SENT_173	[p13l334t789r429b877],
3	others	NNS	O	other	prep_by	1	SENT_173	[p13l470t789r725b869],
4	,	,	O	,	_	0	SENT_173	[p13l470t789r725b869],
5	demonstrating	VBG	O	demonstrate	dep	1	SENT_173	[p13l769t789r1321b877],
6	augmented	JJ	O	augmented	amod	8	SENT_173	[p13l1363t789r1787b877],
7	stromelysin	NN	O	stromelysin	nn	8	SENT_173	[p13l1828t799r2117b857, p13l7t890r194b978],
8	expression	NN	O	expression	dobj	5	SENT_173	[p13l228t890r641b978],
9	in	IN	O	in	_	0	SENT_173	[p13l674t890r747b957],
10	human	JJ	O	human	amod	12	SENT_173	[p13l780t890r1043b958],
11	atherosclerotic	JJ	O	atherosclerotic	amod	12	SENT_173	[p13l1078t890r1645b958],
12	lesions.6-11	NN	O	lesions.6-11	prep_in	5	SENT_173	[p13l1681t889r2114b958],
13	These	DT	O	these	det	14	SENT_173	[p13l7t991r236b1059],
14	studies	NNS	O	study	dep	12	SENT_173	[p13l300t991r562b1059],
15	all	DT	O	all	advmod	12	SENT_173	[p13l626t991r718b1059],
16	described	VBN	O	describe	partmod	12	SENT_173	[p13l779t991r1150b1059],
17	qualitative	JJ	O	qualitative	amod	18	SENT_173	[p13l1209t991r1616b1079],
18	changes	NNS	O	change	dobj	16	SENT_173	[p13l1677t991r1985b1079],
19	in	IN	O	in	_	0	SENT_173	[p13l2047t991r2121b1058],
20	stromelysin	NN	O	stromelysin	nn	22	SENT_173	[p13l10t1092r459b1180],
21	gene	NN	O	gene	nn	22	SENT_173	[p13l493t1113r672b1180],
22	expression	NN	O	expression	prep_in	16	SENT_173	[p13l707t1092r1120b1180],
23	in	IN	O	in	_	0	SENT_173	[p13l1153t1092r1227b1159],
24	atherosclerotic	JJ	O	atherosclerotic	amod	25	SENT_173	[p13l1261t1092r1828b1160],
25	tissues	NNS	O	tissue	prep_in	22	SENT_173	[p13l1863t1092r2118b1160],
26	where	WRB	O	where	advmod	31	SENT_173	[p13l7t1193r241b1261],
27	active	JJ	O	active	amod	29	SENT_173	[p13l276t1193r504b1261],
28	matrix	NN	O	matrix	nn	29	SENT_173	[p13l537t1193r788b1261],
29	remodeling	NN	O	remodeling	nsubj	31	SENT_173	[p13l820t1193r1261b1281],
30	is	VBZ	O	be	aux	31	SENT_173	[p13l1294t1193r1355b1261],
31	taking	VBG	O	take	advcl	16	SENT_173	[p13l1389t1193r1629b1281],
32	place	NN	O	place	dobj	31	SENT_173	[p13l1662t1193r1886b1281],
33	,	,	O	,	_	0	SENT_173	[p13l1662t1193r1886b1281],
34	compared	VBN	O	compare	_	0	SENT_173	[p13l1923t1214r2117b1261, p13l6t1294r221b1382],
35	with	IN	O	with	prepc_compared_with	16	SENT_173	[p13l246t1294r417b1362],
36	unaffected	JJ	O	unaffected	amod	37	SENT_173	[p13l441t1294r851b1362],
37	vessels	NNS	O	vessel	pobj	16	SENT_173	[p13l876t1294r1147b1362],
38	where	WRB	O	where	advmod	41	SENT_173	[p13l1175t1294r1409b1362],
39	there	EX	O	there	expl	41	SENT_173	[p13l1435t1294r1627b1362],
40	is	VBZ	O	be	auxpass	41	SENT_173	[p13l1653t1294r1713b1362],
41	limited	VBN	O	limit	rcmod	37	SENT_173	[p13l1741t1294r2035b1375],
42	,	,	O	,	_	0	SENT_173	[p13l1741t1294r2035b1375],
43	if	IN	O	if	dep	47	SENT_173	[p13l2064t1294r2127b1361],
44	any	DT	O	any	dep	43	SENT_173	[p13l9t1416r165b1483],
45	,	,	O	,	_	0	SENT_173	[p13l9t1416r165b1483],
46	connective	JJ	O	connective	amod	47	SENT_173	[p13l217t1395r635b1463],
47	tissue	NN	O	tissue	dobj	41	SENT_173	[p13l682t1395r901b1463],
48	turnover	NN	O	turnover	dep	47	SENT_173	[p13l948t1405r1295b1463],
49	.	.	O	.	_	0	SENT_173	[p13l948t1405r1295b1463],

1	The	DT	O	the	det	2	SENT_174	[p13l1347t1395r1495b1463],
2	data	NNS	O	datum	nsubj	5	SENT_174	[p13l1544t1395r1704b1463],
3	presented	VBN	O	present	partmod	2	SENT_174	[p13l1748t1395r2121b1483],
4	here	RB	O	here	advmod	3	SENT_174	[p13l6t1496r171b1564],
5	relate	VBP	O	relate	_	0	SENT_174	[p13l214t1496r428b1564],
6	only	RB	O	only	advmod	5	SENT_174	[p13l472t1496r641b1584],
7	to	TO	O	to	_	0	SENT_174	[p13l684t1506r757b1564],
8	individuals	NNS	O	individual	prep_to	5	SENT_174	[p13l801t1496r1229b1564],
9	with	IN	O	with	_	0	SENT_174	[p13l1274t1496r1445b1564],
10	measurable	JJ	O	measurable	amod	11	SENT_174	[p13l1487t1496r1928b1564],
11	atherosclerosis	NN	O	atherosclerosis	prep_with	5	SENT_174	[p13l1973t1496r2117b1564, p13l8t1597r485b1678],
12	,	,	O	,	_	0	SENT_174	[p13l1973t1496r2117b1564, p13l8t1597r485b1678],
13	in	IN	O	in	_	0	SENT_174	[p13l523t1597r596b1664],
14	whom	WP	O	whom	rel	20	SENT_174	[p13l632t1597r874b1665],
15	the	DT	O	the	det	16	SENT_174	[p13l907t1597r1023b1665],
16	progression	NN	O	progression	nsubj	20	SENT_174	[p13l1057t1597r1510b1685],
17	of	IN	O	of	_	0	SENT_174	[p13l1546t1597r1630b1665],
18	disease	NN	O	disease	prep_of	16	SENT_174	[p13l1659t1597r1936b1665],
19	will	MD	O	will	aux	20	SENT_174	[p13l1972t1597r2120b1665],
20	reﬂect	VB	O	reﬂect	rcmod	11	SENT_174	[p13l6t1698r249b1766],
21	active	JJ	O	active	amod	22	SENT_174	[p13l297t1698r525b1766],
22	connective	JJ	O	connective	amod	24	SENT_174	[p13l574t1698r992b1766],
23	tissue	NN	O	tissue	nn	24	SENT_174	[p13l1040t1698r1259b1766],
24	remodeling	NN	O	remodeling	dobj	20	SENT_174	[p13l1306t1698r1767b1786],
25	.	.	O	.	_	0	SENT_174	[p13l1306t1698r1767b1786],

1	Genetic	JJ	O	genetic	amod	2	SENT_175	[p13l1821t1698r2119b1766],
2	variation	NN	O	variation	nsubj	13	SENT_175	[p13l7t1799r350b1867],
3	between	IN	O	between	_	0	SENT_175	[p13l377t1799r700b1867],
4	individuals	NNS	O	individual	prep_between	2	SENT_175	[p13l727t1799r1155b1867],
5	in	IN	O	in	_	0	SENT_175	[p13l1185t1799r1259b1866],
6	the	DT	O	the	det	7	SENT_175	[p13l1285t1799r1402b1867],
7	control	NN	O	control	prep_in	4	SENT_175	[p13l1430t1799r1702b1867],
8	of	IN	O	of	_	0	SENT_175	[p13l1732t1799r1816b1867],
9	expression	NN	O	expression	prep_of	7	SENT_175	[p13l1837t1820r2117b1887, p13l10t1900r167b1968],
10	of	IN	O	of	_	0	SENT_175	[p13l206t1900r290b1968],
11	stromelysin	NN	O	stromelysin	prep_of	9	SENT_175	[p13l325t1900r774b1988],
12	may	MD	O	may	aux	13	SENT_175	[p13l812t1922r976b1988],
13	result	VB	O	result	_	0	SENT_175	[p13l1014t1900r1231b1968],
14	in	IN	O	in	_	0	SENT_175	[p13l1267t1900r1341b1967],
15	quantitative	JJ	O	quantitative	amod	16	SENT_175	[p13l1379t1900r1836b1988],
16	differences	NNS	O	difference	prep_in	13	SENT_175	[p13l1875t1900r2118b1968, p13l8t2022r218b2069],
17	in	IN	O	in	_	0	SENT_175	[p13l266t2001r339b2068],
18	the	DT	O	the	det	19	SENT_175	[p13l384t2001r500b2069],
19	level	NN	O	level	prep_in	13	SENT_175	[p13l546t2001r732b2069],
20	of	IN	O	of	_	0	SENT_175	[p13l779t2001r863b2069],
21	this	DT	O	this	det	22	SENT_175	[p13l901t2001r1037b2069],
22	enzyme	NN	O	enzyme	prep_of	19	SENT_175	[p13l1086t2022r1385b2089],
23	in	IN	O	in	_	0	SENT_175	[p13l1431t2001r1504b2068],
24	atherosclerotic	JJ	O	atherosclerotic	amod	25	SENT_175	[p13l1551t2001r2118b2069],
25	tissues	NNS	O	tissue	prep_in	22	SENT_175	[p13l7t2102r285b2182],
26	,	,	O	,	_	0	SENT_175	[p13l7t2102r285b2182],
27	potentially	RB	O	potentially	advmod	13	SENT_175	[p13l330t2102r744b2190],
28	affecting	VBG	O	affect	xcomp	13	SENT_175	[p13l790t2102r1130b2190],
29	the	DT	O	the	det	30	SENT_175	[p13l1173t2102r1289b2170],
30	extent	NN	O	extent	dobj	28	SENT_175	[p13l1333t2112r1569b2170],
31	to	TO	O	to	_	0	SENT_175	[p13l1610t2112r1682b2170],
32	which	WDT	O	which	rel	37	SENT_175	[p13l1726t2102r1962b2170],
33	the	DT	O	the	det	35	SENT_175	[p13l2004t2102r2120b2170],
34	vascular	JJ	O	vascular	amod	35	SENT_175	[p13l7t2203r330b2271],
35	matrix	NN	O	matrix	nsubjpass	37	SENT_175	[p13l356t2203r607b2271],
36	is	VBZ	O	be	auxpass	37	SENT_175	[p13l635t2203r694b2271],
37	remodeled	VBN	O	remodel	rcmod	30	SENT_175	[p13l723t2203r1153b2284],
38	,	,	O	,	_	0	SENT_175	[p13l723t2203r1153b2284],
39	thus	RB	O	thus	advmod	40	SENT_175	[p13l1184t2203r1341b2271],
40	inﬂuencing	VBG	O	inﬂuencing	xcomp	13	SENT_175	[p13l1371t2203r1806b2291],
41	the	DT	O	the	det	42	SENT_175	[p13l1833t2203r1949b2271],
42	rate	NN	O	rate	dobj	40	SENT_175	[p13l1976t2214r2120b2271],
43	of	IN	O	of	_	0	SENT_175	[p13l8t2304r92b2372],
44	lesion	NN	O	lesion	nn	45	SENT_175	[p13l125t2304r355b2372],
45	growth	NN	O	growth	prep_of	42	SENT_175	[p13l394t2304r686b2392],
46	.	.	O	.	_	0	SENT_175	[p13l394t2304r686b2392],

1	The	DT	O	the	det	3	SENT_176	[p13l730t2304r878b2372],
2	previous	JJ	O	previous	amod	3	SENT_176	[p13l916t2304r1248b2392],
3	studies	NNS	O	study	nsubj	6	SENT_176	[p13l1292t2304r1555b2372],
4	did	VBD	O	do	aux	6	SENT_176	[p13l1597t2304r1719b2372],
5	not	RB	O	not	neg	6	SENT_176	[p13l1756t2314r1880b2372],
6	show	VB	O	show	_	0	SENT_176	[p13l1920t2304r2119b2372],
7	genotype	NN	O	genotype	nn	10	SENT_176	[p13l8t2405r690b2493],
8	—	NN	O	—	nn	10	SENT_176	[p13l8t2405r690b2493],
9	speciﬁc	NN	O	speciﬁc	nn	10	SENT_176	[p13l8t2405r690b2493],
10	differences	NNS	O	difference	dobj	6	SENT_176	[p13l726t2405r1153b2473],
11	in	IN	O	in	_	0	SENT_176	[p13l1190t2405r1263b2472],
12	levels	NNS	O	level	prep_in	10	SENT_176	[p13l1297t2405r1519b2473],
13	of	IN	O	of	_	0	SENT_176	[p13l1557t2405r1641b2473],
14	stromelysin	NN	O	stromelysin	nn	15	SENT_176	[p13l1672t2405r2120b2493],
15	expression	NN	O	expression	prep_of	12	SENT_176	[p13l8t2506r421b2594],
16	in	IN	O	in	_	0	SENT_176	[p13l461t2506r534b2573],
17	atherosclerotic	JJ	O	atherosclerotic	amod	18	SENT_176	[p13l576t2506r1143b2574],
18	tissues	NNS	O	tissue	prep_in	15	SENT_176	[p13l1185t2506r1463b2587],
19	,	,	O	,	_	0	SENT_176	[p13l1185t2506r1463b2587],
20	only	RB	O	only	advmod	15	SENT_176	[p13l1508t2506r1676b2594],
21	up	RB	O	up	advmod	25	SENT_176	[p13l1716t2506r2117b2594],
22	—	CD	NUMBER	—	num	23	SENT_176	[p13l1716t2506r2117b2594],
23	regula	NN	O	regulum	pobj	21	SENT_176	[p13l1716t2506r2117b2594],
24	—	CD	NUMBER	—	num	25	SENT_176	[p13l1716t2506r2117b2594],
25	tion	NN	O	tion	dep	15	SENT_176	[p13l7t2607r156b2675],
26	of	IN	O	of	_	0	SENT_176	[p13l192t2607r276b2675],
27	expression	NN	O	expression	prep_of	25	SENT_176	[p13l305t2607r719b2695],
28	in	IN	O	in	_	0	SENT_176	[p13l754t2607r827b2674],
29	diseased	JJ	O	diseased	amod	30	SENT_176	[p13l863t2607r1190b2675],
30	vessels	NNS	O	vessel	prep_in	27	SENT_176	[p13l1225t2607r1496b2675],
31	compared	VBN	O	compare	_	0	SENT_176	[p13l1534t2607r1916b2695],
32	with	IN	O	with	prepc_compared_with	6	SENT_176	[p13l1950t2607r2121b2675],
33	controls	NNS	O	control	pobj	6	SENT_176	[p13l8t2709r337b2777],
34	.	.	O	.	_	0	SENT_176	[p13l8t2709r337b2777],

1	Similar	JJ	O	similar	amod	2	SENT_177	[p13l135t2810r418b2879],
2	analyses	NNS	O	analysis	nsubjpass	9	SENT_177	[p13l454t2810r777b2898],
3	to	TO	O	to	_	0	SENT_177	[p13l815t2821r887b2878],
4	those	DT	O	those	prep_to	2	SENT_177	[p13l924t2810r1127b2878],
5	reported	VBN	O	report	partmod	4	SENT_177	[p13l1162t2810r1486b2898],
6	here	RB	O	here	advmod	5	SENT_177	[p13l1520t2810r1685b2878],
7	have	VBP	O	have	aux	9	SENT_177	[p13l1721t2810r1903b2878],
8	been	VBN	O	be	auxpass	9	SENT_177	[p13l1938t2810r2121b2878],
9	performed	VBN	O	perform	_	0	SENT_177	[p13l6t2911r411b2999],
10	in	IN	O	in	_	0	SENT_177	[p13l464t2911r537b2978],
11	the	DT	O	the	det	13	SENT_177	[p13l590t2911r706b2979],
12	REGRESS	NNP	O	REGRESS	nn	13	SENT_177	[p13l760t2911r1181b2979],
13	study	NN	O	study	prep_in	9	SENT_177	[p13l1243t2911r1447b2999],
14	to	TO	O	to	aux	15	SENT_177	[p13l1501t2921r1573b2979],
15	evaluate	VB	O	evaluate	xcomp	9	SENT_177	[p13l1629t2911r1949b2979],
16	the	DT	O	the	det	17	SENT_177	[p13l2004t2911r2120b2979],
17	effect	NN	O	effect	dobj	15	SENT_177	[p13l8t3012r228b3080],
18	on	IN	O	on	_	0	SENT_177	[p13l262t3033r355b3080],
19	disease	NN	O	disease	nn	20	SENT_177	[p13l390t3012r668b3080],
20	progression	NN	O	progression	prep_on	15	SENT_177	[p13l702t3012r1155b3100],
21	of	IN	O	of	_	0	SENT_177	[p13l1190t3012r1274b3080],
22	the	DT	O	the	det	24	SENT_177	[p13l1302t3012r1418b3080],
23	ASP9ASN	NN	O	asp9asn	nn	24	SENT_177	[p13l1453t3012r1861b3101],
24	mutation	NN	O	mutation	prep_of	20	SENT_177	[p13l1896t3022r2117b3080, p13l7t3113r156b3181],
25	in	IN	O	in	_	0	SENT_177	[p13l207t3113r280b3180],
26	the	DT	O	the	det	29	SENT_177	[p13l331t3113r447b3181],
27	lipoprotein	NN	O	lipoprotein	nn	29	SENT_177	[p13l499t3113r924b3201],
28	lipase	NN	O	lipase	nn	29	SENT_177	[p13l975t3113r1199b3201],
29	gene	NN	O	gene	prep_in	24	SENT_177	[p13l1252t3113r1523b3201],
30	,18	CD	NUMBER	,18	dep	29	SENT_177	[p13l1252t3113r1523b3201],
31	of	IN	O	of	_	0	SENT_177	[p13l1578t3113r1662b3181],
32	the	DT	O	the	det	34	SENT_177	[p13l1706t3113r1822b3181],
33	TaqIB	NN	O	taqib	nn	34	SENT_177	[p13l1878t3115r2114b3201],
34	polymorphism	NN	O	polymorphism	prep_of	29	SENT_177	[p13l6t3214r574b3302],
35	in	IN	O	in	_	0	SENT_177	[p13l622t3214r695b3281],
36	the	DT	O	the	det	39	SENT_177	[p13l744t3214r861b3282],
37	cholesteryl	NN	O	cholesteryl	nn	39	SENT_177	[p13l912t3214r1335b3302],
38	ester	NN	O	ester	nn	39	SENT_177	[p13l1386t3224r1568b3282],
39	transfer	NN	O	transfer	prep_in	34	SENT_177	[p13l1616t3214r1913b3282],
40	protein	NN	O	protein	dep	29	SENT_177	[p13l1959t3235r2117b3302, p13l7t3314r243b3395],
41	,19	CD	NUMBER	,19	num	40	SENT_177	[p13l1959t3235r2117b3302, p13l7t3314r243b3395],
42	and	CC	O	and	_	0	SENT_177	[p13l303t3315r439b3383],
43	of	IN	O	of	dep	29	SENT_177	[p13l497t3315r580b3383],
44	the	DT	O	the	det	47	SENT_177	[p13l630t3315r746b3383],
45	—	CD	NUMBER	—	num	47	SENT_177	[p13l813t3314r1196b3383],
46	455G/A	NN	O	455g/a	nn	47	SENT_177	[p13l813t3314r1196b3383],
47	polymorphism	NN	O	polymorphism	pobj	43	SENT_177	[p13l1251t3315r1819b3403],
48	in	IN	O	in	_	0	SENT_177	[p13l1874t3315r1947b3382],
49	the	DT	O	the	prep_in	15	SENT_177	[p13l2004t3315r2120b3383],
50	,	,	O	,	_	0	SENT_177	[p13l10t3416r497b3504],
51	B	NN	O	b	nn	56	SENT_177	[p13l10t3416r497b3504],
52	—	NN	O	—	nn	56	SENT_177	[p13l10t3416r497b3504],
53	ﬁbrinogen	NN	O	ﬁbrinogen	nn	56	SENT_177	[p13l10t3416r497b3504],
54	gene	NN	O	gene	nn	56	SENT_177	[p13l523t3416r797b3504],
55	.2	NN	NUMBER	.2	nn	56	SENT_177	[p13l523t3416r797b3504],
56	°	NN	O	°	appos	49	SENT_177	[p13l523t3416r797b3504],
57	For	IN	O	for	_	0	SENT_177	[p13l822t3418r957b3484],
58	these	DT	O	these	det	61	SENT_177	[p13l980t3416r1177b3484],
59	3	CD	NUMBER	3	num	61	SENT_177	[p13l1205t3417r1244b3485],
60	genetic	JJ	O	genetic	amod	61	SENT_177	[p13l1275t3416r1551b3504],
61	variations	NNS	O	variation	prep_for	65	SENT_177	[p13l1578t3416r1980b3497],
62	,	,	O	,	_	0	SENT_177	[p13l1578t3416r1980b3497],
63	we	PRP	O	we	nsubj	65	SENT_177	[p13l2009t3438r2120b3485],
64	also	RB	O	also	advmod	65	SENT_177	[p13l9t3517r160b3585],
65	observed	VBD	O	observe	rcmod	56	SENT_177	[p13l194t3517r543b3585],
66	that	IN	O	that	complm	69	SENT_177	[p13l574t3517r719b3585],
67	they	PRP	O	they	nsubjpass	69	SENT_177	[p13l750t3517r914b3605],
68	were	VBD	O	be	auxpass	69	SENT_177	[p13l948t3538r1133b3585],
69	associated	VBN	O	associate	ccomp	65	SENT_177	[p13l1168t3517r1565b3585],
70	with	IN	O	with	_	0	SENT_177	[p13l1596t3517r1767b3585],
71	progression	NN	O	progression	prep_with	69	SENT_177	[p13l1798t3538r2118b3605, p13l10t3618r167b3686],
72	of	IN	O	of	_	0	SENT_177	[p13l199t3618r283b3686],
73	disease	NN	O	disease	prep_of	71	SENT_177	[p13l309t3618r607b3698],
74	,	,	O	,	_	0	SENT_177	[p13l309t3618r607b3698],
75	as	IN	O	as	mark	76	SENT_177	[p13l644t3639r718b3686],
76	measured	VBN	O	measure	advcl	15	SENT_177	[p13l752t3618r1123b3686],
77	by	IN	O	by	_	0	SENT_177	[p13l1152t3618r1248b3706],
78	changes	NNS	O	change	prep_by	76	SENT_177	[p13l1280t3618r1588b3706],
79	in	IN	O	in	_	0	SENT_177	[p13l1622t3618r1695b3685],
80	MOD	NN	O	mod	prep_in	78	SENT_177	[p13l1726t3618r1949b3686],
81	and	CC	O	and	_	0	SENT_177	[p13l1984t3618r2121b3686],
82	MSD	NN	O	msd	conj_and	80	SENT_177	[p13l6t3720r234b3788],
83	.	.	O	.	_	0	SENT_177	[p13l6t3720r234b3788],

1	The	DT	O	the	det	2	SENT_178	[p13l272t3719r421b3787],
2	magnitude	NN	O	magnitude	_	0	SENT_178	[p13l454t3719r862b3807],
3	of	IN	O	of	_	0	SENT_178	[p13l897t3719r981b3787],
4	the	DT	O	the	det	5	SENT_178	[p13l1007t3719r1123b3787],
5	differences	NNS	O	difference	prep_of	2	SENT_178	[p13l1157t3719r1584b3787],
6	in	IN	O	in	_	0	SENT_178	[p13l1619t3719r1692b3786],
7	MOD	NN	O	mod	prep_in	5	SENT_178	[p13l1724t3720r1948b3788],
8	and	CC	O	and	cc	5	SENT_178	[p13l1985t3719r2121b3787],

1	MSD	NN	O	msd	nn	2	SENT_179	[p14l6t14r213b82],
2	reduction	NN	O	reduction	nsubj	4	SENT_179	[p14l241t14r607b82],
3	was	VBD	O	be	cop	4	SENT_179	[p14l634t35r780b82],
4	similar	JJ	O	similar	_	0	SENT_179	[p14l812t14r1078b82],
5	to	TO	O	to	_	0	SENT_179	[p14l1103t24r1175b82],
6	that	DT	O	that	prep_to	4	SENT_179	[p14l1202t14r1347b82],
7	observed	VBN	O	observe	partmod	6	SENT_179	[p14l1373t14r1722b82],
8	for	IN	O	for	_	0	SENT_179	[p14l1748t14r1860b82],
9	5A5A	NN	O	5a5a	nn	12	SENT_179	[p14l1887t14r2121b82],
10	and	CC	O	and	_	0	SENT_179	[p14l9t115r146b183],
11	6A6A	NN	O	6a6a	nn	12	SENT_179	[p14l179t115r413b183],
12	patients	NNS	O	patient	prep_for	7	SENT_179	[p14l444t115r743b203],
13	in	IN	O	in	_	0	SENT_179	[p14l778t115r851b182],
14	this	DT	O	this	det	15	SENT_179	[p14l883t115r1019b183],
15	study	NN	O	study	prep_in	7	SENT_179	[p14l1057t115r1282b203],
16	.	.	O	.	_	0	SENT_179	[p14l1057t115r1282b203],

1	However	RB	O	however	advmod	6	SENT_180	[p14l1320t116r1694b195],
2	,	,	O	,	_	0	SENT_180	[p14l1320t116r1694b195],
3	an	DT	O	a	det	4	SENT_180	[p14l1732t136r1820b183],
4	association	NN	O	association	nsubjpass	6	SENT_180	[p14l1854t115r2117b183, p14l9t216r199b284],
5	was	VBD	O	be	auxpass	6	SENT_180	[p14l231t238r377b285],
6	found	VBN	O	find	_	0	SENT_180	[p14l410t216r635b284],
7	between	IN	O	between	_	0	SENT_180	[p14l664t216r987b285],
8	the	DT	O	the	det	9	SENT_180	[p14l1018t216r1134b284],
9	genotype	NN	O	genotype	prep_between	6	SENT_180	[p14l1167t227r1519b304],
10	and	CC	O	and	_	0	SENT_180	[p14l1553t216r1690b284],
11	the	DT	O	the	det	12	SENT_180	[p14l1720t216r1836b284],
12	risk	NN	O	risk	prep_between	6	SENT_180	[p14l1866t216r2013b284],
13	of	IN	O	of	_	0	SENT_180	[p14l2043t216r2126b284],
14	restenosis	NN	O	restenosis	prep_of	12	SENT_180	[p14l6t317r386b385],
15	only	RB	O	only	advmod	14	SENT_180	[p14l425t317r593b405],
16	for	IN	O	for	_	0	SENT_180	[p14l630t317r742b385],
17	the	DT	O	the	det	19	SENT_180	[p14l775t317r891b385],
18	stromelysin	NN	O	stromelysin	nn	19	SENT_180	[p14l930t317r1379b405],
19	polymorphism	NN	O	polymorphism	prep_for	14	SENT_180	[p14l1413t317r1999b405],
20	.	.	O	.	_	0	SENT_180	[p14l1413t317r1999b405],

1	We	PRP	O	we	nsubj	2	SENT_181	[p14l131t419r264b486],
2	tried	VBD	O	try	_	0	SENT_181	[p14l295t418r473b486],
3	to	TO	O	to	aux	4	SENT_181	[p14l502t428r574b486],
4	analyze	VB	O	analyze	xcomp	2	SENT_181	[p14l608t418r901b506],
5	whether	IN	O	whether	complm	18	SENT_181	[p14l933t418r1245b486],
6	individuals	NNS	O	individual	nsubj	18	SENT_181	[p14l1274t418r1702b486],
7	that	WDT	O	that	nsubj	8	SENT_181	[p14l1736t418r1881b486],
8	had	VBD	O	have	rcmod	6	SENT_181	[p14l1909t418r2049b486],
9	a	DT	O	a	det	10	SENT_181	[p14l2081t439r2121b486],
10	combination	NN	O	combination	dobj	8	SENT_181	[p14l8t519r492b587],
11	of	IN	O	of	_	0	SENT_181	[p14l522t519r606b587],
12	bad	JJ	O	bad	amod	13	SENT_181	[p14l628t519r768b587],
13	alleles	NNS	O	allele	prep_of	10	SENT_181	[p14l799t519r1041b587],
14	for	IN	O	for	_	0	SENT_181	[p14l1073t519r1186b587],
15	these	DT	O	these	det	17	SENT_181	[p14l1213t519r1410b587],
16	4	CD	NUMBER	4	num	17	SENT_181	[p14l1440t520r1486b586],
17	polymorphisms	NNS	O	polymorphism	prep_for	8	SENT_181	[p14l1515t519r2118b607],
18	had	VBD	O	have	ccomp	4	SENT_181	[p14l6t620r146b688],
19	more	RBR	O	more	num	21	SENT_181	[p14l186t641r384b688],
20	disease	NN	O	disease	nn	21	SENT_181	[p14l427t620r704b688],
21	progression	NN	O	progression	dobj	18	SENT_181	[p14l745t620r1219b708],
22	,	,	O	,	_	0	SENT_181	[p14l745t620r1219b708],
23	but	CC	O	but	_	0	SENT_181	[p14l1262t620r1387b688],
24	the	DT	O	the	det	25	SENT_181	[p14l1427t620r1543b688],
25	study	NN	O	study	nsubj	28	SENT_181	[p14l1588t620r1792b708],
26	did	VBD	O	do	aux	28	SENT_181	[p14l1836t620r1958b688],
27	not	RB	O	not	neg	28	SENT_181	[p14l1998t630r2122b688],
28	have	VB	O	have	conj_but	2	SENT_181	[p14l6t721r188b789],
29	enough	JJ	O	enough	amod	30	SENT_181	[p14l224t721r508b809],
30	power	NN	O	power	dobj	28	SENT_181	[p14l541t742r785b809],
31	to	TO	O	to	aux	32	SENT_181	[p14l819t731r890b789],
32	perform	VB	O	perform	infmod	30	SENT_181	[p14l926t721r1239b809],
33	such	JJ	O	such	amod	34	SENT_181	[p14l1276t721r1449b789],
34	analyses	NNS	O	analysis	dobj	32	SENT_181	[p14l1486t721r1831b809],
35	.	.	O	.	_	0	SENT_181	[p14l1486t721r1831b809],

1	This	DT	O	this	det	2	SENT_182	[p14l132t822r300b890],
2	study	NN	O	study	nsubj	3	SENT_182	[p14l359t822r563b910],
3	contributes	VBZ	O	contribute	_	0	SENT_182	[p14l618t822r1045b890],
4	to	TO	O	to	_	0	SENT_182	[p14l1100t832r1172b890],
5	the	DT	O	the	det	7	SENT_182	[p14l1226t822r1342b890],
6	growing	VBG	O	grow	amod	7	SENT_182	[p14l1397t822r1717b910],
7	literature	NN	O	literature	prep_to	3	SENT_182	[p14l1771t822r2119b890],
8	identifying	VBG	O	identify	partmod	7	SENT_182	[p14l7t923r430b1011],
9	vascular	JJ	O	vascular	amod	11	SENT_182	[p14l473t923r796b991],
10	matrix	NN	O	matrix	nn	11	SENT_182	[p14l835t923r1086b991],
11	remodeling	NN	O	remodeling	dobj	8	SENT_182	[p14l1126t923r1567b1011],
12	as	IN	O	as	_	0	SENT_182	[p14l1611t944r1685b991],
13	an	DT	O	a	det	15	SENT_182	[p14l1730t944r1817b991],
14	important	JJ	O	important	amod	15	SENT_182	[p14l1858t923r2117b1011, p14l7t1034r152b1092],
15	mechanism	NN	O	mechanism	prep_as	8	SENT_182	[p14l184t1024r627b1092],
16	contributing	VBG	O	contribute	partmod	15	SENT_182	[p14l661t1024r1133b1112],
17	to	TO	O	to	_	0	SENT_182	[p14l1168t1034r1240b1092],
18	the	DT	O	the	det	19	SENT_182	[p14l1275t1024r1391b1092],
19	growth	NN	O	growth	prep_to	16	SENT_182	[p14l1428t1024r1700b1112],
20	of	IN	O	of	_	0	SENT_182	[p14l1735t1024r1819b1092],
21	atherosclerotic	JJ	O	atherosclerotic	amod	22	SENT_182	[p14l1849t1024r2117b1092, p14l10t1125r332b1193],
22	lesions	NNS	O	lesion	prep_of	19	SENT_182	[p14l378t1125r664b1193],
23	.	.	O	.	_	0	SENT_182	[p14l378t1125r664b1193],

1	To	TO	O	to	_	0	SENT_183	[p14l713t1127r817b1193],
2	our	PRP$	O	we	poss	3	SENT_183	[p14l863t1147r991b1193],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_183	[p14l1031t1125r1478b1213],
4	,	,	O	,	_	0	SENT_183	[p14l1031t1125r1478b1213],
5	this	DT	O	this	nsubj	9	SENT_183	[p14l1525t1125r1661b1193],
6	is	VBZ	O	be	cop	9	SENT_183	[p14l1706t1125r1766b1193],
7	the	DT	O	the	det	9	SENT_183	[p14l1811t1125r1927b1193],
8	ﬁrst	NN	O	ﬁrst	nn	9	SENT_183	[p14l1972t1125r2122b1193],
9	study	NN	O	study	_	0	SENT_183	[p14l10t1226r214b1314],
10	describing	VBG	O	describe	partmod	9	SENT_183	[p14l256t1226r657b1314],
11	a	DT	O	a	det	13	SENT_183	[p14l700t1247r740b1294],
12	genetic	JJ	O	genetic	amod	13	SENT_183	[p14l780t1226r1055b1314],
13	association	NN	O	association	dobj	10	SENT_183	[p14l1099t1226r1528b1294],
14	with	IN	O	with	_	0	SENT_183	[p14l1568t1226r1738b1294],
15	risk	NN	O	risk	prep_with	10	SENT_183	[p14l1777t1226r1923b1294],
16	of	IN	O	of	_	0	SENT_183	[p14l1962t1226r2046b1294],
17	a	DT	O	a	det	19	SENT_183	[p14l2081t1247r2121b1294],
18	clinical	JJ	O	clinical	amod	19	SENT_183	[p14l8t1327r290b1395],
19	outcome	NN	O	outcome	prep_of	15	SENT_183	[p14l340t1337r671b1395],
20	requiring	VBG	O	require	partmod	19	SENT_183	[p14l719t1327r1073b1415],
21	repeat	NN	O	repeat	nn	22	SENT_183	[p14l1122t1337r1359b1415],
22	angioplasty	NN	O	angioplasty	dobj	20	SENT_183	[p14l1408t1327r1872b1415],
23	.	.	O	.	_	0	SENT_183	[p14l1408t1327r1872b1415],

1	This	DT	O	this	nsubj	34	SENT_184	[p14l1925t1327r2116b1407],
2	,	,	O	,	_	0	SENT_184	[p14l1925t1327r2116b1407],
3	together	RB	O	together	_	0	SENT_184	[p14l7t1428r325b1516],
4	with	IN	O	with	_	0	SENT_184	[p14l371t1428r542b1497],
5	the	DT	O	the	det	6	SENT_184	[p14l589t1428r705b1496],
6	evidence	NN	O	evidence	prep_together_with	34	SENT_184	[p14l754t1428r1096b1496],
7	we	PRP	O	we	nsubj	8	SENT_184	[p14l1145t1450r1254b1497],
8	present	VBP	DATE	present	rcmod	6	SENT_184	[p14l1301t1439r1583b1516],
9	showing	VBG	O	show	xcomp	8	SENT_184	[p14l1632t1428r1955b1516],
10	the	DT	O	the	det	11	SENT_184	[p14l2004t1428r2120b1496],
11	effect	NN	O	effect	dobj	9	SENT_184	[p14l8t1529r228b1597],
12	of	IN	O	of	_	0	SENT_184	[p14l259t1529r342b1597],
13	this	DT	O	this	det	14	SENT_184	[p14l367t1529r503b1597],
14	variant	NN	O	variant	prep_of	11	SENT_184	[p14l537t1529r807b1597],
15	on	IN	O	on	_	0	SENT_184	[p14l838t1550r931b1597],
16	the	DT	O	the	det	17	SENT_184	[p14l963t1529r1079b1597],
17	response	NN	O	response	prep_on	14	SENT_184	[p14l1109t1550r1448b1617],
18	to	TO	O	to	_	0	SENT_184	[p14l1480t1539r1552b1597],
19	medication	NN	O	medication	prep_to	9	SENT_184	[p14l1585t1529r2016b1597],
20	in	IN	O	in	_	0	SENT_184	[p14l2047t1529r2120b1596],
21	determining	VBG	O	determine	prepc_in	9	SENT_184	[p14l8t1630r474b1718],
22	clinical	JJ	O	clinical	amod	23	SENT_184	[p14l502t1630r785b1698],
23	event	NN	O	event	dobj	21	SENT_184	[p14l812t1630r1202b1698],
24	—	CD	NUMBER	—	num	26	SENT_184	[p14l812t1630r1202b1698],
25	free	JJ	O	free	amod	26	SENT_184	[p14l812t1630r1202b1698],
26	survival	NN	O	survival	dep	23	SENT_184	[p14l1232t1630r1540b1698],
27	and	CC	O	and	_	0	SENT_184	[p14l1568t1630r1705b1698],
28	the	DT	O	the	det	29	SENT_184	[p14l1730t1630r1846b1698],
29	risk	NN	O	risk	dobj	21	SENT_184	[p14l1871t1630r2018b1698],
30	of	IN	O	of	_	0	SENT_184	[p14l2043t1630r2127b1698],
31	disease	NN	O	disease	nn	32	SENT_184	[p14l8t1731r285b1799],
32	progression	NN	O	progression	prep_of	29	SENT_184	[p14l343t1731r817b1819],
33	,	,	O	,	_	0	SENT_184	[p14l343t1731r817b1819],
34	suggests	VBZ	O	suggest	_	0	SENT_184	[p14l882t1742r1204b1819],
35	strongly	RB	O	strongly	advmod	34	SENT_184	[p14l1268t1731r1581b1819],
36	that	IN	O	that	complm	49	SENT_184	[p14l1640t1731r1785b1799],
37	genetic	JJ	O	genetic	amod	38	SENT_184	[p14l1843t1731r2119b1819],
38	variation	NN	O	variation	nsubj	49	SENT_184	[p14l7t1832r350b1900],
39	in	IN	O	in	_	0	SENT_184	[p14l388t1832r461b1899],
40	the	DT	O	the	det	41	SENT_184	[p14l498t1832r614b1900],
41	MMPs	NNS	O	mmp	prep_in	38	SENT_184	[p14l652t1834r913b1900],
42	and	CC	O	and	_	0	SENT_184	[p14l954t1832r1111b1912],
43	,	,	O	,	_	0	SENT_184	[p14l954t1832r1111b1912],
44	possibly	RB	O	possibly	dep	41	SENT_184	[p14l1151t1832r1495b1920],
45	,	,	O	,	_	0	SENT_184	[p14l1151t1832r1495b1920],
46	their	PRP$	O	they	poss	47	SENT_184	[p14l1536t1832r1713b1900],
47	inhibitors	NNS	O	inhibitor	conj_and	41	SENT_184	[p14l1749t1832r2118b1900],
48	may	MD	O	may	aux	49	SENT_184	[p14l7t1954r171b2021],
49	have	VB	O	have	ccomp	34	SENT_184	[p14l208t1933r389b2001],
50	a	DT	O	a	det	52	SENT_184	[p14l429t1954r469b2001],
51	signiﬁcant	JJ	O	signiﬁcant	amod	52	SENT_184	[p14l507t1933r909b2021],
52	impact	NN	O	impact	dobj	49	SENT_184	[p14l944t1933r1208b2021],
53	on	IN	O	on	_	0	SENT_184	[p14l1244t1954r1338b2001],
54	interindividual	JJ	O	interindividual	amod	55	SENT_184	[p14l1375t1933r1945b2001],
55	differences	NNS	O	difference	prep_on	52	SENT_184	[p14l1984t1933r2117b2001, p14l7t2034r327b2102],
56	in	IN	O	in	_	0	SENT_184	[p14l385t2034r458b2101],
57	the	DT	O	the	det	58	SENT_184	[p14l515t2034r631b2102],
58	progression	NN	O	progression	prep_in	49	SENT_184	[p14l686t2034r1140b2122],
59	of	IN	O	of	_	0	SENT_184	[p14l1197t2034r1281b2102],
60	atherosclerosis	NN	O	atherosclerosis	prep_of	58	SENT_184	[p14l1332t2034r1926b2102],
61	.	.	O	.	_	0	SENT_184	[p14l1332t2034r1926b2102],

1	We	PRP	O	we	nsubj	2	SENT_185	[p14l1987t2036r2120b2102],
2	believe	VBP	O	believe	_	0	SENT_185	[p14l6t2135r285b2203],
3	that	IN	O	that	complm	6	SENT_185	[p14l328t2135r473b2203],
4	these	DT	O	these	det	5	SENT_185	[p14l514t2135r711b2203],
5	data	NNS	O	datum	nsubj	6	SENT_185	[p14l754t2135r915b2203],
6	support	VBP	O	support	ccomp	2	SENT_185	[p14l959t2145r1247b2223],
7	a	DT	O	a	det	9	SENT_185	[p14l1290t2156r1329b2203],
8	major	JJ	O	major	amod	9	SENT_185	[p14l1370t2135r1597b2223],
9	role	NN	O	role	dobj	6	SENT_185	[p14l1636t2135r1786b2203],
10	for	IN	O	for	_	0	SENT_185	[p14l1829t2135r1941b2203],
11	this	DT	O	this	det	12	SENT_185	[p14l1982t2135r2118b2203],
12	family	NN	O	family	prep_for	9	SENT_185	[p14l7t2236r258b2324],
13	of	IN	O	of	_	0	SENT_185	[p14l289t2236r373b2304],
14	proteins	NNS	O	protein	prep_of	12	SENT_185	[p14l394t2236r704b2324],
15	in	IN	O	in	_	0	SENT_185	[p14l735t2236r809b2303],
16	dictating	VBG	O	dictate	prepc_in	6	SENT_185	[p14l839t2236r1175b2324],
17	the	DT	O	the	det	18	SENT_185	[p14l1205t2236r1321b2304],
18	course	NN	O	course	dobj	16	SENT_185	[p14l1351t2257r1602b2304],
19	of	IN	O	of	_	0	SENT_185	[p14l1633t2236r1717b2304],
20	disease	NN	O	disease	prep_of	18	SENT_185	[p14l1740t2236r2017b2304],
21	in	IN	O	in	_	0	SENT_185	[p14l2047t2236r2120b2303],
22	this	DT	O	this	det	25	SENT_185	[p14l7t2337r143b2405],
23	complex	NN	O	complex	nn	25	SENT_185	[p14l181t2337r513b2425],
24	multifactorial	JJ	O	multifactorial	amod	25	SENT_185	[p14l548t2337r1075b2405],
25	disorder	NN	O	disorder	prep_in	16	SENT_185	[p14l1112t2337r1447b2405],
26	.	.	O	.	_	0	SENT_185	[p14l1112t2337r1447b2405],

1	856	CD	NUMBER	856	_	0	SENT_186	[p14l9t2592r148b2659],
2	THE	DT	O	the	det	4	SENT_186	[p14l234t2601r354b2658],
3	AMERICAN	NNP	MISC	AMERICAN	nn	4	SENT_186	[p14l396t2600r758b2659],
4	JOURNAL	NNP	O	JOURNAL	dep	1	SENT_186	[p14l792t2600r1100b2669],
5	OF	IN	O	of	_	0	SENT_186	[p14l1139t2600r1229b2658],
6	CARD	NNP	O	CARD	prep_of	4	SENT_186	[p14l1273t2600r1766b2658],
7	|	CD	NUMBER	|	num	6	SENT_186	[p14l1273t2600r1766b2658],
8	OLOOY	NNP	O	OLOOY	dep	1	SENT_186	[p14l1273t2600r1766b2658],
9	®	CD	NUMBER	®	num	8	SENT_186	[p14l1273t2600r1766b2658],
10	VOL	NNP	O	VOL	dep	8	SENT_186	[p14l1880t2600r2023b2659],
11	.	.	O	.	_	0	SENT_186	[p14l1880t2600r2023b2659],

1	83	CD	NUMBER	83	_	0	SENT_187	[p14l2075t2600r2153b2658],

1	l.	NNP	O	l.	nn	3	SENT_188	[p14l19t2837r61b2885],
2	Sing	NNP	O	Sing	nn	3	SENT_188	[p14l81t2838r197b2898],
3	CF	NN	O	cf	_	0	SENT_188	[p14l216t2839r308b2893],
4	,	,	O	,	_	0	SENT_188	[p14l216t2839r308b2893],
5	Moll	NNP	PERSON	Moll	nn	6	SENT_188	[p14l327t2838r453b2885],
6	PP	NNP	O	PP	appos	3	SENT_188	[p14l470t2839r554b2885],
7	.	.	O	.	_	0	SENT_188	[p14l470t2839r554b2885],

1	Genetics	NNP	O	Genetics	_	0	SENT_189	[p14l576t2838r801b2885],
2	of	IN	O	of	_	0	SENT_189	[p14l820t2838r877b2885],
3	atherosclerosis	NN	O	atherosclerosis	prep_of	1	SENT_189	[p14l891t2838r1291b2885],
4	.	.	O	.	_	0	SENT_189	[p14l891t2838r1291b2885],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_190	[p14l1306t2839r1414b2885],
2	Rev	NN	PERSON	rev	nn	3	SENT_190	[p14l1430t2840r1529b2885],
3	Gen	NN	O	gen	_	0	SENT_190	[p14l1548t2839r1652b2885],
4	1990	CD	DATE	1990	dep	3	SENT_190	[p14l1676t2839r2144b2893],
5	;	:	O	;	_	0	SENT_190	[p14l1676t2839r2144b2893],
6	24:171	CD	NUMBER	24:171	num	7	SENT_190	[p14l1676t2839r2144b2893],
7	-187	CD	NUMBER	-187	dep	3	SENT_190	[p14l1676t2839r2144b2893],
8	.	.	O	.	_	0	SENT_190	[p14l1676t2839r2144b2893],

1	2	LS	NUMBER	2	_	0	SENT_191	[p14l13t2913r61b2962],
2	.	.	O	.	_	0	SENT_191	[p14l13t2913r61b2962],

1	Scandinavian	JJ	O	scandinavian	amod	5	SENT_192	[p14l87t2915r437b2962],
2	Simvastatin	NNP	O	Simvastatin	nn	5	SENT_192	[p14l461t2915r767b2962],
3	Survival	NNP	O	Survival	nn	5	SENT_192	[p14l791t2915r1010b2962],
4	Study	NNP	O	Study	nn	5	SENT_192	[p14l1034t2915r1183b2975],
5	Group	NNP	O	Group	_	0	SENT_192	[p14l1206t2915r1385b2975],
6	.	.	O	.	_	0	SENT_192	[p14l1206t2915r1385b2975],

1	Randomised	JJ	O	randomised	amod	2	SENT_193	[p14l1410t2915r1737b2961],
2	trial	NN	O	trial	_	0	SENT_193	[p14l1758t2915r1862b2961],
3	of	IN	O	of	_	0	SENT_193	[p14l1885t2915r1942b2961],
4	cholesterol	NN	O	cholesterol	nn	5	SENT_193	[p14l1960t2915r2145b2961, p14l12t2992r130b3038],
5	lowering	NN	O	lowering	prep_of	2	SENT_193	[p14l160t2992r391b3052],
6	in	IN	O	in	_	0	SENT_193	[p14l421t2992r470b3037],
7	4444	CD	DATE	4444	num	8	SENT_193	[p14l498t2992r628b3037],
8	patients	NNS	O	patient	prep_in	5	SENT_193	[p14l657t2992r859b3052],
9	with	IN	O	with	_	0	SENT_193	[p14l890t2992r1005b3038],
10	coronary	JJ	O	coronary	amod	12	SENT_193	[p14l1034t3006r1264b3052],
11	heart	NN	O	heart	nn	12	SENT_193	[p14l1294t2992r1424b3038],
12	disease	NN	O	disease	prep_with	8	SENT_193	[p14l1453t2992r1654b3038],
13	:	:	O	:	_	0	SENT_193	[p14l1453t2992r1654b3038],
14	the	DT	O	the	det	21	SENT_193	[p14l1688t2992r1766b3038],
15	Scandinavian	JJ	O	scandinavian	amod	21	SENT_193	[p14l1797t2992r2148b3039],
16	Simvastatin	NNP	O	Simvastatin	nn	21	SENT_193	[p14l14t3068r320b3115],
17	Survival	NNP	O	Survival	nn	21	SENT_193	[p14l345t3068r564b3115],
18	Study	NNP	O	Study	nn	21	SENT_193	[p14l589t3068r739b3128],
19	(	CD	NUMBER	(	num	21	SENT_193	[p14l765t3069r887b3126],
20	4S	NN	O	4	nn	21	SENT_193	[p14l765t3069r887b3126],
21	)	NN	O	)	dep	2	SENT_193	[p14l765t3069r887b3126],
22	.	.	O	.	_	0	SENT_193	[p14l765t3069r887b3126],

1	Lancet	NNP	O	Lancet	_	0	SENT_194	[p14l912t3070r1093b3115],
2	1994	CD	DATE	1994	num	1	SENT_194	[p14l1120t3069r1687b3123],
3	;	:	O	;	_	0	SENT_194	[p14l1120t3069r1687b3123],
4	344:1383	CD	DURATION	344:1383	number	5	SENT_194	[p14l1120t3069r1687b3123],
5	-1389	CD	DURATION	-1389	dep	1	SENT_194	[p14l1120t3069r1687b3123],
6	.	.	O	.	_	0	SENT_194	[p14l1120t3069r1687b3123],

1	3	LS	NUMBER	3	_	0	SENT_195	[p14l13t3144r61b3193],
2	.	.	O	.	_	0	SENT_195	[p14l13t3144r61b3193],

1	Shepherd	NNP	O	Shepherd	nn	2	SENT_196	[p14l99t3146r344b3206],
2	J	NNP	O	J	_	0	SENT_196	[p14l376t3147r414b3201],
3	,	,	O	,	_	0	SENT_196	[p14l376t3147r414b3201],
4	Cobbe	NNP	ORGANIZATION	Cobbe	nn	5	SENT_196	[p14l451t3146r620b3193],
5	SM	NNP	ORGANIZATION	SM	appos	2	SENT_196	[p14l656t3147r761b3201],
6	,	,	O	,	_	0	SENT_196	[p14l656t3147r761b3201],
7	Ford	NNP	ORGANIZATION	Ford	appos	5	SENT_196	[p14l797t3146r921b3193],
8	1	CD	NUMBER	1	num	7	SENT_196	[p14l954t3147r988b3201],
9	,	,	O	,	_	0	SENT_196	[p14l954t3147r988b3201],
10	Isles	NNP	ORGANIZATION	Isles	nn	11	SENT_196	[p14l1024t3146r1141b3193],
11	CG	NNP	ORGANIZATION	CG	appos	5	SENT_196	[p14l1178t3147r1280b3201],
12	,	,	O	,	_	0	SENT_196	[p14l1178t3147r1280b3201],
13	Lorimer	NNP	ORGANIZATION	Lorimer	nn	14	SENT_196	[p14l1316t3146r1531b3193],
14	AR	NNS	ORGANIZATION	ar	appos	5	SENT_196	[p14l1563t3147r1667b3201],
15	,	,	O	,	_	0	SENT_196	[p14l1563t3147r1667b3201],
16	Macfarlane	NNP	PERSON	Macfarlane	nn	17	SENT_196	[p14l1703t3146r2000b3193],
17	PW	NNP	O	PW	appos	5	SENT_196	[p14l2034t3147r2145b3201],
18	,	,	O	,	_	0	SENT_196	[p14l2034t3147r2145b3201],
19	McKillop	NNP	PERSON	McKillop	nn	21	SENT_196	[p14l11t3223r265b3283],
20	J	NNP	PERSON	J	nn	21	SENT_196	[p14l286t3224r310b3270],
21	H	NNP	PERSON	H	appos	5	SENT_196	[p14l313t3224r372b3278],
22	,	,	O	,	_	0	SENT_196	[p14l313t3224r372b3278],
23	Packard	NNP	O	Packard	nn	24	SENT_196	[p14l396t3223r606b3269],
24	CJ	NNP	O	CJ	appos	5	SENT_196	[p14l628t3223r708b3270],
25	.	.	O	.	_	0	SENT_196	[p14l628t3223r708b3270],

1	Prevention	NNP	O	Prevention	_	0	SENT_197	[p14l732t3223r1016b3269],
2	of	IN	O	of	_	0	SENT_197	[p14l1037t3223r1094b3269],
3	coronary	JJ	O	coronary	amod	5	SENT_197	[p14l1112t3238r1342b3283],
4	heart	NN	O	heart	nn	5	SENT_197	[p14l1363t3223r1494b3269],
5	disease	NN	O	disease	prep_of	1	SENT_197	[p14l1516t3223r1702b3269],
6	with	IN	O	with	_	0	SENT_197	[p14l1725t3223r1840b3270],
7	pravastatin	NN	O	pravastatin	prep_with	5	SENT_197	[p14l1860t3223r2148b3283],
8	in	IN	O	in	_	0	SENT_197	[p14l12t3300r61b3345],
9	men	NNS	O	man	prep_in	1	SENT_197	[p14l85t3314r196b3346],
10	with	IN	O	with	_	0	SENT_197	[p14l220t3300r335b3346],
11	hypercholesterolemia	NN	O	hypercholesterolemia	prep_with	9	SENT_197	[p14l358t3300r934b3359],
12	.	.	O	.	_	0	SENT_197	[p14l358t3300r934b3359],

1	N	NN	O	n	nn	3	SENT_198	[p14l959t3301r1008b3346],
2	Engl	NNP	O	Engl	nn	3	SENT_198	[p14l1026t3300r1150b3359],
3	J	NNP	O	J	nsubj	4	SENT_198	[p14l1171t3301r1204b3346],
4	Med	VBD	O	med	_	0	SENT_198	[p14l1221t3300r1341b3346],
5	1995	CD	DATE	1995	dobj	4	SENT_198	[p14l1368t3299r1935b3354],
6	;	:	O	;	_	0	SENT_198	[p14l1368t3299r1935b3354],
7	333:1301	CD	DURATION	333:1301	num	8	SENT_198	[p14l1368t3299r1935b3354],
8	-1307	CD	DURATION	-1307	dep	5	SENT_198	[p14l1368t3299r1935b3354],
9	.	.	O	.	_	0	SENT_198	[p14l1368t3299r1935b3354],

1	4	LS	NUMBER	4	_	0	SENT_199	[p14l11t3374r61b3423],
2	.	.	O	.	_	0	SENT_199	[p14l11t3374r61b3423],

1	Jukema	NNP	O	Jukema	nn	2	SENT_200	[p14l83t3376r284b3422],
2	JW	NNP	O	JW	_	0	SENT_200	[p14l303t3377r403b3430],
3	,	,	O	,	_	0	SENT_200	[p14l303t3377r403b3430],
4	Bruschke	NNP	ORGANIZATION	Bruschke	nn	5	SENT_200	[p14l427t3376r673b3422],
5	AVG	NNP	ORGANIZATION	AVG	appos	2	SENT_200	[p14l694t3377r848b3430],
6	,	,	O	,	_	0	SENT_200	[p14l694t3377r848b3430],
7	van	NNP	PERSON	van	nn	9	SENT_200	[p14l872t3391r965b3422],
8	Boven	NNP	PERSON	Boven	nn	9	SENT_200	[p14l985t3377r1156b3422],
9	AJ	NNP	PERSON	AJ	appos	5	SENT_200	[p14l1176t3377r1261b3430],
10	,	,	O	,	_	0	SENT_200	[p14l1176t3377r1261b3430],
11	Reiber	NNP	PERSON	Reiber	nn	12	SENT_200	[p14l1285t3376r1459b3422],
12	JH	NNP	O	JH	appos	5	SENT_200	[p14l1479t3377r1564b3430],
13	,	,	O	,	_	0	SENT_200	[p14l1479t3377r1564b3430],
14	Bal	NN	O	bal	nn	15	SENT_200	[p14l1587t3376r1677b3422],
15	ET	NNP	O	ET	appos	5	SENT_200	[p14l1697t3377r1791b3430],
16	,	,	O	,	_	0	SENT_200	[p14l1697t3377r1791b3430],
17	Zwinderman	NNP	O	Zwinderman	nn	18	SENT_200	[p14l1813t3376r2148b3422],
18	AH	NNP	O	AH	appos	5	SENT_200	[p14l11t3453r119b3507],
19	,	,	O	,	_	0	SENT_200	[p14l11t3453r119b3507],
20	Jansen	NNP	PERSON	Jansen	nn	21	SENT_200	[p14l144t3454r318b3500],
21	H	NNP	PERSON	H	appos	5	SENT_200	[p14l340t3454r400b3508],
22	,	,	O	,	_	0	SENT_200	[p14l340t3454r400b3508],
23	Boerma	NNP	PERSON	Boerma	nn	24	SENT_200	[p14l425t3454r632b3499],
24	GJ	NNP	O	GJ	appos	5	SENT_200	[p14l655t3453r739b3507],
25	,	,	O	,	_	0	SENT_200	[p14l655t3453r739b3507],
26	Van	NNP	PERSON	Van	nn	28	SENT_200	[p14l764t3468r857b3499],
27	Rappard	NNP	PERSON	Rappard	nn	28	SENT_200	[p14l880t3453r1101b3513],
28	FM	NNP	O	FM	appos	5	SENT_200	[p14l1123t3454r1230b3508],
29	,	,	O	,	_	0	SENT_200	[p14l1123t3454r1230b3508],
30	Lie	NN	O	lie	nn	31	SENT_200	[p14l1255t3453r1341b3499],
31	KI	NNP	O	KI	appos	5	SENT_200	[p14l1365t3454r1431b3499],
32	.	.	O	.	_	0	SENT_200	[p14l1458t3491r1466b3499],

1	Effects	NNS	O	effect	_	0	SENT_201	[p14l1491t3453r1674b3499],
2	of	IN	O	of	_	0	SENT_201	[p14l1700t3453r1756b3499],
3	lipid	NN	O	lipid	nn	4	SENT_201	[p14l1775t3453r1894b3513],
4	lowering	NN	O	lowering	prep_of	1	SENT_201	[p14l1916t3453r2147b3513],
5	by	IN	O	by	_	0	SENT_201	[p14l11t3530r75b3589],
6	pravastatin	NN	O	pravastatin	prep_by	1	SENT_201	[p14l113t3530r400b3589],
7	on	IN	O	on	_	0	SENT_201	[p14l440t3544r503b3576],
8	progression	NN	O	progression	prep_on	1	SENT_201	[p14l540t3530r845b3589],
9	and	CC	O	and	_	0	SENT_201	[p14l885t3530r977b3576],
10	regression	NN	O	regression	prep_on	1	SENT_201	[p14l1014t3530r1283b3590],
11	of	IN	O	of	_	0	SENT_201	[p14l1322t3530r1378b3576],
12	coronary	JJ	O	coronary	amod	14	SENT_201	[p14l1413t3544r1644b3589],
13	artery	NN	O	artery	nn	14	SENT_201	[p14l1684t3537r1833b3589],
14	disease	NN	O	disease	prep_of	1	SENT_201	[p14l1873t3530r2060b3576],
15	in	IN	O	in	_	0	SENT_201	[p14l2098t3530r2147b3575],
16	symptomatic	JJ	O	symptomatic	amod	17	SENT_201	[p14l14t3607r348b3667],
17	men	NNS	O	man	prep_in	1	SENT_201	[p14l373t3622r484b3654],
18	with	IN	O	with	_	0	SENT_201	[p14l508t3607r624b3654],
19	normal	JJ	O	normal	amod	25	SENT_201	[p14l647t3607r831b3654],
20	to	TO	O	to	_	0	SENT_201	[p14l855t3614r904b3654],
21	moderately	RB	O	moderately	advmod	22	SENT_201	[p14l928t3607r1221b3667],
22	elevated	JJ	O	elevated	amod	23	SENT_201	[p14l1246t3607r1464b3654],
23	serum	NN	O	serum	prep_to	19	SENT_201	[p14l1489t3622r1646b3654],
24	cholesterol	NN	O	cholesterol	nn	25	SENT_201	[p14l1669t3607r1955b3654],
25	levels	NNS	O	level	prep_with	1	SENT_201	[p14l1980t3607r2143b3654],
26	.	.	O	.	_	0	SENT_201	[p14l1980t3607r2143b3654],

1	“	NN	O	“	_	0	SENT_202	[p14l14t3684r141b3730],
2	The	DT	O	the	det	4	SENT_202	[p14l14t3684r141b3730],
3	regression	NN	O	regression	nn	4	SENT_202	[p14l163t3684r432b3744],
4	growth	NN	O	growth	dep	1	SENT_202	[p14l454t3684r638b3744],
5	evaluation	NN	O	evaluation	nn	7	SENT_202	[p14l660t3684r932b3730],
6	statin	NN	O	statin	nn	7	SENT_202	[p14l956t3684r1095b3730],
7	study	NN	O	study	dep	4	SENT_202	[p14l1118t3684r1284b3744],
8	”	CD	NUMBER	”	number	9	SENT_202	[p14l1118t3684r1284b3744],
9	(	CD	NUMBER	(	num	10	SENT_202	[p14l1310t3684r1651b3741],
10	REGRESS	NNS	O	regress	dep	1	SENT_202	[p14l1310t3684r1651b3741],
11	)	CD	NUMBER	)	dep	10	SENT_202	[p14l1310t3684r1651b3741],
12	.	.	O	.	_	0	SENT_202	[p14l1310t3684r1651b3741],

1	Circulation	NN	O	circulation	_	0	SENT_203	[p14l1680t3684r1977b3731],
2	1995	CD	DATE	1995	num	1	SENT_203	[p14l2006t3684r2145b3739],
3	;	:	O	;	_	0	SENT_203	[p14l2006t3684r2145b3739],
4	91:2528	CD	DURATION	91:2528	number	5	SENT_203	[p14l13t3760r410b3806],
5	-2540	CD	DURATION	-2540	dep	1	SENT_203	[p14l13t3760r410b3806],
6	.	.	O	.	_	0	SENT_203	[p14l13t3760r410b3806],

1	5	CD	NUMBER	5	_	0	SENT_204	[p15l13t23r61b71],
2	.	.	O	.	_	0	SENT_204	[p15l13t23r61b71],

1	Sacks	NNP	O	Sacks	nn	2	SENT_205	[p15l96t24r244b71],
2	FM	NNP	O	FM	dep	37	SENT_205	[p15l276t25r384b79],
3	,	,	O	,	_	0	SENT_205	[p15l276t25r384b79],
4	Pfeffer	NNP	PERSON	Pfeffer	nn	5	SENT_205	[p15l417t24r599b71],
5	MA	NNP	PERSON	MA	appos	2	SENT_205	[p15l629t25r747b79],
6	,	,	O	,	_	0	SENT_205	[p15l629t25r747b79],
7	Moye	NNP	LOCATION	Moye	nn	8	SENT_205	[p15l780t25r932b84],
8	LA	NNP	LOCATION	LA	appos	2	SENT_205	[p15l963t25r1063b79],
9	,	,	O	,	_	0	SENT_205	[p15l963t25r1063b79],
10	Rouleau	NNP	PERSON	Rouleau	nn	11	SENT_205	[p15l1097t24r1313b71],
11	JL	NNP	O	JL	appos	2	SENT_205	[p15l1344t25r1422b79],
12	,	,	O	,	_	0	SENT_205	[p15l1344t25r1422b79],
13	Rutherford	NNP	ORGANIZATION	Rutherford	nn	14	SENT_205	[p15l1456t24r1743b71],
14	JD	NNP	ORGANIZATION	JD	appos	2	SENT_205	[p15l1773t25r1859b79],
15	,	,	O	,	_	0	SENT_205	[p15l1773t25r1859b79],
16	Cole	NNP	O	Cole	nn	17	SENT_205	[p15l1893t24r2014b71],
17	TG	NN	O	tg	appos	2	SENT_205	[p15l2045t25r2145b79],
18	,	,	O	,	_	0	SENT_205	[p15l2045t25r2145b79],
19	Brown	NNP	PERSON	Brown	nn	20	SENT_205	[p15l12t102r189b147],
20	L	NNP	O	L	appos	2	SENT_205	[p15l214t102r267b155],
21	,	,	O	,	_	0	SENT_205	[p15l214t102r267b155],
22	Wamica	NNP	ORGANIZATION	Wamica	nn	23	SENT_205	[p15l294t101r516b147],
23	JW	NNP	ORGANIZATION	JW	appos	2	SENT_205	[p15l540t102r640b155],
24	,	,	O	,	_	0	SENT_205	[p15l540t102r640b155],
25	Arnold	NNP	ORGANIZATION	Arnold	nn	26	SENT_205	[p15l668t101r853b147],
26	JMO	NNP	ORGANIZATION	JMO	appos	2	SENT_205	[p15l877t101r1022b155],
27	,	,	O	,	_	0	SENT_205	[p15l877t101r1022b155],
28	Wun	NNP	O	Wun	nn	29	SENT_205	[p15l1048t102r1176b147],
29	C-C	NNP	O	C-C	appos	2	SENT_205	[p15l1201t101r1322b155],
30	,	,	O	,	_	0	SENT_205	[p15l1201t101r1322b155],
31	Davis	NNP	PERSON	Davis	nn	32	SENT_205	[p15l1350t101r1500b147],
32	BR	NNP	PERSON	BR	appos	2	SENT_205	[p15l1527t102r1627b155],
33	,	,	O	,	_	0	SENT_205	[p15l1527t102r1627b155],
34	Braunwald	NNP	PERSON	Braunwald	nn	35	SENT_205	[p15l1655t101r1942b147],
35	E.	NNP	O	E.	appos	2	SENT_205	[p15l1966t102r2018b147],
36	The	DT	O	the	det	37	SENT_205	[p15l2047t101r2147b147],
37	effect	NN	O	effect	_	0	SENT_205	[p15l12t178r160b224],
38	of	IN	O	of	_	0	SENT_205	[p15l187t178r244b224],
39	pravastatin	NN	O	pravastatin	prep_of	37	SENT_205	[p15l266t178r553b237],
40	on	IN	O	on	_	0	SENT_205	[p15l580t192r644b224],
41	coronary	JJ	O	coronary	amod	42	SENT_205	[p15l671t192r901b237],
42	events	NNS	O	event	prep_on	39	SENT_205	[p15l930t185r1094b224],
43	after	IN	O	after	_	0	SENT_205	[p15l1124t178r1242b224],
44	myocardial	JJ	O	myocardial	amod	45	SENT_205	[p15l1268t178r1561b237],
45	infarction	NN	O	infarction	prep_after	42	SENT_205	[p15l1588t178r1842b224],
46	in	IN	O	in	_	0	SENT_205	[p15l1869t178r1918b223],
47	patients	NNS	O	patient	prep_in	45	SENT_205	[p15l1944t178r2146b237],
48	with	IN	O	with	_	0	SENT_205	[p15l12t255r127b302],
49	average	JJ	O	average	amod	51	SENT_205	[p15l152t270r352b315],
50	cholesterol	NN	O	cholesterol	nn	51	SENT_205	[p15l377t255r662b302],
51	levels	NNS	O	level	prep_with	47	SENT_205	[p15l686t255r851b302],
52	.	.	O	.	_	0	SENT_205	[p15l686t255r851b302],

1	N	NN	O	n	nn	3	SENT_206	[p15l875t257r925b302],
2	Engl	NNP	O	Engl	nn	3	SENT_206	[p15l942t255r1066b314],
3	J	NNP	O	J	nsubj	4	SENT_206	[p15l1087t257r1120b302],
4	Med	VBD	O	med	_	0	SENT_206	[p15l1137t255r1257b302],
5	1995	CD	DATE	1995	dobj	4	SENT_206	[p15l1284t255r1851b310],
6	;	:	O	;	_	0	SENT_206	[p15l1284t255r1851b310],
7	335:1001	CD	DURATION	335:1001	num	8	SENT_206	[p15l1284t255r1851b310],
8	-1009	CD	DURATION	-1009	dep	5	SENT_206	[p15l1284t255r1851b310],
9	.	.	O	.	_	0	SENT_206	[p15l1284t255r1851b310],

1	6	CD	NUMBER	6	_	0	SENT_207	[p15l12t329r61b379],
2	.	.	O	.	_	0	SENT_207	[p15l12t329r61b379],

1	Henney	NNP	ORGANIZATION	Henney	nn	2	SENT_208	[p15l96t333r297b392],
2	AM	NNP	ORGANIZATION	AM	dep	21	SENT_208	[p15l330t333r448b387],
3	,	,	O	,	_	0	SENT_208	[p15l330t333r448b387],
4	Wakeley	NNP	PERSON	Wakeley	nn	5	SENT_208	[p15l482t332r714b392],
5	PR	NNP	O	PR	appos	2	SENT_208	[p15l747t333r839b386],
6	,	,	O	,	_	0	SENT_208	[p15l747t333r839b386],
7	Davies	NNP	ORGANIZATION	Davies	nn	8	SENT_208	[p15l874t332r1053b378],
8	MJ	NNP	ORGANIZATION	MJ	appos	2	SENT_208	[p15l1087t333r1183b386],
9	,	,	O	,	_	0	SENT_208	[p15l1087t333r1183b386],
10	Foster	NNP	O	Foster	nn	11	SENT_208	[p15l1217t333r1381b378],
11	K	NNP	O	K	appos	2	SENT_208	[p15l1413t333r1472b386],
12	,	,	O	,	_	0	SENT_208	[p15l1413t333r1472b386],
13	Hembry	NNP	O	Hembry	nn	14	SENT_208	[p15l1507t332r1719b392],
14	R	NNP	O	R	appos	2	SENT_208	[p15l1753t333r1808b386],
15	,	,	O	,	_	0	SENT_208	[p15l1753t333r1808b386],
16	Murphy	NNP	PERSON	Murphy	nn	17	SENT_208	[p15l1843t332r2052b392],
17	G	NNP	PERSON	G	appos	2	SENT_208	[p15l2086t332r2145b386],
18	,	,	O	,	_	0	SENT_208	[p15l2086t332r2145b386],
19	Humphries	NNP	PERSON	Humphries	nn	20	SENT_208	[p15l12t409r300b468],
20	S.	NNP	O	S.	appos	2	SENT_208	[p15l338t409r384b455],
21	Localization	NN	O	localization	_	0	SENT_208	[p15l421t409r748b455],
22	of	IN	O	of	_	0	SENT_208	[p15l783t409r840b455],
23	stromelysin	NN	O	stromelysin	nn	25	SENT_208	[p15l872t409r1175b468],
24	gene	NN	O	gene	nn	25	SENT_208	[p15l1209t423r1331b468],
25	expression	NN	O	expression	prep_of	21	SENT_208	[p15l1366t409r1645b468],
26	in	IN	O	in	_	0	SENT_208	[p15l1679t409r1728b454],
27	atherosclerotic	JJ	O	atherosclerotic	amod	28	SENT_208	[p15l1764t409r2146b455],
28	plaques	NNS	O	plaque	prep_in	25	SENT_208	[p15l11t486r209b546],
29	by	IN	O	by	prep	25	SENT_208	[p15l233t486r297b546],
30	in	FW	O	in	nn	31	SENT_208	[p15l322t488r368b533],
31	situ	FW	O	situ	dep	32	SENT_208	[p15l392t488r484b533],
32	hybridization	NN	O	hybridization	dep	29	SENT_208	[p15l507t486r869b546],
33	.	.	O	.	_	0	SENT_208	[p15l507t486r869b546],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_209	[p15l894t488r1022b533],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_209	[p15l1042t486r1157b533],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_209	[p15l1174t486r1314b533],
4	Sciences	NNPS	ORGANIZATION	Sciences	nn	5	SENT_209	[p15l1334t487r1558b533],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_209	[p15l1587t487r1698b533],
6	1991	CD	DATE	1991	dep	5	SENT_209	[p15l1729t487r1950b541],
7	;	:	O	;	_	0	SENT_209	[p15l1729t487r1950b541],
8	88	CD	NUMBER	88	num	10	SENT_209	[p15l1729t487r1950b541],
9	:	:	O	:	_	0	SENT_209	[p15l1729t487r1950b541],
10	81548158	CD	NUMBER	81548158	dep	5	SENT_209	[p15l1980t486r2149b533, p15l15t562r154b608],
11	.	.	O	.	_	0	SENT_209	[p15l1980t486r2149b533, p15l15t562r154b608],

1	7	CD	NUMBER	7	_	0	SENT_210	[p15l13t637r61b685],
2	.	.	O	.	_	0	SENT_210	[p15l13t637r61b685],

1	Galis	NNP	PERSON	Galis	nn	2	SENT_211	[p15l89t638r223b685],
2	ZS	NNP	O	ZS	_	0	SENT_211	[p15l250t639r339b693],
3	,	,	O	,	_	0	SENT_211	[p15l250t639r339b693],
4	Sukhova	NNP	PERSON	Sukhova	nn	5	SENT_211	[p15l369t639r596b685],
5	GK	NNP	PERSON	GK	appos	2	SENT_211	[p15l621t639r728b693],
6	,	,	O	,	_	0	SENT_211	[p15l621t639r728b693],
7	Lark	NNP	O	Lark	nn	8	SENT_211	[p15l755t639r879b685],
8	MW	NNP	O	MW	appos	5	SENT_211	[p15l903t640r1035b693],
9	,	,	O	,	_	0	SENT_211	[p15l903t640r1035b693],
10	Libby	NNP	LOCATION	Libby	nn	11	SENT_211	[p15l1063t638r1218b698],
11	P.	NNP	O	P.	appos	2	SENT_211	[p15l1244t640r1292b685],
12	Increased	VBN	O	increase	amod	13	SENT_211	[p15l1321t638r1571b685],
13	expression	NN	O	expression	dep	2	SENT_211	[p15l1596t638r1874b698],
14	of	IN	O	of	_	0	SENT_211	[p15l1901t638r1957b685],
15	matrix	NN	O	matrix	nn	16	SENT_211	[p15l1978t638r2147b685],
16	metalloproteinases	NNS	O	metalloproteinase	prep_of	13	SENT_211	[p15l12t716r501b776],
17	and	CC	O	and	_	0	SENT_211	[p15l523t716r616b763],
18	matrix	NN	O	matrix	nn	20	SENT_211	[p15l636t716r805b763],
19	degrading	JJ	O	degrading	amod	20	SENT_211	[p15l826t716r1085b776],
20	activity	NN	O	activity	prep_of	13	SENT_211	[p15l1107t716r1301b776],
21	in	IN	O	in	_	0	SENT_211	[p15l1321t716r1371b762],
22	vulnerable	JJ	O	vulnerable	amod	23	SENT_211	[p15l1390t716r1665b763],
23	regions	NNS	O	region	prep_in	13	SENT_211	[p15l1685t716r1876b776],
24	of	IN	O	of	_	0	SENT_211	[p15l1898t716r1954b763],
25	human	JJ	O	human	amod	27	SENT_211	[p15l1970t716r2148b763],
26	atherosclerotic	JJ	O	atherosclerotic	amod	27	SENT_211	[p15l13t793r395b839],
27	plaques	NNS	O	plaque	prep_of	13	SENT_211	[p15l419t793r632b853],
28	.	.	O	.	_	0	SENT_211	[p15l419t793r632b853],

1	J	NNP	O	J	nn	3	SENT_212	[p15l657t795r690b840],
2	Clin	NNP	O	Clin	nn	3	SENT_212	[p15l713t793r820b840],
3	Invest	NNP	O	Invest	_	0	SENT_212	[p15l843t794r1002b839],
4	1994	CD	DATE	1994	num	3	SENT_212	[p15l1029t793r1250b848],
5	;	:	O	;	_	0	SENT_212	[p15l1029t793r1250b848],
6	94	CD	NUMBER	94	num	8	SENT_212	[p15l1029t793r1250b848],
7	:	:	O	:	_	0	SENT_212	[p15l1029t793r1250b848],
8	2493-2503	CD	DATE	2493-2503	dep	3	SENT_212	[p15l1279t793r1585b840],
9	.	.	O	.	_	0	SENT_212	[p15l1279t793r1585b840],

1	8	CD	NUMBER	8	_	0	SENT_213	[p15l14t867r61b916],
2	.	.	O	.	_	0	SENT_213	[p15l14t867r61b916],

1	Galis	NNP	PERSON	Galis	nn	2	SENT_214	[p15l81t870r215b916],
2	ZS	NNP	O	ZS	_	0	SENT_214	[p15l233t870r322b924],
3	,	,	O	,	_	0	SENT_214	[p15l233t870r322b924],
4	Muszynski	NNP	PERSON	Muszynski	nn	5	SENT_214	[p15l341t869r627b929],
5	M	NNP	O	M	appos	2	SENT_214	[p15l644t871r715b924],
6	,	,	O	,	_	0	SENT_214	[p15l644t871r715b924],
7	Sukhova	NNP	O	Sukhova	nn	8	SENT_214	[p15l736t870r963b916],
8	GK	NNP	O	GK	appos	2	SENT_214	[p15l980t870r1086b924],
9	,	,	O	,	_	0	SENT_214	[p15l980t870r1086b924],
10	Simon-Morrissey	NNP	PERSON	Simon-Morrissey	nn	11	SENT_214	[p15l1107t869r1562b929],
11	E	NNP	O	E	appos	2	SENT_214	[p15l1579t871r1631b924],
12	,	,	O	,	_	0	SENT_214	[p15l1579t871r1631b924],
13	Libby	NNP	LOCATION	Libby	nn	14	SENT_214	[p15l1650t869r1806b929],
14	P.	NNP	O	P.	appos	2	SENT_214	[p15l1822t871r1870b916],
15	Enhanced	VBN	O	enhance	partmod	14	SENT_214	[p15l1890t870r2148b916],
16	expression	NN	O	expression	dobj	15	SENT_214	[p15l12t947r291b1007],
17	of	IN	O	of	_	0	SENT_214	[p15l318t947r374b993],
18	Vascular	JJ	O	vascular	amod	20	SENT_214	[p15l396t947r615b993],
19	matrix	NN	O	matrix	nn	20	SENT_214	[p15l639t947r809b993],
20	metalloproteinases	NNS	O	metalloproteinase	prep_of	16	SENT_214	[p15l835t947r1324b1007],
21	induced	VBN	O	induce	partmod	20	SENT_214	[p15l1351t947r1558b993],
22	in	FW	O	in	nn	23	SENT_214	[p15l1584t947r1633b993],
23	vitro	FW	O	vitro	advmod	21	SENT_214	[p15l1659t947r1781b993],
24	by	IN	O	by	_	0	SENT_214	[p15l1807t947r1871b1007],
25	cytokines	NNS	O	cytokine	agent	21	SENT_214	[p15l1898t947r2146b1007],
26	and	CC	O	and	_	0	SENT_214	[p15l13t1024r105b1070],
27	in	IN	O	in	_	0	SENT_214	[p15l133t1024r182b1069],
28	regions	NNS	O	region	prep_in	21	SENT_214	[p15l208t1024r399b1084],
29	of	IN	O	of	_	0	SENT_214	[p15l429t1024r485b1070],
30	human	JJ	O	human	amod	32	SENT_214	[p15l508t1024r686b1070],
31	atherosclerotic	JJ	O	atherosclerotic	amod	32	SENT_214	[p15l714t1024r1096b1070],
32	lesions	NNS	O	lesion	prep_of	28	SENT_214	[p15l1125t1024r1319b1070],
33	.	.	O	.	_	0	SENT_214	[p15l1125t1024r1319b1070],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_215	[p15l1345t1025r1453b1070],
2	NY	NNP	O	NY	nn	4	SENT_215	[p15l1479t1025r1566b1071],
3	Acad	NNP	O	Acad	nn	4	SENT_215	[p15l1583t1024r1723b1070],
4	Sciences	NNPS	O	Sciences	_	0	SENT_215	[p15l1748t1025r1972b1071],
5	1995	CD	DATE	1995	dep	4	SENT_215	[p15l2006t1024r2144b1078],
6	;	:	O	;	_	0	SENT_215	[p15l2006t1024r2144b1078],
7	748:501	CD	NUMBER	748:501	num	8	SENT_215	[p15l12t1099r369b1145],
8	-507	CD	NUMBER	-507	dep	4	SENT_215	[p15l12t1099r369b1145],
9	.	.	O	.	_	0	SENT_215	[p15l12t1099r369b1145],

1	9	CD	NUMBER	9	_	0	SENT_216	[p15l12t1175r61b1224],
2	.	.	O	.	_	0	SENT_216	[p15l12t1175r61b1224],

1	Galis	NNP	PERSON	Galis	nn	2	SENT_217	[p15l89t1177r223b1224],
2	ZS	NNP	O	ZS	nsubj	22	SENT_217	[p15l250t1177r339b1232],
3	,	,	O	,	_	0	SENT_217	[p15l250t1177r339b1232],
4	Sukhova	NNP	PERSON	Sukhova	nn	5	SENT_217	[p15l368t1177r596b1224],
5	GK	NNP	PERSON	GK	appos	2	SENT_217	[p15l621t1177r727b1232],
6	,	,	O	,	_	0	SENT_217	[p15l621t1177r727b1232],
7	Kranzhofer	NNP	PERSON	Kranzhofer	nn	8	SENT_217	[p15l756t1177r1053b1223],
8	R	NNP	PERSON	R	appos	2	SENT_217	[p15l1077t1178r1133b1232],
9	,	,	O	,	_	0	SENT_217	[p15l1077t1178r1133b1232],
10	Clark	NNP	PERSON	Clark	nn	11	SENT_217	[p15l1161t1177r1306b1224],
11	S	NNP	PERSON	S	appos	2	SENT_217	[p15l1332t1177r1378b1232],
12	,	,	O	,	_	0	SENT_217	[p15l1332t1177r1378b1232],
13	Libby	NNP	PERSON	Libby	nn	17	SENT_217	[p15l1406t1177r1561b1237],
14	P.	NNP	PERSON	P.	nn	17	SENT_217	[p15l1586t1178r1634b1224],
15	Macrophage	NN	PERSON	macrophage	nn	17	SENT_217	[p15l1662t1177r1988b1237],
16	foam	NN	O	foam	nn	17	SENT_217	[p15l2014t1177r2148b1223],
17	cells	NNS	O	cell	appos	2	SENT_217	[p15l12t1254r129b1300],
18	from	IN	O	from	_	0	SENT_217	[p15l156t1254r283b1300],
19	experimental	JJ	O	experimental	amod	20	SENT_217	[p15l308t1254r648b1314],
20	atheroma	NN	O	atheroma	prep_from	17	SENT_217	[p15l676t1254r918b1300],
21	constitutively	RB	O	constitutively	advmod	22	SENT_217	[p15l944t1254r1298b1314],
22	produce	VBP	O	produce	_	0	SENT_217	[p15l1324t1254r1534b1314],
23	matrix-degrading	JJ	O	matrix-degrading	amod	24	SENT_217	[p15l1560t1254r2014b1314],
24	proteinase	NN	O	proteinase	dobj	22	SENT_217	[p15l2039t1268r2145b1314, p15l11t1329r205b1375],
25	.	.	O	.	_	0	SENT_217	[p15l2039t1268r2145b1314, p15l11t1329r205b1375],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_218	[p15l231t1331r358b1375],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_218	[p15l379t1329r494b1375],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_218	[p15l512t1329r653b1375],
4	Sciences	NNPS	ORGANIZATION	Sciences	nn	5	SENT_218	[p15l673t1330r897b1376],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_218	[p15l927t1330r1037b1376],
6	1995	CD	DATE	1995	dep	5	SENT_218	[p15l1069t1329r1545b1383],
7	;	:	O	;	_	0	SENT_218	[p15l1069t1329r1545b1383],
8	92:402	CD	NUMBER	92:402	num	9	SENT_218	[p15l1069t1329r1545b1383],
9	-406	CD	NUMBER	-406	dep	5	SENT_218	[p15l1069t1329r1545b1383],
10	.	.	O	.	_	0	SENT_218	[p15l1069t1329r1545b1383],

1	10	CD	NUMBER	10	_	0	SENT_219	[p15l19t1405r96b1454],
2	.	.	O	.	_	0	SENT_219	[p15l19t1405r96b1454],

1	Brown	JJ	PERSON	brown	amod	2	SENT_220	[p15l124t1408r301b1453],
2	DL	NN	O	dl	_	0	SENT_220	[p15l326t1408r427b1462],
3	,	,	O	,	_	0	SENT_220	[p15l326t1408r427b1462],
4	Hibbs	NNP	PERSON	Hibbs	nn	5	SENT_220	[p15l455t1407r609b1453],
5	MS	NN	O	m	appos	2	SENT_220	[p15l636t1407r743b1462],
6	,	,	O	,	_	0	SENT_220	[p15l636t1407r743b1462],
7	Kearney	NNP	PERSON	Kearney	nn	8	SENT_220	[p15l773t1408r991b1467],
8	M	NNP	O	M	appos	2	SENT_220	[p15l1017t1408r1088b1462],
9	,	,	O	,	_	0	SENT_220	[p15l1017t1408r1088b1462],
10	Loushin	NNP	PERSON	Loushin	nn	11	SENT_220	[p15l1116t1407r1330b1453],
11	C	NNP	O	C	appos	2	SENT_220	[p15l1357t1407r1412b1462],
12	,	,	O	,	_	0	SENT_220	[p15l1357t1407r1412b1462],
13	Isner	NNP	PERSON	Isner	nn	14	SENT_220	[p15l1440t1408r1571b1453],
14	JM	NN	O	jm	appos	2	SENT_220	[p15l1595t1408r1691b1454],
15	.	.	O	.	_	0	SENT_220	[p15l1595t1408r1691b1454],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_221	[p15l1720t1407r2069b1453],
2	of	IN	O	of	_	0	SENT_221	[p15l2095t1407r2152b1453],
3	92-kD	JJ	O	92-kd	amod	4	SENT_221	[p15l13t1484r176b1531],
4	gelatinase	NN	O	gelatinase	prep_of	1	SENT_221	[p15l196t1484r455b1543],
5	in	IN	O	in	_	0	SENT_221	[p15l473t1484r522b1529],
6	human	JJ	O	human	amod	9	SENT_221	[p15l539t1484r716b1530],
7	coronary	JJ	O	coronary	amod	9	SENT_221	[p15l733t1498r964b1543],
8	atherosclerotic	JJ	O	atherosclerotic	amod	9	SENT_221	[p15l983t1484r1365b1530],
9	lesions	NNS	O	lesion	prep_in	1	SENT_221	[p15l1383t1484r1577b1530],
10	.	.	O	.	_	0	SENT_221	[p15l1383t1484r1577b1530],

1	Association	NNP	O	Association	_	0	SENT_222	[p15l1597t1484r1905b1530],
2	of	IN	O	of	_	0	SENT_222	[p15l1923t1484r1980b1530],
3	active	JJ	O	active	amod	5	SENT_222	[p15l1993t1484r2147b1530],
4	enzyme	NN	O	enzyme	nn	5	SENT_222	[p15l12t1575r214b1620],
5	synthesis	NN	O	synthesis	prep_of	1	SENT_222	[p15l240t1560r475b1620],
6	with	IN	O	with	_	0	SENT_222	[p15l501t1560r615b1607],
7	unstable	JJ	O	unstable	amod	8	SENT_222	[p15l638t1560r855b1607],
8	angina	NN	O	angina	prep_with	1	SENT_222	[p15l881t1560r1066b1620],
9	.	.	O	.	_	0	SENT_222	[p15l881t1560r1066b1620],

1	Circulation	NN	O	circulation	_	0	SENT_223	[p15l1096t1560r1392b1607],
2	1995	CD	DATE	1995	num	1	SENT_223	[p15l1423t1560r1957b1615],
3	;	:	O	;	_	0	SENT_223	[p15l1423t1560r1957b1615],
4	91:2125	CD	DURATION	91:2125	number	5	SENT_223	[p15l1423t1560r1957b1615],
5	-2131	CD	DURATION	-2131	dep	1	SENT_223	[p15l1423t1560r1957b1615],
6	.	.	O	.	_	0	SENT_223	[p15l1423t1560r1957b1615],

1	1	CD	NUMBER	1	num	2	SENT_224	[p15l19t1637r35b1684],
2	1	CD	NUMBER	1	_	0	SENT_224	[p15l55t1637r96b1685],
3	.	.	O	.	_	0	SENT_224	[p15l55t1637r96b1685],

1	Nikkari	NNP	ORGANIZATION	Nikkari	_	0	SENT_225	[p15l115t1638r313b1685],
2	ST	JJ	ORGANIZATION	st	dep	1	SENT_225	[p15l332t1638r419b1693],
3	,	,	O	,	_	0	SENT_225	[p15l332t1638r419b1693],
4	O’Brien	NN	O	o’brien	nn	5	SENT_225	[p15l439t1638r652b1685],
5	KD	NN	O	kd	appos	2	SENT_225	[p15l669t1639r775b1693],
6	,	,	O	,	_	0	SENT_225	[p15l669t1639r775b1693],
7	Furguson	NN	O	furguson	nn	8	SENT_225	[p15l794t1639r1041b1698],
8	M	NN	O	m	appos	2	SENT_225	[p15l1056t1639r1128b1692],
9	,	,	O	,	_	0	SENT_225	[p15l1056t1639r1128b1692],
10	Hatsukami	NNP	ORGANIZATION	Hatsukami	nn	11	SENT_225	[p15l1147t1638r1429b1684],
11	T	NN	ORGANIZATION	t	appos	2	SENT_225	[p15l1446t1639r1499b1693],
12	,	,	O	,	_	0	SENT_225	[p15l1446t1639r1499b1693],
13	Welgus	NNP	O	Welgus	nn	14	SENT_225	[p15l1517t1638r1715b1698],
14	HG	NNP	O	HG	appos	2	SENT_225	[p15l1733t1638r1840b1692],
15	,	,	O	,	_	0	SENT_225	[p15l1733t1638r1840b1692],
16	Aplers	NNP	O	Aplers	nn	17	SENT_225	[p15l1859t1638r2031b1698],
17	CE	NNP	O	CE	appos	2	SENT_225	[p15l2050t1638r2145b1693],
18	,	,	O	,	_	0	SENT_225	[p15l2050t1638r2145b1693],
19	Clowes	NNP	O	Clowes	nn	20	SENT_225	[p15l13t1715r205b1761],
20	AW	NNP	O	AW	appos	2	SENT_225	[p15l245t1715r366b1761],
21	.	.	O	.	_	0	SENT_225	[p15l245t1715r366b1761],

1	Interstitial	JJ	O	interstitial	amod	2	SENT_226	[p15l408t1715r676b1761],
2	collagenase	NN	O	collagenase	_	0	SENT_226	[p15l715t1715r1019b1774],
3	(	CD	NUMBER	(	num	6	SENT_226	[p15l1060t1715r1305b1772],
4	MMP-1	NN	O	mmp-1	nn	6	SENT_226	[p15l1060t1715r1305b1772],
5	)	NN	O	)	nn	6	SENT_226	[p15l1060t1715r1305b1772],
6	expression	NN	O	expression	dep	2	SENT_226	[p15l1347t1715r1625b1774],
7	in	IN	O	in	_	0	SENT_226	[p15l1664t1715r1713b1760],
8	human	JJ	O	human	amod	10	SENT_226	[p15l1751t1715r1928b1761],
9	carotid	NN	O	carotid	nn	10	SENT_226	[p15l1967t1715r2148b1761],
10	atherosclerosis	NN	O	atherosclerosis	prep_in	6	SENT_226	[p15l13t1792r413b1838],
11	.	.	O	.	_	0	SENT_226	[p15l13t1792r413b1838],

1	Circulation	NN	O	circulation	nn	2	SENT_227	[p15l443t1792r740b1838],
2	l995	NN	O	l995	_	0	SENT_227	[p15l771t1792r1304b1846],
3	;	:	O	;	_	0	SENT_227	[p15l771t1792r1304b1846],
4	92:1393	CD	NUMBER	92:1393	number	5	SENT_227	[p15l771t1792r1304b1846],
5	—	CD	NUMBER	—	dep	2	SENT_227	[p15l771t1792r1304b1846],
6	1398	CD	DATE	1398	dep	5	SENT_227	[p15l771t1792r1304b1846],
7	.	.	O	.	_	0	SENT_227	[p15l771t1792r1304b1846],

1	12	CD	NUMBER	12	_	0	SENT_228	[p15l19t1867r96b1916],
2	.	.	O	.	_	0	SENT_228	[p15l19t1867r96b1916],

1	Ye	NNP	O	Ye	nn	2	SENT_229	[p15l126t1870r200b1915],
2	S	NNP	O	S	_	0	SENT_229	[p15l229t1869r276b1924],
3	,	,	O	,	_	0	SENT_229	[p15l229t1869r276b1924],
4	Eriksson	NNP	PERSON	Eriksson	nn	5	SENT_229	[p15l306t1869r534b1915],
5	P	NN	PERSON	p	appos	2	SENT_229	[p15l561t1870r610b1924],
6	,	,	O	,	_	0	SENT_229	[p15l561t1870r610b1924],
7	Hamsten	NN	O	hamsten	nn	8	SENT_229	[p15l640t1870r871b1915],
8	A	NN	O	a	appos	5	SENT_229	[p15l899t1870r958b1924],
9	,	,	O	,	_	0	SENT_229	[p15l899t1870r958b1924],
10	Kurkinen	NN	O	kurkinen	nn	11	SENT_229	[p15l989t1869r1234b1915],
11	M	NN	O	m	appos	5	SENT_229	[p15l1261t1870r1332b1924],
12	,	,	O	,	_	0	SENT_229	[p15l1261t1870r1332b1924],
13	Humphries	NNP	ORGANIZATION	Humphries	nn	14	SENT_229	[p15l1362t1869r1650b1929],
14	SE	NN	ORGANIZATION	se	appos	5	SENT_229	[p15l1681t1870r1768b1924],
15	,	,	O	,	_	0	SENT_229	[p15l1681t1870r1768b1924],
16	Henney	NNP	PERSON	Henney	nn	17	SENT_229	[p15l1797t1870r1999b1929],
17	AM	NNP	O	AM	appos	5	SENT_229	[p15l2027t1870r2144b1915],
18	.	.	O	.	_	0	SENT_229	[p15l2027t1870r2144b1915],

1	Progression	NN	O	progression	nsubjpass	6	SENT_230	[p15l11t1946r320b2006],
2	of	IN	O	of	_	0	SENT_230	[p15l352t1946r409b1992],
3	coronary	JJ	O	coronary	amod	4	SENT_230	[p15l437t1960r667b2005],
4	atherosclerosis	NN	O	atherosclerosis	prep_of	1	SENT_230	[p15l701t1946r1087b1992],
5	is	VBZ	O	be	auxpass	6	SENT_230	[p15l1120t1946r1160b1992],
6	associated	VBN	O	associate	_	0	SENT_230	[p15l1195t1946r1463b1992],
7	with	IN	O	with	_	0	SENT_230	[p15l1494t1946r1609b1992],
8	a	DT	O	a	det	11	SENT_230	[p15l1641t1960r1669b1992],
9	common	JJ	O	common	amod	11	SENT_230	[p15l1700t1960r1927b1992],
10	genetic	JJ	O	genetic	amod	11	SENT_230	[p15l1960t1946r2146b2006],
11	variant	NN	O	variant	prep_with	6	SENT_230	[p15l12t2023r194b2070],
12	of	IN	O	of	_	0	SENT_230	[p15l227t2023r284b2070],
13	the	DT	O	the	det	16	SENT_230	[p15l314t2023r392b2070],
14	human	JJ	O	human	amod	16	SENT_230	[p15l426t2023r604b2070],
15	stromelysin-1	NN	O	stromelysin-1	nn	16	SENT_230	[p15l640t2023r991b2083],
16	promoter	NN	O	promoter	prep_of	11	SENT_230	[p15l1030t2031r1271b2083],
17	which	WDT	O	which	nsubj	18	SENT_230	[p15l1305t2023r1464b2070],
18	results	VBZ	O	result	rcmod	16	SENT_230	[p15l1497t2023r1665b2070],
19	in	IN	O	in	_	0	SENT_230	[p15l1702t2023r1751b2069],
20	reduced	VBN	O	reduce	amod	22	SENT_230	[p15l1784t2023r1992b2070],
21	gene	NN	O	gene	nn	22	SENT_230	[p15l2026t2038r2148b2083],
22	expression	NN	O	expression	prep_in	18	SENT_230	[p15l12t2100r304b2160],
23	.	.	O	.	_	0	SENT_230	[p15l12t2100r304b2160],

1	J	NNP	O	J	nn	3	SENT_231	[p15l329t2102r362b2147],
2	Biol	NNP	O	Biol	nn	3	SENT_231	[p15l380t2100r491b2146],
3	Chem	NNP	O	Chem	_	0	SENT_231	[p15l516t2100r664b2147],
4	1996	CD	DATE	1996	num	3	SENT_231	[p15l694t2100r1326b2155],
5	;	:	O	;	_	0	SENT_231	[p15l694t2100r1326b2155],
6	271:13055	CD	NUMBER	271:13055	number	7	SENT_231	[p15l694t2100r1326b2155],
7	—	CD	NUMBER	—	dep	3	SENT_231	[p15l694t2100r1326b2155],
8	13060	CD	NUMBER	13060	dep	7	SENT_231	[p15l694t2100r1326b2155],
9	.	.	O	.	_	0	SENT_231	[p15l694t2100r1326b2155],

1	13	CD	NUMBER	13	_	0	SENT_232	[p15l19t2174r96b2224],
2	.	.	O	.	_	0	SENT_232	[p15l19t2174r96b2224],

1	Ye	NN	O	ye	nn	2	SENT_233	[p15l118t2178r193b2223],
2	S	NN	O	s	_	0	SENT_233	[p15l214t2177r261b2231],
3	,	,	O	,	_	0	SENT_233	[p15l214t2177r261b2231],
4	Watts	NNP	ORGANIZATION	Watts	nn	5	SENT_233	[p15l283t2178r434b2223],
5	GF	NN	ORGANIZATION	gf	appos	2	SENT_233	[p15l456t2177r551b2231],
6	,	,	O	,	_	0	SENT_233	[p15l456t2177r551b2231],
7	Mandalia	NNP	LOCATION	Mandalia	nn	8	SENT_233	[p15l573t2177r820b2223],
8	S	NNP	LOCATION	S	appos	2	SENT_233	[p15l841t2177r888b2231],
9	,	,	O	,	_	0	SENT_233	[p15l841t2177r888b2231],
10	Humphries	NNP	ORGANIZATION	Humphries	nn	11	SENT_233	[p15l911t2177r1199b2236],
11	SE	NN	ORGANIZATION	se	appos	2	SENT_233	[p15l1222t2177r1309b2231],
12	,	,	O	,	_	0	SENT_233	[p15l1222t2177r1309b2231],
13	Henney	NNP	PERSON	Henney	nn	14	SENT_233	[p15l1332t2178r1533b2236],
14	AM	NNP	O	AM	appos	2	SENT_233	[p15l1554t2177r1671b2223],
15	.	.	O	.	_	0	SENT_233	[p15l1554t2177r1671b2223],

1	Genetic	JJ	O	genetic	amod	2	SENT_234	[p15l1695t2177r1895b2223],
2	variation	NN	O	variation	nsubjpass	9	SENT_234	[p15l1916t2177r2148b2223],
3	in	IN	O	in	_	0	SENT_234	[p15l12t2254r61b2300],
4	the	DT	O	the	det	7	SENT_234	[p15l88t2254r167b2301],
5	human	JJ	O	human	amod	7	SENT_234	[p15l194t2254r372b2301],
6	stromelysin	NN	O	stromelysin	nn	7	SENT_234	[p15l401t2254r703b2314],
7	promoter	NN	O	promoter	prep_in	2	SENT_234	[p15l729t2261r971b2314],
8	is	VBZ	O	be	auxpass	9	SENT_234	[p15l997t2254r1037b2301],
9	associated	VBN	O	associate	_	0	SENT_234	[p15l1067t2254r1335b2301],
10	with	IN	O	with	_	0	SENT_234	[p15l1361t2254r1477b2301],
11	progression	NN	O	progression	prep_with	9	SENT_234	[p15l1503t2254r1808b2314],
12	of	IN	O	of	_	0	SENT_234	[p15l1837t2254r1893b2301],
13	coronary	JJ	O	coronary	amod	14	SENT_234	[p15l1917t2269r2147b2314],
14	atherosclerosis	NN	O	atherosclerosis	prep_of	11	SENT_234	[p15l13t2331r413b2377],
15	.	.	O	.	_	0	SENT_234	[p15l13t2331r413b2377],

1	Br	NN	O	br	nn	3	SENT_235	[p15l438t2332r507b2376],
2	Heart	NNP	O	Heart	nn	3	SENT_235	[p15l526t2333r681b2377],
3	J	NNP	O	J	_	0	SENT_235	[p15l701t2333r734b2377],
4	1995	CD	DATE	1995	num	3	SENT_235	[p15l760t2331r1235b2385],
5	;	:	O	;	_	0	SENT_235	[p15l760t2331r1235b2385],
6	73:209	CD	NUMBER	73:209	number	7	SENT_235	[p15l760t2331r1235b2385],
7	-215	CD	NUMBER	-215	dep	3	SENT_235	[p15l760t2331r1235b2385],
8	.	.	O	.	_	0	SENT_235	[p15l760t2331r1235b2385],

1	14	CD	NUMBER	14	_	0	SENT_236	[p15l19t2406r96b2454],
2	.	.	O	.	_	0	SENT_236	[p15l19t2406r96b2454],

1	Humphries	NNP	O	Humphries	nn	2	SENT_237	[p15l118t2408r406b2467],
2	SE	NN	O	se	nsubj	36	SENT_237	[p15l430t2408r517b2462],
3	,	,	O	,	_	0	SENT_237	[p15l430t2408r517b2462],
4	Luong	NNP	ORGANIZATION	Luong	nn	5	SENT_237	[p15l539t2409r708b2468],
5	LA	NNP	ORGANIZATION	LA	dep	25	SENT_237	[p15l729t2408r829b2462],
6	,	,	O	,	_	0	SENT_237	[p15l729t2408r829b2462],
7	Talmud	NNP	ORGANIZATION	Talmud	nn	8	SENT_237	[p15l851t2408r1054b2454],
8	PJ	NNP	ORGANIZATION	PJ	appos	5	SENT_237	[p15l1074t2409r1148b2462],
9	,	,	O	,	_	0	SENT_237	[p15l1074t2409r1148b2462],
10	Frick	NNP	ORGANIZATION	Frick	nn	11	SENT_237	[p15l1170t2408r1308b2454],
11	MH	NNP	ORGANIZATION	MH	appos	5	SENT_237	[p15l1327t2409r1445b2462],
12	,	,	O	,	_	0	SENT_237	[p15l1327t2409r1445b2462],
13	Kesaniemi	NNP	LOCATION	Kesaniemi	appos	5	SENT_237	[p15l1469t2408r1761b2462],
14	,	,	O	,	_	0	SENT_237	[p15l1469t2408r1761b2462],
15	Pasternack	NNP	PERSON	Pasternack	nn	16	SENT_237	[p15l1783t2408r2067b2454],
16	A	NNP	O	A	appos	5	SENT_237	[p15l2086t2408r2145b2462],
17	,	,	O	,	_	0	SENT_237	[p15l2086t2408r2145b2462],
18	Taskinen	NNP	PERSON	Taskinen	nn	19	SENT_237	[p15l12t2485r251b2532],
19	MR	NN	PERSON	mr	appos	5	SENT_237	[p15l280t2486r395b2540],
20	,	,	O	,	_	0	SENT_237	[p15l280t2486r395b2540],
21	Syvanne	NNP	O	Syvanne	nn	22	SENT_237	[p15l429t2486r651b2545],
22	M.	NNP	O	M.	appos	5	SENT_237	[p15l680t2486r751b2532],
23	The	NNP	O	The	nn	24	SENT_237	[p15l783t2485r883b2532],
24	5A/6A	NNP	O	5A/6A	dep	25	SENT_237	[p15l915t2485r1090b2532],
25	polymorphism	NN	O	polymorphism	dep	36	SENT_237	[p15l1119t2485r1502b2545],
26	in	IN	O	in	_	0	SENT_237	[p15l1531t2485r1580b2531],
27	the	DT	O	the	det	28	SENT_237	[p15l1610t2485r1688b2532],
28	promoter	NN	O	promoter	prep_in	25	SENT_237	[p15l1717t2492r1958b2545],
29	of	IN	O	of	_	0	SENT_237	[p15l1987t2485r2044b2532],
30	the	DT	O	the	det	31	SENT_237	[p15l2069t2485r2147b2532],
31	stromelysin-1	NN	O	stromelysin-1	prep_of	28	SENT_237	[p15l14t2562r365b2622],
32	(	CD	NUMBER	(	num	35	SENT_237	[p15l409t2562r655b2619],
33	MMP-3	NN	O	mmp-3	nn	35	SENT_237	[p15l409t2562r655b2619],
34	)	NN	O	)	nn	35	SENT_237	[p15l409t2562r655b2619],
35	gene	NN	O	gene	nsubj	36	SENT_237	[p15l693t2576r814b2622],
36	predicts	VBZ	O	predict	_	0	SENT_237	[p15l850t2562r1055b2622],
37	progression	NN	O	progression	nsubj	43	SENT_237	[p15l1091t2562r1397b2622],
38	of	IN	O	of	_	0	SENT_237	[p15l1433t2562r1490b2608],
39	angiographically	RB	O	angiographically	advmod	40	SENT_237	[p15l1522t2562r1960b2622],
40	determined	VBN	O	determine	amod	42	SENT_237	[p15l1997t2562r2145b2608, p15l12t2639r175b2685],
41	coronary	JJ	O	coronary	amod	42	SENT_237	[p15l197t2653r427b2698],
42	artery	NN	O	artery	prep_of	37	SENT_237	[p15l451t2646r600b2698],
43	disease	NN	O	disease	xcomp	36	SENT_237	[p15l623t2639r810b2685],
44	in	IN	O	in	_	0	SENT_237	[p15l832t2639r882b2684],
45	men	NNS	O	man	prep_in	43	SENT_237	[p15l904t2653r1015b2685],
46	in	IN	O	in	_	0	SENT_237	[p15l1037t2639r1086b2684],
47	the	DT	O	the	det	50	SENT_237	[p15l1108t2639r1186b2685],
48	LOCAT	NN	O	locat	nn	50	SENT_237	[p15l1208t2639r1426b2685],
49	gemﬁbrozil	NN	O	gemﬁbrozil	nn	50	SENT_237	[p15l1448t2639r1748b2699],
50	study	NN	O	study	prep_in	45	SENT_237	[p15l1773t2639r1924b2698],
51	.	.	O	.	_	0	SENT_237	[p15l1773t2639r1924b2698],

1	Atherosclerosis	NN	O	atherosclerosis	nn	2	SENT_238	[p15l1945t2639r2145b2685, p15l12t2715r239b2761],
2	l998	NN	O	l998	_	0	SENT_238	[p15l269t2715r713b2769],
3	;	:	O	;	_	0	SENT_238	[p15l269t2715r713b2769],
4	139:49	CD	NUMBER	139:49	number	5	SENT_238	[p15l269t2715r713b2769],
5	—	CD	NUMBER	—	dep	2	SENT_238	[p15l269t2715r713b2769],
6	56	CD	NUMBER	56	dep	5	SENT_238	[p15l269t2715r713b2769],
7	.	.	O	.	_	0	SENT_238	[p15l269t2715r713b2769],

1	15	CD	NUMBER	15	_	0	SENT_239	[p15l19t2792r96b2840],
2	.	.	O	.	_	0	SENT_239	[p15l19t2792r96b2840],

1	Kobashigawa	NNP	O	Kobashigawa	nn	2	SENT_240	[p15l116t2793r472b2853],
2	JA	NNP	O	JA	_	0	SENT_240	[p15l488t2793r573b2847],
3	,	,	O	,	_	0	SENT_240	[p15l488t2793r573b2847],
4	Katznelson	NNP	PERSON	Katznelson	nn	5	SENT_240	[p15l594t2793r887b2839],
5	S	NNP	O	S	appos	2	SENT_240	[p15l906t2793r952b2847],
6	,	,	O	,	_	0	SENT_240	[p15l906t2793r952b2847],
7	Laks	NNP	PERSON	Laks	nn	8	SENT_240	[p15l972t2793r1096b2839],
8	H	NNP	O	H	appos	5	SENT_240	[p15l1116t2794r1175b2847],
9	,	,	O	,	_	0	SENT_240	[p15l1116t2794r1175b2847],
10	Johnson	NNP	PERSON	Johnson	nn	11	SENT_240	[p15l1194t2793r1408b2839],
11	JA	NNP	O	JA	appos	5	SENT_240	[p15l1425t2793r1510b2847],
12	,	,	O	,	_	0	SENT_240	[p15l1425t2793r1510b2847],
13	Yeatman	NNP	PERSON	Yeatman	nn	14	SENT_240	[p15l1531t2794r1765b2839],
14	L	NNP	PERSON	L	appos	5	SENT_240	[p15l1782t2794r1835b2848],
15	,	,	O	,	_	0	SENT_240	[p15l1782t2794r1835b2848],
16	Wang	NNP	ORGANIZATION	Wang	nn	17	SENT_240	[p15l1854t2794r2009b2853],
17	XM	NNP	ORGANIZATION	XM	appos	5	SENT_240	[p15l2026t2794r2145b2847],
18	,	,	O	,	_	0	SENT_240	[p15l2026t2794r2145b2847],
19	Chia	NNP	PERSON	Chia	nn	20	SENT_240	[p15l13t2869r135b2916],
20	D	NNP	PERSON	D	appos	5	SENT_240	[p15l151t2871r211b2924],
21	,	,	O	,	_	0	SENT_240	[p15l151t2871r211b2924],
22	Terasaki	NNP	PERSON	Terasaki	nn	23	SENT_240	[p15l230t2869r453b2916],
23	PI	NN	O	pi	appos	5	SENT_240	[p15l470t2871r541b2924],
24	,	,	O	,	_	0	SENT_240	[p15l470t2871r541b2924],
25	Sabad	NNP	LOCATION	Sabad	nn	26	SENT_240	[p15l562t2870r719b2916],
26	A	NNP	O	A	appos	5	SENT_240	[p15l735t2870r795b2924],
27	,	,	O	,	_	0	SENT_240	[p15l735t2870r795b2924],
28	Cogert	NNP	O	Cogert	nn	29	SENT_240	[p15l815t2870r992b2929],
29	GA.	NNP	O	GA.	appos	5	SENT_240	[p15l1009t2870r1114b2916],
30	.	.	O	.	_	0	SENT_240	[p15l1009t2870r1114b2916],

1	Effect	NN	O	effect	_	0	SENT_241	[p15l1134t2869r1294b2916],
2	of	IN	O	of	_	0	SENT_241	[p15l1310t2869r1366b2916],
3	pravastatin	NN	O	pravastatin	prep_of	1	SENT_241	[p15l1378t2869r1665b2929],
4	on	IN	O	on	_	0	SENT_241	[p15l1682t2884r1745b2916],
5	outcomes	NNS	O	outcome	prep_on	1	SENT_241	[p15l1763t2877r2010b2916],
6	after	IN	O	after	_	0	SENT_241	[p15l2030t2869r2149b2916],
7	cardiac	JJ	O	cardiac	amod	8	SENT_241	[p15l12t2947r198b2994],
8	transplantation	NN	O	transplantation	prep_after	5	SENT_241	[p15l223t2947r625b3007],
9	.	.	O	.	_	0	SENT_241	[p15l223t2947r625b3007],

1	N	NN	O	n	nn	3	SENT_242	[p15l649t2949r699b2994],
2	Engl	NNP	O	Engl	nn	3	SENT_242	[p15l716t2947r840b3006],
3	J	NNP	O	J	nsubj	4	SENT_242	[p15l861t2949r895b2994],
4	Med	VBD	O	med	_	0	SENT_242	[p15l911t2947r1031b2994],
5	1995	CD	DATE	1995	dobj	4	SENT_242	[p15l1058t2947r1179b2994],
6	;	:	O	;	_	0	SENT_242	[p15l1188t2947r1567b3002],
7	333:621	CD	NUMBER	333:621	num	8	SENT_242	[p15l1188t2947r1567b3002],
8	-627	CD	NUMBER	-627	dep	5	SENT_242	[p15l1188t2947r1567b3002],
9	.	.	O	.	_	0	SENT_242	[p15l1188t2947r1567b3002],

1	16	CD	NUMBER	16	_	0	SENT_243	[p15l19t3022r96b3071],
2	.	.	O	.	_	0	SENT_243	[p15l19t3022r96b3071],

1	Smeets	NNS	O	smeet	nn	2	SENT_244	[p15l126t3024r311b3071],
2	B	NN	O	b	nsubj	24	SENT_244	[p15l339t3025r394b3078],
3	,	,	O	,	_	0	SENT_244	[p15l339t3025r394b3078],
4	Poddighe	NNP	PERSON	Poddighe	nn	5	SENT_244	[p15l423t3024r669b3084],
5	J	NNP	PERSON	J	appos	2	SENT_244	[p15l695t3025r719b3071],
6	,	,	O	,	_	0	SENT_244	[p15l724t3062r734b3078],
7	Brunner	NNP	PERSON	Brunner	nn	8	SENT_244	[p15l762t3025r977b3070],
8	H	NNP	O	H	appos	2	SENT_244	[p15l1002t3025r1061b3079],
9	,	,	O	,	_	0	SENT_244	[p15l1002t3025r1061b3079],
10	Ropers	NNP	O	Ropers	nn	11	SENT_244	[p15l1090t3025r1273b3084],
11	HH	NNP	O	HH	appos	2	SENT_244	[p15l1301t3025r1407b3078],
12	,	,	O	,	_	0	SENT_244	[p15l1301t3025r1407b3078],
13	Wieringa	NNP	PERSON	Wieringa	nn	16	SENT_244	[p15l1435t3024r1680b3084],
14	B.	NNP	O	B.	nn	16	SENT_244	[p15l1705t3025r1760b3070],
15	Tight	NNP	O	Tight	nn	16	SENT_244	[p15l1790t3024r1931b3084],
16	linkage	NN	O	linkage	appos	2	SENT_244	[p15l1956t3024r2147b3084],
17	between	IN	O	between	_	0	SENT_244	[p15l11t3101r229b3147],
18	myotonic	JJ	O	myotonic	amod	19	SENT_244	[p15l257t3100r502b3160],
19	dystrophy	NN	O	dystrophy	prep_between	16	SENT_244	[p15l532t3100r792b3160],
20	and	CC	O	and	_	0	SENT_244	[p15l822t3100r914b3147],
21	apolipoprotein	NN	O	apolipoprotein	nn	23	SENT_244	[p15l943t3100r1322b3160],
22	E	NN	O	e	nn	23	SENT_244	[p15l1351t3102r1389b3146],
23	genes	NNS	O	gene	conj_and	19	SENT_244	[p15l1418t3115r1564b3160],
24	revealed	VBD	O	reveal	_	0	SENT_244	[p15l1593t3100r1815b3147],
25	with	IN	O	with	_	0	SENT_244	[p15l1842t3100r1957b3147],
26	allelespeciﬁc	JJ	O	allelespeciﬁc	amod	27	SENT_244	[p15l1987t3100r2145b3147, p15l14t3178r210b3238],
27	oligonucleotides	NNS	O	oligonucleotide	prep_with	24	SENT_244	[p15l235t3178r679b3238],
28	.	.	O	.	_	0	SENT_244	[p15l235t3178r679b3238],

1	Human	JJ	O	human	amod	2	SENT_245	[p15l704t3180r897b3224],
2	Genet	NNP	PERSON	Genet	_	0	SENT_245	[p15l924t3179r1078b3225],
3	l988	CD	NUMBER	l988	dep	2	SENT_245	[p15l1106t3178r1395b3233],
4	;	:	O	;	_	0	SENT_245	[p15l1106t3178r1395b3233],
5	80:49	CD	NUMBER	80:49	num	6	SENT_245	[p15l1106t3178r1395b3233],
6	-52	CD	NUMBER	-52	dep	2	SENT_245	[p15l1405t3178r1516b3225],
7	.	.	O	.	_	0	SENT_245	[p15l1405t3178r1516b3225],

1	17	CD	NUMBER	17	_	0	SENT_246	[p15l19t3254r96b3302],
2	.	.	O	.	_	0	SENT_246	[p15l19t3254r96b3302],

1	Luc	NN	PERSON	luc	nn	2	SENT_247	[p15l121t3256r221b3301],
2	G	NN	PERSON	g	_	0	SENT_247	[p15l245t3255r304b3310],
3	,	,	O	,	_	0	SENT_247	[p15l245t3255r304b3310],
4	Bard	NNP	PERSON	Bard	nn	5	SENT_247	[p15l330t3255r456b3301],
5	J-M	NNP	PERSON	J-M	appos	2	SENT_247	[p15l478t3256r597b3309],
6	,	,	O	,	_	0	SENT_247	[p15l478t3256r597b3309],
7	Arveiler	NNP	ORGANIZATION	Arveiler	nn	8	SENT_247	[p15l622t3255r841b3301],
8	D	NNP	ORGANIZATION	D	appos	2	SENT_247	[p15l862t3256r922b3309],
9	,	,	O	,	_	0	SENT_247	[p15l862t3256r922b3309],
10	Evans	NNP	PERSON	Evans	nn	11	SENT_247	[p15l947t3256r1105b3301],
11	A	NNP	O	A	appos	2	SENT_247	[p15l1129t3255r1189b3309],
12	,	,	O	,	_	0	SENT_247	[p15l1129t3255r1189b3309],
13	Cambou	NNP	O	Cambou	nn	14	SENT_247	[p15l1215t3255r1435b3301],
14	JP	NNP	O	JP	appos	2	SENT_247	[p15l1458t3256r1532b3309],
15	,	,	O	,	_	0	SENT_247	[p15l1458t3256r1532b3309],
16	Bingham	NNP	PERSON	Bingham	nn	17	SENT_247	[p15l1558t3255r1798b3315],
17	A	NNP	O	A	appos	2	SENT_247	[p15l1820t3255r1880b3310],
18	,	,	O	,	_	0	SENT_247	[p15l1820t3255r1880b3310],
19	Amouyel	NNP	ORGANIZATION	Amouyel	nn	20	SENT_247	[p15l1905t3255r2147b3315],
20	P	NN	ORGANIZATION	p	appos	2	SENT_247	[p15l12t3333r61b3386],
21	,	,	O	,	_	0	SENT_247	[p15l12t3333r61b3386],
22	Schaffer	NNP	PERSON	Schaffer	nn	23	SENT_247	[p15l91t3331r311b3378],
23	P	NN	PERSON	p	appos	2	SENT_247	[p15l335t3333r384b3386],
24	,	,	O	,	_	0	SENT_247	[p15l335t3333r384b3386],
25	Ruidavets	NN	O	ruidavet	nn	26	SENT_247	[p15l413t3331r672b3378],
26	JB	NN	O	jb	appos	2	SENT_247	[p15l699t3333r781b3386],
27	,	,	O	,	_	0	SENT_247	[p15l699t3333r781b3386],
28	Cambien	NNP	O	Cambien	nn	30	SENT_247	[p15l810t3331r1045b3378],
29	F.	NNP	O	F.	nn	30	SENT_247	[p15l1071t3333r1119b3378],
30	Impact	NNP	O	Impact	appos	2	SENT_247	[p15l1148t3333r1330b3391],
31	of	IN	O	of	_	0	SENT_247	[p15l1355t3331r1412b3378],
32	apolipoprotein	NN	O	apolipoprotein	nn	34	SENT_247	[p15l1435t3331r1815b3391],
33	E	NN	O	e	nn	34	SENT_247	[p15l1840t3333r1879b3377],
34	polymorphism	NN	O	polymorphism	prep_of	30	SENT_247	[p15l1904t3331r2146b3391, p15l11t3409r171b3469],
35	on	IN	O	on	_	0	SENT_247	[p15l204t3424r267b3455],
36	lipoproteins	NNS	O	lipoprotein	prep_on	34	SENT_247	[p15l299t3409r610b3469],
37	and	CC	O	and	_	0	SENT_247	[p15l645t3409r737b3455],
38	risk	NN	O	risk	appos	2	SENT_247	[p15l768t3409r868b3455],
39	of	IN	O	of	_	0	SENT_247	[p15l899t3409r956b3455],
40	myocardial	JJ	O	myocardial	amod	41	SENT_247	[p15l984t3409r1277b3469],
41	infarction	NN	O	infarction	prep_of	38	SENT_247	[p15l1310t3409r1576b3455],
42	.	.	O	.	_	0	SENT_247	[p15l1310t3409r1576b3455],

1	The	DT	O	the	det	2	SENT_248	[p15l1612t3409r1712b3455],
2	ECTIM	NNP	O	ECTIM	_	0	SENT_248	[p15l1745t3409r1947b3456],
3	Study	NNP	O	Study	dep	2	SENT_248	[p15l1982t3409r2144b3469],
4	.	.	O	.	_	0	SENT_248	[p15l1982t3409r2144b3469],

1	Arterioscler	NNP	O	Arterioscler	nn	2	SENT_249	[p15l7t3486r330b3532],
2	Thromb	NNP	O	Thromb	_	0	SENT_249	[p15l354t3486r556b3532],
3	1994	CD	DATE	1994	num	2	SENT_249	[p15l587t3486r1120b3540],
4	;	:	O	;	_	0	SENT_249	[p15l587t3486r1120b3540],
5	14:14	CD	NUMBER	14:14	num	6	SENT_249	[p15l587t3486r1120b3540],
6	l2-1419	NN	O	l2-1419	dep	2	SENT_249	[p15l587t3486r1120b3540],
7	.	.	O	.	_	0	SENT_249	[p15l587t3486r1120b3540],

1	18	CD	NUMBER	18	_	0	SENT_250	[p15l19t3560r96b3609],
2	.	.	O	.	_	0	SENT_250	[p15l19t3560r96b3609],

1	Jukema	NNP	O	Jukema	nn	2	SENT_251	[p15l123t3563r323b3609],
2	JW	NNP	O	JW	_	0	SENT_251	[p15l347t3564r447b3617],
3	,	,	O	,	_	0	SENT_251	[p15l347t3564r447b3617],
4	van	NNP	PERSON	van	nn	6	SENT_251	[p15l475t3577r567b3609],
5	Boven	NNP	PERSON	Boven	nn	6	SENT_251	[p15l593t3564r762b3609],
6	AJ	NNP	PERSON	AJ	appos	2	SENT_251	[p15l788t3563r873b3617],
7	,	,	O	,	_	0	SENT_251	[p15l788t3563r873b3617],
8	Groenemeijer	NNP	O	Groenemeijer	nn	9	SENT_251	[p15l901t3562r1260b3622],
9	B	NNP	O	B	appos	6	SENT_251	[p15l1285t3564r1341b3617],
10	,	,	O	,	_	0	SENT_251	[p15l1285t3564r1341b3617],
11	Zwinderman	NNP	O	Zwinderman	nn	12	SENT_251	[p15l1368t3562r1702b3609],
12	AH	NNP	O	AH	appos	6	SENT_251	[p15l1727t3563r1834b3617],
13	,	,	O	,	_	0	SENT_251	[p15l1727t3563r1834b3617],
14	Reiber	NNP	PERSON	Reiber	nn	15	SENT_251	[p15l1862t3562r2036b3609],
15	JH	NNP	O	JH	appos	6	SENT_251	[p15l2060t3564r2145b3617],
16	,	,	O	,	_	0	SENT_251	[p15l2060t3564r2145b3617],
17	Bruschke	NNP	O	Bruschke	nn	18	SENT_251	[p15l12t3640r258b3686],
18	AV	NNP	O	AV	appos	6	SENT_251	[p15l275t3641r383b3695],
19	,	,	O	,	_	0	SENT_251	[p15l275t3641r383b3695],
20	Henneman	NNP	PERSON	Henneman	nn	21	SENT_251	[p15l403t3641r685b3686],
21	JA	NNP	O	JA	appos	6	SENT_251	[p15l702t3641r788b3695],
22	,	,	O	,	_	0	SENT_251	[p15l702t3641r788b3695],
23	Molhoek	NNP	O	Molhoek	nn	24	SENT_251	[p15l808t3640r1045b3686],
24	GP	NNP	O	GP	appos	6	SENT_251	[p15l1062t3640r1157b3695],
25	,	,	O	,	_	0	SENT_251	[p15l1062t3640r1157b3695],
26	Bruin	NNP	ORGANIZATION	Bruin	nn	27	SENT_251	[p15l1177t3640r1325b3686],
27	T	NN	ORGANIZATION	t	appos	6	SENT_251	[p15l1342t3641r1395b3695],
28	,	,	O	,	_	0	SENT_251	[p15l1342t3641r1395b3695],
29	Jansen	NNP	PERSON	Jansen	nn	30	SENT_251	[p15l1414t3641r1589b3687],
30	H	NNP	O	H	appos	6	SENT_251	[p15l1606t3641r1665b3695],
31	,	,	O	,	_	0	SENT_251	[p15l1606t3641r1665b3695],
32	Gagné	NNP	O	Gagné	nn	33	SENT_251	[p15l1686t3640r1855b3700],
33	E	NNP	O	E	appos	6	SENT_251	[p15l1872t3641r1925b3695],
34	,	,	O	,	_	0	SENT_251	[p15l1872t3641r1925b3695],
35	Hayden	NNP	PERSON	Hayden	nn	36	SENT_251	[p15l1945t3640r2148b3700],
36	MR	NN	PERSON	mr	appos	6	SENT_251	[p15l11t3718r126b3771],
37	,	,	O	,	_	0	SENT_251	[p15l11t3718r126b3771],
38	Kastelein	NNP	PERSON	Kastelein	nn	39	SENT_251	[p15l164t3717r409b3763],
39	JJ	NN	PERSON	jj	appos	6	SENT_251	[p15l443t3718r506b3763],
40	.	.	O	.	_	0	SENT_251	[p15l443t3718r506b3763],

1	The	DT	O	the	det	4	SENT_252	[p15l543t3717r644b3763],
2	Asp9	NN	O	asp9	nn	4	SENT_252	[p15l678t3717r807b3777],
3	Asn	NN	O	asn	nn	4	SENT_252	[p15l842t3717r946b3763],
4	mutation	NN	O	mutation	nsubjpass	11	SENT_252	[p15l980t3717r1212b3763],
5	in	IN	O	in	_	0	SENT_252	[p15l1246t3717r1296b3762],
6	the	DT	O	the	det	9	SENT_252	[p15l1330t3717r1408b3763],
7	lipoprotein	NN	O	lipoprotein	nn	9	SENT_252	[p15l1443t3717r1729b3777],
8	lipase	NN	O	lipase	nn	9	SENT_252	[p15l1764t3717r1915b3776],
9	gene	NN	O	gene	prep_in	4	SENT_252	[p15l1950t3731r2071b3777],
10	is	VBZ	O	be	auxpass	11	SENT_252	[p15l2106t3717r2146b3763],
11	associated	VBN	O	associate	_	0	SENT_252	[p16l13t15r281b62],
12	with	IN	O	with	_	0	SENT_252	[p16l310t15r425b62],
13	increased	VBN	O	increase	amod	14	SENT_252	[p16l456t15r702b62],
14	progression	NN	O	progression	prep_with	11	SENT_252	[p16l731t15r1036b75],
15	of	IN	O	of	_	0	SENT_252	[p16l1067t15r1124b62],
16	coronary	JJ	O	coronary	amod	17	SENT_252	[p16l1150t30r1381b75],
17	atherosclerosis	NN	O	atherosclerosis	prep_of	14	SENT_252	[p16l1413t15r1813b62],
18	.	.	O	.	_	0	SENT_252	[p16l1413t15r1813b62],

1	Circulation	NN	O	circulation	_	0	SENT_253	[p16l1849t15r2147b62],
2	1996	CD	DATE	1996	num	1	SENT_253	[p16l18t93r552b147],
3	;	:	O	;	_	0	SENT_253	[p16l18t93r552b147],
4	94:1913	CD	NUMBER	94:1913	number	5	SENT_253	[p16l18t93r552b147],
5	—	CD	NUMBER	—	dep	1	SENT_253	[p16l18t93r552b147],
6	1918	CD	DATE	1918	dep	5	SENT_253	[p16l18t93r552b147],
7	.	.	O	.	_	0	SENT_253	[p16l18t93r552b147],

1	19	CD	NUMBER	19	_	0	SENT_254	[p16l19t168r96b217],
2	.	.	O	.	_	0	SENT_254	[p16l19t168r96b217],

1	Kuivenhoven	NNP	O	Kuivenhoven	nn	2	SENT_255	[p16l121t170r472b216],
2	JA	NNP	O	JA	_	0	SENT_255	[p16l493t170r579b224],
3	,	,	O	,	_	0	SENT_255	[p16l493t170r579b224],
4	Jukema	NNP	O	Jukema	nn	5	SENT_255	[p16l603t170r803b216],
5	JW	NNP	O	JW	appos	2	SENT_255	[p16l823t171r924b224],
6	,	,	O	,	_	0	SENT_255	[p16l823t171r924b224],
7	Zwinderman	NNP	O	Zwinderman	nn	8	SENT_255	[p16l947t170r1281b216],
8	AH	NNP	O	AH	appos	5	SENT_255	[p16l1303t170r1410b224],
9	,	,	O	,	_	0	SENT_255	[p16l1303t170r1410b224],
10	de	FW	O	de	nn	12	SENT_255	[p16l1435t170r1494b216],
11	Knijff	FW	O	knijff	nn	12	SENT_255	[p16l1518t170r1680b229],
12	P	NN	O	p	appos	5	SENT_255	[p16l1697t171r1746b224],
13	,	,	O	,	_	0	SENT_255	[p16l1697t171r1746b224],
14	McPherson	NN	PERSON	mcpherson	nn	15	SENT_255	[p16l1770t170r2067b216],
15	R	NN	PERSON	r	appos	5	SENT_255	[p16l2089t171r2145b224],
16	,	,	O	,	_	0	SENT_255	[p16l2089t171r2145b224],
17	Bruschke	NNP	ORGANIZATION	Bruschke	nn	18	SENT_255	[p16l12t246r258b291],
18	AVG	NNP	ORGANIZATION	AVG	appos	5	SENT_255	[p16l288t246r442b299],
19	,	,	O	,	_	0	SENT_255	[p16l288t246r442b299],
20	Lie	NN	O	lie	nn	21	SENT_255	[p16l475t245r561b291],
21	KI	NNP	O	KI	appos	5	SENT_255	[p16l593t247r673b300],
22	,	,	O	,	_	0	SENT_255	[p16l593t247r673b300],
23	Kastelein	NNP	PERSON	Kastelein	nn	24	SENT_255	[p16l706t245r952b291],
24	JJP	NNP	O	JJP	appos	5	SENT_255	[p16l981t247r1081b291],
25	.	.	O	.	_	0	SENT_255	[p16l981t247r1081b291],

1	The	DT	O	the	det	2	SENT_256	[p16l1114t246r1214b291],
2	role	NN	O	role	_	0	SENT_256	[p16l1244t245r1345b291],
3	of	IN	O	of	_	0	SENT_256	[p16l1376t245r1433b291],
4	a	DT	O	a	det	6	SENT_256	[p16l1460t260r1487b291],
5	common	JJ	O	common	amod	6	SENT_256	[p16l1517t260r1744b291],
6	Variant	JJ	O	variant	prep_of	2	SENT_256	[p16l1774t245r1956b291],
7	of	IN	O	of	_	0	SENT_256	[p16l1986t245r2043b291],
8	the	DT	O	the	det	13	SENT_256	[p16l2068t246r2147b291],
9	cholesteryl	NN	O	cholesteryl	nn	13	SENT_256	[p16l12t323r298b383],
10	ester	NN	O	ester	nn	13	SENT_256	[p16l321t330r444b369],
11	transfer	NN	O	transfer	nn	13	SENT_256	[p16l464t323r664b369],
12	protein	NN	O	protein	nn	13	SENT_256	[p16l684t323r869b383],
13	gene	NN	O	gene	prep_of	2	SENT_256	[p16l892t338r1013b383],
14	in	IN	O	in	_	0	SENT_256	[p16l1035t323r1085b369],
15	the	DT	O	the	det	16	SENT_256	[p16l1106t323r1184b369],
16	progression	NN	O	progression	prep_in	2	SENT_256	[p16l1206t323r1511b383],
17	of	IN	O	of	_	0	SENT_256	[p16l1533t323r1590b369],
18	coronary	JJ	O	coronary	amod	19	SENT_256	[p16l1608t338r1839b383],
19	atherosclerosis	NN	O	atherosclerosis	prep_of	16	SENT_256	[p16l1863t323r2145b369, p16l11t399r147b444],
20	.	.	O	.	_	0	SENT_256	[p16l1863t323r2145b369, p16l11t399r147b444],

1	N	NN	O	n	nn	3	SENT_257	[p16l172t400r221b445],
2	Engl	NNP	O	Engl	nn	3	SENT_257	[p16l239t399r363b457],
3	J	NNP	O	J	nsubj	4	SENT_257	[p16l384t400r417b445],
4	Med	VBD	O	med	_	0	SENT_257	[p16l434t399r554b444],
5	1998	CD	DATE	1998	dobj	4	SENT_257	[p16l581t399r1024b452],
6	;	:	O	;	_	0	SENT_257	[p16l581t399r1024b452],
7	338:86	CD	NUMBER	338:86	number	8	SENT_257	[p16l581t399r1024b452],
8	—	CD	NUMBER	—	dep	5	SENT_257	[p16l581t399r1024b452],
9	93	CD	NUMBER	93	dep	8	SENT_257	[p16l581t399r1024b452],
10	.	.	O	.	_	0	SENT_257	[p16l581t399r1024b452],

1	20	CD	NUMBER	20	_	0	SENT_258	[p16l13t473r96b522],
2	.	.	O	.	_	0	SENT_258	[p16l13t473r96b522],

1	De	NNP	PERSON	De	nn	3	SENT_259	[p16l129t476r204b521],
2	Maat	NNP	PERSON	Maat	nn	3	SENT_259	[p16l235t476r370b521],
3	MPM	NNP	LOCATION	MPM	nsubjpass	33	SENT_259	[p16l400t476r566b529],
4	,	,	O	,	_	0	SENT_259	[p16l400t476r566b529],
5	Kastelein	NNP	PERSON	Kastelein	nn	6	SENT_259	[p16l601t475r846b521],
6	JJP	NNP	O	JJP	appos	3	SENT_259	[p16l877t476r977b529],
7	,	,	O	,	_	0	SENT_259	[p16l877t476r977b529],
8	Jukema	NNP	O	Jukema	nn	9	SENT_259	[p16l1010t475r1211b521],
9	JW	NNP	O	JW	appos	3	SENT_259	[p16l1241t476r1341b529],
10	,	,	O	,	_	0	SENT_259	[p16l1241t476r1341b529],
11	Zwinderman	NNP	O	Zwinderman	nn	12	SENT_259	[p16l1374t475r1708b521],
12	AH	NNP	O	AH	appos	3	SENT_259	[p16l1739t476r1846b529],
13	,	,	O	,	_	0	SENT_259	[p16l1739t476r1846b529],
14	Jansen	NNP	PERSON	Jansen	nn	15	SENT_259	[p16l1880t476r2054b521],
15	H	NNP	O	H	appos	3	SENT_259	[p16l2085t476r2145b529],
16	,	,	O	,	_	0	SENT_259	[p16l2085t476r2145b529],
17	Groenemeier	NNP	O	Groenemeier	nn	18	SENT_259	[p16l13t552r354b599],
18	B	NNP	O	B	appos	3	SENT_259	[p16l377t553r433b606],
19	,	,	O	,	_	0	SENT_259	[p16l377t553r433b606],
20	Bruschke	NNP	O	Bruschke	nn	21	SENT_259	[p16l459t552r706b598],
21	AVG	NNP	O	AVG	appos	3	SENT_259	[p16l730t552r884b607],
22	,	,	O	,	_	0	SENT_259	[p16l730t552r884b607],
23	Kluft	NNP	O	Kluft	nn	27	SENT_259	[p16l912t552r1049b598],
24	C.	NNP	O	C.	nn	27	SENT_259	[p16l1073t552r1127b599],
25	—	NNP	O	—	nn	27	SENT_259	[p16l1162t552r1420b599],
26	455G/A	NNP	O	455G/A	nn	27	SENT_259	[p16l1162t552r1420b599],
27	polymorphism	NN	O	polymorphism	appos	3	SENT_259	[p16l1443t552r1826b612],
28	of	IN	O	of	_	0	SENT_259	[p16l1850t552r1906b598],
29	the	DT	O	the	det	31	SENT_259	[p16l1926t552r2005b598],
30	Bﬁbrinogen	NN	O	bﬁbrinogen	nn	31	SENT_259	[p16l2031t552r2145b611, p16l11t629r243b688],
31	gene	NN	O	gene	prep_of	27	SENT_259	[p16l269t643r391b688],
32	is	VBZ	O	be	auxpass	33	SENT_259	[p16l416t629r456b675],
33	associated	VBN	O	associate	_	0	SENT_259	[p16l485t629r752b675],
34	with	IN	O	with	_	0	SENT_259	[p16l777t629r891b675],
35	the	DT	O	the	det	36	SENT_259	[p16l916t629r995b675],
36	progression	NN	O	progression	prep_with	33	SENT_259	[p16l1019t629r1324b689],
37	of	IN	O	of	_	0	SENT_259	[p16l1351t629r1407b675],
38	coronary	JJ	O	coronary	amod	39	SENT_259	[p16l1429t643r1659b688],
39	atherosclerosis	NN	O	atherosclerosis	prep_of	36	SENT_259	[p16l1686t629r2071b675],
40	in	IN	O	in	_	0	SENT_259	[p16l2098t629r2148b674],
41	symptomatic	JJ	O	symptomatic	amod	42	SENT_259	[p16l14t706r348b766],
42	men	NNS	O	man	prep_in	39	SENT_259	[p16l373t721r497b753],
43	.	.	O	.	_	0	SENT_259	[p16l373t721r497b753],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_260	[p16l520t706r842b753],
2	Thromb	NNP	O	Thromb	nn	4	SENT_260	[p16l866t706r1068b753],
3	Vasc	NNP	O	Vasc	nn	4	SENT_260	[p16l1097t708r1218b753],
4	Biol	NNP	O	Biol	_	0	SENT_260	[p16l1240t706r1351b753],
5	1998	CD	DATE	1998	num	4	SENT_260	[p16l1379t706r1847b761],
6	;	:	O	;	_	0	SENT_260	[p16l1379t706r1847b761],
7	18:265	CD	NUMBER	18:265	number	8	SENT_260	[p16l1379t706r1847b761],
8	-271	CD	NUMBER	-271	dep	4	SENT_260	[p16l1379t706r1847b761],
9	.	.	O	.	_	0	SENT_260	[p16l1379t706r1847b761],

1	MARCH	NN	DATE	march	_	0	SENT_261	[p16l51t935r306b995],
2	15	CD	DATE	15	num	1	SENT_261	[p16l363t936r457b1005],
3	,	,	DATE	,	_	0	SENT_261	[p16l363t936r457b1005],
4	1999	CD	DATE	1999	appos	1	SENT_261	[p16l517t935r686b994],

